cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
35975,"N,N',N''-tributyl-1-methylsilanetriamine",240-462-2,16411-33-9,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,42,H302:41;H225:38;H314:41;H318:41;H335:1;H315:1;H319:1;H336:1
35978,"Amines, C13-15-alkyl, ethoxylated",615-220-8,70955-14-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,24,H302:19;H318:18;H315:18;Not classified:5;H314:1;H400:1;H410:1
35981,Calcium sulphite,233-596-8,10257-55-3,Not Classified,REACH registration C&L,37,Not classified:37
35983,"(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid",443-560-5,88784-33-2,Eye Irrit. 2,Harmonised C&L,0,H319:0
35984,2-octyldodecyl 5-oxo-L-prolinate,253-604-3,37673-37-3,Skin Sens. 1B,REACH registration C&L,40,H317:4;Not classified:36
35991,Amber,232-520-0,9000-02-6,Not Classified,Notified C&L,7,Not classified:7
35992,Cyclophosphamide,200-015-4,50-18-0,Acute Tox. 3;Muta. 1B;Carc. 1B;Repr. 1A,Notified C&L,67,H360:64;H350:66;H340:64;H301:42;H302:24;H318:25;H372:25;H311:1;H331:1;H361:1;H411:1;H341:1;H400:1;H335:1;H315:1;H319:1
35998,1-(bromomethyl)-4-methoxybenzene,608-101-7,2746-25-0,Skin Corr. 1B,Notified C&L,47,H314:47
36008,Ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate,619-510-5,141573-95-7,Not Classified,Notified C&L,2,Not classified:1;H319:1;H302:1;H335:1;H315:1
36011,"Hydrocarbons, C16-C20, n-alkanes, isoalkanes, cyclics,",919-029-3,1174522-19-0,Asp. Tox. 1,REACH registration C&L,502,H304:502
36018,"4'-Ethyl-2,3-difluorbiphenyl-4-boronic acid",929-209-3,1123312-95-7,Eye Irrit. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H319:2;H373:2;H400:2;H410:2
36020,"1-amino-N-(3-bromo-9,10-dihydro-9,10-dioxo-2-anthryl)-9,10-dihydro-9,10-dioxoanthracene-2-carboxamide",258-148-9,52740-90-6,Skin Sens. 1,Notified C&L,9,H317:9
36022,Allylmagnesium chloride,220-067-1,2622-05-1,Flam. Liq. 2;Water-react. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,81,H318:2;H225:31;H314:81;H260:77;H250:49;H261:4;H351:1
36024,1-bromohenicosafluorodecane,206-201-1,307-43-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
36025,"fenoxaprop-P-ethyl (ISO);ethyl (2R)-2-{4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy}propanoate",615-273-7,71283-80-2,Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H373:0;H400:0;H410:0
36026,[N-[2-[bis(carboxymethyl)amino]ethyl]-N-(2-hydroxyethyl)glycinato(3-)]iron,241-142-5,17084-02-5,Met. Corr. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,183,H315:172;H319:172;H290:172;Not classified:11
36027,"Narcissus jonquilla, ext.",290-086-8,90064-25-8,Not Classified,Notified C&L,73,Not classified:73
36031,"Oils, avocado, unsaponifiable fraction",294-825-5,91770-40-0,Not Classified,Notified C&L,1,Not classified:1
36032,o-(phenoxymethyl)benzoic acid,211-967-5,724-98-1,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,44,H319:44;H302:38;H400:38;H335:5;H315:6
36033,"Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-,mono-C12-20-alkyl ethers, phosphates, sodium salts (GRS)",614-847-4,68954-88-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,43,H319:43;H315:43
36035,α-chloro-4-nitrotoluene,202-822-7,100-14-1,Acute Tox. 4;Skin Corr. 1B,Notified C&L,46,H302:46;H314:46;H332:4;H341:4;H318:2
36038,"(-)-3,4-Dihydroxynorephedrine",617-417-4,829-74-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H302:38;H335:38;H315:38;H319:38;H312:38;H332:38
36039,(3-chloropropyl)diethoxymethylsilane,236-828-6,13501-76-3,Skin Irrit. 2,REACH registration C&L,28,H315:28;H319:1
36043,"3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione",411-920-0,106917-30-0,Acute Tox. 4;Skin Corr. 1A;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H400:0;H373:0;H314:0;H331:0;H410:0
36046,"N-[(1,1,3,3-tetramethylbutyl)phenyl]naphthalen-1-amine",257-406-8,51772-35-1,Aquatic Chronic 4,REACH registration C&L,112,H413:102;H412:10;H317:5
36048,Tristrontium nitride,234-795-2,12033-82-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;Not classified:1
36052,"3,4,5-Trifluoroaniline",605-341-4,163733-96-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H335:43;H315:48;H302:9;H373:4;H312:9;H332:8
36053,Tetramethyl orthocarbonate,217-438-5,1850-14-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H225:41;H335:41;H315:42;H226:1
36054,"azinphos-ethyl (ISO);O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate",220-147-6,2642-71-9,Acute Tox. 2;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H311:0;H300:0;H400:0;H410:0
36058,Dichloromaleic anhydride,214-343-0,1122-17-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
36069,"(6R-trans)-7-amino-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",261-491-7,58909-56-1,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,4,H317:4;H334:4;H319:1;H315:1
36070,"4,6-dimethylpyrimidine-2-thione",244-911-3,22325-27-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:44;H335:43;H315:44;H317:2;H302:2
36073,"4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol",410-600-8,124719-26-2,Skin Irrit. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H400:0;H315:0;H410:0
36074,5-hydroxy-4-oxo-4H-pyran-2-carboxylic acid,207-891-7,499-78-5,Acute Tox. 4,Notified C&L,38,H302:38
36080,"3,4-dihydro-2,2-dimethyl-2H-pyrrole 1-oxide",222-011-1,3317-61-1,Not Classified,Notified C&L,2,Not classified:2
36081,"4-ethoxybenzene-1,3-diammonium dichloride",267-125-2,67801-06-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
36082,"Alkanes, C14-16",292-448-0,90622-46-1,Not Classified,Notified C&L,45,Not classified:23;H304:22
36089,"α,α-dimethylbenzyl hydroperoxide;cumene hydroperoxide",201-254-7,80-15-9,Org. Perox. E;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H373:0;H314:0;H411:0;H331:0;H312:0;H242:0
36090,2-deoxy-D-glucose,205-823-0,154-17-6,Not Classified,Notified C&L,2,Not classified:2
36092,"(2,4-Difluorophenyl)-4-piperidylmethanone Oxime Hydrochloride",603-927-4,135634-18-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,53,H319:53;H315:53
36093,phenylhydrazine hydrochloride,248-259-0,27140-08-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 3;Muta. 2;Carc. 1B;STOT RE 1;Aquatic Acute 1,Harmonised C&L,0,H350:0;H400:0;H315:0;H311:0;H317:0;H319:0;H331:0;H301:0;H372:0;H341:0
36094,N-(4-chlorophenyl)-2-[(4-methyl-2-nitrophenyl)azo]-3-oxobutyramide,260-618-3,57206-89-0,Not Classified,Notified C&L,1,Not classified:1
36098,"1,2,3,4-tetrabromobutane",216-221-2,1529-68-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,38,H318:38;H411:38;H335:38;H315:38
36099,"Benzyl (S)-2,5-dioxooxazolidine-4-acetate",237-026-9,13590-42-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H315:1
36101,"5-(phenylmethyl)imidazolidine-2,4-dione",222-563-3,3530-82-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
36102,"Tannins, compds. with (R)-3-hydroxy-α-[(methylamino)methyl]benzenemethanol",215-810-1,1416-03-1,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1,Notified C&L,2,H302:2;H335:2;H317:2;H334:2;H319:2;H312:2;H332:2
36103,"Ethyl 3-oxo-3-(2,3,4,5-tetrafluorophenyl)propanoate",700-167-6,94695-50-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
36104,4-amino-1-hydroxy-2-phenoxyanthraquinone,301-223-9,93982-34-4,Not Classified,Notified C&L,1,Not classified:1
36108,8-bromo-1-naphthoic acid,217-045-9,1729-99-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40,H319:40;H302:40;H335:2;H315:2
36111,Iron(3+) acetate,217-396-8,1834-30-6,,Notified C&L,1,Not classified:1
36113,"2,4'-dinitro-1,1'-biphenyl",210-124-9,606-81-5,Eye Dam. 1,Notified C&L,38,H318:38
36114,Quinine,205-003-2,130-95-0,Acute Tox. 4;Skin Sens. 1A,REACH registration C&L,326,H317:325;H302:173;H334:165;H319:55;H315:55;H335:15;H332:1
36115,4-(4-trans-Butylcyclohexyl)-benzoic acid-(4-cyano-3-fluorphenylester),618-820-8,92118-83-7,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
36120,Tetrasodium 4-[[1-hydroxy-6-[[[[5-hydroxy-6-[(2-methyl-4-sulphonatophenyl)azo]-7-sulphonato-2-naphthyl]amino]carbonyl]amino]-3-sulphonato-2-naphthyl]azo]benzoate,265-365-2,65072-27-7,Not Classified,Notified C&L,84,Not classified:84
36125,Tridec-1-yne,247-511-7,26186-02-7,Flam. Liq. 3,Notified C&L,1,H226:1
36127,Methyl elaidate,217-712-4,1937-62-8,Not Classified,Notified C&L,1,Not classified:1
36128,"4,4'-azobis[4-cyanovaleric] acid",220-135-0,2638-94-0,Self-react. D,REACH registration C&L,374,H242:132;H228:210;H412:32;Not classified:1;H319:1;H302:2;H315:1
36129,3-[N-(2-hydroxyethyl)-m-toluidino]propiononitrile,204-360-1,119-95-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
36131,1-benzoylpiperidine,212-280-3,776-75-0,Eye Dam. 1,Notified C&L,38,H318:38
36134,1-[(2-methyl-1H-imidazol-1-yl)methyl]-2-naphthol,428-170-5,185554-99-8,Aquatic Acute 1,Notified C&L,2,Not classified:1;H410:1;H400:1;H411:1
36136,"Copper, C5-23-branched carboxylate naphthenate complexes",295-912-0,92200-86-7,Not Classified,Notified C&L,1,Not classified:1
36138,"Fatty acids, C8-10, zinc salts",293-048-9,91051-00-2,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,14,H400:12;H411:12;Not classified:2
36140,4-chlorobenzenesulphonic acid,202-690-0,98-66-8,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,60,H318:8;H314:60;H302:54;H312:1;H332:1
36141,1-(dimethylamino)-2-methylpropan-2-ol,604-227-1,14123-48-9,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H315:1;H226:1
36143,"Ethyl 5,5-dimethyl-2,4-dioxohexanoate",236-478-4,13395-36-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1;H312:1;H332:1
36153,cyclopentyl(trimethoxy)silane,604-361-0,143487-47-2,Flam. Liq. 3;Skin Irrit. 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,6,H401:1;H315:6;H411:1;H226:6;H319:5;H335:4
36155,"3-(S)-1-Carbamoyl-1,1-diphenylmethyl)pyrrolidine L-tartrate",603-789-5,134002-26-9,Not Classified,Notified C&L,1,Not classified:1
36157,"4,4'-[methylenebis(methylimino)]bis[1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one]",212-369-7,810-16-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
36159,3-isopropylphenyl methylcarbamate,200-572-3,64-00-6,Acute Tox. 3;Acute Tox. 1,Notified C&L,3,H310:3;H301:3
36172,"1,1',1''-[methylidynetris(oxy)]trispropane",210-704-1,621-76-1,Not Classified,REACH registration C&L,41,Not classified:2;H319:39;H335:38;H315:39
36174,"[4-[4-(diethylamino)-α-[4-(ethylamino)-1-naphthyl]benzylidene]cyclohexa-2,5-dien-1-ylidene]diethylammonium chloride",219-232-0,2390-60-5,Acute Tox. 3;Eye Dam. 1;Aquatic Chronic 1,REACH registration C&L,701,H318:169;H301:655;H410:169;H319:489;H400:612;H315:116;Not classified:44;H302:6;H411:6;H312:4;H314:2
36177,Tetrabutylammonium (cyano-C)trihydroborate,256-073-6,43064-96-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
36178,"1-bromo-3,5-dichlorobenzene",243-270-7,19752-55-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45;H302:1;H312:1;H332:1
36185,DL-phenylalanine,205-756-7,150-30-1,Not Classified,Notified C&L,111,Not classified:110;H319:1;H335:1;H315:1
36189,"Fatty acids, C16-18, zinc salts",293-049-4,91051-01-3,Not Classified,REACH registration C&L,398,Not classified:382;H412:16
36190,2-(2-ethoxyethoxy)ethyl methacrylate,256-196-5,45127-97-7,,Notified C&L,2,H319:2;H335:2;H315:2
36196,Bis(2-chloroethyl) 2-chloroethylphosphonate,228-557-7,6294-34-4,Acute Tox. 4;Repr. 2;STOT RE 2;Aquatic Chronic 3,Notified C&L,44,H361:33;H373:33;H302:44;H412:33;H332:1;H312:1
36197,Bis(4-chlorobenzyl) oxalate,419-860-7,,STOT RE 2,Notified C&L,1,H373:1
36198,"Soybean oil, sulfated, sodium salt",263-111-5,61790-16-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,31,H319:29;H315:29;Not classified:2
36199,Butylmalonic acid,208-602-7,534-59-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
36200,N-(1-cyanoethyl)formamide,248-440-4,27394-99-6,Acute Tox. 4;Eye Irrit. 2;Repr. 1B,REACH registration C&L,84,H319:84;H302:84;H360:84
36204,Copper(II) 4-oxopent-2-en-2-olate,236-477-9,13395-16-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,189,H319:168;H335:166;H315:168;H400:22;H410:22;Not classified:7;H361:2;H302:3;H312:3;H332:3
36209,"Fatty acids, tallow, hydrogenated, potassium salts",268-892-6,68153-66-2,Not Classified,Notified C&L,11,Not classified:11
36210,3-iodopentane,217-313-5,1809-05-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H226:1
36211,"Laminaria saccharina, ext.",289-982-1,90046-14-3,Not Classified,Notified C&L,88,Not classified:88
36212,N-(2-cyanoethyl)glycine,221-418-1,3088-42-4,,Notified C&L,6,H302:5;H332:5;H312:6;H315:1;H319:1
36213,"1-(Bromomethyl)-2-bromo-4,5-dimethoxybenzene",610-978-6,53207-00-4,Skin Corr. 1;Skin Sens. 1,REACH registration C&L,5,H317:4;H314:4;H302:1;H335:1;H315:1;H319:1;H312:1;H332:1
36214,Bis(nonylphenyl)amine,253-249-4,36878-20-3,Not Classified,REACH registration C&L,648,Not classified:38;H412:34;H413:576;H315:1
36217,Hexyl butyrate,220-136-6,2639-63-6,Not Classified,REACH registration C&L,1661,Not classified:1660;H411:1
36221,"Benzene, 1,4-bis(1,1-dimethylethyl)-2,5-dimethoxy-",615-933-4,7323-63-9,Not Classified,Notified C&L,1,Not classified:1
36225,"Carbonic acid, manganese(2+) salt (1:1), hydrate",608-950-3,34156-69-9,,Notified C&L,38,Not classified:38
36229,Tetramethyl orthosilicate,211-656-4,681-84-5,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 1,REACH registration C&L,265,H330:204;H318:184;H315:159;H226:190;Not classified:60;H335:86;H372:60;H302:26;H370:23;H314:22;H225:18;H371:1;H360:1;H319:1
36231,[2H12]cyclohexanol,266-389-6,66522-78-9,Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H335:38;H302:38;H332:38;H315:38
36242,"1,3-Difluor-5-(4-(trans-4-pentylcyclohexyl)-1-cyclohexen-1-y l)benzen",604-628-1,148151-02-4,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
36245,"2-Furanmethanol, homopolymer",607-645-2,25212-86-6,Not Classified,Notified C&L,21,Not classified:21
36247,"(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate",604-067-2,138199-71-0,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1;Repr. 2;Lact.,Notified C&L,60,H361:44;H302:59;H317:56;H334:56;H362:43;H373:1;H336:1;H371:1;H341:1;H410:3;H400:2
36251,α-4-dimethyl-α-(1-methylcyclopropyl)benzyl alcohol,277-577-2,73728-61-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
36255,"2,2'-methylenedianiline",229-512-4,6582-52-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H302:2;H335:2;H315:2
36256,"Praseodymium(III,IV) oxide",234-857-9,12037-29-5,Not Classified,REACH registration C&L,324,Not classified:214;H319:104;H315:100;H335:52;H413:6
36257,Potassium dimethyldithiocarbamate,204-875-1,128-03-0,Skin Irrit. 2;Aquatic Acute 1,REACH registration C&L,43,H400:43;H315:5
36260,Furoyl chloride,215-082-5,1300-32-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,REACH registration C&L,1,H302:1;H314:1;H312:1;H332:1
36262,"3,3-bis(4-hydroxy-m-tolyl)phthalide",209-881-8,596-27-0,Not Classified,Notified C&L,18,Not classified:17;H302:1;H335:1;H315:1;H319:1;H312:1;H332:1;H351:1
36263,4-chloro-2-nitrobenzaldehyde,226-915-7,5551-11-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
36264,N-carboxymethyliminobis(ethylenenitrilo)tetra(acetic acid),200-652-8,67-43-6,Eye Irrit. 2;Acute Tox. 4;STOT RE 2,Harmonised C&L,0,H319:0;H373:0;H332:0
36266,Manganese neodecanoate,248-374-6,27253-32-3,STOT RE 2,REACH registration C&L,83,H373:10;H315:42;H302:20;H332:19;Not classified:9;H413:2;H319:1
36267,3-methylnonane,227-631-6,5911-04-6,Flam. Liq. 3,Notified C&L,43,H226:43
36268,MOLYBDATE DE TETRAKIS(TRIDODECYLAMMONIUM),419-690-3,88020-55-7,,Notified C&L,1,Not classified:1
36272,Bis(chloromethyl)dimethylsilane,220-848-7,2917-46-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H226:39;H318:1;H314:1
36273,"3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole",613-778-7,65347-55-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H302:3;H335:3;H315:3;H319:3;H312:3;H332:3
36274,Dimenhydrinate,208-350-8,523-87-5,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1;STOT SE 3,Notified C&L,103,H302:102;H335:52;H315:53;H311:52;H319:53;H330:52;H360:1;H301:1;H312:1
36275,(E)-dodec-8-enyl acetate,253-904-4,38363-29-0,Skin Irrit. 2,Notified C&L,7,H315:7
36278,"2-[[2-chloro-5-(trifluoromethyl)phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutyramide",270-005-2,68399-99-5,Not Classified,Notified C&L,1,Not classified:1
36281,salts of 2-naphthylamine,210-313-6,612-52-2,Acute Tox. 4;Carc. 1A;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H350:0;H411:0
36282,Diphenylzinc,214-082-2,1078-58-6,Pyr. Sol. 1,Notified C&L,43,H250:38;H228:5;H318:1;H315:1
36285,"Acetic acid, copper(2+) salt, monohydrate",611-978-9,6046-93-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,257,H302:257;H335:180;H315:180;H400:253;H319:180;H314:67;H410:97;H318:33;H411:1
36288,"3,9-dimethyl-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 3,9-dioxide",221-088-9,3001-98-7,Not Classified,REACH registration C&L,1,Not classified:1
36289,"1H-imidazole-4,5-dicarbonitrile",214-344-6,1122-28-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,55,H318:41;H335:46;H315:47;H302:13;H319:6;Not classified:2;H317:1;H311:1;H331:1;H301:1;H412:1
36290,"9,10-anthracenedione, 1,4-diamino-, N,N'-mixed 2-hydroxyethyl and methyl derivatives",219-604-2,2475-46-9,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1,Notified C&L,51,H317:47;H302:40;H400:40;H319:6;H315:4;H412:3;Not classified:2;H411:1
36291,C.I. Acid Violet 66,602-082-9,12220-53-0,Not Classified,Notified C&L,1,Not classified:1
36294,"1-(2,6-dimethylphenoxy)acetone",258-292-2,53012-41-2,,Notified C&L,2,H302:1;H412:1
36295,Ethyl (S)-2-oxiranylacetate,601-154-7,112083-63-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H302:38;H335:43;H315:43;H319:43;H312:38;H332:38;H227:1
36297,2-ethylhexanal,204-596-5,123-05-7,Flam. Liq. 3;Skin Sens. 1B;Repr. 2,REACH registration C&L,1794,H317:1483;H361:1483;H226:1794;H319:311;H315:310;H335:109;H411:4
36299,"2,2-bis(p-chlorophenyl)ethanol",220-148-1,2642-82-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H302:38;H335:38;H315:38;H319:38;H312:38;H332:38
36301,Di-o-tolyl ether,225-233-7,4731-34-4,,Notified C&L,33,Not classified:33
36302,4-chloro-4'-methoxybenzophenone,234-131-1,10547-60-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
36304,3-(2-Bromo-acetyl)-5-chloro-thiophene-2-sulfonic acid (3-methoxy-propyl)-amide,926-644-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H302:2;H332:2;H312:2
36309,N-trans-cinnamoylimidazole,214-510-8,1138-15-4,,Notified C&L,4,H319:4;H335:4;H315:4
36312,"(R*,S*)-1,2,3,4-tetrachlorobutane",249-059-6,28507-96-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H332:38;H312:38
36314,Benzotriazole,202-394-1,95-14-7,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1752,H319:1444;H302:1696;H411:225;H315:5;H332:736;H412:741;H312:118;H318:93;H228:87;H336:55;H330:77;H341:55;Not classified:35;H301:20;H335:8;H413:1;H331:1
36320,Potassium nicotinate,240-586-7,16518-17-5,Not Classified,Notified C&L,1,Not classified:1
36321,2-[(p-methyl-α-phenylbenzyl)oxy]ethyl(dimethyl)ammonium chloride,223-691-2,4024-34-4,,Notified C&L,1,H302:1
36336,5-nitro-o-toluidine,202-765-8,99-55-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 2;Aquatic Chronic 3,Harmonised C&L,0,H311:0;H331:0;H412:0;H301:0;H351:0
36340,3-methylquinoxalin-2-ol,237-807-4,14003-34-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
36342,Cyclohexanecarbaldehyde,218-057-7,2043-61-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,70,H319:62;H335:61;H315:62;H226:70;H302:2
36344,3-amino-4-chlorobenzenesulphonyl fluoride,206-710-9,368-72-9,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H314:38
36346,Dichromium iron tetraoxide,215-159-3,1308-31-2,,Notified C&L,62,Not classified:61;H317:1;H302:1;H332:1
36347,Maltodextrin,232-940-4,9050-36-6,Not Classified,Notified C&L,1705,Not classified:1705
36350,"Cuprate(6-), [2-[[[[3-[[4-chloro-6-[[4-[[4-chloro-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2,5-disulfophenyl]amino]-1,3,5-triazin-2-yl]amino]-2-hydroxy-5-sulfophenyl]azo]phenylmethyl]azo]-5-sulfobenzoato(8-)]-, hexahydrogen, (SP-4-3)-",300-133-7,93921-06-3,Not Classified,Notified C&L,8,Not classified:8
36353,Dichromium nickel tetraoxide,234-636-7,12018-18-7,Skin Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H317:43;H350:43;H400:38;H410:38
36356,"1,3-diacetoxy-1,1,3,3-tetrabutyldistannoxane",227-755-0,5967-09-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,38,H302:38;H314:38;H312:38;H332:38
36357,Rhenium trichloride,236-987-1,13569-63-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43
36359,α-(aminomethyl)benzyl alcohol,231-469-1,7568-93-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
36360,"(,Z,Z)-4-(heptadec-8-enylidene)-3-(hexadec-7-enyl)oxetan-2-one",259-939-1,56000-16-9,Aquatic Chronic 4,Notified C&L,20,H413:20
36371,"1-Butene, polymer with ethene and 1-propene",607-824-5,25895-47-0,Not Classified,Notified C&L,37,Not classified:36;H228:1
36373,"1,5,7-Octatrien-3-ol, 3,7-dimethyl-, (3R,5E)-",606-431-6,20053-88-7,Not Classified,Notified C&L,113,Not classified:113
36374,(ethoxymethoxy)cyclododecane,261-332-1,58567-11-6,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1641,H317:1405;H411:1405;H315:1640;H319:196;H412:235;Not classified:1
36376,"4,4'-Methylenediphenyl diisocyanate, oligomeric reaction products with 2,4'-diisocyanatodiphenylmethane and oxydipropanol",500-270-4,88288-99-7,Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,85,H335:85;H317:85;H334:85;H318:83;H373:85;H314:83;H332:85;H351:85;H315:2;H319:2
36377,Tetraethylgermanium,209-905-7,597-63-7,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H302:43;H335:42;H315:43;H226:43;H319:43
36381,"Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich;Refinery gas",270-763-4,68477-82-7,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H350:0;H220:0;H340:0
36382,"1,4-dichlorobut-2-ene",212-121-8,764-41-0,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H350:0;H400:0;H311:0;H314:0;H301:0;H410:0;H330:0
36391,"1,1'-sulphinylbis[3-methylbutane]",231-775-5,7726-23-0,Skin Sens. 1,Notified C&L,38,H317:38
36393,Polygalacturonase,232-885-6,9032-75-1,Resp. Sens. 1,Notified C&L,1367,H334:1367
36395,"[1aR-(1aα,4β,4aβ,7α,7aβ,7bα)]-decahydro-1,1,4,7-tetramethyl-1H-cycloprop[e]azulen-4-ol",209-003-3,552-02-3,Not Classified,Notified C&L,9,Not classified:8;H319:1;H315:1
36397,"1,3,6-Naphthalenetrisulfonic acid, 7,7'-[1,3-propanediylbis[imino(6-fluoro-1,3,5-triazine-4,2-diyl)imino[2-[(aminocarbonyl)amino]-4,1-phenylene]-2,1-diazenediyl]]bis-, sodium salt (1:?)",604-373-6,143683-24-3,Not Classified,Notified C&L,3,Not classified:3
36398,2-hydroxypyridine 1-oxide,236-100-8,13161-30-3,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,90,H318:3;H315:67;H319:64;H335:61;Not classified:23;H302:1;H332:1
36399,1-cyclohexyl-5-ethylbarbituric acid,212-653-0,837-32-1,,Notified C&L,1,H302:1;H332:1;H312:1
36400,"2-Imidazolidinone, dihydroxydimethyl-",603-114-4,126022-26-2,Not Classified,Notified C&L,1,Not classified:1
36401,Dioctadecyl phthalate,237-971-7,14117-96-5,Not Classified,Notified C&L,15,Not classified:15
36407,D-malic acid,211-262-2,636-61-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,93,H318:85;H335:86;H315:87;Not classified:4;H319:5
36408,"2-Propenoic acid, telomer with sodium sulfite (1:1), sodium salt",614-534-2,68479-09-4,,Notified C&L,58,Not classified:58
36411,"Disodium [4-hydroxy-5-[(1,2,3,4-tetrahydro-2,4-dioxo-3-quinolyl)azo]benzene-1,3-disulphonato(4-)]cuprate(2-)",276-365-7,72139-09-4,Not Classified,Notified C&L,2039,Not classified:2039
36413,2-(diethylamino)ethyl oleate,256-223-0,45296-12-6,Not Classified,Notified C&L,3,Not classified:2;H318:1;H314:1
36420,Uric acid,200-720-7,69-93-2,Not Classified,REACH registration C&L,31,Not classified:30;H319:1;H335:1;H315:1
36422,"N,N-dimethyl-4-(o-tolylazo)aniline",223-088-4,3731-39-3,Acute Tox. 4,Notified C&L,1,H302:1
36424,"N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide",403-790-9,108673-51-4,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
36425,O-benzyl-N-[(tert-butoxy)carbonyl]-L-tyrosine,218-349-4,2130-96-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1;H312:1;H332:1
36427,"2,4,4-trimethylpent-2-ene",203-488-5,107-40-4,Flam. Liq. 2;Aquatic Chronic 2,Notified C&L,188,H225:188;H411:87;H335:43;H315:43;H304:39;H319:43
36428,"Benzoic acid, 3-fluoro-5-methyl-",921-093-2,518070-19-4,,Notified C&L,4,H319:4;H335:4;H315:4
36431,"Fatty acids, C14-18 and C16-18-unsatd., iso-Pr esters",285-540-7,85116-87-6,Not Classified,Notified C&L,1,Not classified:1
36435,Vinyl isononanoate,247-883-0,26655-50-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
36439,"1,6-Hexanediamine, N,N'-bis(2,2,6,6-tetramethyl-4-piperidinyl)-, polymer with 2,4,6-trichloro-1,3,5-triazine, reaction products with, N-butyl-1-butanamine and N-butyl-2,2,6,6-tetramethyl-4-piperidinamine",606-265-4,192268-64-7,Not Classified,Notified C&L,1,Not classified:1
36440,Pin-2(10)-ene,204-872-5,127-91-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1,Notified C&L,2268,H317:2212;H304:2262;H315:1805;H226:2207;H400:591;H410:630;H413:55;H335:39;H319:43;H411:11;Not classified:3;H302:4;H312:4;H332:4
36441,"1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane",241-536-7,17557-23-2,Skin Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H317:0;H315:0
36445,dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate,400-460-6,,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H412:0
36446,"Amides, coco, N-(2-hydroxypropyl)",269-793-0,68333-82-4,Eye Dam. 1,Notified C&L,53,H318:51;H412:13;H315:6;H319:2
36448,"N-[4-[4-[4-[[5-(2,4-difluorophenyl)tetrahydro-5-(1H,-1,2,4-triazol-1-yl-methyl)-furan-3-yl]methyloxy]phenyl]-1-piperazinyl]phenyl]-1-[1-ethyl-2-(phenylethoxy)propyl]hydrazinecarbonamide",917-777-5,,Aquatic Chronic 4,Notified C&L,1,H413:1
36451,4-(4-trans-Propylcyclohexyl)-benzoic acid-(4-cyano-3-fluorphenyl)ester,618-819-2,92118-82-6,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
36452,2-amino-5-nitrobenzonitrile,241-446-8,17420-30-3,Not Classified,Notified C&L,14,Not classified:9;H319:5;H335:4;H315:5;H361:1
36455,"Sodium 1-amino-9,10-dihydro-4-[5-[(2-hydroxyethyl)sulphamoyl]-3,4-xylidino]-9,10-dioxoanthracene-2-sulphonate",247-269-2,25797-81-3,Skin Sens. 1B,REACH registration C&L,30,H317:16;Not classified:13;H334:4;H412:2;H319:1
36459,proquinazid (ISO);6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one,606-168-7,189278-12-4,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H351:0
36460,DCNS 170 (Hydrolysed),481-930-8,,Met. Corr. 1;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H317:1;H318:1;H314:1;H290:1
36463,Methyl hydrogenphosphonate,237-027-4,13590-71-1,,Notified C&L,33,Not classified:33
36470,"11β,21-dihydroxypregn-4-ene-3,20-dione 21-acetate",214-635-8,1173-26-8,Skin Sens. 1,Notified C&L,38,H317:38
36472,"2,5-dimethylbenzoselenazole",220-579-5,2818-89-5,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H373:38;H331:38;H301:38;H410:38
36475,"Chromate(5-), bis[5-amino-4-hydroxy-3-[(2-hydroxy-5-nitrophenyl)azo]-2,7-naphthalenedisulfonato(4-)]-, potassium sodium",928-483-1,,Not Classified,REACH registration C&L,2,Not classified:2
36479,"Pine, Pinus ponderosa, ext.",307-206-2,97553-47-4,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Muta. 2;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H304:1;H400:1;H315:1;H317:1;H351:1;H226:1;H410:1;H341:1
36480,"Magnesium zinc fluoride, manganese-doped",310-031-4,102110-32-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H315:1
36483,"Platinum, 1,3-diethenyl-1,1,3,3-tetramethyldisiloxane complexes",270-844-4,68478-92-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Repr. 1B,Notified C&L,171,H361:83;H335:98;H315:102;H318:55;H360:55;H312:58;H332:58;H319:47;Not classified:37;H413:34;H225:21;H226:15;H302:3
36485,"2,5-dimethoxyphenylacetic acid",217-151-5,1758-25-4,Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:5
36486,4-Amino-2-chlorophenol,609-733-6,3964-52-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H302:44;H335:44;H315:45;H319:45;H312:40;H332:40
36487,2-bromophenylacetic acid,242-509-2,18698-97-0,,Notified C&L,10,H319:9;H335:8;H315:9;H314:1
36490,"3-methoxy-2,2-dimethyloxirane",247-514-3,26196-04-3,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H225:39;H335:38;H315:39
36492,"1,4:3,6-dianhydro-D-mannitol",211-374-1,641-74-7,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
36496,4-methylpentan-2-one oxime,203-298-2,105-44-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,43,H319:37;H302:36;H315:37;Not classified:6
36497,"2,3-Epoxy-1H-cyclopenta[a]phenanthrene,androstan-17-ol",601-593-4,119302-19-1,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Muta. 2;STOT RE 1,Notified C&L,19,H317:16;H318:16;H301:16;H372:16;H341:16;H361:2;H302:3;H335:2;H315:2;H373:2;H319:2;H312:3;H332:3
36502,Neoheptanoyl chloride,284-158-8,84788-19-2,Skin Corr. 1A;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
36506,2-ethoxyethanol;ethylene glycol monoethyl ether,203-804-1,110-80-5,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Repr. 1B,Harmonised C&L,0,H331:0;H302:0;H360:0;H226:0
36509,Oct-2-en-4-one,225-071-7,4643-27-0,Flam. Liq. 3;Skin Irrit. 2,Notified C&L,1475,H315:1290;H226:1294;H319:94;Not classified:89;H335:2;H302:1
36512,3-morpholinopropylamine,204-590-2,123-00-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,665,H302:576;H318:572;H314:665;H312:70;Not classified:2
36517,2-amino-5-bromobenzonitrile,254-387-8,39263-32-6,Not Classified,REACH registration C&L,45,Not classified:2;H317:38;H302:40;H332:40;H312:40;H311:2;H331:2;H301:3;H335:3;H315:4;H319:4
36518,"2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran",604-317-0,142874-81-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H302:1;H332:1;H312:1;Not classified:1
36520,Butyl 2-methylcrotonate,232-084-1,7785-64-0,Not Classified,Notified C&L,88,Not classified:88
36521,"3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane",426-750-2,151860-15-0,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H412:0
36523,Trisilicon tetranitride,234-796-8,12033-89-5,Not Classified,REACH registration C&L,220,Not classified:213;H335:7;H319:1;H315:1
36530,Potassium hypochlorite,231-909-2,7778-66-7,Not Classified,Notified C&L,1,Not classified:1
36538,"4,4-dimethyl-2-hydroxy-2-phenylmorpholinium bromide",224-317-0,4303-88-2,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,38,H335:38;H315:38;H311:38;H319:38;H331:38;H301:38
36542,"Oxirane, reaction products with ammonia, diethanolamine fraction, ethoxylated",289-180-1,86089-11-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
36543,"3,7-dimethyl-6-octenyl 2-methylcrotonate",246-426-2,24717-85-9,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,243,H317:13;H400:13;H410:13;Not classified:229;H302:1;H412:1
36545,4'-tert-butyl-4-chlorobutyrophenone,256-077-8,43076-61-5,Aquatic Chronic 2,REACH registration C&L,94,H411:93;H317:91;H302:91;H318:91;H319:1;H315:1
36546,N-2-hydroxyethyllactamide,226-546-1,5422-34-4,Not Classified,REACH registration C&L,1398,Not classified:1360;H318:37;H302:1;H332:1;H312:1
36551,"O-(2,4-dinitrophenyl)hydroxylamine",241-512-6,17508-17-7,Acute Tox. 4;Skin Sens. 1,Notified C&L,42,H317:41;H302:41;H319:2;H335:2;H315:2;H312:1;H332:1
36555,Copper(II) fumarate,248-444-6,27405-89-6,Acute Tox. 4,Notified C&L,1,H302:1
36556,"Di-sec-butylphenol, mixed isomers",226-854-6,5510-99-6,Not Classified,REACH registration C&L,101,Not classified:63;H314:38
36557,"Nickel, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, chlorosulfonyl derivs., reaction products with 2-[(4-aminophenyl)sulfonyl]ethyl hydrogen sulfate monosodium salt, sodium salts",305-644-9,94891-43-7,Aquatic Chronic 2,REACH registration C&L,3,H411:2;Not classified:1
36561,(benzylamine)trifluoroboron,211-802-7,696-99-1,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,33,H319:2;H302:33;H412:2;H314:31
36566,(octadecanoato-O)oxoaluminium,236-521-7,13419-15-3,Not Classified,Notified C&L,17,Not classified:17
36568,2-(2-ethoxyethoxy)-2-methylpropane,257-196-8,51422-54-9,Flam. Liq. 3;Acute Tox. 4;Repr. 2;STOT RE 2,Notified C&L,187,H361:83;H373:116;H332:116;H226:184;H319:38;H335:38;H315:68;Not classified:3
36573,"1,2,3-propanetriyl tris[12-(acetoxy)octadecanoate]",205-363-0,139-43-5,Aquatic Chronic 4,REACH registration C&L,2,H413:2
36574,"2-ethylhexanoic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",254-020-1,38584-87-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,8,H318:6;H315:6;Not classified:2
36576,ergocalciferol (ISO);Vitamin D2,200-014-9,50-14-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2;STOT RE 1,Harmonised C&L,0,H311:0;H330:0;H301:0;H372:0
36577,Methylenecyclopropane,228-142-0,6142-73-0,Flam. Liq. 2;Press. Gas (Comp.);Acute Tox. 4,Notified C&L,38,H302:38;H225:38;H280:38
36581,Dioctadecyl hydrogen phosphate,221-237-8,3037-89-6,Skin Corr. 1B,Notified C&L,7,H314:6;Not classified:1
36586,"Slimes and Sludges, steel-coating tin",273-741-2,69012-42-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;Repr. 1B;Aquatic Chronic 3,Notified C&L,1,H302:1;H315:1;H318:1;H360:1;H319:1;H312:1;H412:1;H332:1
36587,6-chlorothymol,201-930-1,89-68-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H335:42;H315:46
36593,"5-fluoro-1,3-di­methyl-",619-823-7,494793-67-8,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H351:0
36596,TFA-Lys,423-900-9,,Not Classified,Notified C&L,2,Not classified:2
36599,5-bromo-DL-tryptophan,229-464-4,6548-09-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
36601,N-methyl-4-nitroaniline,202-823-2,100-15-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,48,H311:48;H373:47;H331:48;H412:2;H301:48;H411:4;H335:1;H315:1;H319:1
36602,Potassium p-hydroxybenzenesulphonate,250-071-9,30145-40-5,Not Classified,Notified C&L,1,Not classified:1
36603,"2,3-dihydroxypropyl butyrate",209-165-5,557-25-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
36607,2'-hydroxyacetanilide,210-396-9,614-80-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,48,H319:47;H315:47;H335:4;H302:3
36608,Ruthenium disodium tetraoxide,241-079-3,17001-79-5,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,83,H317:83;H302:83;H318:83;H411:83
36609,Dysprosium trichloride,233-039-9,10025-74-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H335:39;H315:40;Not classified:1
36610,benzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride,428-290-8,120606-08-8,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H318:0;H400:0;H410:0
36612,Hygromycin B,250-545-5,31282-04-9,Acute Tox. 2;Acute Tox. 2;Eye Dam. 1;Acute Tox. 2;Resp. Sens. 1,Notified C&L,144,H334:137;H318:138;H310:139;H300:144;H330:143;H317:6;H319:1;H332:1;H335:1;H315:1
36614,"3-Methoxy-18-methyl-1,3,5(10)-estratrien-17 beta-ol",609-222-8,3625-82-9,Aquatic Chronic 4,Notified C&L,1,H413:1
36618,"L-Valine, N-(methoxycarbonyl)-3-methyl-",605-292-9,162537-11-3,Not Classified,Notified C&L,14,Not classified:14
36619,4-tert-butylphenyl cyclopropyl ketone,254-078-8,38675-79-5,Skin Sens. 1,Notified C&L,127,H317:127
36620,1-phenylethyl butyrate,222-409-5,3460-44-4,Not Classified,Notified C&L,88,Not classified:88
36621,"Benzenesulfonic acid, mono-C10-16-alkyl derivs., compds. with diethanolamine",272-578-4,68891-02-1,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,21,H302:21;H335:20;H318:21;H314:20;H412:20;H315:1
36626,Bis(3-methylbutyl) sebacate,233-736-8,10340-42-8,Not Classified,Notified C&L,6,Not classified:6
36627,Nitarsone,202-695-8,98-72-6,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H331:39;H400:39;H301:39;H410:39
36631,Malachite green,603-805-0,13425-25-7,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H302:38;H318:38
36634,N-cyclohexylacetoacetamide,214-475-9,1132-42-9,Acute Tox. 4,Notified C&L,38,H302:38
36640,1-bromopentadecafluoroheptane,206-799-4,375-88-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
36641,"2-[2-[(4-methoxyphenyl)amino]vinyl]-1,3,3-trimethyl-3H-indolium acetate",261-896-9,59737-02-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H302:2;H400:2;H315:2;H319:2;H410:2
36642,"Hexasodium 2,2'-[[6-morpholino-1,3,5-triazine-2,4-diyl]bis[imino(2-sulphonato-4,1-phenylene)vinylene(3-sulphonato-4,1-phenylene)]]bis[2H-naphtho[1,2-d]triazole-5-sulphonate]",277-447-5,73398-48-8,Not Classified,Notified C&L,1,Not classified:1
36643,2-phenylbutyryl chloride,253-241-0,36854-57-6,Skin Corr. 1B,REACH registration C&L,46,H314:46;H318:1;H290:1
36644,"2,4-Dichloro-3-aminophenol hydrochloride",612-192-9,61693-43-4,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,15,H317:15;H302:15;H318:14;H411:14;H335:1;H315:1;H319:1
36646,Tylosin,215-754-8,1401-69-0,Skin Sens. 1;Resp. Sens. 1;Aquatic Acute 1,Notified C&L,45,H317:44;H334:44;H400:38;H319:4;H410:2;H302:1;H335:2;H315:2
36654,Sucrose laurate,246-873-3,25339-99-5,Not Classified,Notified C&L,31,Not classified:31
36655,"Borago officinalis, ext.",281-661-4,84012-16-8,Not Classified,Notified C&L,20,Not classified:20
36659,Polyanetholesulfonic acid sodium salt,613-263-7,63589-56-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H302:1;H332:1;H312:1
36663,"(3β,5β)-3-[(O-β-D-glucopyranosyl-(1→6)-O-β-D-glucopyranosyl-(1→4)-2,6-dideoxy-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide",251-439-1,33279-57-1,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,40,H330:38;H300:38;H310:38;H331:2;H373:2;H301:2
36664,Potassium 6-(p-toluidino)naphthalene-2-sulphonate,251-196-1,32752-10-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
36668,ammonium polysulphides,232-989-1,9080-17-5,Skin Corr. 1B;Aquatic Acute 1,Harmonised C&L,0,H314:0;H400:0
36671,"Formic acid, 1-methylpropyl ester",611-764-5,589-40-2,Flam. Liq. 2,Notified C&L,239,H225:234;Not classified:5
36676,Thulium oxide,234-851-6,12036-44-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:46;H335:46;H315:46;Not classified:4
36677,"Disodium 8-[[4'-[(4-ethoxyphenyl)azo][1,1'-biphenyl]-4-yl]azo]-7-hydroxynaphthalene-1,3-disulphonate",222-560-7,3530-19-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1
36680,"pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate",422-930-1,171599-84-1,Aquatic Chronic 3,Harmonised C&L,0,H412:0
36681,"Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",269-629-8,68308-09-8,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H350:0;H220:0;H340:0
36683,oxan-4-amine hydrochloride,608-821-1,33024-60-1,,Notified C&L,5,H319:3;H335:3;H315:3;H302:2;H332:1;H312:1
36684,"trans-3,4-(methylenedioxy)cinnamic acid",219-151-0,2373-80-0,Aquatic Chronic 2,REACH registration C&L,14,H411:1;H315:13;H319:5;H335:4
36685,Sulisobenzone,223-772-2,4065-45-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,547,H317:310;H319:320;H315:466;H318:173;Not classified:53;H335:94;H412:17;H316:11;H361:6;H314:1
36688,"Disodium 3-[[2-(acetylamino)-4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]phenyl]azo]naphthalene-1,5-disulphonate",225-646-2,4988-30-1,Aquatic Chronic 3,Notified C&L,2,H412:1;Not classified:1
36692,"Extracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",297-827-4,93763-10-1,Carc. 1B,Harmonised C&L,0,H350:0
36697,Diisopropyl sebacate,231-306-4,7491-02-3,Not Classified,REACH registration C&L,94,Not classified:94
36698,Barbituric acid,200-658-0,67-52-7,Not Classified,REACH registration C&L,156,Not classified:69;H319:86;H335:83;H315:85;H314:1
36699,4-(hydroxymethylphosphinyl)-L-2-aminobutanoyl-L-alanyl-L-alanine,609-147-0,35597-43-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H335:38;H315:38
36700,Alloy of FeSi,617-088-7,8049-17-0,Water-react. 2,Notified C&L,50,H261:50;H302:4;H332:4;H312:4
36701,6-chloropyridin-2-ol,240-909-1,16879-02-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45;H302:5
36704,1-benzyl-4-hydrazinopiperidine dihydrochloride,281-403-0,83949-42-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H302:2;H332:2;H312:2
36707,"Benzene, C10-13-alkyl derivs.",267-051-0,67774-74-7,Asp. Tox. 1,REACH registration C&L,2637,H304:492;Not classified:2089;H400:62;H315:6;H332:2;H300:1
36708,2-Amino-4-methyl-thiazole-5-carboxylic acid ethyl ester; hydrochloride,610-980-7,53266-92-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1;H312:1;H332:1
36710,Cyclobenzaprine,206-145-8,303-53-7,Not Classified,Notified C&L,1,Not classified:1
36711,"3,5-dimethylpyrazole",200-657-5,67-51-6,Acute Tox. 4;Repr. 2;STOT RE 2,REACH registration C&L,287,H361:144;H373:144;H302:240;Not classified:41;H319:101;H335:86;H315:100;H332:1;H312:1
36716,"Alcohols, C11-15-secondary, ethoxylated propoxylated",614-584-5,68551-14-4,Aquatic Chronic 3,Notified C&L,119,H412:70;H315:39;H302:39;H318:39;H312:39;H411:6;Not classified:5;H332:1
36718,3-(Benzyloxy)-1-propanol,610-399-9,4799-68-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:41;H335:40;H315:41;H302:1;Not classified:1
36720,Potassium p-tert-butylbenzoate,240-587-2,16518-26-6,Not Classified,Notified C&L,2,Not classified:1;H302:1;H360:1;H411:1;H372:1
36722,Glycerol trimethacrylate,231-004-2,7401-88-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
36724,"3-ethoxy-1,1,5-trimethylcyclohexane",266-722-5,67583-77-1,Flam. Liq. 3;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1595,H317:52;H411:52;H226:1595;H319:1543;H315:1543;H410:24
36725,"1,2-Cyclohexanedicarboxylic acid, 4-methyl-",611-560-6,57567-84-7,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1,Notified C&L,38,H317:38;H302:38;H318:38;H334:38
36726,"Adipic acid, oligomeric reaction product with diethylenetriamine",919-438-7,,Not Classified,Notified C&L,3,Not classified:3
36727,Cinnamamide,210-707-8,621-79-4,Acute Tox. 4,Notified C&L,42,H302:42
36728,"Waxes and Waxy substances, shellac",307-913-6,97766-50-2,Not Classified,Notified C&L,4,Not classified:4
36730,"2,4-dibromobenzaldehyde",611-376-6,5629-98-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1;H312:1;H332:1
36731,"N,N'-methylenedistearamide",203-657-3,109-23-9,Aquatic Chronic 4,REACH registration C&L,34,H413:34
36736,"3,4,5-trimethoxyphenethylamine",200-190-7,54-04-6,Acute Tox. 4,Notified C&L,1,H302:1
36737,Dianhydro-D-mannitol monooleate,246-872-8,25339-93-9,Not Classified,Notified C&L,18,Not classified:18
36742,"3,5,5-trimethylhexyl acetate",261-245-9,58430-94-7,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1657,H411:1423;H315:1423;Not classified:193;H226:41;H410:1;H400:1
36743,"Fatty acids, tallow, hydrogenated, reaction products with 2-[(2-aminoethyl)amino]ethanol",268-893-1,68153-67-3,Aquatic Chronic 2,Notified C&L,11,H411:6;Not classified:4;H318:1;H315:1
36745,"2-(3,3-dimethylbicyclo[2.2.1]hept-2-ylidene)ethanol",218-755-1,2226-05-3,Eye Irrit. 2,Notified C&L,88,H319:88
36749,Calcium glycerophosphate,248-328-5,27214-00-2,Not Classified,REACH registration C&L,107,Not classified:104;H318:1;H315:2;H302:1;H319:1
36756,Methyl 1-methylpyrrol-2-acetate,257-478-0,51856-79-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:40;H335:39;H315:40;Not classified:2
36758,"1,2-dichloro-4-nitrobenzene",202-764-2,99-54-7,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1;Acute Tox. 3;Aquatic Chronic 1,REACH registration C&L,45,H317:41;H331:2;H312:1;H301:1;H410:1;H319:40;H302:44;H411:5;H341:4;H315:1
36761,"reaction mass of: (1R*,2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene;(2R*,3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene",425-570-1,185429-83-8,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
36763,Holmium oxide,235-015-3,12055-62-8,Not Classified,Notified C&L,11,Not classified:11
36768,"Ethanone, 1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazol-3-yl]-, 1-(O-acetyloxime)",455-590-6,478556-66-0,Acute Tox. 4;Skin Sens. 1B,Notified C&L,83,H317:83;H302:83
36770,"1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluoro-8-iodooctane",218-056-1,2043-57-4,Not Classified,REACH registration C&L,85,Not classified:40;H319:45;H335:44;H315:45
36773,"1-(1,2,3,4,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan-1-one",268-979-9,68155-67-9,Not Classified,Notified C&L,94,Not classified:36;H317:52;H411:32;H315:52;H410:26
36775,2-oxopyran-5-carboxylic acid,207-899-0,500-05-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
36783,"Glycerol, propoxylated, esters with acrylic acid, reaction products with 2-aminoethanol",500-737-2,162492-04-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2173,H319:2173;H335:2143;H315:2143
36785,"4,4'-dithiodianiline",211-961-2,722-27-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:41;H315:42
36790,Pent-2-enal,212-120-2,764-39-6,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 3;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1551,H302:1321;H225:1551;H311:1321;H317:1321;H411:1286;H319:1321;H315:10
36791,"6-amino-2-(2,4-dimethylphenyl)-1H-benz[de]isoquinoline-1,3(2H)-dione",219-607-9,2478-20-8,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,37,H400:35;H410:35;Not classified:2
36799,5-methoxyuracil,229-580-5,6623-81-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
36800,"Soybean oil, polymd.",614-279-7,68122-64-5,Not Classified,Notified C&L,13,Not classified:13
36804,Pentyl D-glucoside,309-363-2,100231-63-8,Eye Irrit. 2,REACH registration C&L,20,H319:2;H318:18;H315:18
36807,"2-(2,5-dichlorophenyl)acetamide",220-062-4,2621-62-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
36810,4-[[4-(aminocarbonyl)phenyl]azo]-N-(2-ethoxyphenyl)-3-hydroxynaphthalene-2-carboxamide,220-509-3,2786-76-7,Not Classified,REACH registration C&L,786,Not classified:681;H317:101;H319:3;H412:1
36811,"4-[(2-chlorophenyl)[4-(ethylimino)-3-methylcyclohexa-2,5-dien-1-ylidene]methyl]-N-ethyl-o-toluidine monohydrochloride",223-528-5,3943-82-6,Acute Tox. 4,Notified C&L,1,H302:1
36816,N-ethyl-N-(m-tolyl)ethylenediamine,242-914-4,19248-13-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;H335:1;H314:1
36818,"Fatty acids, coco, hydrogenated",273-118-5,68938-15-8,Not Classified,REACH registration C&L,5,Not classified:2;H319:3;H335:2;H315:2
36821,"N,N'-bis(2-hydroxyethyl)dithiooxamide",204-431-7,120-86-5,Acute Tox. 3,Notified C&L,38,H301:38
36822,"Larch, Larix decidua, ext.",289-987-9,90046-19-8,Not Classified,Notified C&L,185,Not classified:184;H335:1;H315:1;H317:1;H411:1;H319:1
36824,Chloropyramine hydrochloride,228-216-2,6170-42-9,Acute Tox. 4,Notified C&L,3,H302:3;H335:1;H315:1;H319:1;H312:1;H332:1
36825,"Lup-20(29)-en-28-oic acid, 3-hydroxy-, (3β)-",207-448-8,472-15-1,Not Classified,Notified C&L,29,Not classified:29
36832,"Dimethyl 2,2'-azobis(2-methylpropionate)",219-976-6,2589-57-3,Self-react. D;Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Muta. 2;STOT RE 2;Aquatic Acute 1,REACH registration C&L,8,H302:8;H400:6;H317:6;H373:6;H319:6;H242:8;H332:7;H341:6;H312:1;H412:1
36833,Sodium [N-[2-[bis(carboxymethyl)amino]ethyl]-N-(2-hydroxyethyl)glycinato(4-)]ferrate(1-),257-036-7,51181-50-1,Not Classified,REACH registration C&L,5,Not classified:5
36836,"Quaternary ammonium compounds, C12-18-alkyltrimethyl, Me sulfates",295-480-3,92061-68-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,59,H302:59;H318:59;H314:59;H400:59
36837,"Propanenitrile, 3-[[4-[2-(4-nitrophenyl)diazenyl]phenyl](phenylmethyl)amino]-",619-236-6,96662-24-7,Not Classified,Notified C&L,4,Not classified:4
36839,"1,1-dibromo-2,2-difluoroethylene",207-068-2,430-85-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1;H312:1;H332:1
36841,Neomenthol,207-723-2,491-01-0,Skin Irrit. 2,Notified C&L,113,H315:113;H319:49
36843,"Fatty acids, C14-18 and C16-18-unsatd., mixed esters with adipic acid and trimethylolpropane",287-397-6,85507-75-1,Not Classified,REACH registration C&L,2,Not classified:2
36850,cadmium diformate;cadmiumformate,224-729-0,4464-23-7,Acute Tox. 3;Acute Tox. 3;Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H373:0;H331:0;H301:0;H410:0;H351:0
36852,Benperidol,218-172-2,2062-84-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,33,H302:33;H332:32;H362:1
36853,4-chloro-1-(2-thienyl)butan-1-one,256-076-2,43076-59-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
36855,"3,7-dimethyloct-6-enyl 5-oxo-DL-prolinate",264-895-1,64431-70-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H332:38;H312:38
36858,Decyl 2-ethylhexanoate,298-078-6,93777-46-9,Not Classified,REACH registration C&L,1,Not classified:1
36860,"2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11-icosafluoroundecan-1-ol",206-209-5,307-70-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
36865,4-aminobenzoic acid,205-753-0,150-13-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,219,H319:161;H302:95;Not classified:53;H317:65;H335:76;H315:77;H412:4;H413:3;H312:1;H332:1
36867,"2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate",431-770-1,216698-07-6,Aquatic Chronic 4,Harmonised C&L,0,H413:0
36869,"4-isopropyl-5,5-dimethyl-1,3-dioxane",222-709-6,3583-00-4,Flam. Liq. 3,Notified C&L,234,H226:234
36870,"(pentane-2,4-dionato-O,O')rubidium",266-210-1,66169-93-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,38,H302:38;H335:38;H315:38;H319:38;H312:38;H332:38;H351:38
36878,Benzo[b]thiophene,202-395-7,95-15-8,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,51,H302:51;H411:45;H335:1;H315:1;H319:1;H332:3;H312:2;Not classified:1
36881,"Tetrakis[[2,2',2''-nitrilotris[ethanolato]](1-)-N,O]zirconium",309-811-7,101033-44-7,Not Classified,REACH registration C&L,127,Not classified:2;H319:124;H335:52;H315:56;H226:4;H412:1
36882,Molybdenum disilicide,235-231-8,12136-78-6,Not Classified,REACH registration C&L,49,Not classified:11;H302:38;H332:38;H312:38
36883,"3-(4'-bromo[1,1'-biphenyl]-4-yl)-3,4-dihydronaphthalen-1(2H)-one",262-162-0,60313-01-1,Aquatic Chronic 1,Notified C&L,1,H410:1
36884,"Sodium N,N-diethylsulphanilate",275-022-9,70916-35-7,Eye Dam. 1,Notified C&L,9,H318:9
36888,3-piperidinopropionitrile,221-417-6,3088-41-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H302:39;H335:39;H315:40;H319:40;H312:39;H332:39;H311:1;H331:1;H301:1
36889,"Phosphoric acid, isodecyl ester",260-263-4,56572-86-2,Skin Corr. 1A;Eye Dam. 1;STOT SE 3;STOT SE 3,Notified C&L,26,H335:20;H318:26;H314:26;H315:20
36890,Propyl isocyanate,203-803-6,110-78-1,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,39,H302:38;H225:39;H335:38;H315:39;H317:39;H334:39;H318:38;H312:38;H332:38;H311:1;H319:1;H331:1;H301:1
36893,"3-(3,4-dihydroxyphenyl)propionic acid",214-083-8,1078-61-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
36894,Visnadine,207-515-1,477-32-7,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H302:38;H400:38;H410:38
36898,"[1,2,3,9,10,16,17,23,24-nonabromo-11,25-dichloro-29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]copper",270-370-8,68425-85-4,Not Classified,Notified C&L,18,Not classified:18
36904,"Reaction mass of [3-(trimethoxysilyl) propyl]urea, [3-(dimethoxyethoxysilyl) propyl]urea, [3-(methoxydiethoxysilyl) propyl]urea and [3-(triethoxysilyl) propyl]urea.",449-160-7,,Not Classified,REACH registration C&L,2,Not classified:2
36912,(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-(2-aminoethyl)oxime maleate,612-212-6,61718-82-9,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Aquatic Chronic 1,Notified C&L,199,H302:199;H335:141;H318:152;H410:140;H332:152;H317:16;H334:16;H312:16;H319:6;H331:6;H400:2;H314:1;H370:1;H361:1
36914,"2-Propen-1-aminium, N,N-Dimethyl-N-2-Propenyl-, chloride polymer with 2-propenamide",607-965-2,26590-05-6,Aquatic Chronic 3,Notified C&L,831,H412:657;Not classified:106;H411:68
36918,Tetrahydrothiopyran-3-ol,244-766-6,22072-19-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,2,H302:2;H335:2;H315:2;H319:2;H312:2;H332:2
36921,"2-1H-indol-3-ylisothiourea, monohydroiodide",247-638-8,26377-76-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H335:38;H315:38
36923,"2,3-dimethylpyrazine",227-630-0,5910-89-4,Flam. Liq. 3;Acute Tox. 4,Notified C&L,1664,H302:1663;H226:1664;H335:50;H315:50;H318:46;H319:5
36925,2-(p-hydroxyphenylazo)benzoic acid,216-655-2,1634-82-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H302:1;H312:1;H332:1
36926,"Leach residues, zinc ore, lead-contg.",293-314-4,91053-49-5,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;Muta. 1B;Carc. 1A;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,68,H350:66;H400:67;H315:68;H318:68;H360:68;H340:66;H410:67;H301:66;H372:66;H330:66;H373:2;H411:1;H302:1;H332:1
36928,"Hedychium spicatum, ext.",297-383-1,93455-95-9,Not Classified,Notified C&L,1,Not classified:1
36929,Methyl hydroxymethoxyacetate,243-271-2,19757-97-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,127,H302:87;H318:87;H314:87;H226:84;H319:40;H227:1;H315:2;H317:1
36932,"2,4,6-triisopropylbenzoyl chloride",260-614-1,57199-00-5,,Notified C&L,5,H314:5
36934,"Lubricating oils (petroleum), C>25, hydrotreated bright stock-based",276-735-8,72623-83-7,Not Classified,Notified C&L,55,Not classified:42;H361:8;H350:8;H372:9;H304:8;H371:1;H319:1;H332:1;H341:1
36935,1-(4-fluoro-1-naphthyl)ethan-1-one,206-261-9,316-68-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43
36936,"5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine",213-878-7,1046-56-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,132,H319:132;H302:127;H335:131;H315:132
36939,Diphosphoryl tetrachloride,236-824-4,13498-14-1,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,52,H318:4;H314:52;H290:1
36940,"Glycerides, coco mono- and di-, ethoxylated",614-376-4,68201-46-7,Not Classified,Notified C&L,94,Not classified:94
36942,"1,2,3,4,5,6,7,8,9,10-decahydro-5,9-methanobenzocycloocten-11-one",245-158-3,22690-27-3,Not Classified,Notified C&L,88,Not classified:88
36946,"Benzenesulfonic acid, 3-[2-[2-hydroxy-3-[[(2-methylphenyl)amino]carbonyl]-1-naphthalenyl]diazenyl]-4-methoxy-, 4-nitrophenyl ester",612-905-3,61968-79-4,,Notified C&L,33,Not classified:33
36948,α-hexylcinnamaldehyde,202-983-3,101-86-0,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,2408,H317:2399;H400:1555;H411:1508;H410:151;H315:32;Not classified:2;H319:5;H335:3;H314:3;H412:1
36949,"4-chloro-1,2-dihydropyridazine-3,6-dione",226-422-7,5397-64-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
36950,Undecanoic acid,203-964-2,112-37-8,Skin Irrit. 2,REACH registration C&L,197,H315:164;H319:138;H335:135;H318:32;H314:32;Not classified:1
36951,"2,5-dihydroxy-3,6-dimethyl-3,6-bis(dihydroxyphosphinyl)-1,4,2,5-dioxadiphosphorane-2,5-dioxide, hexasodium salt",928-304-7,,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,0,No data
36954,2-methoxy-5-nitrophenol,211-269-0,636-93-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H302:44;H335:45;H315:47
36955,"2-Oxiranemethanol, homopolymer, nonylphenyl ether",614-260-3,68072-38-8,Not Classified,Notified C&L,2,Not classified:2
36956,2-iodo-p-xylene,214-347-2,1122-42-5,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,43,H319:43;H411:38;H315:43
36971,Anatase (TiO2),215-280-1,1317-70-0,Not Classified,Notified C&L,258,Not classified:249;H351:7;H302:3;H319:2;H332:2;H315:2;H335:2
36972,2-methylamino-1-phenylpropan-2-ol hydrochloride,246-090-7,24221-86-1,Acute Tox. 4,Notified C&L,41,H302:40;H319:1;H315:1;H226:1
36973,"Salicylic acid, compound with 2-aminoethanol (1:1)",261-963-2,59866-70-5,Not Classified,Notified C&L,3,Not classified:3
36974,"Fatty acids, C14-18 and C16-18-unsatd., isotridecyl esters",285-541-2,85116-88-7,Not Classified,REACH registration C&L,14,Not classified:14
36976,"2,2-dimethylpropane-1,3-diol reaction product with propylene oxide (1-4.5 PO)",610-848-9,52479-58-0,Not Classified,REACH registration C&L,25,Not classified:25
36979,3-nitrophthalic anhydride,211-373-6,641-70-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H335:47;H315:48;H302:1;H332:1
36982,"3,3,3-tris(p-chlorophenyl)propionic acid",218-509-3,2168-06-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
36984,2-o-tolylethanol,243-349-6,19819-98-8,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,1512,H302:2;H318:2;Not classified:1510
36986,Decyl palmitate,255-724-1,42232-27-9,Not Classified,Notified C&L,2,Not classified:2
36987,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-henicosafluorododecyl acrylate",241-732-2,17741-60-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,91,H319:88;H335:88;H315:88;Not classified:3
36988,6-methylsulphonylbenzothiazol-2-ylamine,241-537-2,17557-67-4,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38;H301:38
36990,"Alkanes, C4-12",269-792-5,68333-81-3,Flam. Liq. 3;Asp. Tox. 1;STOT SE 3,Notified C&L,3,H304:3;H336:3;H226:3
36991,"3,4,7a,9,10,10a-hexahydro-9-hydroxy-5-methoxy-1H,12H-furo[3',2':4,5]furo[2,3-h]pyrano[3,4-c][1]benzopyran-1,12-dione",243-807-5,20421-10-7,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;Carc. 2,Notified C&L,38,H330:38;H300:38;H310:38;H351:38
36993,Hept-2-en-4-one,225-070-1,4643-25-8,Not Classified,Notified C&L,89,Not classified:89
36994,methyl formate,203-481-7,107-31-3,Flam. Liq. 1;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Harmonised C&L,0,H302:0;H335:0;H224:0;H319:0;H332:0
36995,"4,4-piperidinediol, hydrochloride",254-779-9,40064-34-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,61,H319:60;H335:59;H315:60;Not classified:1
36998,2-nitrophenyl-beta-D-galactopyranoside,206-716-1,369-07-3,,Notified C&L,4,H335:3;H319:1;H315:1;Not classified:1
37001,3-chloro-2-fluorobenzonitrile,301-934-4,94087-40-8,Acute Tox. 4;Acute Tox. 4,Notified C&L,45,H312:39;H332:43;H302:4;H315:7;H311:6;H319:7;H335:2;H331:2;H301:2
37004,4-[cyclohexylidene(4-hydroxyphenyl)methyl]phenol,225-972-5,5189-40-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1;H312:1;H332:1
37005,"Bentonite, compds. with dimethyldioctadecylammonium chloride",277-286-0,73138-28-0,Not Classified,Notified C&L,3,Not classified:3
37006,Olivine-group minerals,215-281-7,1317-71-1,Eye Irrit. 2,Notified C&L,21,H319:20;Not classified:1
37012,"Sodium [2S-(2α,5α,6β)]-3,3-dimethyl-6-[[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",214-636-3,1173-88-2,Resp. Sens. 1,Notified C&L,5,H334:4;H319:2;H335:3;H315:2;H317:1
37015,"Diphosphoric acid, ammonium salt",245-159-9,22690-73-9,Not Classified,REACH registration C&L,1,Not classified:1
37017,"Phenol, dodecyl-, branched, sulfurized",306-115-5,96152-43-1,Repr. 1B;Aquatic Chronic 4,REACH registration C&L,22,H413:22;H360:1;H361:21
37021,"4-hydroxybenzoic acid, isodecylester",920-194-9,,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,1,H317:1;H319:1;H413:1
37022,"2,2'-methylenebis[6-cyclohexyl-p-cresol]",223-773-8,4066-02-8,Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,29,H319:2;H413:27;H315:1;Not classified:1
37023,"slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate",295-859-3,92129-57-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H302:0;H350:0;H400:0;H315:0;H317:0;H334:0;H360:0;H410:0;H372:0;H332:0;H341:0
37024,Citrus nobilis (Mandarin Orange) peel oil,616-920-6,8008-31-9,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,236,H304:187;H400:182;H315:188;H317:187;H226:225;H410:182;Not classified:10;H411:5;H319:1;H361:1;H302:1
37025,"5-[[p-(benzylmethylamino)phenyl]azo]-1,4-dimethyl-1H-1,2,4-triazolium chloride",249-670-8,29508-47-2,Not Classified,REACH registration C&L,48,Not classified:41;H302:5;H318:7;H412:7
37026,"disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate;C.I. Direct Black 38",217-710-3,1937-37-7,Carc. 1B;Repr. 2,Harmonised C&L,0,H361:0;H350:0
37028,"Poly(oxy-1,2-ethanediyl), α-sulfo-ω-(9-octadecen-1-yloxy)-, ammonium salt (1:1)",615-885-4,73018-88-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,6,H319:6;H315:6
37030,3-bromo-6-methoxy-2-methylbenzoic acid,606-929-3,220901-25-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
37031,"4-amino-N-(1,1-dimethylethyl)-4,5-dihydro-3-(1-methylethyl)-5-oxo-1H-1,2,4-triazole-1-carboxamide",603-373-3,129909-90-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,127,H302:127;H332:127
37032,C26H20Br2N3NaO6S,601-843-2,12216-97-6,Not Classified,Notified C&L,3,Not classified:2;H317:1;H412:1
37035,"Caseins, hydrolyzates",265-363-1,65072-00-6,Not Classified,Notified C&L,1420,Not classified:1420
37036,tepraloxydim (ISO);(RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one,604-715-4,149979-41-9,Carc. 2;Repr. 2,Harmonised C&L,0,H361:0;H351:0
37037,"Poppy, Papaver somniferum, ext.",283-510-8,84650-40-8,Not Classified,Notified C&L,89,Not classified:89
37038,Disodium hexachloroosmate,215-152-5,1307-81-9,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3,Notified C&L,45,H311:39;H318:38;H314:40;H331:39;H301:39;H319:5;H302:5;H335:5;H315:5;H290:1
37039,4-methylimidazol-5-ylmethanolhydrochloride,254-021-7,38585-62-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
37040,Methyl 4-hydroxyphenylacetate,238-050-2,14199-15-6,Not Classified,REACH registration C&L,49,Not classified:2;H319:47;H335:46;H315:47
37043,"α,α,β,β-tetrafluoro-2-methylphenetole",255-682-4,42145-66-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H226:38;H311:1;H330:1;H301:1
37048,Hexadecyldimethylamine N-oxide,230-429-0,7128-91-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,472,H318:466;H315:472;H400:26;H302:6;H319:6;H410:6
37050,Butanedione,207-069-8,431-03-8,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT RE 1,REACH registration C&L,1673,H302:1552;H225:1642;H315:1667;H319:16;H372:4;H332:12;H317:1494;H318:1626;H373:1496;H331:1621;H335:42;Not classified:8;H412:3
37055,Bromopropylmagnesium,213-162-4,927-77-5,Water-react. 1;Skin Corr. 1B,Notified C&L,66,H314:66;H260:66;H225:27;H302:1;H335:1;H371:1;H372:1
37056,Potassium phenylacetate,235-845-6,13005-36-2,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,16,H302:16;H318:16
37057,"tetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7-disulfonate",413-070-6,,Skin Sens. 1,Harmonised C&L,0,H317:0
37068,Prajmalium bitartrate,219-975-0,2589-47-1,Acute Tox. 3;Repr. 2,Notified C&L,10,H361:9;H301:10;H331:1
37069,"1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-castor-oil acyl derivs., hydroxides, inner salts",289-181-7,86089-12-5,Flam. Liq. 3,Notified C&L,42,H319:41;H411:33;H226:33;H318:1
37071,Octyl isothiocyanate,224-625-5,4430-45-9,Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,45,H312:44;H314:44;H332:44;H301:41;H302:4;H335:1;H315:1;H331:1;H319:1
37075,1-bromooctan-2-one,248-014-8,26818-08-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H318:1;H312:1;H332:1
37079,Trifluperidol hydrochloride,218-170-1,2062-77-3,Acute Tox. 3,Notified C&L,38,H301:38
37086,Benzothiazole,202-396-2,95-16-9,Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,1658,H311:1452;H319:1451;H332:1449;H301:1450;H373:26;H302:208;H331:1
37093,"2,4,6-trifluoropyrimidine",211-801-1,696-82-2,,Notified C&L,6,H314:6;H335:2;H319:1;H315:1
37096,methyl acetoacetate,203-299-8,105-45-3,Eye Irrit. 2,Harmonised C&L,0,H319:0
37097,"2,2,3,3-tetrafluoropropyl acrylate",230-957-1,7383-71-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40;H226:40;H302:1;H350:1;H312:1;H332:1
37101,Ethyl (E)-oct-4-enoate,279-035-0,78989-37-4,Not Classified,Notified C&L,88,Not classified:88
37103,"4''-Ethyl-2',3,4,5-tetrafluor-1,1':4',1''-terphenyl",608-770-5,326894-55-7,Not Classified,REACH registration C&L,1,Not classified:1
37104,"Imidazolium compounds, 1-(carboxymethyl)-4,5-dihydro-1-(hydroxyethyl)-2-norcoco alkyl, hydroxides, monosodium salts",269-910-5,68390-66-9,Eye Dam. 1,Notified C&L,14,H318:14
37105,"N,N'-bis(3-aminopropyl)piperazine",230-589-1,7209-38-3,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,97,H302:14;H317:14;H318:54;H314:97;H412:14;H312:18
37109,"2-[2-[(4-methoxyphenyl)amino]vinyl]-1,3,3-trimethyl-3H-indolium hydrogen sulphate",261-895-3,59737-01-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H302:2;H400:2;H315:2;H319:2;H410:2
37110,Diphenyl selenide,214-474-3,1132-39-4,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H400:43;H373:43;H331:42;H301:42;H410:43;H302:1;H330:1
37111,"Hydrocarbons, C12-C16, isoalkanes, cyclics, <2% aromatics",927-676-8,,Asp. Tox. 1,REACH registration C&L,64,H304:64
37113,1-benzyl-5-phenylbarbituric acid,276-940-2,72846-00-5,Not Classified,REACH registration C&L,44,Not classified:4;H319:2;H302:2;H301:38
37117,5-Bromo-2-chlorobenzoyl chloride,606-860-9,21900-52-7,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1;Aquatic Acute 1,Notified C&L,39,H302:39;H400:38;H317:38;H334:38;H314:39;H312:1;H332:1
37121,"Cellulose, 2-hydroxyethyl ether, polymer with ethanedial",614-858-4,68957-96-0,Not Classified,Notified C&L,32,Not classified:32
37132,Disodium 4-[2-[2-[2-(dodecyloxy)ethoxy]ethoxy]ethyl] 2-sulphonatosuccinate,255-062-3,40754-59-4,Not Classified,REACH registration C&L,11,Not classified:6;H319:4;H318:5;H315:4;H302:1
37135,4-fluoroacetophenone,206-960-9,403-42-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,61,H319:60;H335:58;H315:60;H302:1
37137,Titanium zinc trioxide,234-850-0,12036-43-0,Acute Tox. 4,Notified C&L,42,H302:38;H332:4
37139,o-methylcinnamic acid,219-150-5,2373-76-4,,Notified C&L,6,H319:6;H335:5;H315:6
37144,Ethyl 4-nitrobenzoylacetate,212-656-7,838-57-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
37147,Reaction products of trimethylolpropane triglycidyl ether and acrylic acid,603-303-1,128819-84-1,Skin Irrit. 2;Skin Sens. 1A;Aquatic Chronic 3,REACH registration C&L,3,H317:2;H315:1;H412:1;H319:1;H318:1;H301:1
37148,Silver trifluoroacetate,221-004-0,2966-50-9,Acute Tox. 2;Aquatic Acute 1,Notified C&L,44,H300:38;H400:43;H319:6;H335:6;H315:6
37152,"3,3,4,4,5,5,6,6-octafluoroocta-1,7-diene",211-650-1,678-65-9,Flam. Liq. 2,Notified C&L,3,H225:2;H413:1;H226:1
37155,"3-carboxy-1-ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxoquinoline monomethanesulphonate",274-613-9,70458-95-6,Skin Irrit. 2;Eye Irrit. 2;Repr. 1A,Notified C&L,4,H319:3;H360:1;H315:2;H301:1;H302:1;H335:1
37159,Tris[oxalate(2-)]dicerium,205-362-5,139-42-4,Not Classified,REACH registration C&L,40,Not classified:1;H302:39;H312:39
37161,Pethidine hydrochloride,200-013-3,50-13-5,Acute Tox. 3,Notified C&L,69,H301:68;H317:18;H334:18;H373:16;H331:18;H372:16;H361:3;H412:2;H336:2;H341:1;H362:1;H400:1
37166,cis-2-methylcyclopropanecarboxylic acid,228-141-5,6142-57-0,Skin Corr. 1B,Notified C&L,1,H314:1
37168,Perfluoroheptanoic acid,206-798-9,375-85-9,Acute Tox. 4;Skin Corr. 1B,Notified C&L,50,H302:40;H314:47;Not classified:3;H318:1;H290:1
37169,"(±)-1,7,7-trimethyl-3-[(4-methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one",253-242-6,36861-47-9,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,436,H373:2;H400:365;H410:388;H361:42;Not classified:7;H319:1;H315:1
37173,"Slimes and Sludges, zinc sulfate electrolytic",273-742-8,69012-43-7,Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,8,H302:8;H400:8;H360:8;H410:8;H372:8;H332:8;H351:8
37174,"5,7-dichloro-4-hydroxyquinoline",427-420-0,21873-52-9,Aquatic Chronic 2,Harmonised C&L,0,H411:0
37176,"Phenol, 2,3-difluoro-4-[(trans,trans)-4'-propyl[1,1'-bicyclohexyl]-4-yl]-",606-618-2,207448-09-7,Not Classified,Notified C&L,1,Not classified:1
37178,Dimethyl L-cystinate dihydrochloride,251-261-4,32854-09-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;Not classified:1
37179,Difluprednate,245-815-4,23674-86-4,Not Classified,Notified C&L,4,Not classified:1;H373:2;H302:1;H332:1;H312:1;H361:1;H360:1
37180,"2,5-dimethylhexan-2-ol",223-085-8,3730-60-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H302:38;H318:38;H335:38;H315:38;H226:5
37181,(Z)-hexadec-11-en-1-ol,260-337-6,56683-54-6,Skin Irrit. 2,Notified C&L,3,H315:3;H319:1;H335:1
37183,4-(bromomethyl)benzophenone,251-197-7,32752-54-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
37186,Glycopyrronium bromide,209-887-0,596-51-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:43;H335:43;H315:43;H302:11;H312:2;H317:1;H360:1;H362:1;H332:1
37193,4-nitrophenylhydrazine,202-824-8,100-16-3,Flam. Sol. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H302:39;H335:38;H315:39;H317:38;H319:39;H312:38;H228:38;H242:1;Not classified:1
37194,Diethyl(2-(6-(2-phenylacetamido)penicillanoyloxy)ethyl)ammonium iodide,212-367-6,808-71-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,2,H335:1;H315:1;H317:2;H334:2;H319:1
37199,Phenacemide,200-570-2,63-98-9,Acute Tox. 4,Notified C&L,38,H302:38
37200,"2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid",611-959-5,60239-18-1,Eye Irrit. 2,REACH registration C&L,55,H319:55;H335:39;H315:50;H317:10
37202,"Caseins, ammonium complexes",618-417-7,9005-42-9,Not Classified,Notified C&L,1,Not classified:1
37204,o-tolylthiourea,210-395-3,614-78-8,Eye Irrit. 2,Notified C&L,45,H319:39;H301:6;H335:1;H315:1;H311:1;H331:1
37207,"Tail gas (petroleum), isomerized naphtha fractionation stabilizer;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]",269-628-2,68308-08-7,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H350:0;H220:0;H340:0
37209,"reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate",404-986-7,,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H318:0;H400:0;H410:0
37212,methanol,200-659-6,67-56-1,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT SE 1,Harmonised C&L,0,H225:0;H370:0;H311:0;H331:0;H301:0
37213,5-(Benzylthio)-1H-tetrazole,606-853-0,21871-47-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H318:44;H335:44;H315:44;H319:1
37214,"Benzyl (S)-[1-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]-3-methylbutyl]carbamate",222-256-4,3397-35-1,,Notified C&L,1,H302:1;H332:1;H312:1
37215,"3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol",410-010-0,104333-00-8,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0
37216,4-tert-butylbenzoic acid,202-696-3,98-73-7,Acute Tox. 4;STOT RE 1;Repr. 1B,Harmonised C&L,0,H302:0;H360:0;H372:0
37217,"Adenosine 5'-(trihydrogen diphosphate), 2'-deoxy-, disodium salt",276-280-5,72003-83-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,38,H335:38;H315:38;H311:38;H319:38;H331:38;H301:38
37218,"3,5-dihydroxybenzonitrile",242-859-6,19179-36-3,,Notified C&L,4,H302:4;H335:4;H315:4;H319:4;H332:4
37220,"1,1,1,2,2,3,3,4,4-nonafluoro-6-iodohexane",218-055-6,2043-55-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47;H302:1;H312:1;H332:1
37225,Novobiocin,206-146-3,303-81-1,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H317:38;H302:38
37226,"Ethyl 3,5-dichloro-4-hexadecyloxycarbonyloxybenzoate",404-740-9,115895-09-5,Aquatic Chronic 4,Notified C&L,2,H413:2
37230,"1-Piperidinecarboxylic acid, 4-(8-chloro-6,11-dihydro-11-hydroxy-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-, ethyl ester",603-730-3,133284-74-9,,Notified C&L,2,H302:1;Not classified:1
37233,"1,3-benzenediamine, 4-methyl-, sulfurized, heat-treated, thiosulfonated",215-430-6,1326-52-9,Not Classified,Notified C&L,5,Not classified:5
37236,2-methyl-4-nitrophenol,202-763-7,99-53-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H302:39;H335:38;H315:39
37237,Dicerium tritungsten dodecaoxide,236-639-9,13454-74-5,Skin Sens. 1,Notified C&L,42,H317:42;H335:4;H315:4;H334:4;H319:4
37239,Imipraminoxide,229-907-1,6829-98-7,,Notified C&L,1,H302:1
37242,"Cyclosiloxanes, Me Ph",614-221-0,68037-54-7,Not Classified,Notified C&L,23,Not classified:23
37243,"p-(1,1,2,2-tetrafluoroethoxy)benzaldehyde",252-497-0,35295-36-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
37247,"3,4-dimethylhex-3-en-2-one",216-656-8,1635-02-5,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3,Notified C&L,10,H311:10;H302:10;H226:10
37252,"(2S,3S,4S,5R,6R)-6-[[(3S,4S,4aR,6aR,6bS,8R,8aR,9R,10R,12aS,14aR,14bR)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(Z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3,5-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxane-2-carboxylic acid",600-985-2,11072-93-8,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H302:1;H335:1;H411:1;H319:1;H332:1
37253,"Undecanedioic acid, compound with 2,2'-iminodiethanol (1:2)",285-122-4,85029-99-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT RE 2,Notified C&L,2,H373:1;H302:1;H318:1;H315:2;H319:1
37254,"3-Pentanone, 1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-, reaction products with 2-propyn-1-ol",271-889-2,68611-23-4,Aquatic Chronic 1,REACH registration C&L,259,H410:3;Not classified:256
37256,Tripentyl borate,210-706-2,621-78-3,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38
37258,Heptene,246-871-2,25339-56-4,Flam. Liq. 2;Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,87,H225:87;H400:87;H304:87;H410:87
37259,"Buxus sempervirens, ext.",281-663-5,84012-17-9,Flam. Liq. 3,Notified C&L,2,H226:2
37260,3-methylbutyl heptanoate,203-658-9,109-25-1,Not Classified,Notified C&L,89,Not classified:89
37263,Dibutyl glutarate,229-581-0,6624-57-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
37266,p-toluenesulphonic acid (containing a maximum of 5 % H,203-180-0,104-15-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H319:0;H335:0;H315:0
37273,Chloroquine,200-191-2,54-05-7,Acute Tox. 4,Notified C&L,39,H302:39
37276,"N,N-dimethylpyridine-2-ethylamine",228-608-3,6304-27-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H314:1
37277,"Fatty acids, vegetable-oil, reaction products with diethylenetriamine",268-894-7,68153-72-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:3;H315:3;H317:1;H314:1
37282,"1,5-anhydro-D-glucitol",205-829-3,154-58-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
37283,3-chloro-7-hydroxy-4-methyl-2-benzopyrone,228-217-8,6174-86-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
37284,"(25R)-spirost-5-ene-1β,3β-diol",207-447-2,472-11-7,Not Classified,Notified C&L,3,Not classified:2;H302:1
37285,"Esterification products of fatty acids, C16 and C16-18 (even numbered, unsaturated) alkyl and adipic acid with pentaerythritol",923-900-3,,Not Classified,REACH registration C&L,1,Not classified:1
37287,2-iodoacetamide,205-630-1,144-48-9,Acute Tox. 3;Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 4,Notified C&L,178,H317:166;H413:118;H334:158;H301:176;H311:10;H330:10;H335:9;H315:10;H319:10;Not classified:1
37290,N-vinylformamide,236-102-9,13162-05-5,Acute Tox. 4;Eye Dam. 1;Repr. 1B;STOT RE 2;Self-react. G,REACH registration C&L,183,Not classified:79;H302:147;H373:5;H318:147;H360:4;H335:38;H315:39
37291,2'-deoxy-5-methylcytidine,212-655-1,838-07-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:4;H335:4;H315:4
37293,Ethyl hexanoate,204-640-3,123-66-0,Flam. Liq. 3;Skin Irrit. 2,REACH registration C&L,1734,H315:88;H226:1733;H319:49;H335:48;H302:1;H225:1;H332:1
37298,"1-(1,2,3,5,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan-1-one",268-978-3,68155-66-8,Aquatic Chronic 2,Notified C&L,183,H411:98;H317:86;H315:86;H410:84;H319:1;H400:2
37299,"2-chloro-α,α,α-trifluoro-5-nitrotoluene",212-287-1,777-37-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H302:41;H335:40;H315:46;H312:5;H332:6;H311:1;H331:1;H301:1
37302,"potassium (4S)-2,2-dimethyl-1,3-dioxolane-4-carboxylate",601-466-3,117205-81-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
37304,"Sulfuric acid, mono-C8-18-alkyl esters, sodium salts",268-589-9,68130-43-8,Eye Irrit. 2,Notified C&L,443,H319:442;Not classified:1
37307,"Hydrocarbons, C13-C18, n-alkanes, isoalkanes, cyclics, < 2% aromatics",921-050-8,,Asp. Tox. 1,REACH registration C&L,1,H304:1
37309,Methylcyclohexadiene,250-269-5,30640-46-1,Flam. Liq. 2,Notified C&L,130,H225:130;H304:50
37316,"Bis(2,3-epoxypropyl) cyclohex-4-ene-1,2-dicarboxylate",244-435-6,21544-03-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,3,H317:3;H319:3;H315:3
37317,"Boswellia papyrifera, ext.",289-621-8,89957-99-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H317:1;H319:1;H315:1
37323,"Ethers, C5-6-branched alkyl Me",295-322-3,91995-60-7,Flam. Liq. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,1,H302:1;H225:1;H336:1
37325,4-hydroxybutyl acrylate,219-606-3,2478-10-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,282,H317:227;H302:268;H318:227;H315:273;H335:43;H319:46;H312:41;H332:41;Not classified:9;H411:4
37326,"Benzeneacetic acid, α-hydroxy-, ethyl ester",610-127-9,4358-88-7,,Notified C&L,1,H319:1;H315:1
37331,"Benzene, mono-C10-16-alkyl derivs.",272-577-9,68890-99-3,Not Classified,Notified C&L,36,Not classified:36
37337,"Amines, polyethylenepoly-, reaction products with molybdenum oxide (MoO2) and succinic anhydride polyisobutenyl derivs., sulfurized",606-084-0,186432-61-1,Not Classified,Notified C&L,33,Not classified:32;H413:1
37343,"1-amino-4-anilino-9,10-dihydro-9,10-dioxo-2-anthracenesulphonic acid",220-508-8,2786-71-2,Not Classified,Notified C&L,4,Not classified:3;H319:1
37344,"Ethyl 3,4-dihydroxybenzoate",223-529-0,3943-89-3,Skin Sens. 1;Eye Dam. 1,REACH registration C&L,82,H317:4;H318:4;H319:78;H335:76;H315:78
37352,Heptylbenzene,214-084-3,1078-71-3,Aquatic Acute 1,Notified C&L,41,H400:38;Not classified:3
37353,Cimetidine,257-232-2,51481-61-9,Eye Dam. 1,Notified C&L,138,H318:54;H360:79;H373:35;H361:3;H351:3;H317:2;H334:2;Not classified:1;H302:1;H341:1
37354,Diindium triselenide,235-016-9,12056-07-4,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H400:42;H373:42;H331:42;H301:42;H410:42
37356,4-isopropylcyclohex-2-en-1-one,207-898-5,500-02-7,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1520,H311:1520;H319:1520;H315:1520;H301:1520
37357,Neoisomenthol,207-724-8,491-02-1,Skin Irrit. 2,Notified C&L,146,H315:146;H319:24
37359,"2,3,6-trichloroanisole",256-561-9,50375-10-5,Not Classified,Notified C&L,4,Not classified:4
37361,Methyl 1-methylpyrrolidine-2-acetate,257-477-5,51856-76-9,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H302:1;H412:1
37363,1-bromo-6-chlorohexane,228-555-6,6294-17-3,,Notified C&L,6,H319:6;H335:5;H315:6
37364,4-allyl-2-methoxyphenyl benzyl ether,260-703-5,57371-42-3,Not Classified,Notified C&L,88,Not classified:88
37367,"Methacryloamidopropyl-pentamethyl-1,3-propylene-2-ol-ammonium dichloride",617-909-9,86702-10-5,Aquatic Chronic 3,REACH registration C&L,1,H412:1
37368,Diolat,439-580-9,,Not Classified,Notified C&L,1,Not classified:1
37381,N-benzyloxycarbonyl-L-tryptophan,231-074-4,7432-21-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:2;H335:2;H315:2;Not classified:2
37384,3-methoxyphenol,205-754-6,150-19-6,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4,Notified C&L,57,H302:56;H315:56;H311:55;H318:55;H332:54;H335:5;H319:1;H312:1;H301:1
37385,Pimozide,218-171-7,2062-78-4,Acute Tox. 4,Notified C&L,45,H302:45;H361:2;H410:2;H318:1;H335:1;H315:1
37392,"Myrocarpus frondosus, ext.",294-497-3,91722-94-0,Skin Sens. 1B;Eye Irrit. 2B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,71,H317:30;H319:27;H400:34;H410:71
37393,"Mandarin orange, ext.",284-521-0,84929-38-4,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1776,H304:1762;H315:1763;H317:1764;H411:84;H226:1762;H400:1484;H410:1496;Not classified:11;H314:3;H401:3;H225:1;H361:1
37400,"Benzoic acid, 4-(cyanomethyl)-2-ethoxy-, ethyl ester",619-436-3,99470-01-6,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H312:2;H332:2
37402,2-isopropyl-5-methylhexan-1-ol,218-119-3,2051-33-4,Not Classified,Notified C&L,6,Not classified:6
37403,1-(methoxymethyl)propylamine,264-149-5,63448-63-5,Flam. Liq. 2;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H225:1;H314:1
37404,Undec-10-enoic acid,203-965-8,112-38-9,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,1785,H319:1785;H400:52;H315:1785;H412:1689;H411:91;H335:46;H410:13
37405,Lofemizole,265-818-4,65571-68-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
37407,"Glycine, N-(phosphonomethyl)-, ammonium salt",601-309-9,114370-14-8,Aquatic Chronic 2,Notified C&L,91,H411:91
37409,Methyl benzenesulphonate,201-256-8,80-18-2,Acute Tox. 4;Skin Corr. 1C;Muta. 2,REACH registration C&L,78,H302:75;H314:77;H341:23;H317:43;H318:3;H301:1;H319:1;H335:1;H315:1
37413,"Benzyl ether of 1,1,3,3-tetramethylbutylphenoxypolyethoxyethanol",612-049-0,60864-33-7,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,162,H302:128;H412:146;H301:20;Not classified:14;H318:1;H411:2
37414,"Hydrazinecarboxylic acid, 2-[1-[4-(ethoxycarbonyl)phenyl]ethylidene]-, 1,1-dimethylethyl ester",617-956-5,870822-87-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,33,H302:33;H332:33;H312:33
37418,2-(Isobutyl)-4-hydroxy-4-methyl tetrahydropyran,613-238-0,63500-71-0,Eye Irrit. 2,Notified C&L,305,H319:280;H315:25
37419,"3,4,5,6-tetrachloro-2-(2,4,5,7-tetrabromo-3,6-dihydroxyxanthen-9-yl)benzoic acid, aluminium salt",282-941-9,84473-86-9,Not Classified,REACH registration C&L,11,Not classified:11
37422,2-(ethylthio)ethanol,203-802-0,110-77-0,Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,45,H318:2;H412:1;H314:44;H302:1;H312:1;H332:1
37423,"Aminopeptidase, microsomal",232-942-5,9054-63-1,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,38,H334:38;H319:38;H335:38;H315:38
37426,"Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, γ-lactone",238-493-1,14487-05-9,STOT SE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,8,H400:7;H371:7;H410:7;Not classified:1
37427,"(o-tolyl N-[5-[3,5-bis[4-methyl-3-[(2-methylphenoxy)carbonylamino]phenyl]-2,4,6-trioxo-1,3,5-triazinan-1-yl]-2-methyl-phenyl]carbamate )",614-515-9,68456-07-5,Skin Corr. 1B;Resp. Sens. 1;Muta. 2;STOT RE 2,Notified C&L,5,H334:4;H373:4;H314:4;H341:4;Not classified:1
37428,Sodium 2-(2-dodecyloxyethoxy)ethyl sulphate,221-416-0,3088-31-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,175,H318:126;H315:170;H317:49;H319:9;Not classified:4;H302:1;H335:1;H411:1
37429,"Tetra-n-butyl titanate, polymer with water",500-687-1,162303-51-7,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;STOT SE 3,REACH registration C&L,105,H335:99;H315:104;H318:100;H226:88;H336:99;H302:17;H319:5
37430,"3-Butenoic acid, 4-phenyl-, methyl ester, (3E)-",609-001-6,34541-74-7,Aquatic Chronic 2,Notified C&L,38,H411:38
37432,"1,2,4-trimethylpiperazine",204-430-1,120-85-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
37435,Hexadecane-1-thiol,220-846-6,2917-26-2,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,42,H319:42;H413:40;Not classified:1;H317:1;H335:1;H315:1
37436,1-[4-(methoxymethyl)phenyl]ethan-1-one,244-767-1,22072-50-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
37437,trans-1-Fluor-4-(4-hexylcyclohexyl)-benzene,617-254-9,81711-13-9,Met. Corr. 1;Skin Corr. 1B;Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1;H314:1;H290:1
37440,reaction product of: polyethylene-polyamine-(C,417-450-2,,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H319:0;H315:0;H412:0
37443,"Tar bases, coal, aniline fraction;Distillate Bases;[The distillation fraction boiling in the range of approximately 180 °C to 200 °C (356 °F to 392 °F) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar. It contains chiefly aniline, collidines, lutidines and toluidines.]",295-541-4,92062-27-6,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
37445,2-[4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl]ethyl decanoate,262-615-2,61120-81-8,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Repr. 2,Notified C&L,10,H361:10;H302:10;H317:10;H318:10;H330:10
37447,"Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed;Petroleum gas;[A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.]",270-765-5,68477-83-8,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H350:0;H220:0;H340:0
37448,"Lavender, Lavandula hybrida abrial, ext.",297-384-7,93455-96-0,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1401,H317:1397;H315:1323;H412:1381;H304:38;H371:25;H318:13;H411:19;Not classified:1
37451,Potassium hydrogen oxalate,204-873-0,127-95-7,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,12,H302:12;H312:12
37457,"5,12-dihydroquino[2,3-b]acridine-7,14-dione",213-879-2,1047-16-1,Not Classified,REACH registration C&L,738,Not classified:735;H332:2;H318:1;H315:1
37458,"2-Propenoic acid, 2-methyl-, polymer with ethyl 2-propenoate",607-646-8,25212-88-8,,Notified C&L,494,H332:243;Not classified:171;H413:80;H330:80
37461,"Resins, copaiba",232-526-3,9000-12-8,Asp. Tox. 1,Notified C&L,113,H304:113
37463,3-methyl-2-pentylcyclopentan-1-one,235-969-0,13074-63-0,Not Classified,Notified C&L,90,Not classified:90
37464,5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole,420-820-6,,Flam. Liq. 3;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0;H226:0
37465,reaction products of formaldehyde and 4-nonylpenol and triethylenetetramine and 2-piperazin-1-ylethylamine,922-006-0,,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H317:1;H318:1;H314:1
37469,(S)-(+)-Styrene oxide,606-638-1,20780-54-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;Carc. 1B,Notified C&L,42,H350:42;H315:42;H311:42;H319:42;H331:40;H335:1;H301:1;H361:1;H317:1;H373:1;H336:1;H332:1;H341:1
37472,N-cyclohexyl-N'-phenyl-p-phenylenediamine,202-984-9,101-87-1,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,16,H317:16;H411:16
37473,o-[(4-hydroxyphenyl)sulphonyl]phenol,226-421-1,5397-34-2,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;Muta. 2,Notified C&L,118,H302:83;H314:83;H312:83;H332:83;H341:83;Not classified:34;H319:1;H315:1
37474,N-(2-chloroethyl)-N-ethylaniline,202-159-3,92-49-9,Acute Tox. 3;Acute Tox. 3,Notified C&L,33,H311:33;H301:33
37476,"2,3-dihydro-6,7-dimethyl-2-thioxo-1H-pteridin-4-one",258-932-0,54030-51-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H335:38;H315:38
37478,"Ditetradecyl [R(R*,R*)]-tartrate",304-118-6,94237-18-0,Not Classified,Notified C&L,2,Not classified:2
37480,Salinomycin,258-290-1,53003-10-4,Acute Tox. 2,Notified C&L,39,H300:39
37484,"(S)-β,3,4-trihydroxyphenethylammonium [R-(R*,R*)]-hydrogen tartrate",211-268-5,636-88-4,Acute Tox. 3,Notified C&L,38,H301:38
37485,Demecolcine,207-514-6,477-30-5,Acute Tox. 2,Notified C&L,39,H300:38;H301:1
37488,4-[(4-methoxybenzylidene)amino]benzonitrile,235-900-4,13036-19-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
37493,"2,4-dichlorobenzenethiol",214-346-7,1122-41-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,45,H319:45;H315:45;H302:6;H335:6;H312:2;H332:2;H311:1;H331:1;H301:1
37497,Sodium hydroxybenzenesulphonate,215-087-2,1300-51-2,Not Classified,Notified C&L,79,Not classified:40;H319:39
37499,magnesium bis(dipropan-2-ylazanide),480-180-9,,Flam. Liq. 2;Water-react. 1;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4,Notified C&L,1,H302:1;H225:1;H314:1;H332:1;H260:1
37500,4-[[(2-aminoethyl)thio]methyl]-5-methylimidazole,254-022-2,38585-67-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
37501,"Bis(2,3,3,3-tetrachloropropyl) ether",204-870-4,127-90-2,Not Classified,Notified C&L,52,Not classified:52
37502,2-chloro-6-ethoxypyridine,255-681-9,42144-78-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H302:38;H318:38;H335:43;H315:43;H319:5
37504,"Amides, tallow, hydrogenated, N,N'-(iminodi-2,1-ethanediyl)bis-",269-795-1,68333-84-6,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,8,H314:7;H400:7;H410:7;Not classified:1
37508,Hexamethylenediamine phosphate,241-538-8,17558-97-3,Not Classified,Notified C&L,2,Not classified:2
37512,4-tert-butylphenylacetic acid,251-264-0,32857-63-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:2;H302:1;H335:2
37514,Molybdenum sulfide,235-721-1,12612-50-9,Not Classified,REACH registration C&L,48,Not classified:48
37515,2-chloro-6-fluorobenzonitrile,211-571-2,668-45-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H302:44;H335:40;H315:45;H319:45;H312:40;H332:44;H311:5;H331:1;H301:1
37516,4-(1H-tetrazol-5-yl)-1-tetrazene-1-carboxamidine,208-720-9,539-57-1,Unst. Expl.,Notified C&L,1,H200:1
37526,Copper D-gluconate,235-844-0,13005-35-1,Not Classified,Notified C&L,4,Not classified:4
37530,Tetradecyltriphenylphosphonium bromide,247-267-1,25791-20-2,,Notified C&L,5,H319:5;H335:4;H315:5
37532,2-[N-o-methoxyphenyl)carbamoyl]-3-naphthyl acetate,230-428-5,7128-79-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
37534,Phosphonium iodide,235-189-0,12125-09-6,Not Classified,Notified C&L,1,Not classified:1
37541,2-Fluoro-4-nitroanisole,610-263-9,455-93-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:41;H335:40;H315:41;H302:4
37543,"Benzene, 1-(4-ethyl-1-cyclohexen-1-yl)-3,5-difluoro-",616-142-7,748186-54-1,Not Classified,Notified C&L,1,Not classified:1
37544,"N,N,N',N'-tetramethyl-4,4'-azodianiline",228-388-9,6257-64-3,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,38,H335:38;H315:38;H311:38;H319:38;H331:38;H301:38
37545,"β-Alanine, N-coco alkyl derivs., compds. with triethanolamine",287-996-2,85631-48-7,Not Classified,Notified C&L,1,Not classified:1
37547,"1-(2,4-dichloro-phenyl)-5-trichloromethyl-1.H.-[1,2,4]triazole-3-carboxylic acid ethyl ester",600-392-9,103112-35-2,Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,194,H350:194;H400:194;H410:194
37554,2-(2-heptadecyl-2-imidazolin-1-yl)ethanol,202-397-8,95-19-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Repr. 1B,Notified C&L,4,H317:1;H319:2;H360:1;H315:2;H302:1;H314:1;H400:1;H410:1;Not classified:1
37555,2-phenoxyethylamine,217-153-6,1758-46-9,Skin Corr. 1B;Eye Dam. 1,Notified C&L,44,H318:38;H314:44
37556,"2-Propanamine, compd. with boron trifluoride, reaction products with Bu glycidyl ether",270-846-5,68478-97-7,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 1,REACH registration C&L,152,H317:14;H318:14;H314:152;H303:1;H410:14;H302:151
37557,"1,5-diamino-4,8-dihydroxy(4-methoxyphenyl)anthraquinone",250-547-6,31288-44-5,Not Classified,Notified C&L,49,Not classified:49
37563,"Soybean oil, ester with propylene glycol",275-020-8,70914-16-8,Not Classified,Notified C&L,1,Not classified:1
37565,p-ethylbenzenesulphonic acid,202-693-7,98-69-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H314:38
37567,Epirizole,242-507-1,18694-40-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H302:38;H335:38;H315:38;H319:38;H312:38;H332:38
37568,"1-(3,3-dimethylcyclohexyl)pent-4-en-1-one",422-330-8,56973-87-6,Aquatic Chronic 2,Harmonised C&L,0,H411:0
37570,cyclohexane,203-806-2,110-82-7,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H225:0;H400:0;H315:0;H304:0;H410:0;H336:0
37571,(S)-(-)-alpha-methoxyphenylacetic acid,247-492-5,26164-26-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
37573,"Lavender, Lavandula hybrida grosso, ext.",297-385-2,93455-97-1,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,121,H317:115;H412:113;H315:18;H411:6;H319:7;Not classified:1;H304:2
37576,(R)-2-Methylsuccinic acid 4-methyl ester,617-190-1,81025-83-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39;H226:38
37579,o-chlorophenethylic alcohol,243-348-0,19819-95-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
37584,"5,6-dihydroxyindole",412-130-9,3131-52-0,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H318:0;H411:0
37586,2-mesyl-4-nitroaniline,202-529-4,96-74-2,Skin Sens. 1,Notified C&L,40,H317:40
37587,"D-Phenylalanine, 4-chloro-N-[(1,1-dimethylethoxy)carbonyl]-",611-492-7,57292-44-1,Not Classified,Notified C&L,1,Not classified:1
37589,"Acetamide, N-[4-bromo-3-(trifluoromethyl)phenyl]-",609-933-3,41513-05-7,,Notified C&L,4,H319:4;H335:4;H315:4
37591,Tridecylbenzene,204-592-3,123-02-4,Aquatic Acute 1,Notified C&L,3,H400:3
37593,"Sodium 6-amino-5-[[4-chloro-3-[[(2,4-dimethylphenyl)amino]sulphonyl]phenyl]azo]-4-hydroxynaphthalene-2-sulphonate",276-115-7,71873-39-7,Eye Irrit. 2,REACH registration C&L,79,H319:12;Not classified:63;H412:3;H413:1
37594,"(R)-α,α,4-trimethylcyclohex-3-ene-1-methyl acetate",232-082-0,7785-54-8,Aquatic Chronic 2,Notified C&L,139,H411:121;Not classified:18
37595,"L-Asparagine, N2-(2-quinolinylcarbonyl)-",603-965-1,136465-98-0,Not Classified,Notified C&L,1,Not classified:1
37601,Propylidynetrimethyl trimethacrylate,221-950-4,3290-92-4,Aquatic Chronic 2,REACH registration C&L,790,H411:586;Not classified:195;H360:41;H319:7;H315:7;H317:4;H335:4
37603,"Tetrakis(pentane-2,4-dionato-O,O')zirconium",241-510-5,17501-44-9,Not Classified,REACH registration C&L,130,Not classified:4;H302:126;H335:40;H315:41;H319:41;H312:41;H332:41;H361:1
37606,"1,1,1-trimethoxybutane",256-079-9,43083-12-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H226:44
37607,"(tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide",404-250-5,115099-55-3,Skin Sens. 1,Harmonised C&L,0,H317:0
37611,"2,4-dinitrophenyl thiocyanate",216-477-5,1594-56-5,,Notified C&L,5,H319:5;H335:5;H315:5;H341:4;H228:1
37613,N-(2-(p-bromophenoxy)ethyl)pyrrolidine,214-100-9,1081-73-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
37616,"Decachloro-1,1'-biphenyl",218-115-1,2051-24-3,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,4,H373:4;H400:4;H410:4
37618,Rutile (TiO2),215-282-2,1317-80-2,Not Classified,REACH registration C&L,649,Not classified:636;H302:7;H351:12;H319:1;H332:1;H315:1;H335:1
37620,"Ethyl 2,4-dioxohexanoate",236-228-4,13246-52-1,Not Classified,Notified C&L,89,Not classified:88;H302:1;H335:1;H315:1;H319:1;H227:1
37621,Ethylpyrazine,237-691-5,13925-00-3,Acute Tox. 4,Notified C&L,1501,H302:1327;H226:214;H335:71;H315:72;H318:40;H319:32
37622,O-benzyl-L-alanine toluene-p-sulphonate,255-969-4,42854-62-6,Not Classified,Notified C&L,1,Not classified:1
37624,"Ethyl 5-methyl-2,4-dioxohexanoate",264-728-2,64195-85-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
37629,(R)-(+)-Styrene oxide,606-637-6,20780-53-4,Acute Tox. 4;Eye Irrit. 2;Carc. 1B,Notified C&L,56,H319:56;H312:55;H350:56;H361:1;H302:1;H315:1;H311:1;H317:1;H373:1;H336:1;H341:1
37636,"1,1,2-trichloro-2,3,3-trifluorocyclobutane",211-804-8,697-17-6,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H302:43;H335:39;H319:39;H312:43;H332:43;H315:1
37637,2-(2-(2-methoxyethoxy)ethoxy)ethanol,203-962-1,112-35-6,Not Classified,REACH registration C&L,299,Not classified:261;H319:39;H315:38
37641,2-ethoxyethyl 2-cyanoacrylate,244-692-4,21982-43-4,Not Classified,Notified C&L,127,Not classified:127
37645,"Valerian, Valeriana wallichii, ext.",290-405-0,90131-89-8,Asp. Tox. 1;Aquatic Chronic 2,Notified C&L,1,H304:1;H411:1
37646,"3-[2-[decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenenaphthyl]ethylidene]dihydro-4-hydroxyfuran-2(3H)-one",226-852-5,5508-58-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,90,H319:90;H335:90;H315:90
37650,"Tetrasodium 7,7'-(carbonyldiimino)bis[4-hydroxy-3-[(6-sulphonato-2-naphthyl)azo]naphthalene-2-sulphonate]",249-171-5,28706-25-4,Not Classified,REACH registration C&L,191,Not classified:191
37651,"Slimes and Sludges, precious metal refining",308-516-0,98072-61-8,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,20,H400:20;H410:20
37653,"Fatty acids, C16-18 and C18-unsatd., mixed esters with glycerol and propylene glycol",285-542-8,85116-89-8,Not Classified,Notified C&L,1,Not classified:1
37656,Mephenytoin,200-012-8,50-12-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:40;H302:41;H335:40;H315:40;H361:1;H400:1
37657,"(R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate",445-750-3,839705-03-2,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H302:0;H318:0;H412:0
37664,"p,p',p''-tris(diethylamino)trityl alcohol",209-886-5,596-49-6,Not Classified,REACH registration C&L,10,Not classified:9;H319:1;H302:1;H400:1;H332:1
37665,(Hydrocarbon oils),617-002-8,8020-83-5,Not Classified,Notified C&L,106,Not classified:91;H318:15
37674,Methyl o-toluate,201-932-2,89-71-4,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,122,H319:44;H315:44;Not classified:78;H335:42
37680,"imidazo[1,2-b]pyridazin hydrochloride",431-510-5,18087-70-2,Acute Tox. 4;Eye Irrit. 2,Harmonised C&L,0,H319:0;H302:0
37685,N-ethylpyridine-2-ethylamine,228-607-8,6304-26-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
37686,"Evernia furfuracea, ext., ethanolyzed",619-081-4,94944-93-1,Skin Sens. 1,Notified C&L,101,H317:101
37687,Anthracene-9-carboxylic acid,211-964-9,723-62-6,Not Classified,REACH registration C&L,10,Not classified:3;H319:6;H335:5;H315:6;H301:1
37688,Cerium(4+) disulphate,237-029-5,13590-82-4,Skin Corr. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,58,H314:12;H400:5;H410:5;H319:44;H335:42;H315:44;H272:6;H318:2;Not classified:1
37689,o-tolylurea,210-394-8,614-77-7,Acute Tox. 3;Eye Irrit. 2,Notified C&L,39,H319:38;H301:38;H302:1;H332:1;H312:1
37692,Zinc dipropionate,209-167-6,557-28-8,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,11,H318:3;H400:3;H411:3;H319:4;H335:4;H315:4;Not classified:4
37695,4-nitroanisole,202-825-3,100-17-4,,Notified C&L,11,H412:6;H341:8;Not classified:3
37696,2-methylbenzoselenazole,220-577-4,2818-88-4,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H400:38;H373:38;H331:38;H301:38;H410:38;H302:1
37697,1-methyl-3-phenyl-1-piperazine,431-180-2,5271-27-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H315:0;H318:0;H312:0;H412:0
37701,4-nitro-o-xylene,202-761-6,99-51-4,Not Classified,REACH registration C&L,45,Not classified:1;H302:43;H332:43;H312:43;H330:1;H300:1;H310:1
37705,Geranyl isovalerate,203-655-2,109-20-6,Not Classified,Notified C&L,307,Not classified:307
37709,"3,5-dimethoxybenzonitrile",242-858-0,19179-31-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H302:42;H335:38;H315:38;H319:38;H312:42;H332:42;H311:1;H331:1;H301:1
37710,"[S(R*,R*)]-2-amino-1-(p-nitrophenyl)propane-1,3-diol",221-001-4,2964-48-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
37713,Chromium dioxide,234-630-4,12018-01-8,Eye Irrit. 2,Notified C&L,70,H319:69;Not classified:1
37715,"3,4'-dimethyl-1,1'-biphenyl",230-958-7,7383-90-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
37717,"clothianidin (ISO);3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine",606-701-3,210880-92-5,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H400:0;H410:0
37719,"reaction mass of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;trisodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;disodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;tetrasodium 5-{4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate",444-050-5,,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H412:0
37721,"Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.'-1,4-butanediylbis(.omega.-hydroxy-, 9(Z)-9-octadecenoate",614-256-1,68071-15-8,Aquatic Chronic 3,Notified C&L,43,H412:43
37726,"Dodecanedioic acid, compound with 2,2'-iminodiethanol (1:2)",285-125-0,85030-01-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT RE 2,Notified C&L,1,H373:1;H302:1;H318:1;H315:1
37727,(E)-2-decenoic acid,206-378-5,334-49-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H315:2;H314:1
37728,(2R)-3-[(acetamidomethyl)sulfanyl]-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid,617-794-5,86060-81-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:45;H315:45;Not classified:2;H318:1;H302:1
37734,"2,4-bis(dodecylthiomethyl)-6-methyl-phenol",600-982-6,110675-26-8,Skin Sens. 1B,Notified C&L,39,H317:32;Not classified:7
37736,3-ethylhexan-3-ol,209-908-3,597-76-2,,Notified C&L,5,H319:5;H335:5;H315:5
37737,Cobalt trihydroxide,215-153-0,1307-86-4,Not Classified,Notified C&L,2,Not classified:1;H334:1;H319:1;H413:1
37739,Benzyldiphenylamine,210-127-5,606-87-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H302:38;H335:38;H315:38;H400:38;H319:38;H410:38
37740,"(1S,3R,5R,7S)-3-Aminoadamantan-1-ol",615-098-6,702-82-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,REACH registration C&L,48,H302:5;H413:4;H335:47;H315:48;H319:48;H314:1
37743,4-amino-5-hydroxynaphthalene-1-sulphonic acid,201-491-6,83-64-7,Skin Corr. 1B,Notified C&L,39,H314:38;H319:1;H315:1
37744,Methyl dodecylbenzenesulphonate,257-847-6,52319-06-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
37746,"Hop, Humulus lupulus, ext., isomerized, potassium salt",305-203-0,94349-84-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,6,H302:3;H317:3;H318:3;H314:3;H312:3;Not classified:3
37748,2-hydroxyethanesulphonic acid,203-484-3,107-36-8,Skin Corr. 1B,REACH registration C&L,32,H314:29;H318:26;H412:2;Not classified:1;H319:2;H302:1;H335:1;H315:2
37751,Sodium niobate,234-798-9,12034-09-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:42;H335:42;H315:42;Not classified:1
37754,Icosyl methacrylate,256-220-4,45294-18-6,Not Classified,REACH registration C&L,636,Not classified:8;H319:628;H335:628;H315:628
37758,Desoxycortone pivalate,212-366-0,808-48-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,41,H302:40;H332:40;H312:40;H413:1;H361:1;H335:1;H315:1;H319:1
37763,tert-butylhydrazine monohydrochloride,231-001-6,7400-27-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT RE 1,REACH registration C&L,101,H302:43;H335:66;H315:66;H319:100;H372:4;H312:34;H311:1;H301:1;H330:1;H411:1;H412:1
37765,Ceftezole,608-028-0,26973-24-0,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H317:1;H334:1
37771,Diphenyl hydrogen phosphate,212-657-2,838-85-7,Skin Corr. 1B,Notified C&L,24,H314:17;Not classified:5;H319:2;H335:2;H315:2;H302:1;H290:1;H312:1
37775,"Fatty acids, soya, esters with propylene glycol",267-054-7,67784-79-6,Not Classified,Notified C&L,1,Not classified:1
37778,Scandium oxalate (2:3),236-523-8,13419-51-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H312:1
37779,"Fatty acids, tall-oil, reaction products with triethanolamine",267-053-1,67784-78-5,Not Classified,REACH registration C&L,151,Not classified:72;H319:61;H315:61;H318:18;H314:18
37780,"(R)-N-((5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1H-benzo[c]pyran-7-yl)carbonyl)-3-phenylalanine",206-143-7,303-47-9,Acute Tox. 2;Eye Irrit. 2;Acute Tox. 2;Carc. 2;Repr. 2,Notified C&L,8,H361:4;H319:3;H300:8;H330:3;H351:8;H413:5;H373:1;H362:1
37781,Hydrogen bis[4-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]benzenesulphonamidato(2-)]cobaltate(1-),256-613-0,50525-57-0,Not Classified,Notified C&L,8,Not classified:5;H318:1;H412:2;H319:1
37782,"3,8-diamino-6-phenylphenanthridine",257-602-3,52009-64-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H302:38;H335:42;H315:42
37785,Benzyl diethyl phosphite,220-452-4,2768-31-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
37793,2-Iodobenzonitrile,610-156-7,4387-36-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,43,H319:42;H302:41;H315:4;H311:1;H331:1;H301:1;H335:3;H332:2;H312:2
37800,Choline chloride,200-655-4,67-48-1,Not Classified,REACH registration C&L,564,Not classified:206;H319:356;H335:354;H315:356;H400:1;H318:1;H290:1
37801,"2,3-dimethylvaleraldehyde",251-193-5,32749-94-3,Flam. Liq. 3;Skin Sens. 1B,Notified C&L,10,H317:10;H226:10
37802,Benzylthiourea,210-709-9,621-83-0,,Notified C&L,8,H301:6;H302:1;H319:1;H335:1;H315:1
37803,"Benzeneacetonitrile, 2-methyl-.alpha.-[2-[[(octylsulfonyl)oxy]imino]-3(2H)- thienylidene]-",457-510-5,852246-54-9,Flam. Sol. 2;Skin Sens. 1,Notified C&L,83,H317:83;H228:83
37805,4-(4-Hydroxyphenly)cyclohexanone,600-672-0,105640-07-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
37807,"1,2-diphenyl-1H-indole-3-carbaldehyde",249-562-0,29329-99-5,,Notified C&L,4,H319:4;H335:4;H315:4
37809,p-nitrophenyl 2-acetamido-2-deoxy-β-D-galactopyranoside,239-024-3,14948-96-0,Not Classified,Notified C&L,2,Not classified:2
37812,2-(trifluoromethyl)phenylacetonitrile,221-239-9,3038-47-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H302:42;H335:44;H315:45;H319:45;H312:42;H332:42;H301:2;H311:1;H331:1
37813,Gum benzoin,232-523-7,9000-05-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1385,H317:1289;H319:1315;H315:1315;H412:1288;Not classified:68;H411:1;H302:1;H373:1;H318:1
37815,Potassium decafluoro(pentafluoroethyl)cyclohexanesulphonate,266-724-6,67584-42-3,Not Classified,Notified C&L,6,Not classified:5;H319:1;H302:1;H335:1;H315:1
37818,"2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride",419-360-9,163661-77-6,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
37820,"Propanoic acid, 2-cyano-2-methyl-, methyl ester",615-749-4,72291-30-6,Eye Irrit. 2,REACH registration C&L,85,H319:85;H335:1;H315:1;H301:1
37828,Hexafluoroglutaryl dichloride,211-651-7,678-77-3,,Notified C&L,8,H314:8;H335:2;H318:1;H290:1
37832,fenbutatin oxide (ISO);bis(tris(2-methyl-2-phenylpropyl)tin)oxide,236-407-7,13356-08-6,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H315:0;H319:0;H410:0;H330:0
37833,C.I. Reactive Blue 71,603-160-5,12677-15-5,,Notified C&L,36,Not classified:36
37834,Pholcodine,208-102-9,509-67-1,Acute Tox. 4,Notified C&L,7,H302:6;H332:2;H312:1;H311:1;H331:1;H301:1
37835,"6,6-dimethyl-2-methylenebicyclo[3.1.1]hept-3-yl acetate",214-085-9,1078-95-1,Not Classified,Notified C&L,88,Not classified:88
37836,"Boswellia frereana, ext.",296-876-9,93164-94-4,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H304:2;H400:1;H315:2;H317:2;H226:2;H410:1;H411:1
37837,"Oils, palm kernel, sulfated, sodium salts",296-485-3,92704-52-4,Not Classified,Notified C&L,1,Not classified:1
37841,"L-Arginine, N2-[(1,1-dimethylethoxy)carbonyl]-, hydrochloride (1:1)",609-191-0,35897-34-8,Not Classified,Notified C&L,1,Not classified:1
37842,17-β-hydroxyestr-4-en-3-one 17-propionate,230-587-0,7207-92-3,Carc. 2,Notified C&L,38,H351:38
37843,"p-dodecylbenzenesulphonic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",221-415-5,3088-30-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
37847,"Fatty acids, vegetable-oil, reaction products with diethylenetriamine, acetates",268-895-2,68153-73-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,34,Not classified:32;H400:34;H410:34
37849,Isooctyl palmitate,215-675-9,1341-38-4,Aquatic Acute 1,REACH registration C&L,2,H400:2
37853,5'-O-[bis(4-methoxyphenyl)benzyl]-2'-deoxyuridine,245-814-9,23669-79-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H302:38;H335:38;H315:38;H319:38;H332:38
37854,"Caseins, calcium complexes",618-418-2,9005-43-0,Not Classified,Notified C&L,1,Not classified:1
37857,"1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10-henicosafluoro-12-iodododecane",218-054-0,2043-54-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,91,H319:91;H335:91;H315:91
37859,[No public or meaningful name is available],683-102-3,526-07-8,Skin Sens. 1,Notified C&L,1,H317:1
37860,"Soybean oil, epoxidized, ether with ethylene glycol",287-836-1,85586-34-1,Not Classified,REACH registration C&L,1,Not classified:1
37861,2-benzoyloxyethyltrimethylammonium chloride,221-000-9,2964-09-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
37863,"2,2,3,3,3-pentafluoropropyl methacrylate",256-191-8,45115-53-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H226:44
37865,C.I. Acid Red 336,602-735-8,12239-11-1,Not Classified,Notified C&L,2,Not classified:2
37867,4-nitro-o-toluidine,202-762-1,99-52-5,Acute Tox. 3;Aquatic Chronic 2,REACH registration C&L,46,H411:45;H301:46;H311:44;H373:42;H331:44;H315:1;H319:1;H341:1
37868,"Vetiveria zizanioides, ext.",282-490-8,84238-29-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1521,H317:1464;H319:1463;H411:31;H315:1488;Not classified:31;H304:3
37869,"2,3,4-trichlorobut-1-ene",219-397-9,2431-50-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H335:0;H315:0;H400:0;H319:0;H331:0;H410:0;H351:0
37870,Methyl (trimethylsilyl)acetate,220-845-0,2916-76-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38;H226:38
37873,Iodoacetonitrile,210-860-0,624-75-9,Acute Tox. 4;Skin Corr. 1B,Notified C&L,45,H302:44;H314:45;H312:4;H332:4;H318:1;H335:1;H311:1;H319:1;H301:1;H330:1
37876,Iron tribenzoate,238-566-8,14534-87-3,Acute Tox. 4,Notified C&L,12,H302:11;Not classified:1
37883,2-aminocyclopentanemethylamine,244-434-0,21544-02-5,Not Classified,Notified C&L,33,Not classified:24;H302:8;H318:8;H314:9;H331:8;H312:8;H227:1
37888,Sulfamethoxazole,211-963-3,723-46-6,Not Classified,Notified C&L,158,Not classified:53;H317:58;H319:57;H335:56;H315:57;H400:37;H410:37;H334:9;H302:1;H350:1;H341:1;H351:2;H411:2;H360:1;H361:1;H301:1
37890,1-(3-chloropropyl)-4-methylpiperazine,203-181-6,104-16-5,Acute Tox. 3;Skin Mild Irrit. 3;Aquatic Chronic 4,REACH registration C&L,4,H413:2;H301:2;H316:2;H302:2;H335:1;H315:1;H319:1;H332:1
37893,"Pepper (Piper), P. nigrum, ext.",284-524-7,84929-41-9,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1527,H304:1520;H315:1526;H317:1526;H411:22;H226:1523;H400:1461;H410:1502;H319:75;H301:34;H335:1
37894,Decyl chloroformate,259-668-9,55488-51-2,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H318:39;H314:39;H290:1;H310:1;H300:1;H330:1
37896,Ditungsten pentaoxide,234-854-2,12036-84-9,Not Classified,Notified C&L,2,Not classified:2
37897,Dipotassium dodecenylsuccinate,260-612-0,57195-28-5,Skin Corr. 1;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,52,H317:2;H318:2;H314:2;H319:29;H315:29;Not classified:21
37898,"1H-Pyrazole-4-carboxylic acid, ethyl ester",609-452-9,37622-90-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H335:47;H315:48
37900,"Scale (coating), copper",273-744-9,69012-45-9,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,24,H319:24;H302:6;H411:24;H332:12;H350:18;H373:18;H360:18;H317:6;H351:6
37905,"Acetamide, N-[(3S)-tetrahydro-2,5-dioxo-3-furanyl]-",609-893-7,41148-79-2,Not Classified,Notified C&L,1,Not classified:1
37906,Bis(amidinourea) phosphate,284-608-3,84946-06-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
37910,Praseodymium(3+) perchlorate,236-822-3,13498-07-2,,Notified C&L,4,H319:4;H272:4;H335:4;H315:4
37912,Phenyl N-phenylphosphoramidochloridate,257-400-5,51766-21-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
37913,2-methyl-4-(o-tolylazo)benzenediazonium hydrogen sulphate,202-985-4,101-89-3,Carc. 1B,Notified C&L,38,H350:38
37915,"5-[(4-anilino-5-sulphonaphthyl)azo]-4-hydroxynaphthalene-2,7-disulphonic acid",231-304-3,7488-76-8,Not Classified,Notified C&L,2,Not classified:2
37919,LAVANDIN OIL GROSSO,617-009-6,8022-15-9,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,147,H317:104;H315:93;H412:93;H304:34;H335:2;H319:6;H411:3;H302:1;H312:1;H332:2
37922,m-aminobenzenesulphonanilide,201-259-4,80-21-7,Acute Tox. 4,Notified C&L,2,H302:1;H319:1;H335:1;H315:1
37923,"Sodium N,N-bis(2-hydroxyethyl)glycinate",205-360-4,139-41-3,Not Classified,REACH registration C&L,58,Not classified:3;H318:55;H314:55;H351:55
37924,"Lantana camara, ext.",289-985-8,90046-17-6,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,3,H317:3;H411:3;H304:2;H226:2;H315:1
37925,"Octanoic acid, 4-methyl-2-pentylbutyl ester",617-930-3,868839-23-0,Not Classified,Notified C&L,83,Not classified:83
37928,5-methylthiophene-2-carboxylic acid,217-640-3,1918-79-2,,Notified C&L,6,H319:6;H335:5;H315:6;H302:1
37929,"Naphthenic acids, lithium salts",262-987-6,61788-56-5,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,31,H318:3;H314:3;Not classified:26;H319:2;H411:2;H335:2;H315:2
37930,4-morpholinopropanesulphonic acid,214-478-5,1132-61-2,Not Classified,REACH registration C&L,301,Not classified:26;H319:272;H335:270;H315:272;H302:2;H311:1;H301:1
37931,"β-Alanine, N-[3-(acetylamino)-4-[2-(4-nitrophenyl)diazenyl]phenyl]-N-(3-methoxy-3-oxopropyl)-, methyl ester",614-389-5,68248-10-2,,Notified C&L,1,Not classified:1
37940,"2,4-dimethylpyridine 1-oxide",214-349-3,1122-45-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
37947,1-(4-nitrophenyl)glycerol,218-624-9,2207-68-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:41;H315:41
37948,"benzene-1,2,4-tricarboxylic acid 1,2-anhydride;trimellitic anhydride",209-008-0,552-30-7,Eye Dam. 1;Skin Sens. 1;STOT SE 3;Resp. Sens. 1,Harmonised C&L,0,H317:0;H318:0;H335:0;H334:0
37949,3-hydroxy-N-(3-morpholinopropyl)-2-naphthamide,233-426-2,10155-47-2,Not Classified,Notified C&L,1,Not classified:1
37950,"Cyclohexane, oxidized, aq. ext., sodium salt",272-812-5,68915-39-9,,REACH registration C&L,85,Not classified:85
37952,p-hydroxyvalerophenone,219-978-7,2589-71-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
37953,"Tin, dross",273-695-3,69011-52-5,Acute Tox. 3;Skin Corr. 1B;Carc. 1A;Repr. 1A;STOT RE 2;Aquatic Acute 1,REACH registration C&L,1,H350:1;H400:1;H373:1;H360:1;H314:1;H301:1;H410:1
37955,"bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate",413-930-0,130066-57-8,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H410:0
37961,"Aluminium, 2-(1,3-dihydro-3-oxo-5-sulfo-2H-indol-2-ylidene)-2,3-dihydro-3-oxo-1H-indole-5-sulfonic acid complex",240-589-3,16521-38-3,Not Classified,REACH registration C&L,157,Not classified:157
37962,"Inosine, compound with (2-hydroxypropyl)dimethylammonium p-acetamidobenzoate (1:3)",253-162-1,36703-88-5,Not Classified,Notified C&L,3,Not classified:3
37963,spinosyn A,620-162-1,131929-60-7,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
37964,4-methylheptan-3-one,612-136-3,6137-11-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,2,H335:2;H315:2;H226:2;H319:2;H332:2
37966,Nonacosafluoro-1-iodotetradecane,206-207-4,307-63-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
37972,"Fatty acids, C16-22, esters with pentaerythritol",283-078-0,84539-90-2,Not Classified,Notified C&L,8,Not classified:8
37974,"1-ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate",259-154-4,54406-48-3,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,42,H302:39;H411:39;H400:3;H410:3
37976,"3,5-di-tert-butylphenol",214-513-4,1138-52-9,Skin Corr. 1B,Notified C&L,39,H314:38;Not classified:1
37980,2-Methyl-3-(3-sulfopropyl)benzoxazolium salt,611-144-4,54443-97-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
37983,"Disodium 4-amino-5-hydroxy-3-[[4-[(4-hydroxyphenyl)azo]phenyl]azo]-6-(phenylazo)naphthalene-2,7-disulphonate",281-032-4,83846-56-4,Not Classified,Notified C&L,1,Not classified:1
37986,"Dismutase, superoxide",232-943-0,9054-89-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;Not classified:1
37987,"Carbamic acid, (3-isocyanato-4-methylphenyl)-, 2-ethylhexyl ester",610-708-7,51604-48-9,Skin Sens. 1;Eye Irrit. 2,Notified C&L,42,H317:26;H319:26;Not classified:16;H334:1;H226:1;H331:1;H351:1
37989,Lanthanum disilicide,235-017-4,12056-90-5,,Notified C&L,4,H319:4;H335:4;H315:4
37990,1-methoxy-4-phenylpyridinium tetrafluoroborate,263-884-9,63123-42-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
37991,[3-(trifluoromethyl)phenyl]hydrazine,206-713-5,368-78-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H302:45;H335:39;H315:46;H319:46;H312:45;H332:44;H311:1;H331:1;H301:1
37993,DL-4-hydroxy-3-methoxyphenylethyleneglycol - piperazine (2:1),266-689-7,67423-45-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
37996,"Tar bases, coal, distn. residues;Distillate Bases;[The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of coal tars. It contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.]",295-544-0,92062-29-8,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
37997,trans-2-ethylcyclopropanemethanol,253-699-1,37882-55-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H226:1
37998,10-(3-chloropropyl)-2-(methylsulphonyl)-10H-phenothiazine,254-776-2,40051-30-7,,Notified C&L,1,H302:1;H311:1;H319:1;H312:1;H331:1;H301:1;H332:1
38000,5-mehoxy-1-[4-(trifluoromethyl)penyl]-1-pentanone,612-211-0,61718-80-7,Eye Irrit. 2,Notified C&L,42,H319:42
38007,"3,7-Diazabicyclo[3.3.1]nonane-1,5-dicarboxylic acid, 3-methyl-9-oxo-2,4-di-2-pyridinyl-7-(2-pyridinylmethyl)-, 1,5-dimethyl ester, (1R,2S,4R,5S)-rel-",618-281-9,895520-71-5,Acute Tox. 4;Skin Sens. 1;Carc. 1B,REACH registration C&L,2,H317:2;H302:2;H350:2
38009,2-hydroxycyclohexan-1-one,208-570-4,533-60-8,,Notified C&L,1,H319:1;H228:1;H335:1;H315:1
38012,"Myrocarpus fastigiatus, ext.",294-496-8,91722-93-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1422,H400:1384;H410:1386;Not classified:36;H317:45;H319:12
38013,"Amines, tallow alkyl, ethoxylated, phosphates",614-405-0,68308-48-5,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 1,Notified C&L,126,H318:126;H315:126;H410:126;H400:15;H302:2
38017,Indapamide,248-012-7,26807-65-8,Repr. 2,Notified C&L,65,H361:57;H319:5;H315:5;H302:3;H335:1;H332:2;H362:4;H400:1;H372:3;H410:1;H317:1;Not classified:1
38018,"Gases (petroleum), C2-return stream;Refinery gas;[A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydrogen with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contains predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.]",270-766-0,68477-84-9,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H350:0;H220:0;H340:0
38019,(E)-N-(6-chloro-pyridin-3-ylmethyl)-N-ethyl-N'-methyl-2-nitro-vinylidene-diamine,601-735-5,120738-89-8,Acute Tox. 4,Notified C&L,157,H302:157;H412:1
38020,N-isopropyl-3-(4-fluorophenyl)-1H-indole,418-790-4,93957-49-4,Aquatic Chronic 4,Harmonised C&L,0,H413:0
38025,(3-chloro-2-hydroxypropyl)dodecyldimethylammonium chloride,255-578-9,41892-01-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,97,H302:95;H318:10;H315:42;H310:55;H319:32;H410:32
38028,Cobalt molybdenum hydroxide oxide phosphate,268-586-2,68130-37-0,Not Classified,Notified C&L,1,Not classified:1
38029,Dysprosium,231-073-9,7429-91-6,Not Classified,REACH registration C&L,104,Not classified:25;H413:21;H315:21;H319:21;H251:21;H228:62;H250:17;H252:17;H260:17
38030,Diethyl isopentylmalonate,226-424-8,5398-08-3,Acute Tox. 4,Notified C&L,38,H302:38
38037,"9H-fluorene-9,9-diyldimethanol",610-170-3,4425-93-8,Not Classified,REACH registration C&L,40,Not classified:2;H302:38
38041,1-(4-tert-butylphenyl)-4-(4-hydroxypiperidin-1-yl)butan-1-one,619-298-4,97928-18-2,Acute Tox. 4,REACH registration C&L,2,H302:2
38043,"Thiodicarbonic diamide ([(H2N)C(S)]2S), tetramethyl-, reaction products with 1,2-oxathiolane 2,2-dioxide",271-560-3,68585-54-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,57,H302:56;H312:56;Not classified:1
38047,"O-methyl-N,N'-diisopropylisourea",259-275-2,54648-79-2,Flam. Liq. 3,Notified C&L,39,H226:39
38052,Leupeptin,600-443-5,103476-89-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,5,H302:3;H332:2;H312:2;H361:1;Not classified:1
38053,"1-Naphthalenediazonium, 8-hydroxy-3,6-disulfo-, hydroxide, inner salt, reaction products with 2-hydroxy-3,5-dinitrobenzenediazonium hydroxide inner salt, 4-nitrobenzenediazonium chloride and resorcinol, sodium salts",286-276-5,85203-84-5,Skin Irrit. 2,Notified C&L,1,H315:1
38058,1-amino-4-hydroxy-2-(2-phenoxyethoxy)anthraquinone,241-443-1,17418-59-6,Not Classified,Notified C&L,2,Not classified:2
38061,Metolazone,241-539-3,17560-51-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
38065,Di-tert-butyl sec-butylidene diperoxide,218-507-2,2167-23-9,Org. Perox. C;Aquatic Chronic 4,REACH registration C&L,97,H413:7;H242:59;H319:52;H315:90;H224:52;H318:38;H335:38;H240:38
38066,Diethyl disulphide,203-805-7,110-81-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,161,H319:91;H335:90;H315:87;H226:161;H411:1
38068,"N,N'-[6,13-diacetamido-2,9-diethoxy-3,10-triphenodioxazinediyl]bis(benzamide)",241-734-3,17741-63-8,Not Classified,REACH registration C&L,120,Not classified:120
38071,Cobalt boride,235-722-7,12619-68-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 1B,Notified C&L,42,H319:42;H350:38;H335:42;H315:42;H341:4
38074,"11-β,17-α-dihydroxypregn-4-ene-3,20-dione",211-375-7,641-77-0,Repr. 2;STOT RE 2,REACH registration C&L,3,H361:3;H373:3
38075,Hept-3-ene,209-769-9,592-78-9,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,43,H225:43;H304:39
38076,Uridine 5'-(disodium dihydrogen triphosphate),243-347-5,19817-92-6,Not Classified,Notified C&L,6,Not classified:5;H319:1;H315:1
38079,"Fatty acids, tallow, hydrogenated, reaction products with oleic acid and triethanolamine",269-912-6,68390-91-0,Not Classified,Notified C&L,22,Not classified:22
38080,"N,N-dimethylaminoacetohydrazide monohydrochloride",208-721-4,539-64-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
38082,3(or 5)-aminosalicylic acid,257-230-1,51481-17-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
38089,"2,5-Difluoroanisole",616-247-8,75626-17-4,,Notified C&L,7,H319:7;H335:5;H315:7;H226:7
38090,"(S)-1,1'-Binaphthalene-2,2'-diol",606-050-5,18531-99-2,Acute Tox. 3;Eye Irrit. 2,Notified C&L,49,H319:48;H301:45;H335:6;H315:8;H341:1;H311:1;H331:1
38091,laurylamine ethoxylated (>2.5 moles EO),608-569-2,31017-83-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 1,Notified C&L,36,H302:36;H318:36;H315:25;H410:25;H400:10;H412:10
38092,Dodecylbenzene,204-591-8,123-01-3,Aquatic Chronic 4,Notified C&L,115,H413:38;Not classified:56;H400:20;H315:20;H410:20;H304:1
38093,Pentaerythritol tetrabenzoate,224-079-8,4196-86-5,Not Classified,REACH registration C&L,564,Not classified:2;H302:562
38098,Taurine,203-483-8,107-35-7,Not Classified,REACH registration C&L,1708,Not classified:364;H319:1344;H335:1343;H315:1344
38099,"(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-12,4-triazol-1-yl)-2-butanol (1R)-10-camphorsulfonate",927-721-1,,Acute Tox. 3;Carc. 2;Repr. 1B,REACH registration C&L,2,H360:2;H301:2;H351:2
38101,C.I. Reactive Yellow 77,617-767-8,85854-36-0,Not Classified,Notified C&L,1,Not classified:1
38102,Diammonium hexachloroosmate,235-188-5,12125-08-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:46;H335:41;H315:46;H302:6;Not classified:3;H312:1;H332:1
38103,"Guanidine, monohydrofluoride",609-517-1,38078-70-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H302:1;H332:1;H315:1
38104,"Sodium 2,5-dichloro-4-[4-[[3-[(ethylphenylamino)sulphonyl]-p-tolyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate",276-114-1,71873-38-6,Aquatic Chronic 3,Notified C&L,43,H412:40;Not classified:3
38105,Tetraphenyl orthosilicate,214-638-4,1174-72-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H314:38
38108,sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate,410-150-2,147703-65-9,Skin Sens. 1,Harmonised C&L,0,H317:0
38111,sodium 2-amino-5-methylbenzenesulfonate,611-210-2,54914-95-3,Not Classified,Notified C&L,83,Not classified:83
38114,2-ethyl-6-methylpyrazine,237-692-0,13925-03-6,Acute Tox. 4,Notified C&L,155,H302:145;H226:42;Not classified:10;H335:1;H315:1;H319:1
38117,"2-Naphthalenesulfonic acid, 4-hydroxy-3-[(2-hydroxy-5-nitro-3- sulfophenyl)azo]-6-[(sulfomethyl)amino]-, trisodium salt",618-306-3,89806-58-6,Not Classified,REACH registration C&L,85,Not classified:2;H412:83
38118,Decahydroquinoline,218-116-7,2051-28-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H302:38;H335:38;H315:39
38119,"2,3-dihydro-1H-pyrrolo[1,2-a]benzimidazole",231-770-8,7724-48-3,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,85,H319:83;H302:84;H412:83;Not classified:1
38124,Zeolites,215-283-8,1318-02-1,Not Classified,Notified C&L,932,Not classified:790;H312:57;H319:59;H335:57;H373:11;H332:11;H315:20;H370:4;H372:5;H413:4;H350:2;H341:1
38125,"Propane-1,2-diol, monoformate",264-729-8,64202-75-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
38130,"9β,11β-epoxy-17,21-dihydroxypregna-1,4-diene-3,20-dione 21-acetate",254-079-3,38680-83-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B;Aquatic Chronic 3,REACH registration C&L,1,H335:1;H315:1;H360:1;H319:1;H412:1
38131,"2,6-difluoroaniline",226-853-0,5509-65-9,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,116,H302:113;H335:58;H315:63;H226:116;H319:63;H312:109;H332:109;H317:53;H311:5;H373:4;H331:5;H301:1
38132,Pefloxacine,274-611-8,70458-92-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H335:38;H315:38
38133,Alkyl (C16-18)polyethyleneglycol tetra decylene glycolether,619-192-8,96081-39-9,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,61,H317:52;H319:61;H411:61
38135,"3,6,9,12-tetra-azatetradecamethylenediamine;pentacthylenehexamine",223-775-9,4067-16-7,Skin Corr. 1B;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H314:0;H400:0;H410:0
38139,"1,1,1,3,3-pentachlorobutane",244-691-9,21981-33-9,Not Classified,REACH registration C&L,1,Not classified:1
38140,Dilithium selenide,235-230-2,12136-60-6,Water-react. 2;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H373:38;H261:38;H331:38;H301:38;H410:38
38145,"Guar gum, 2-hydroxypropyl ether",609-675-1,39421-75-5,Not Classified,Notified C&L,218,Not classified:180;H334:38
38153,Metharbital,200-011-2,50-11-3,,Notified C&L,1,H400:1
38154,Pullulan,232-945-1,9057-02-7,Not Classified,Notified C&L,12,Not classified:12
38157,"3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1)",246-590-5,25059-78-3,Aquatic Chronic 3,Harmonised C&L,0,H412:0
38159,5-isopropyl-2-methylphenetole,225-238-4,4732-13-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1414,H319:1326;H302:1287;H315:1326;Not classified:88;H335:39
38161,"21-hydroxypregn-4-ene-3,20-dione 21-heptanoate",215-820-6,1420-68-4,Repr. 1A;STOT RE 2,Notified C&L,24,H373:24;H360:24
38165,Ethyl 2-methylvalerate,254-384-1,39255-32-8,Flam. Liq. 3,REACH registration C&L,1857,H226:1856;H411:1;Not classified:1
38169,"[1S-(1α,4aα,5α,7α,7aα)]-1,4a,5,6,7,7a-hexahydro-4a,5,7-trihydroxy-7-methylcyclopenta[c]pyran-1-yl β-D-glucopyranoside",230-050-0,6926-08-5,Acute Tox. 4,Notified C&L,3,H302:3
38170,Ethyl ethynyl ether,213-164-5,927-80-0,Flam. Liq. 2;Asp. Tox. 1;STOT SE 3;Repr. 2;STOT RE 2,Notified C&L,45,H361:44;H225:45;H304:40;H373:44;H336:39;H315:6;H411:6;H312:1;H332:1;H351:1
38171,"Formaldehyde, polymer with methylphenol and phenol",618-543-2,9039-25-2,Skin Sens. 1B,Notified C&L,70,H317:62;H319:16;Not classified:8
38175,"1,4-diisopropylbenzene",202-826-9,100-18-5,Skin Irrit. 2,REACH registration C&L,63,H315:44;H413:39;H361:11;H335:11;H400:12;H410:12;H336:11;Not classified:5;H302:3;H332:3;H312:3;H319:1
38176,"1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12-pentacosafluoro-12-iodododecane",206-205-3,307-60-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:45;H315:45
38178,"1,3-diethyldihydro-2-thioxopyrimidine-4,6(1H,5H)-dione",226-010-7,5217-47-0,Acute Tox. 3;Skin Sens. 1,Notified C&L,39,H317:39;H301:39
38180,o-hydroxyphenylacetic acid,210-393-2,614-75-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,134,H319:134;H335:133;H315:134
38186,Octahydro-2H-1-benzopyran-2-one,224-623-4,4430-31-3,Eye Dam. 1,REACH registration C&L,1647,H318:116;H319:1288;Not classified:243;H302:24;H312:24
38187,"Distillates (petroleum), heavy thermal cracked, polymd., hydrogenated",618-177-3,88526-47-0,Not Classified,Notified C&L,68,Not classified:68
38189,2-methylindole,202-398-3,95-20-5,Eye Dam. 1,Notified C&L,139,H318:129;H302:9;H319:2;H335:2;H315:2;H332:1;H312:1;H410:1
38199,Iron(3+) acrylate,259-667-3,55488-18-1,,Notified C&L,5,H317:4;H319:1;H335:1;H315:1
38201,Piperidine-1-propanesulphonic acid,214-476-4,1132-60-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
38204,4-azoniaoctamethylenediammonium trichloride,206-379-0,334-50-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:47;H315:47
38207,"Alkenes, C24-54-branched and linear a-",603-486-8,131459-42-2,Aquatic Chronic 4,Notified C&L,128,H413:118;Not classified:10
38216,"Ethanaminium, N,N,N-trimethyl-2-[[](2-methyl-1-oxo-2-propen-1-yl)oxy]-, chloride (1:1), homopolymer",607-876-9,26161-33-1,Aquatic Chronic 2,Notified C&L,158,H411:98;H412:36;Not classified:23;H400:1;H410:1
38217,Sodium tantalum trioxide,234-799-4,12034-15-0,Not Classified,Notified C&L,1,Not classified:1
38219,Tannins,215-753-2,1401-55-4,Eye Irrit. 2,REACH registration C&L,2199,H319:1586;H412:544;Not classified:124;H315:38
38222,Diethylbenzene,246-874-9,25340-17-4,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Aquatic Chronic 1,REACH registration C&L,2004,H410:1070;H304:1936;H315:1984;H226:1657;H400:1012;H411:877;H319:672;H335:68;Not classified:14
38225,"Amines, N-tallow alkyltrimethylenedi-, dioleates",268-902-9,68153-99-1,Skin Irrit. 2;Eye Irrit. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,4,H400:4;H315:4;H373:4;H411:4;H319:4
38226,"Mixture of mono-, di- and triesters obtained with isooctadecanoic acid and hydrogenated castor oil",460-380-2,,Not Classified,REACH registration C&L,3,Not classified:3
38228,2-isobutylpyridine,228-606-2,6304-24-1,Flam. Liq. 3,Notified C&L,94,H226:88;H319:6;H335:6;H315:6;H302:1
38232,Methyl 3-[(2-methoxy-2-oxoethyl)thio]propionate,231-002-1,7400-45-5,Flam. Liq. 3,Notified C&L,49,H226:49
38235,Tioguanine,205-827-2,154-42-7,Acute Tox. 3,Notified C&L,47,H301:46;H341:7;H351:3;H350:1;H400:2;H360:3;H340:1;H371:1;H410:2;H319:1;H315:1;H302:1
38240,"3,4-dihydroxybenzoic acid",202-760-0,99-50-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,168,H319:136;H335:135;H315:136;H411:32
38241,Dodecyl isobutyrate,229-583-1,6624-71-1,Not Classified,Notified C&L,88,Not classified:88
38245,butyl butyrate,203-656-8,109-21-7,Flam. Liq. 3,Harmonised C&L,0,H226:0
38250,"(S,S)-(+)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II)",606-134-1,188264-84-8,Acute Tox. 4;Acute Tox. 3;Acute Tox. 4,Notified C&L,39,H311:38;H302:38;H332:38;Not classified:1
38251,"1,1,1,3,3-Pentafluoropropane (R245fa)",610-280-1,460-73-1,Not Classified,Notified C&L,150,Not classified:64;H336:47;H319:39
38252,.alpha.-2-propen-1-yl-.omega.-hydroxypoly[oxy(methylethylene)],618-551-6,9042-19-7,Eye Dam. 1,Notified C&L,629,H318:486;H302:101;Not classified:42
38255,"4,4'-methylenedi-o-toluidine",212-658-8,838-88-0,Acute Tox. 4;Skin Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H350:0;H400:0;H317:0;H410:0
38257,"2,4-Dinitro-6-(1-methylheptyl)phenol",481-830-4,3687-22-7,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 1,Notified C&L,55,H315:55;H317:55;H318:55;H301:55;H410:55
38259,Isopentyl butyrate,262-226-8,60415-61-4,Not Classified,Notified C&L,152,Not classified:88;H226:64
38266,(6L)lithium fluoride,238-958-9,14885-65-5,Acute Tox. 3;Repr. 2;Lact.,Notified C&L,40,H361:39;H362:39;H301:40;H319:1;H335:1;H315:1
38267,"2,2,3,3,4,4,5,5,6,6,7,7,7-tridecafluoroheptan-1-ol",206-796-8,375-82-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:2;H315:3
38271,3-oxo-4-azaandrost-5-ene-17β-carboxylic acid,407-830-6,103335-54-2,Aquatic Chronic 2,REACH registration C&L,4,H411:2;Not classified:2
38274,"Linseed oil, maleated",268-897-3,68153-83-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,90,H319:83;H318:83;H315:83;Not classified:7
38275,"Slags, precious metal refining",308-515-5,98072-60-7,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;Carc. 1A;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,20,H350:20;H400:20;H317:20;H318:20;H360:20;H314:20;H410:20;H301:20;H372:20;H332:20
38278,"O,O,O-triphenyl phosphorothioate",209-909-9,597-82-0,Not Classified,REACH registration C&L,1118,Not classified:97;H361:863;H413:545;H412:30
38279,cobalt oxide,215-154-6,1307-96-6,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H302:0;H400:0;H410:0
38282,N-methyl-m-anisidine,238-259-9,14318-66-2,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H317:38;H302:38
38284,2-[(4-chloro-2-nitrophenyl)azo]-N-(4-ethoxyphenyl)-3-oxobutyramide,257-848-1,52320-66-8,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,20,H400:3;H410:3;Not classified:17
38285,"Birch, Betula alba, ext.",281-660-9,84012-15-7,Not Classified,Notified C&L,158,Not classified:100;H226:58;H319:1
38286,Barium chromate,233-660-5,10294-40-3,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 2;Resp. Sens. 1;Muta. 1B;Carc. 1A;Repr. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,483,H361:8;H350:72;H400:60;H311:8;H317:84;H334:24;H340:8;H410:71;H301:90;H372:14;H330:7;H302:371;H332:443;H272:76;H413:16;H335:16;H315:16;H351:16;H319:16;H341:16;H331:10;H271:10;H226:1;H412:1
38287,Piprinhydrinate,210-128-0,606-90-6,Acute Tox. 4,Notified C&L,3,H302:3
38288,"Phosphoric acid, mono (2-ethylhexyl) ester, polymer with oxirane",614-521-1,68460-10-6,Eye Irrit. 2,Notified C&L,6,H319:5;H314:1
38289,"5-nitro-1,2,4-trichlorobenzene",201-931-7,89-69-0,Acute Tox. 3;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,72,H400:38;H312:38;H301:38;H410:38;H332:38;Not classified:33;H302:1
38292,"3-Amino-tricyclo[3,3,1,13,7]decan-1-ol",450-050-6,,Eye Dam. 1,REACH registration C&L,2,H318:2;H313:1
38293,"(α,α,α-trifluoro-4-tolyl)acetic acid",251-263-5,32857-62-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47
38299,N-ε-methyl-L-lysine hydrochloride,231-539-1,7622-29-9,Eye Irrit. 2,Notified C&L,38,H319:38
38302,Ammonium dinitroazanide,453-090-2,,Expl. 1.3;Acute Tox. 4,REACH registration C&L,1,H302:1;H203:1
38304,Magnesium dipropionate,209-166-0,557-27-7,Not Classified,Notified C&L,5,Not classified:5
38306,(12E)-1-oxacyclohexadec-12-en-2-one,634-655-4,111879-80-2,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,161,H400:161;H410:161;H411:24
38307,"5-amino-2-[2-(4-nitro-2-sulphophenyl)vinyl]benzenesulphonic acid, sodium salt",284-133-1,84787-94-0,Not Classified,Notified C&L,1,Not classified:1
38311,"Lard, chlorinated",304-829-1,94279-83-1,Skin Irrit. 2;STOT SE 3,Notified C&L,84,H335:83;H315:83;H317:1
38313,(R)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol,929-946-0,,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2A,REACH registration C&L,2,H317:1;H319:1;H302:1;H301:1
38315,(Z)-non-3-en-1-ol,233-735-2,10340-23-5,Not Classified,Notified C&L,126,Not classified:78;H319:48
38316,4-hydrazinobenzenesulphonic acid,202-694-2,98-71-5,,Notified C&L,7,H319:6;H302:5;H335:6;H315:6;H318:1;H314:1
38319,"1,2-Diaminotoluene, ethoxylated and propoxylated.",614-144-2,67800-94-6,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,142,H319:142;H302:87
38321,"Soybean oil, Me ester",267-055-2,67784-80-9,Not Classified,Notified C&L,344,Not classified:307;H319:23;H317:14;H315:2
38327,"β-d-Glucopyranoside, 1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl, 6-(3-phenyl-2-propenoate), [1aS-[1aα,1bβ,2β(E),5aβ,6β,6aα]]-",248-445-1,27409-30-9,Acute Tox. 4,Notified C&L,1,H302:1
38332,"Dipotassium dihydrogen 4-[5-[3-carboxylato-5-hydroxy-1-(4-sulphonatophenyl)-1H-pyrazol-4-yl]penta-2,4-dienylidene]-4,5-dihydro-5-oxo-1-(4-sulphonatophenyl)-1H-pyrazole-3-carboxylate",257-479-6,51858-17-4,Self-heat. 2;Aquatic Chronic 3,REACH registration C&L,42,H252:2;H412:4;H319:38;H335:38;H315:38
38343,Clomipramine,206-144-2,303-49-1,Acute Tox. 4;STOT SE 3;STOT SE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,42,H302:42;H400:4;H370:4;H410:4;H336:4
38345,"3-amino-5-(2-hydroxyethylcarbamoyl)-2,4,6-triiodobenzoic acid",607-173-7,22871-58-5,Skin Sens. 1,REACH registration C&L,2,H317:2
38356,Cinnamic acid,210-708-3,621-82-9,Not Classified,Notified C&L,1641,Not classified:1631;H319:9;H315:6
38361,(S)-4-[1-hydroxy-2-(methylamino)ethyl]pyrocatechol,205-752-5,150-05-0,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,2,H330:1;H300:1;H310:2;H412:1;H331:1;H301:1
38372,Potassium propan-2-olate,229-909-2,6831-82-9,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT SE 3,REACH registration C&L,101,H302:13;H225:12;H318:95;H314:101;H336:12;H228:88
38374,Ligusticum chuanxiong dry purified extract,453-160-2,,Aquatic Chronic 3,Notified C&L,1,H412:1
38375,"2,3-di-3-pyridylbutane-2,3-diol",225-649-9,4989-59-7,Not Classified,Notified C&L,1,Not classified:1
38376,Amidinouronium hydrogen sulphate,226-269-6,5338-16-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
38379,2-hydroxydecanoic acid,611-068-1,5393-81-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
38380,"Oils, fish, sulfonated",309-814-3,101200-46-8,Eye Irrit. 2,Notified C&L,1,H319:1
38381,Hexafluoroglutaryl difluoride,211-652-2,678-78-4,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,1,H311:1;H331:1;H302:1;H314:1
38388,1-acetyl-2-imidazolidinone,226-388-3,5391-39-9,,Notified C&L,6,Not classified:2;H319:3;H302:3;H315:3;H335:1
38391,"Oils, herring, stearins",296-484-8,92704-51-3,Not Classified,Notified C&L,1,Not classified:1
38394,"Slags, steelmaking, elec. furnace",294-410-9,91722-10-0,Not Classified,Notified C&L,1,Not classified:1
38395,"(5α,6β)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",208-101-3,509-64-8,Acute Tox. 3;Acute Tox. 3,Notified C&L,2,H331:1;H301:1;H302:1
38400,"9,10-dihydroxystearic acid",204-432-2,120-87-6,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,42,H302:38;H413:38;Not classified:2;H319:2;H335:2;H315:2
38403,"Hexasodium 4',4'''-bis(4-sulphonatophenylazo)-1,1''-dihydroxy-6,6''-[(6-morpholino-1,3,5-triazine-2,4-diyl)diimino]bis(naphthalene-2-azobenzene-2',3-disulfonate)",433-950-3,,Not Classified,REACH registration C&L,39,Not classified:39
38404,"Phosphonic acid, (hydroxymethyl)-, ethoxylated",614-830-1,68951-50-8,Not Classified,Notified C&L,1,Not classified:1
38406,5-Fluoro-2-methylbenzoic Acid,608-840-5,33184-16-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H335:47;H315:48
38409,"Benzyldimethyl(tetradecyl)ammonium, salt with 1,2-benzisothiazol-3(2H)-one 1,1-dioxide (1:1)",245-813-3,23661-75-8,Not Classified,Notified C&L,3,Not classified:3
38410,"3-[[9,10-dihydro-9,10-dioxo-4-[(p-tolyl)amino]-1-anthryl]aminopropyl]trimethylammonium methyl sulphate",276-896-4,72828-93-4,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H317:1;H318:1;H400:1;H410:1
38411,Zinc neodecanoate,248-370-4,27253-29-8,Aquatic Chronic 3,REACH registration C&L,539,H412:108;H315:242;Not classified:85;H319:107;H302:56;H411:51;H335:13;H410:14;H373:1;H400:1
38414,Allyl hexanoate,204-642-4,123-68-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,1623,H400:1293;H311:1576;H331:1246;H412:1293;H301:1538;H410:166;H319:173;H315:223;H411:210;H302:84;H312:45;H226:24;H335:1;H332:1;H225:1
38415,2-(trimethylsilyl)ethanol,220-844-5,2916-68-9,Flam. Liq. 3,Notified C&L,54,H226:54;H319:6;H335:5;H315:6;Not classified:2
38418,"Phenol, 2-nonyl-, branched",294-048-1,91672-41-2,Acute Tox. 4;Skin Corr. 1B;Repr. 2;Repr. 2,Notified C&L,57,H361:53;H302:53;H314:53;H400:33;H318:20;H410:33;Not classified:4;H335:1
38420,"octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate",412-960-1,148878-21-1,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H318:0;H412:0
38421,"Soybean oil, epoxidized, reaction products with methanol",287-837-7,85586-35-2,Not Classified,REACH registration C&L,89,Not classified:89
38423,"3,7-bis(ethylamino)-2,8-dimethylphenothiazin-5-ium chloride, compound with zinc chloride",229-516-6,6586-05-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
38424,"N,N-dimethyldocosylamine",244-433-5,21542-96-1,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,97,H302:90;H314:97;H400:90;H410:53;H318:37;H317:7
38425,"fluazinam (ISO);3-chloro-N-[3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine",616-712-5,79622-59-6,Eye Dam. 1;Skin Sens. 1A;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H361:0;H400:0;H317:0;H318:0;H410:0;H332:0
38431,Lead oxide sulfate,234-853-7,12036-76-9,Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,6,H302:1;H400:1;H360:6;H362:1;H410:1;H372:1;H332:6;H351:6;H341:5;H373:5
38433,1-methoxyoctane,213-201-5,929-56-6,,Notified C&L,1,H319:1;H315:1
38434,Carrageenan,232-524-2,9000-07-1,Not Classified,Notified C&L,342,Not classified:301;H351:21;H319:20
38436,"Polymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N,N-di-2-propenylformamide",404-035-6,,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
38437,"1-(2,4,4,5,5-pentamethyl-1-cyclopenten-1-yl)ethan-1-one",236-080-0,13144-88-2,Not Classified,Notified C&L,88,Not classified:54;H317:34
38439,Diphenyliodonium nitrate,211-962-8,722-56-5,Ox. Sol. 2,Notified C&L,76,H272:76;H335:4;H315:4;H319:4;H301:4
38441,"Sulfuric acid, mono-C12-15-alkyl esters, sodium salts",272-575-8,68890-70-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,479,H318:477;H315:477;Not classified:2
38443,Fluoroglycofen-ethyl,616-467-4,77501-90-7,Acute Tox. 4,Notified C&L,38,H302:38
38445,Pentasodium 4-hydroxy-7-[[4-[2-(4-nitro-2-sulphonatophenyl)vinyl]-3-sulphonatophenyl]azo]-3-[[2-sulphonato-4-[(4-sulphonatophenyl)azo]phenyl]azo]naphthalene-2-sulphonate,305-573-3,94713-29-8,Not Classified,Notified C&L,2,Not classified:2
38446,2-bromo-4'-nitroacetophenone,202-789-9,99-81-0,Skin Corr. 1B,Notified C&L,48,H314:48;H318:2
38447,Ytterbium(3+) perchlorate,236-823-9,13498-08-3,,Notified C&L,4,H319:4;H272:4;H335:4;H315:4
38448,(2R)-2-amino-2-phenylacetamide,420-370-0,6485-67-2,Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H317:0;H319:0
38452,327 QRN,424-580-3,,Not Classified,Notified C&L,1,Not classified:1
38456,"2-(1-H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate",423-040-4,125700-67-6,Flam. Sol. 2;Acute Tox. 4,REACH registration C&L,18,H228:9;H302:3;H319:15;H335:15;H315:15;H318:1;H314:1
38458,"PHOSPHORIC ACID ESTER, NEUTRALIZED",614-846-9,68954-84-7,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,218,H319:199;H411:196;H315:218;H318:19
38464,"1,4-phenylenebis[chlorodimethylsilane]",214-086-4,1078-97-3,Skin Corr. 1B,Notified C&L,38,H314:38
38467,Imidazole hydrobromide,483-310-2,,Not Classified,Notified C&L,1,Not classified:1
38470,Butylchlorodihydroxystannane,236-406-1,13355-96-9,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,74,H400:2;H410:2;H302:39;H335:69;H315:64;H319:39;H312:39;H332:39;H318:32;H314:5;Not classified:1
38477,Glycerol monomyristate,248-329-0,27214-38-6,Not Classified,REACH registration C&L,31,Not classified:31
38478,3-methylbenzothiazole-2(3H)-selone,220-506-7,2786-43-8,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H373:38;H331:38;H301:38;H410:38
38479,"2,6-dimethylpyridin-3-ol",214-348-8,1122-43-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
38481,Octan-2-one oxime,230-586-5,7207-49-0,Acute Tox. 3,Notified C&L,38,H301:38
38487,2-amino-N-cyclohexyl-N-methylbenzylamine,260-701-4,57365-08-9,Not Classified,REACH registration C&L,42,Not classified:2;H319:39;H335:39;H315:39;H317:1;H318:1;H314:1
38491,p-menth-3-ene,207-896-4,500-00-5,Not Classified,Notified C&L,88,Not classified:88
38492,"1,2,3,4-tetrachloro-5,5-dimethoxycyclopenta-1,3-diene",218-623-3,2207-27-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
38493,"1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-heptadecafluoro-10-iododecane",218-053-5,2043-53-0,,Notified C&L,130,Not classified:84;H319:46;H335:45;H315:46;H311:1;H331:1;H301:1
38494,"Zinc, dross",273-694-8,69011-50-3,Not Classified,Notified C&L,2,Not classified:2
38495,"Poly(oxy-1,2-ethanediyl), alpha-phosphono-omega-(methylphenoxy)-, dipotassium salt",613-877-5,66057-30-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,23,H319:23;H315:23
38496,5-fluorouridine,206-260-3,316-46-1,,Notified C&L,3,H302:2;H332:2;H351:2;H312:1;H341:1
38497,(4-aminophenylthio)acetic acid,203-182-1,104-18-7,Acute Tox. 3;Resp. Sens. 1,Notified C&L,43,H334:38;H301:38;H319:5;H335:5;H315:5
38500,p-tolyl 3-methylcrotonate,246-422-0,24700-20-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,88,H302:88;H312:88
38501,"5-(Hydroxymethyl)-1,3-thiazole",609-565-3,38585-74-9,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,164,H318:161;H412:161;H314:1;H302:1;H335:2;H315:2;H319:2;H312:1;H332:1
38505,"Leach residues, zinc ore, germanium-contg.",293-313-9,91053-48-4,Not Classified,Notified C&L,1,Not classified:1
38506,"Tetrahydro-2,7a-dimethyl-7aH-oxazolo[2,3-b]oxazole",247-805-5,26562-68-5,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
38508,Pyrrolidine-1-propiononitrile,247-493-0,26165-45-7,Acute Tox. 3,Notified C&L,44,H301:38;H302:5;H315:6;H319:6;H312:5;H332:5;H335:2
38509,"6,7-dihydrodipyrido[1,2-α:2',1'-c]pyrazinediylium dihydroxide",301-467-6,94021-76-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 2;STOT SE 3;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H335:0;H315:0;H400:0;H317:0;H319:0;H410:0;H372:0;H330:0
38512,Asphalt,232-490-9,8052-42-4,Not Classified,REACH registration C&L,702,Not classified:687;H319:15;H315:15
38513,1-(3-(p-tertbutylbenzoyl)-propyl)-4-hydroxypiperidine fumarate,619-300-3,97928-19-3,Eye Dam. 1,REACH registration C&L,1,H318:1
38517,"Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, Me 3-(2-oxiranylmethoxy)propyl, ethers with polyethylene-polypropylene glycol mono-Me ethers",600-240-1,101810-98-4,Not Classified,Notified C&L,1,Not classified:1
38519,"Slags, copper refining",266-970-4,67711-94-8,Acute Tox. 4;Skin Sens. 1;Carc. 1A;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,10,H302:10;H350:10;H400:10;H317:10;H360:10;H411:10;H410:10;H372:10
38521,3-amino-4-hydroxy-N-phenylbenzenesulphonamide,201-258-9,80-20-6,Aquatic Chronic 4,REACH registration C&L,2,H413:1;Not classified:1
38523,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, aminosulfonyl sulfo derivs., ammonium sodium salts, compds. with 2-(diethylamino)ethanol",278-182-8,75300-76-4,Not Classified,Notified C&L,1,Not classified:1
38524,"Dihydro-3-(2-tetradecenyl)furan-2,5-dione",259-153-9,54405-64-0,Not Classified,Notified C&L,1,Not classified:1
38525,"2,4,6-Tri(sec-butyl)phenol, polyglycol ether, monosulfate ester, sodium salt",600-933-9,109909-39-9,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,262,H318:262;H412:201;H411:61;H315:61
38527,Bis(2-ethoxyethyl) ether,203-963-7,112-36-7,Skin Irrit. 2,REACH registration C&L,353,H315:141;H319:190;Not classified:21;H226:1
38529,(2S)-2-Methylpyrrolidine-2-carboxylic acid,610-068-9,42856-71-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
38533,"(E)-3,7-dimethylocta-2,6-diene-1-thiol",254-269-6,39067-80-6,Not Classified,Notified C&L,121,Not classified:94;H317:25;H226:26;H335:2
38534,"1,1,1-Tri((1,3-dioxobutoxy)-methyl)-propane",422-630-9,,Not Classified,Notified C&L,1,Not classified:1
38537,"Isomerase, glucose",232-944-6,9055-00-9,Resp. Sens. 1,Notified C&L,6,H334:6
38542,"1-decanaminium, N-(2-hydroxyethyl)-N,N-dimethyl-, chloride (1:1)",620-235-8,28228-56-0,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;STOT RE 2;Aquatic Acute 1,Notified C&L,8,H302:8;H400:8;H315:8;H311:8;H373:8
38543,"Benzenesulfonic acid, C14-24-branched and linear alkyl derivatives, calcium salts, overbased",601-385-3,115733-10-3,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,36,H317:36;H319:36;H302:36;H334:36
38546,Poly(propylene glycol) diacrylate,610-852-0,52496-08-9,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,86,H317:53;H318:52;H315:54;Not classified:32;H319:2;H335:1;H411:1
38555,"1,2-benzisothiazol-3(2H)-one 1,1-dioxide, calcium salt",229-349-9,6485-34-3,Not Classified,Notified C&L,2,Not classified:2
38556,"Tar bases, coal, collidine fraction;Distillate Bases;[The distillation fraction boiling in the range of approximately 181 °C to 186 °C (356 °F to 367 °F) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.]",295-543-5,92062-28-7,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
38557,"1-(3,4-dimethoxyphenyl)acetone",212-285-0,776-99-8,,Notified C&L,1,H319:1;H335:1;H315:1
38562,2-butyl-5-nitro-1-benzofuran,603-723-5,133238-87-6,Skin Corr. 1A;Eye Dam. 1,Notified C&L,2,H318:1;H314:2;H226:1
38567,"2,5-dichlorobenzylic alcohol",251-850-6,34145-05-6,,Notified C&L,4,H319:4;H335:4;H315:4
38568,"5,5'-diisopropyl-2,2'-dimethylbiphenyl-4,4'-diyl dihypoiodite",209-007-5,552-22-7,Skin Sens. 1B,REACH registration C&L,43,H317:2;H302:41
38570,Dodecan-2-ol,233-500-4,10203-28-8,Skin Irrit. 2,Notified C&L,1,H315:1
38573,"Phosphoric acid, iron(2+) lithium salt (1:1:1)",476-700-9,15365-14-7,Not Classified,REACH registration C&L,39,Not classified:39
38574,"2,5-diamino-4-chloronitrobenzene",247-515-9,26196-45-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H302:1;H315:1;H319:1;H312:1;H332:1
38578,"4'-bromo-α-(phenylmethyl)[1,1'-biphenyl]-4-methanol",262-163-6,60313-17-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 1,Notified C&L,1,H335:1;H315:1;H317:1;H319:1;H410:1
38581,"Gases (petroleum), C4-rich;Petroleum gas;[A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]",270-767-6,68477-85-0,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H350:0;H220:0;H340:0
38584,2-hydroxyethylammonium perbromide,407-440-6,,Ox. Sol. 2;Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Aquatic Acute 1,Harmonised C&L,0,H302:0;H400:0;H317:0;H314:0;H272:0
38586,"4,6-Pteridinedione, 2-amino-1,5-dihydro-, monohydrate",611-886-9,5979-01-1,Not Classified,Notified C&L,1,Not classified:1
38587,Sodium barbiturate,224-507-3,4390-16-3,Not Classified,Notified C&L,1,Not classified:1
38589,aluminium powder (pyrophoric);aluminium powder (stabilised),231-072-3,7429-90-5,,,0,H228:0;H261:0
38592,"diethyl pyridine-2,4-dicarboxylate",680-341-5,41438-38-4,Eye Irrit. 2,REACH registration C&L,2,H319:2
38598,(5-chloro-2-methoxyphenyl)boronic acid,923-256-3,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
38601,"11-(anthraquinon-1-ylamino)anthra[2,1,9-mna]naphth[2,3-h]acridine-5,10,15(16H)-trione",276-361-5,72138-96-6,Not Classified,Notified C&L,9,Not classified:9
38602,(R)-(+)-N ALPHA-DIMETHYLBENZYLAMINE,611-818-8,5933-40-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,39,H302:39;H314:39;H312:39;H332:39
38605,Pyridine-2-carboxylic acid hydrochloride,211-266-4,636-80-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
38608,1-amino-4-hydroxy-2-phenoxyanthraquinone,241-442-6,17418-58-5,Skin Sens. 1A,REACH registration C&L,378,H317:133;Not classified:187;H319:55;H315:8;H412:1;H318:1;H413:2
38611,"Adenosine 5'-(hexahydrogen pentaphosphate), 5'→5'-ester with adenosine, trilithium salt",278-237-6,75522-97-3,Not Classified,Notified C&L,1,Not classified:1
38613,"Bis[[6-anilino-4-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonic acid, compound with 2,2',2''-nitrilotriethanol (1:2)",267-248-1,67828-26-6,Not Classified,Notified C&L,1,Not classified:1
38619,3-propylbicyclo[2.2.1]hept-5-ene-2-carbaldehyde,254-268-0,39067-39-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,260,H319:260;H315:260;H317:1
38621,Isopentyl 2-butenoate,246-958-5,25415-77-4,Not Classified,Notified C&L,89,Not classified:89
38622,Dipentyl hydrogen phosphate,221-537-9,3138-42-9,Skin Corr. 1C;Eye Dam. 1,Notified C&L,485,H318:448;H314:480;H332:7;Not classified:5
38626,"9-Octadecenoic acid (Z)-, reaction products with 3-(dodecenyl)dihydro-2,5-furandione and triethylenetetramine",270-840-2,68478-81-9,Not Classified,Notified C&L,71,Not classified:38;H361:22;H315:32;H412:7;H319:3;H335:3
38628,"4,4'-[1,2-ethanediylbis(oxy)]bisbenzoic acid",223-155-8,3753-05-7,Skin Sens. 1;Aquatic Acute 1,Notified C&L,38,H317:38;H400:38
38629,"Dioleic acid, diester with hexaglycerol",278-358-4,76009-37-5,Not Classified,Notified C&L,3,Not classified:3
38630,"Isohexadecane 2,2,4,4,6,8,8-heptamethylnonane",224-506-8,4390-04-9,Asp. Tox. 1,REACH registration C&L,103,H304:78;H350:36;H315:36;H311:36;H319:36;H301:36;Not classified:27;H332:2
38633,2-(4-chlorophenyl)-2-oxoethyl thiocyanate,242-972-0,19339-59-4,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H317:38;H302:38
38643,"1,2-Difluor-3-propoxybenzol",603-008-8,124728-93-4,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,Not classified:1;H302:1;H400:1;H410:1
38647,Trisodium hydrogen (1-hydroxyethylidene)bisphosphonate,220-200-3,2666-14-0,Acute Tox. 4,Notified C&L,1,H302:1
38648,"2-ethyl-3,5-dimethylpyrazine",237-694-1,13925-07-0,Acute Tox. 4,Notified C&L,1596,H302:1595;H319:38;H315:38;Not classified:1
38650,Liothyronine,229-999-3,6893-02-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,171,H319:169;H335:168;H315:169;H302:1;H373:1
38655,"3-(2,4-Dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one",603-960-4,136426-54-5,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 3;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,194,H400:194;H315:194;H331:194;H312:194;H410:194;H301:194;H372:194
38658,Sodium hydrogencarbonate,205-633-8,144-55-8,Not Classified,REACH registration C&L,6767,Not classified:6729;H319:38;H335:4;H315:4;H318:2;H332:3
38660,"Benzenamine, 2-fluoro-4-iodo-",608-384-7,29632-74-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:46;H335:44;H315:46;H302:6;H312:2;H332:2;H311:1;H331:1;H301:1
38663,Metenolone enantate,206-141-6,303-42-4,Acute Tox. 4;Carc. 2;Repr. 1A;Lact.,Notified C&L,24,H362:24;H302:24;H360:24;H351:24
38664,"trans-(1R,2S)-2-(3,4-difluorophenyl-cyclopropanaminium (2R)-2-hydroxy-2-phenylethanoate",454-140-6,,Acute Tox. 3;Skin Sens. 1;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,4,H317:4;H373:4;H411:4;H301:4;H302:1;H341:1
38666,Ditetradecyl peroxydicarbonate,258-436-4,53220-22-7,Org. Perox. D;Skin Sens. 1,REACH registration C&L,60,H317:4;H242:60;H319:52;H315:52
38668,4-Chloro-2-fluoro-1-iodobenzene,614-191-9,6797-79-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:43;H315:45
38670,"Disodium [4-[4,5-dihydro-4-[[2-hydroxy-5-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonato(4-)]cuprate(2-)",259-032-0,54227-68-8,Not Classified,Notified C&L,6,Not classified:6
38671,Bis(2-hydroxyethyl) azelate,249-723-5,29602-44-6,Not Classified,Notified C&L,22,Not classified:22
38672,2-bromohexane,222-173-3,3377-86-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,17,H319:11;H335:11;H315:11;H226:17
38674,α-2-dibromotoluene,222-334-8,3433-80-5,Skin Corr. 1B,Notified C&L,48,H314:48;H302:1;H318:1;H290:1
38675,Choline hydrogen carbonate,201-137-0,78-73-9,Not Classified,REACH registration C&L,153,Not classified:7;H319:146;H302:84;H335:61;H315:62
38676,"Fatty acids, C9-13-neo-",273-114-3,68938-07-8,Aquatic Chronic 3,REACH registration C&L,9,H412:8;H302:4;Not classified:1
38677,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[[4-[[(3,4-dichlorophenyl)sulfonyl]amino]phenyl]sulfonyl]amino]-, disodium salt",611-736-2,58727-01-8,Acute Tox. 3;Aquatic Chronic 2,Notified C&L,20,H411:20;H301:20
38681,"Copolymer of hexane-1,6-diisocyanate, methanol and oxirane",924-503-8,160994-68-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H317:1;H334:1
38685,"Poly(oxy-1,2-ethanediyl), alpha-sulfo-omega-(nonylphenoxy)-, branched, ammonium salt",614-698-5,68649-55-8,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,817,H319:652;H226:443;H318:328;H411:361;H315:361;H412:13
38686,MD-Abgasvorlage B1007,922-240-3,,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3;Carc. 1B;Aquatic Chronic 2,Notified C&L,1,H302:1;H225:1;H335:1;H315:1;H350:1;H317:1;H318:1;H411:1;H312:1
38690,"Oils, salmon, oleins",296-758-7,93028-65-0,Not Classified,Notified C&L,1,Not classified:1
38691,"(R)-(-)-5-(trans-4-Propylcyclohexyl)-5,6-dihydro-4H-dinaphtho[2,1-f:1',2'-h][1,5]dioxonin",918-758-4,,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
38694,"Poly(oxy-1,2-ethanediyl), α-(4-nonylphenyl)-ω-hydroxy-, branched, phosphates",604-825-2,152143-22-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
38697,4-oxopiperidinium chloride,255-602-8,41979-39-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
38700,9-bromoanthracene,216-359-3,1564-64-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:2;H335:2;H315:2;H341:1;Not classified:1
38702,Tetrahydro-2-methylthiophene,217-270-2,1795-09-1,,Notified C&L,5,H302:4;H335:4;H315:4;H226:4;H319:4;H225:1
38704,"3,4,5-trifluoro-4'-(trans-4-propylcyclohexyl)-[1,1'-biphenyl]",603-547-9,132123-39-8,Not Classified,REACH registration C&L,1,Not classified:1
38705,1-ethyl-2-(nitromethylene)pyrrolidine,247-494-6,26171-04-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
38707,Dipropylaminoacetonitrile,241-978-0,18071-35-7,Acute Tox. 4,Notified C&L,38,H302:38
38709,2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-5-methoxy-3-methylbenzothiazolium methyl sulphate,273-039-6,68929-07-7,Eye Irrit. 2,Notified C&L,2,H319:2
38710,ethyl chloroacetate,203-294-0,105-39-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1,Harmonised C&L,0,H311:0;H331:0;H400:0;H301:0
38711,Ethyl isocyanatoacetate,220-967-4,2949-22-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,47,H302:45;H335:45;H315:45;H317:41;H334:46;H319:46;H332:4;H311:1;H331:2;H301:2
38712,Disodium C-[2-[2-[(1-oxooctadec-9-enyl)amino]ethoxy]ethyl] sulphonatosuccinate,260-143-1,56388-43-3,Eye Dam. 1,Notified C&L,28,H318:28
38715,(2H)formaldehyde,216-775-5,1664-98-8,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;Resp. Sens. 1;Carc. 2,Notified C&L,38,H315:38;H311:38;H317:38;H318:38;H334:38;H331:38;H301:38;H351:38
38719,Oxalacetic acid,206-329-8,328-42-7,Eye Irrit. 2,REACH registration C&L,60,H319:5;H314:55;H318:2;H290:1
38720,Bentone EW,618-268-8,89382-86-5,Not Classified,Notified C&L,83,Not classified:83
38723,"3-Buten-2-one, 4-(tetrahydro-2H-thiopyran-3-yl)-",619-067-8,94723-63-4,Not Classified,Notified C&L,83,Not classified:83
38725,Dextromethorphan,204-752-2,125-71-3,Acute Tox. 3,Notified C&L,76,H301:39;Not classified:36;H302:1;H411:1
38731,Rolitetracycline,212-031-9,751-97-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H335:38;H315:38
38733,Tetraisothiocyanatosilane,229-460-2,6544-02-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Acute Tox. 4,Notified C&L,1,H302:1;H318:1;H314:1;H312:1;H332:1
38736,"m-Phenylenebis(methylamine), oligomeric reaction products with 1,6-bis(2,3-epoxypropoxy) hexane and butyl 2,3-epoxypropyl ether",500-684-5,162303-48-2,Not Classified,Notified C&L,22,Not classified:22
38737,"3,4-difluorobenzamide",285-656-8,85118-04-3,,Notified C&L,6,H319:6;H335:5;H315:6
38738,"fipronil (ISO);(±)-5-amino-1-(2,6-dichloro-α,α,α-trifluoro-para-tolyl)-4-trifluoromethylsulfinyl-pyrazole-3-carbonitrile",424-610-5,120068-37-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H311:0;H331:0;H410:0;H301:0;H372:0
38739,"Addition reaction of M-tolylidene diisocyanate, 2-hydroxyethyl methacrylate, 2-(2-butoxyethoxy)ethanol and 2-dimethylaminoethanol",925-517-7,,Not Classified,Notified C&L,71,Not classified:71
38742,"menadione sodium bisulfite;2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt",204-987-0,130-37-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H319:0;H400:0;H315:0;H410:0
38744,"1-([1,1'-biphenyl]-4-yloxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-one",256-102-2,43121-37-5,,Notified C&L,1,Not classified:1
38752,"6-[2-(2-methyl-1H-imidazol-1-yl)ethyl]-1,3,5-triazine-2,4-diamine",254-074-6,38668-46-1,Repr. 1B,REACH registration C&L,263,H360:3;Not classified:243;H302:14;H318:14;H413:2;H319:1;H315:1
38757,"Pentaerythritol, propoxylated",500-030-9,9051-49-4,Not Classified,REACH registration C&L,357,Not classified:328;H319:29;H315:29
38762,"Pregna-4,17(20)-diene-3,16-dione, (17Z)-",609-604-4,39025-23-5,Skin Irrit. 2,Notified C&L,40,H315:38;H335:2
38763,"Hexa-1,6-diyl diisocyanide",213-202-0,929-57-7,Acute Tox. 3;Eye Irrit. 2;Acute Tox. 3,Notified C&L,38,H311:38;H319:38;H331:38
38765,2-(dimethylamino)ethanethiol hydrochloride,236-221-6,13242-44-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
38766,Dilithium dodecanedioate,282-879-2,84434-86-6,Not Classified,Notified C&L,2,Not classified:2
38767,Methyl phenoxyacetate,218-176-4,2065-23-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,93,H319:92;H335:92;H315:92;H411:1
38770,Terephthalonitrile,210-783-2,623-26-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,42,H319:42;H335:40;H315:41;H320:1
38773,(S)-2-Amino-butylacetamide,615-935-5,7324-11-0,Not Classified,REACH registration C&L,2,Not classified:2
38774,Ethyl 3-(diethylamino)propionate,226-859-3,5515-83-3,Not Classified,REACH registration C&L,1,Not classified:1
38775,Methyl 2-amino-5-bromobenzoate,610-890-8,52727-57-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H335:44;H315:45;H302:1;H332:1;H312:1
38777,rennin,232-645-0,9001-98-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Resp. Sens. 1,Harmonised C&L,0,H334:0;H319:0;H335:0;H315:0
38780,"Chromate(3-), [2-hydroxy-3-[[2-hydroxy-8-[(methoxycarbonyl)amino]-1-naphthalenyl]azo]-5-nitrobenzenesulfonato(3-)][2-hydroxy-3-[(2-hydroxy-1-naphthalenyl)azo]-5-nitrobenzenesulfonato(3-)]-, sodium",285-243-2,85049-71-4,Not Classified,Notified C&L,2,Not classified:2
38781,"2-Butenedioic acid (2Z)-, ammonium salt (1:?), homopolymer",609-684-0,39444-67-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,33,H319:33;H315:33
38782,Alkali salt of substituted amino alkyl sulfonyl aryl diazo naphthalene sulfonate,432-080-1,,Not Classified,REACH registration C&L,1,Not classified:1
38784,3-(phenylsulphonyl)propiononitrile,233-424-1,10154-75-3,,Notified C&L,5,H302:5;H319:1;H335:1;H315:1
38791,"N,N'-ethylenebis[N-methyl-2-[(1-oxo-9-octadecenyl)oxy]-N-[2-[(1-oxo-9-octadecenyl)oxy]propyl]propylammonium] dimethyl disulphate",274-860-2,70773-61-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 4,Notified C&L,1,H318:1;H315:1;H413:1
38794,methoxy(propan-2-ylidene)amine,608-904-2,3376-35-0,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,1,H302:1;H225:1;H335:1;H315:1;H317:1;H318:1;H312:1;H332:1;H351:1
38795,"Fatty acids, tallow, Me esters",262-989-7,61788-61-2,Not Classified,Notified C&L,19,Not classified:19
38797,"Benzenemethanamine, .alpha.-ethyl-",608-356-4,2941-20-0,Acute Tox. 3;Skin Corr. 1A;Eye Irrit. 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,123,H401:1;H314:123;H411:84;H319:1;H301:84;H318:83;H302:39
38799,Lithium cyanide,219-308-3,2408-36-8,Flam. Liq. 3;Acute Tox. 2;Acute Tox. 1;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H400:38;H226:42;H310:38;H410:38;H300:38;H330:42;H311:4;H360:4;H319:4;H301:4
38801,"Curcuma xanthorrhiza, ext.",289-742-6,89998-05-0,Asp. Tox. 1,Notified C&L,28,H304:28;H335:3;H315:3;H317:3;H319:3
38809,disodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3-)cuprate(1-),414-230-8,,Skin Sens. 1,Harmonised C&L,0,H317:0
38815,folpet (ISO);N-(trichloromethylthio)phthalimide,205-088-6,133-07-3,Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;Carc. 2;Aquatic Acute 1,Harmonised C&L,0,H400:0;H317:0;H319:0;H332:0;H351:0
38817,"2-(4-chloro-phenyl)-3-ethyl-5-oxo-2,5-dihydro-pyridazine-4-carboxylic acid",603-312-0,129025-54-3,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H319:89;H400:89;H410:89
38818,Silver vanadium trioxide,236-820-2,13497-94-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,45,H335:44;H315:44;H311:40;H319:44;H331:40;H301:44;Not classified:1
38823,2-(2-Fluorophenyl)-2-(4-fluorophenyl)oxirane,618-153-2,88374-05-4,Acute Tox. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H317:1;H400:1;H310:1;H410:1
38824,Diholmium dioxide sulphide,235-301-8,12162-58-2,Not Classified,Notified C&L,1,Not classified:1
38825,Tin sulphate,231-302-2,7488-55-3,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;STOT SE 3;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,259,H335:254;H315:247;H317:180;H318:25;H373:180;H412:108;H332:151;H319:231;H410:43;H341:43;H400:34;H302:13;H372:8;H361:5;Not classified:2;H314:1
38827,Dodec-1-ene,203-968-4,112-41-4,Asp. Tox. 1,REACH registration C&L,1266,H304:1252;H315:302;H411:64;H400:77;H410:77;Not classified:15;H350:1;H319:1;H336:1
38833,"2,4,6,8,10,12-HEXANITROHEXAAZA ISOWURTZITANE",603-913-8,135285-90-4,Expl. 1.1;Acute Tox. 4,Notified C&L,2,H201:2;H302:2
38834,4-(4-methoxyphenyl)butyric acid,224-849-3,4521-28-2,Not Classified,REACH registration C&L,3,Not classified:1;H319:2;H315:2;H335:1
38835,di-tert-butyl peroxide,203-733-6,110-05-4,Flam. Liq. 2;Org. Perox. E;Muta. 2,Harmonised C&L,0,H225:0;H242:0;H341:0
38837,Phenylphosphonic dichloride,212-534-3,824-72-6,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT SE 3,REACH registration C&L,241,H302:37;H335:104;H318:4;H314:238;H290:13;H319:2;H301:2;Not classified:1
38838,"1,3-dichloro-2-nitrobenzene",210-009-3,601-88-7,Acute Tox. 4;Acute Tox. 3;Skin Sens. 1B;Muta. 2;Carc. 1B;Aquatic Chronic 2,REACH registration C&L,38,H302:3;H350:2;H311:3;H317:2;H411:2;H341:2;H312:34;H412:33;H315:3;H319:3;H332:1;H335:2;H331:1;H301:1
38845,Tris(2-methylallyl)amine,228-674-3,6321-40-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38;H226:38
38846,Propyl 2-methylbutyrate,253-329-9,37064-20-3,Flam. Liq. 3,Notified C&L,137,H226:137
38850,α-methyl-α-phenylpyridine-2-methanol,243-110-6,19490-92-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H302:2;H335:2;H315:2
38852,Methyl(octyl)amine,219-462-1,2439-54-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,45,H318:40;H314:45
38853,2-(Benzylthio)nicotinic Acid,601-206-9,112811-90-2,Eye Irrit. 2,Notified C&L,14,H319:14;H315:1
38857,5-fluoro-o-tolyl isocyanate,266-602-2,67191-93-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H302:38;H335:38;H315:38;H319:38;H312:38;H332:38;H311:2;H331:2;H301:2
38859,Oxamniquine,244-556-4,21738-42-1,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H302:38;H413:38
38862,2-chloropyridin-3-ol,229-635-3,6636-78-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
38866,"(2E,4E)-undeca-2,4-dienal",250-148-7,30361-29-6,Skin Irrit. 2,Notified C&L,1401,H315:1323;Not classified:78;H319:35;H312:35
38869,1-(4-chlorophenyl)-2-cyclopropylpropan-1-one,602-964-3,123989-29-7,Aquatic Chronic 2,Notified C&L,1,H411:1
38870,2-[4-(6-chloro-quinoxalin-2-yloxy)-phenoxy]-propionic acid ethyl ester,616-351-3,76578-14-8,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1,Notified C&L,194,H302:194;H400:194;H312:194
38874,"m-(2,3-epoxypropoxy)-N,N-bis(2,3-epoxypropyl)aniline",275-662-9,71604-74-5,Acute Tox. 4;Skin Sens. 1A;Muta. 2;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,18,H302:4;H317:18;H373:3;H412:3;H341:4;H315:1;H411:1;H312:1
38875,"1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene",412-570-1,119462-56-5,Eye Dam. 1;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H317:0;H373:0;H318:0;H410:0
38877,"3,6,9-trioxaundecamethylene dimethacrylate",203-653-1,109-17-1,Not Classified,REACH registration C&L,65,Not classified:5;H317:42;H319:53;H315:58;H335:15
38879,Benzyldiethyl(2-hydroxyethyl)ammonium chloride,243-111-1,19493-25-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
38883,"L-Lysine, N6-[[(2-chlorophenyl)methoxy]carbonyl]-N2-[(1,1-dimethylethoxy)carbonyl]-",611-174-8,54613-99-9,,Notified C&L,2,Not classified:2
38884,"Disodium 3,3'-dithiobis[propanesulphonate]",248-324-3,27206-35-5,Skin Sens. 1,REACH registration C&L,73,H317:73;H319:2;H226:2
38885,5-chloro-2-methyl-1H-benzimidazole,220-575-3,2818-69-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H302:39;H318:38;H319:1;H315:1
38887,4-fluorobenzamide,212-535-9,824-75-9,,Notified C&L,5,H319:5;H335:5;H315:5
38890,"2,10-epoxypinane",230-055-8,6931-54-0,Not Classified,Notified C&L,247,Not classified:223;H317:24;H400:24;H226:1
38895,"Cyclohexanol, 4-(3-methylbutyl)-",454-810-8,830322-14-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,21,H318:21;H411:21;H315:21
38896,"2-(bromomethyl)-2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolane",262-103-9,60207-89-8,Not Classified,REACH registration C&L,158,Not classified:2;H317:156;H411:156
38898,1-methyl-1H-benzotriazole,236-401-4,13351-73-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
38899,1-(4-pyridyl)acetone,228-605-7,6304-16-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,48,H302:40;H318:40;H335:46;H315:48;H319:8
38900,"Hydrocarbons, C",270-695-5,68476-55-1,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
38903,"Dihydro-3,3-dimethylfuran-2,5-dione",241-371-0,17347-61-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
38904,"N,N-dimethyldodecanamide",221-117-5,3007-53-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,233,H335:173;H315:195;H400:211;H319:195;H412:173;H410:38
38907,"2,2'-[[4-[(2-chloro-4-nitrophenyl)azo]-3-methylphenyl]imino]bisethanol",223-203-8,3769-57-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:48;H302:48;H335:48;H315:48;Not classified:3
38911,Cyclohexyldimethylammonium oleate,265-482-9,65122-23-8,Not Classified,Notified C&L,22,Not classified:22
38916,Methyl N-octadecylterephthalamate,230-836-3,7333-86-0,Not Classified,Notified C&L,51,Not classified:51
38919,3-(2-methoxy-5-methylphenyl)-3-phenylpropanoic acid,600-896-9,109089-77-2,Skin Sens. 1,REACH registration C&L,4,H317:2;H319:2;H315:2
38921,"1-(2-furyl)butane-1,3-dione",247-265-0,25790-35-6,,Notified C&L,4,H319:4;H335:4;H315:4
38922,"Benzothiazole, 2-chloro-6-methoxy-",923-874-3,2605-14-3,,Notified C&L,4,H319:4;H302:4
38928,Phenazopyridine hydrochloride,205-243-8,136-40-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2,Notified C&L,77,H302:77;H335:72;H315:73;H319:73;H351:77;H317:5;H334:4
38932,"Fig, ext.",289-868-1,90028-74-3,Skin Sens. 1,Notified C&L,143,H317:107;H319:37;H225:37;H315:37;Not classified:36
38934,Toluene-3-thiol,203-578-4,108-40-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,49,H318:45;H335:48;H315:49;H400:38;H302:6;H312:6;H332:6;H319:4;H311:2;H331:2;H301:2
38935,"Oleic acid, compound with 1,1',1''-nitrilotri(propan-2-ol) (1:1)",267-888-1,67952-35-6,Not Classified,Notified C&L,31,Not classified:31
38936,hexyl acrylate,219-698-5,2499-95-8,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0,H335:0;H315:0;H317:0;H411:0;H319:0
38939,2-[[4-(dimethylamino)phenyl]azo]benzoic acid monohydrochloride,264-190-9,63451-28-5,,Notified C&L,6,H351:4;Not classified:2
38941,Xylan,232-760-6,9014-63-5,Not Classified,Notified C&L,27,Not classified:27
38942,xylenol,215-089-3,1300-71-6,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0,H311:0;H314:0;H411:0;H301:0
38945,2-aminobenzenesulphonic acid,201-810-9,88-21-1,Eye Irrit. 2,REACH registration C&L,114,H319:49;H317:1;H314:65;H335:4;H315:5;Not classified:2;H318:1
38946,Hept-2-ene,209-768-3,592-77-8,Flam. Liq. 2,Notified C&L,1,H225:1
38947,Ipronidazole,238-957-3,14885-29-1,Acute Tox. 4,Notified C&L,38,H302:38
38950,"4,5-diphenyl-1H-imidazole",211-573-3,668-94-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H335:43;H315:44
38952,6-hydroxynaphthalene-2-sulphonic acid,202-209-4,93-01-6,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,46,H319:5;H315:4;H318:38;H314:39;Not classified:2;H302:1
38953,[bis(2-hydroxyethyl)]methyl[2-[(1-oxooctadecyl)oxy]ethyl]ammonium methyl sulphate,249-173-6,28706-44-7,Not Classified,Notified C&L,122,Not classified:83;H319:39
38956,2-nitrotoluene-4-sulphonamide,230-117-4,6949-23-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
38957,"reaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 63 % by weight;1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight",410-840-3,71566-50-2,Org. Perox. C;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H242:0
38959,"Disodium 5-(acetylamino)-4-hydroxy-3-[(2-methoxyphenyl)azo]naphthalene-2,7-disulphonate",229-584-7,6625-46-3,Not Classified,Notified C&L,31,Not classified:31
38961,Barium hydrogenorthophosphate,233-159-1,10048-98-3,Acute Tox. 4;Acute Tox. 4,Notified C&L,100,H302:99;H332:99;H301:1
38964,Sodium decane-1-sulphonate,236-525-9,13419-61-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:39;H335:39;H315:39;Not classified:2
38965,4-(fluorosulphonyl)-1-hydroxy-2-naphthoic acid,212-659-3,839-78-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
38972,(2-methylallyl)triphenylphosphonium chloride,224-313-9,4303-59-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
38978,"3,6-dioxaoctamethylenediamine",213-203-6,929-59-9,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,344,H317:340;H302:340;H318:262;H314:344;H334:182;H335:62;H412:16
38980,2-nitro-4-toluonitrile,248-019-5,26830-95-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H302:42;H332:42;H312:42;H335:4;H315:4;H319:4;H311:1;H331:1;H301:1
38986,"Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C",309-674-3,100684-04-6,Carc. 1B,Harmonised C&L,0,H350:0
38987,2-[2-methoxy-4-[[(3-methyl-3H-benzothiazol-2-ylidene)hydrazono]methyl]phenoxy]ethyl methacrylate,256-327-6,47660-35-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
38988,"Alcohols, C12-14-secondary, β-(2-hydroxyethoxy)",308-219-6,97926-05-1,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 3,Notified C&L,111,H400:83;H315:111;H412:83;H411:28
38991,"Ferrate(4-), hexakis(cyano-C)-, oxidized N,N-dimethylbenzenamine-N-ethyl-2-methylbenzenamine-formaldehyde reaction products copper(1+) salts",304-786-9,94279-42-2,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,96,H318:96;H400:96;H410:96
38997,"8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine monohydrochloride",261-776-6,59467-96-8,Acute Tox. 4;STOT SE 3;Repr. 2;Lact.,Notified C&L,1,H361:1;H302:1;H336:1;H362:1
38999,"1,3-Naphthalenedisulfonic acid, 7-[2-[4-[[4,6-bis[(3-sulfopropyl)thio]-1,3,5-triazin-2-yl]amino]-3-methoxyphenyl]diazenyl]-, sodium salt (1:4)",606-771-5,214559-61-2,Not Classified,Notified C&L,1,Not classified:1
39000,"1,3,5-tris(2,3-dibromopropyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione",257-913-4,52434-90-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,64,H319:63;H335:57;H315:63;H413:1
39008,[(cyclohexen-1-ylidenemethoxy)methyl]benzene,244-990-4,22428-48-4,Aquatic Chronic 2,Notified C&L,33,H411:33
39010,(α-cyanobenzyl)ammonium chloride,258-680-1,53641-60-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H302:42;H335:42;H315:42;H319:42;H312:42;H332:42
39011,p-formylcinnamic acid,245-608-9,23359-08-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
39012,Pentasodium 4-hydroxy-3-(2-methoxy-5-(2-sulfooxyethanesulfon yl)phenylazo)-7-(sulfomethylamino)-8-(2-sulfo-4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2-sulfonate,464-700-1,,Not Classified,REACH registration C&L,2,Not classified:2
39013,"2,4,5-triethoxybenzophenone",257-729-4,52199-46-9,Aquatic Acute 1,Notified C&L,38,H400:38
39014,"2,3-Dichloro thiophenol",605-631-0,17231-95-7,Acute Tox. 4;Eye Dam. 1,Notified C&L,44,H302:44;H318:38;H319:6;H335:5;H315:6
39024,"3,4-dichlorophenol",202-450-5,95-77-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,53,H302:47;H318:39;H315:51;H335:5;H411:5;H319:12;H312:5;Not classified:1;H311:1;H331:1;H314:1;H301:1
39027,"(3R,3'S,5'R)-3,3'-dihydroxy-β,κ-caroten-6'-one",207-364-1,465-42-9,Not Classified,Notified C&L,10,Not classified:10
39029,O-isopropyl ethylthiocarbamate,205-517-7,141-98-0,Acute Tox. 4;Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,49,H302:39;H315:6;H412:8;H411:33;Not classified:8;H317:2;H410:1
39035,"Benzenamine, 2-bromo-5-methoxy-, hydrochloride (1:1)",603-375-4,129968-11-2,,Notified C&L,1,H319:1;H335:1;H315:1
39038,1-(4-(pyrrolidin-1-yl)but-2-ynyl)pyrrolidin-2-one,200-728-0,70-22-4,Acute Tox. 2;Skin Corr. 1B,Notified C&L,127,H300:127;H314:127
39042,3-pyridylthiourea,250-075-0,30162-37-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H302:41;H335:44;H315:44;H301:4
39045,(3-chloro-2-hydroxypropyl)dimethyloctadecylammonium chloride,221-083-1,3001-63-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 1,Notified C&L,3,H319:2;H302:3;H315:3;H410:3;H400:1;H318:1
39052,"1,3,6-Naphthalenetrisulfonic acid, 7-[2-[2-[(aminocarbonyl)amino]-4-[[4-chloro-6-[methyl[3(or 4)-sulfophenyl]amino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-, sodium salt (1:?)",604-659-0,148878-18-6,Skin Sens. 1,Notified C&L,4,H317:4
39053,α-iodotoluene,210-623-1,620-05-3,,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
39057,"3,3'-(3H-2,1-benzooxathiol-3-ylidene)bis[6-hydroxy-5-methylbenzoic acid S,S-dioxide",219-972-4,2588-24-1,Eye Irrit. 2,Notified C&L,1,H319:1
39058,Isopropyl 3-chloropropionate,211-724-3,691-93-0,Acute Tox. 4,Notified C&L,38,H302:38
39061,"6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile",400-340-3,85136-74-9,Carc. 1B;Aquatic Chronic 4,Harmonised C&L,0,H413:0;H350:0
39062,trans-3-chloroacrylic acid,219-070-0,2345-61-1,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,132,H335:127;H318:90;H314:132
39064,"2,4-dichlorophenyl 3-methoxy-4-nitrophenyl ether",251-266-1,32861-85-1,Acute Tox. 1,Notified C&L,1,H310:1
39065,2-amino-1-(4-bromophenyl)ethan-1-one hydrochloride,226-778-3,5467-72-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H335:44;H315:45;Not classified:1;H302:1
39068,"3-[[4-[(5,6-dichlorobenzothiazol-2-yl)azo]phenyl]ethylamino]propiononitrile",246-710-6,25176-89-0,Not Classified,Notified C&L,54,Not classified:53;H412:1
39077,"N5,N5-dimethylpyridine-2,5-diamine",254-658-0,39856-52-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H302:1;H318:1;H335:1;H315:1
39080,Cerium hydroxide,253-488-4,37382-23-3,Not Classified,Notified C&L,2,Not classified:2
39081,m-acetylphenyl acetate,219-524-8,2454-35-5,Acute Tox. 4,Notified C&L,3,H302:3
39082,"Ethanol, 2-ethoxy-, manufacture of, by-products from",310-288-2,161907-78-4,Skin Corr. 1C;Eye Dam. 1,Notified C&L,55,H318:55;H314:55
39084,Potassium formate(1:2),243-934-6,20642-05-1,Eye Irrit. 2,Notified C&L,87,H319:85;Not classified:2
39087,"N,N'-diphenylguanidine monohydrochloride",246-107-8,24245-27-0,Acute Tox. 3;Eye Dam. 1,REACH registration C&L,37,H318:32;H301:32;H319:5;H302:5
39089,Barium di(toluene-4-sulphonate),218-237-5,2090-08-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H332:38
39090,Reaction products of guar gum and (3-chloro-2-hydroxypropyl)trimethylammonium chloride,613-809-4,65497-29-2,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,242,H400:135;H410:141;Not classified:41;H334:38;H319:60;H335:39;H315:39
39091,Methyl α-D-galactopyranoside,222-251-7,3396-99-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
39092,"2,6-xylyl isocyanide",220-459-2,2769-71-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H302:38;H332:38;H312:38;H311:4;H330:4;H301:4
39096,"Tris(pentane-2,4-dionato-O,O')yttrium",239-607-2,15554-47-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,Not classified:2;H319:2;H335:2;H315:2
39098,"Oils, vegetable, deodorizer distillates, Me esters",273-569-8,68989-97-9,Not Classified,Notified C&L,1,Not classified:1
39102,Chromafenozide,604-382-5,143807-66-3,Aquatic Chronic 2,Notified C&L,4,H411:4
39103,2-methyl-3-(2-methylpropyl)pyrazine,237-693-6,13925-06-9,Not Classified,Notified C&L,91,Not classified:89;H319:2;H315:2;H335:1
39111,"4-benzoyl-1,3-phenylene bis(6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulphonate)",250-425-2,31001-73-7,Not Classified,Notified C&L,69,Not classified:55;H319:14;H302:14;H312:14;H413:14
39114,2-fluoro-4-nitroaniline,206-719-8,369-35-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,40,H302:39;H332:39;H312:39;H311:1;H301:1;H315:1;H319:1
39115,Disulfo copper phthalocyanine amine salt,215-523-1,1328-51-4,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,50,H319:6;H412:3;Not classified:42;H302:5;H413:3;H335:3;H332:3
39117,Isobutyl nitrate,208-842-2,543-29-3,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H302:38;H225:38;H335:38;H315:38;H319:38;H312:38;H332:38
39119,"[hexabutyl[μ-[sulphato(2-)-O,O'':O',O''']]ditin",247-634-6,26377-04-8,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H400:42;H315:42;H319:42;H312:42;H410:42;H301:42;H372:42
39120,"Bean, ext.",285-354-6,85085-22-9,Flam. Liq. 3,Notified C&L,2,H226:1;Not classified:1
39121,"2,4'-dibromoacetophenone",202-783-6,99-73-0,Skin Corr. 1B,Notified C&L,46,H314:46;H318:2;H290:1
39122,2-Heptanethiol,613-083-9,628-00-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1378,H319:1376;H302:1377;H335:1376;H315:1376;H226:92
39126,"1,2-epoxycyclohexane",206-007-7,286-20-4,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3;Muta. 2,REACH registration C&L,151,H302:145;H311:83;H318:76;H314:72;H226:144;H331:63;H341:11;H319:56;H312:77;Not classified:7;H315:1;H332:3
39128,Linoleum cement,927-994-7,,Not Classified,REACH registration C&L,1,Not classified:1
39129,1-dodecyl-2-pyrrolidone,403-730-1,2687-96-9,Skin Corr. 1B;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H314:0;H400:0;H410:0
39132,"2,4-dimethylbenzyl alcohol",240-393-8,16308-92-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
39137,Paromomycin sulphates,215-031-7,1263-89-4,Not Classified,Notified C&L,56,Not classified:53;H319:3;H315:3;H362:1;H302:1;H335:1;H311:1;H331:1;H301:1
39138,4-(thiazol-2-ylazo)resorcinol,218-836-1,2246-46-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
39139,"4-methylthiomorpholine 1,1-dioxide",246-877-5,25343-91-3,,Notified C&L,4,H319:4;H335:4;H315:4
39142,"(17alpha)-3-ethoxy-19-norpregna-3,5-dien-20-yn-17-ol",619-217-2,96487-85-3,Not Classified,REACH registration C&L,2,Not classified:2
39145,S-ethyl-L-homocysteine,235-966-4,13073-35-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
39146,"5-chloro-1,3-dimethyl-1H-pyrazole-4-carbaldehyde",619-538-8,27006-76-4,,Notified C&L,6,H319:6;H335:5;H315:6
39153,Zinc(II) isooctanoate,282-041-6,84082-93-9,Not Classified,Notified C&L,2,Not classified:2
39155,YELLOW DO 2793,426-870-5,,Not Classified,Notified C&L,37,Not classified:37
39156,"Limestone, calcined",293-318-6,91053-52-0,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H315:1
39158,1-benzylpiperidin-3-ol,238-881-0,14813-01-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,45,H319:45;H335:40;H315:45;H301:40
39161,"Cucurbita pepo, ext.",289-741-0,89998-03-8,Flam. Liq. 3,Notified C&L,3,H226:2;Not classified:1
39163,2-(N-methyl N-hydroxyethyl) ammine 2-phenylethanol,920-079-3,,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,1,H335:1;H318:1;H314:1
39164,"1,2-dimethyl-1,1,2,2-tetraphenyldisilane",214-632-1,1172-76-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
39167,Bis(methylcyclohexyl) phthalate,248-765-1,27987-25-3,Skin Irrit. 2;Skin Sens. 1B;Repr. 1B;Aquatic Chronic 3,REACH registration C&L,177,H317:85;H360:85;H315:177;H412:85;H319:68;H335:68
39169,Boron carbide,262-041-2,60063-34-5,Not Classified,Notified C&L,1,Not classified:1
39170,"2,4,6-tris(morpholino)-1,3,5-triazine",240-391-7,16303-23-4,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H302:1;H332:1;H312:1
39173,"Formaldehyde, reaction products with 1,3-benzenedimethanamine and p-tert-butylphenol",605-164-2,158800-93-2,Not Classified,Notified C&L,23,Not classified:22;H302:1;H413:1;H317:1;H314:1;H312:1
39180,nickel tellurium tetraoxide,239-974-9,15852-21-8,Skin Sens. 1;Resp. Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H350:0;H400:0;H317:0;H334:0;H372:0;H410:0
39181,o-chlorocinnamic acid,223-154-2,3752-25-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,46,H302:46;H318:38;H335:45;H315:46;H319:8;H312:2;H332:3
39182,N-amidino-N-methylglycine-2-oxopropionate,429-120-5,208535-04-0,Eye Dam. 1,Harmonised C&L,0,H318:0
39184,Indazol-5-ylamine,242-971-5,19335-11-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:43;H335:42;H315:43;H301:47
39189,6-phenylpyridazin-3(2H)-one,218-505-1,2166-31-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41;H302:1;H312:1;H332:1
39192,"Bis(dibutyldithiocarbamato-S,S')copper",237-695-7,13927-71-4,Not Classified,REACH registration C&L,2,Not classified:1;H317:1
39193,"potassium 2-(2,4-dichlorophenoxy)-(R)-propionate",413-580-9,113963-87-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H302:0;H318:0;H315:0
39194,"(3,4-dihydroxyphenyl)(phenyl)methanone",439-460-6,10425-11-3,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1,H317:1;H411:1
39195,"(R*,S*)-(±)-8-hydroxy-5-[1-hydroxy-2-(isopropylamino)butyl]quinolin-2(1H)-one monohydrochloride",263-763-0,62929-91-3,Repr. 2,Notified C&L,1,H361:1
39198,ME3N,417-330-1,56131-49-8,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
39199,"(R*,S*)-1,4-dimercaptobutane-2,3-diol",229-998-8,6892-68-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,84,H319:84;H335:83;H315:84;H302:3;H312:1;H332:1
39202,"Calcium, carbonate dimethylhexanoate complexes",270-491-6,68442-82-0,Skin Irrit. 2,Notified C&L,1,H315:1
39203,"Artemisia herba-alba densiflora, ext.",297-141-5,93348-02-8,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H302:1;H412:1
39204,"Sodium 4-(4-(N-methylacetamido)phenyl-1-amino)-1-amino-9,10-dioxoanthracene-2-sulphonate",220-201-9,2666-17-3,Not Classified,Notified C&L,6,Not classified:6
39205,2-nitrobenzaldehyde oxime,229-634-8,6635-41-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H302:39;H335:42;H315:43;H319:43;H312:38;H332:38;H301:4
39211,"1,3-DIOXAN-2-ONE",607-395-4,2453-03-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H319:41;H302:40;H315:2;Not classified:1;H335:1
39212,"Calcium 1,3-hydroxypropyl phosphate",261-240-1,58409-70-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;Not classified:1
39213,"Ethanamine, N-ethyl-, polymer with 2-(chloromethyl)oxirane",618-218-5,88907-36-2,Not Classified,Notified C&L,1,Not classified:1
39214,L-ornithine 2-oxoglutarate,225-976-7,5191-97-9,Not Classified,Notified C&L,4,Not classified:4
39218,Isooctan-1-ol,248-133-5,26952-21-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,289,H319:165;H302:172;H315:175;Not classified:94;H318:14;H412:5;H331:2;H335:3;H336:1
39221,2-methyl-6-methyleneoct-7-en-2-ol,208-843-8,543-39-5,Not Classified,REACH registration C&L,263,Not classified:225;H319:38;H315:38
39226,"Ginseng, Panax notoginseng, ext.",304-823-9,94279-78-4,Not Classified,Notified C&L,1,Not classified:1
39227,"Butane-1,4-diol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with trimethyl-1,6-hexanediamine and 3-amino-methyl-3,5,5-trimethylcyclohexylamine",921-868-5,,Not Classified,Notified C&L,9,Not classified:9
39229,Tetradecylamine,217-950-9,2016-42-4,Acute Tox. 4;Asp. Tox. 1;Skin Corr. 1A;Eye Dam. 1;STOT SE 3;STOT SE 3;STOT RE 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,75,H302:34;H304:2;H335:41;H400:73;H318:4;H373:2;H314:36;H410:2;H319:39;H315:39
39232,(Z)-N-(2-aminoethyl)-N-(2-hydroxyethyl)-9-octadecenamide,202-279-6,93-81-2,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,59,H319:47;H411:48;H315:47;Not classified:11;H318:1
39234,"Fatty acids, C10-18-neo-",273-115-9,68938-08-9,Not Classified,Notified C&L,56,Not classified:56
39237,Dioleylamine,254-819-5,40165-68-2,Not Classified,Notified C&L,6,Not classified:6
39238,Ethylenebis(diphenylarsine),224-629-7,4431-24-7,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H331:38;H400:38;H301:38;H410:38
39240,"3,3-bis(chloromethyl)oxetane",201-136-5,78-71-7,Acute Tox. 4,Notified C&L,39,H302:38;H335:1;H315:1;H319:1;H301:1;H330:1
39244,Clostripain,232-822-2,9028-00-6,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,38,H334:38;H319:38;H335:38;H315:38
39245,Cobalt(II) carbonate hydrate,611-532-3,57454-67-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Carc. 2,Notified C&L,39,H302:39;H335:38;H315:38;H317:39;H319:38;H351:38;H350:1;H400:1;H334:1;H360:1;H410:1;H341:1
39246,5-Acetylthiophene-2-carboxylic Acid,609-857-0,4066-41-5,,Notified C&L,6,H319:6;H335:5;H315:6
39248,Phenytoin sodium,211-148-2,630-93-3,Acute Tox. 4;Skin Sens. 1;Carc. 2;Repr. 2,REACH registration C&L,285,H317:252;H302:284;H361:253;H351:243;H360:30;H332:2;H312:2;H301:1
39252,"N,N'-(1,2-dihydroxy-1,2-ethanediyl)bis(acrylamide)",212-780-1,868-63-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H302:44;H335:39;H315:40;H319:40;H312:39;H332:39;H350:4
39253,4-oxo-4H-chromene-2-carboxylic acid,225-583-0,4940-39-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
39257,Potassium hydrogen aspartate,214-226-4,1115-63-5,Not Classified,Notified C&L,1,Not classified:1
39258,"Oils, salmon, stearins",296-759-2,93028-66-1,Not Classified,Notified C&L,1,Not classified:1
39259,(hydroxyethyl)ammonium sodium sulphite,283-687-1,84696-80-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H318:2;H315:2
39260,(dibutylamino)acetonitrile,241-979-6,18071-38-0,Acute Tox. 4,Notified C&L,38,H302:38
39263,molybdenum nickel hydroxide oxide phosphate,268-585-7,68130-36-9,Skin Sens. 1;Resp. Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H350:0;H400:0;H317:0;H334:0;H372:0;H410:0
39269,Octafluoroadipoyl difluoride,253-698-6,37881-62-2,,Notified C&L,1,H335:1;H315:1;H311:1;H331:1;H319:1;H301:1
39270,"3,6,9,12-Tetraoxatetradeca-1,13-diene",402-600-1,765-12-8,Not Classified,REACH registration C&L,91,Not classified:89;H319:2;H335:2;H315:2
39271,Disodium 4-[(5-chloro-4-methyl-2-sulphonatophenyl)azo]-3-hydroxy-2-naphthoate,222-642-2,3564-21-4,Not Classified,Notified C&L,84,Not classified:84
39273,DL-leucine,206-328-2,328-39-2,Not Classified,REACH registration C&L,6,Not classified:6
39275,Dimethylthiocarbamoyl chloride,240-468-5,16420-13-6,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Notified C&L,52,H317:43;H302:43;H314:52;H318:7;H290:7;H350:1;H332:1
39276,oxalic acid,205-634-3,144-62-7,Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H302:0;H312:0
39277,Dichloro(2H2)methane,216-776-0,1665-00-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,53,H335:44;H315:45;H373:42;H319:45;H351:49;H361:3;H302:4;H350:4;H336:2;Not classified:1;H370:1;H411:1;H372:1;H341:1
39278,Sodium D-glycero-D-gulo-heptonate,235-849-8,13007-85-7,Not Classified,REACH registration C&L,118,Not classified:118
39279,"5-(dodecyldithio)-1,3,4-thiadiazole-2(3H)-thione",256-616-7,50530-43-3,Skin Sens. 1,Notified C&L,23,H317:23
39281,"1-(3,4-epoxy-4-methylpentyl)-1-methylallyl acetate",255-459-1,41610-76-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2A;Resp. Sens. 1;STOT SE 3,Notified C&L,1,H335:1;H315:1;H317:1;H334:1;H319:1
39283,"Sulphuric acid, magnesium potassium salt",241-811-1,17855-14-0,Not Classified,Notified C&L,1,Not classified:1
39285,Levorphanol hydrogen tartrate,204-753-8,125-72-4,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B,Notified C&L,38,H335:38;H315:38;H360:38;H319:38;H301:38
39288,nickel(II) palmitate,237-138-8,13654-40-5,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H350:0;H400:0;H317:0;H334:0;H360:0;H410:0;H372:0;H341:0
39289,Riboflavin 5'-(sodium hydrogen phosphate),204-988-6,130-40-5,Not Classified,Notified C&L,66,Not classified:64;H319:2;H335:2;H315:2
39293,"2,4-bis(2,4-diamino-5-methyl-1-benzenazo)toluene",226-541-4,5421-66-9,Not Classified,Notified C&L,3,Not classified:2;H312:1;H315:1
39294,"1,1'-Bis(Diphenylphosphino)ferrocene-palladium(II)dichloride dichloromethane complex",619-128-9,95464-05-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,53,H302:51;H335:46;H315:48;H319:48;H312:47;H332:51;H351:9;H413:1;H317:1;H373:1;H336:1
39298,"Amines, coco alkyl, propoxylated",611-625-9,581079-15-4,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,4,H302:4;H318:4;H314:4;H400:4
39299,3-(4-fluorobenzoyl)propionic acid,206-679-1,366-77-8,Acute Tox. 4,Notified C&L,44,H302:39;H319:6;H335:5;H315:6
39301,"captan (ISO);1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide",205-087-0,133-06-2,Eye Dam. 1;Skin Sens. 1;Acute Tox. 3;Carc. 2;Aquatic Acute 1,Harmonised C&L,0,H400:0;H317:0;H318:0;H331:0;H351:0
39307,3-hydroxypivalic acid,225-419-8,4835-90-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,131,H318:131;H335:43;H315:44;H412:83
39308,"2-chloro-3,5-dinitrobenzoic acid",219-684-9,2497-91-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43
39312,(Z)-N-(1-oxooctadec-9-en-1-yl)-DL-methionine,254-073-0,38665-30-4,Eye Irrit. 2,Notified C&L,33,Not classified:33;H319:33
39314,"Mannich reaction product of diethylaminopropyl amine, nonylphenol, and formaldehyde",918-442-6,,Not Classified,Notified C&L,71,Not classified:71
39320,Disodium dodecenylsuccinate,260-611-5,57195-26-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
39322,"3-chloro-2,2-dimethylpropaneyl chloride",224-311-8,4300-97-4,Skin Corr. 1B;Acute Tox. 1;STOT SE 3,REACH registration C&L,45,H335:41;H314:44;H330:42;H311:1;H331:1;H301:1;Not classified:1;H318:1;H290:1
39324,"Tris(pentane-2,4-dionato-O,O')vanadium",236-759-1,13476-99-8,Acute Tox. 4;Acute Tox. 3;Eye Dam. 1;Acute Tox. 3;STOT SE 3;Muta. 2;Repr. 2;STOT RE 1,REACH registration C&L,58,H361:1;H302:1;H335:51;H311:7;H318:12;H331:1;H372:1;H341:1;H319:39;H315:50;H301:57;H330:6
39326,Tetraoctylphosphonium bromide,245-935-7,23906-97-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,55,H319:39;H335:38;H315:39;H413:15;H314:16;Not classified:1
39327,2-bromo-4-chloro-1-methoxybenzene,612-004-5,60633-25-2,Aquatic Chronic 1,REACH registration C&L,2,H410:1;H319:1;H335:1;H315:1
39334,Di-tert-butyl disulphide,203-734-1,110-06-5,Aquatic Chronic 2,Notified C&L,60,H411:41;H227:11;H304:11;H320:10;H336:19;H319:11;H335:10;H315:3;H317:1;H302:1
39336,Isoxazol-5-amine,238-720-4,14678-05-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H302:2;H335:2;H315:2;H319:2;H312:2;H332:2
39338,"9-Octadecenoic acid (Z)-, methyl ester, sulfurized",283-749-8,84712-59-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H315:2;Not classified:1
39339,Triallyl phosphite,203-060-8,102-84-1,,Notified C&L,4,H312:4;H301:4
39342,"Fatty acids, soya, sodium salts",263-117-8,61790-25-8,Not Classified,Notified C&L,1,Not classified:1
39345,"N,N-bis(2,2-diethoxyethyl)methylamine",230-115-3,6948-86-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38;H226:38
39346,o-(2-chloro-1-methoxyethoxy)phenyl methylcarbamate,257-236-4,51487-69-5,Acute Tox. 2,Notified C&L,38,H300:38
39349,"Nuclease, ribo-",232-646-6,9001-99-4,Resp. Sens. 1,Notified C&L,152,H334:149;H319:5;H335:3;H315:3
39350,"Octanoic acid, compound with 1-aminopropan-2-ol (1:1)",269-030-1,68171-53-9,Not Classified,Notified C&L,25,Not classified:24;H319:1;H315:1
39357,(E)-hex-2-enyl butyrate,258-515-3,53398-83-7,Not Classified,Notified C&L,132,Not classified:91;H319:41;H335:40;H315:41
39359,Sodium fusidate,212-030-3,751-94-0,STOT SE 3,Notified C&L,104,H335:53;H302:51;H319:1;H315:1
39360,reaction mass (ratio not known) of: ammonium 1-C,410-540-2,116726-92-2,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H315:0;H410:0
39361,"N,N'-(decane-1,10-diyldi-1(4H)-pyridyl-4-ylidene)bis(octylammonium) dichloride",274-861-8,70775-75-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,66,H302:65;H400:6;H315:64;H319:64;H410:6;H335:56;H312:54;H412:55;H332:56;Not classified:1
39363,"3,4-difluorobenzyl alcohol",285-657-3,85118-05-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:44;H315:46
39368,Octyl acrylate,219-696-4,2499-59-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,219,H319:186;H335:185;H315:187;H411:99;Not classified:31;H317:4;H318:1
39371,"Fatty acids, coco, Me esters",262-988-1,61788-59-8,Aquatic Acute 1,Notified C&L,57,H400:53;Not classified:4
39374,Selenium disulphide,231-303-8,7488-56-4,Acute Tox. 3;Acute Tox. 3;STOT RE 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,108,H400:102;H311:4;H373:94;H331:92;H301:94;H410:101;H302:4;H300:10;H330:12
39375,Aluminum hypophosphite,479-150-8,7784-22-7,Flam. Sol. 2,REACH registration C&L,494,H228:51;H412:442;Not classified:2
39378,1-(tert-butyldimethylsilyl)-1H-imidazole,259-398-1,54925-64-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:38;H315:43
39388,Heptyl 2-butenoate,240-999-2,16930-99-7,Not Classified,Notified C&L,1,Not classified:1
39391,"Alcohols, lanolin, distn. residues",292-441-2,90622-40-5,Not Classified,REACH registration C&L,18,Not classified:18
39394,Terephthalaldehyde,210-784-8,623-27-8,Not Classified,REACH registration C&L,69,Not classified:47;H319:9;H311:10;H331:10;H302:10;H335:8;H315:8;H312:2
39402,"2,2,6-trimethylcyclohexan-1-one",219-309-9,2408-37-9,Flam. Liq. 3;Acute Tox. 4,Notified C&L,131,H332:64;H226:131;H319:4;H335:4;H315:4
39411,"2,2,3,3,5,5,6,6-octafluoro-4-(trifluoromethyl)morpholine",206-841-1,382-28-5,Acute Tox. 4;Acute Tox. 3;Eye Irrit. 2,REACH registration C&L,19,H311:1;H319:18;H302:1;Not classified:1;H335:17;H315:17
39412,"Adenosine sodio-2',3'-phosphate hydrate",253-328-3,37063-35-7,,Notified C&L,1,H332:1
39415,"(2E,4E)-2,4-decadienoic acid",250-149-2,30361-33-2,Not Classified,REACH registration C&L,11,Not classified:1;H318:10;H314:10
39418,"1H,1'H-[2,2'-biindole]-3,3'-diol",431-920-4,835912-68-0,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,1,H318:1;H314:1
39419,"Resin acids and Rosin acids, reaction products with formaldehyde, potassium salt",295-855-1,92129-53-8,Eye Irrit. 2,REACH registration C&L,4,H319:4
39422,"Disodium [4-hydroxy-3-[(2-hydroxy-5-sulphophenyl)azo]-7-[(2,5,6-trichloro-4-pyrimidinyl)amino]naphthalene-2-sulphonato(4-)]cuprate(2-)",275-661-3,71598-36-2,Not Classified,Notified C&L,31,Not classified:31
39424,1-(4-chlorophenyl)-2-cyclopropylpropan-1-ol,619-846-2,123989-28-6,Skin Sens. 1B;Aquatic Chronic 2,Notified C&L,157,H311:156;H317:157;H411:157
39427,"Fatty acids, C16-18 and C18-unsatd., 1,2-ethanediylbis(oxy-2,1-ethanediyl) esters",292-810-8,91001-41-1,Not Classified,Notified C&L,2,Not classified:2
39428,"3,3,3-trifluoro-2-(trifluoromethyl)propene",206-840-6,382-10-5,Press. Gas (Liq.);Acute Tox. 3,REACH registration C&L,161,H331:160;H280:113;H372:47;H341:47;H330:1;H335:1;H315:1;H319:1
39429,Hexahydroindan,207-813-1,496-10-6,Flam. Liq. 3;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H302:38;H413:38;H226:38
39431,"2,4,6-tris(bromomethyl)mesitylene",244-697-1,21988-87-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,39,H302:38;H318:39;H314:39;H312:38;H332:38
39432,Butyl isovalerate,203-654-7,109-19-3,Flam. Liq. 3,Notified C&L,1680,H226:1639;H319:40;H335:40;H315:41;H317:1
39439,4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide,420-730-7,,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
39440,4-bromo-m-toluidine,230-056-3,6933-10-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H302:43;H335:42;H315:47;H319:47;H312:43;H332:43;H311:4;H301:4
39445,Sodium 4-nitrophenolate,212-536-4,824-78-2,Acute Tox. 4;STOT SE 3,Notified C&L,118,H302:118;H336:66;H335:39;H315:40;H373:39;H319:52;H312:38;H228:39;H332:39;H411:12;H242:13
39448,Pentylpyrazine,228-604-1,6303-75-9,,Notified C&L,4,H319:4;H315:4
39462,"5-(3-dimethylaminopropyl)-10,11-dihydrodibenzo[a,d]cyclohepten-5-ol",214-594-6,1159-03-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,39,H302:39;H332:2;H312:2;H319:36
39464,"N,N-diethyl-1,1-dimethyl-1-(pentafluorophenyl)silylamine",259-665-2,55485-74-0,Skin Corr. 1C;Eye Dam. 1,Notified C&L,2,H318:1;H314:2
39466,"4-sec-butyl-2,6-di-tert-butylphenol",241-533-0,17540-75-9,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 1,REACH registration C&L,273,H317:2;H315:120;H410:82;Not classified:128;H319:65;H335:64;H400:60;H302:1;H312:1;H332:1
39471,Hept-1-ene,209-767-8,592-76-7,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H319:29;H225:38;H315:29;H304:34;H335:5;H302:1
39475,"Imidazolium compounds, 4,5-dihydro-1-methyl-2-norsoya alkyl-1-(2-soya amidoethyl), Me sulfates",274-862-3,70775-90-5,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H318:1;H400:1;H315:1;H410:1
39476,"Tetrasodium 7,7'-(carbonyldiimino)bis[4-hydroxy-3-[(2-methyl-4-sulphonatophenyl)azo]naphthalene-2-sulphonate]",249-172-0,28706-33-4,Not Classified,REACH registration C&L,59,Not classified:59
39477,Trisodium sulphonatosuccinate,236-524-3,13419-59-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,41,H318:40;H315:37;Not classified:1
39481,Beheneth-15,607-974-1,26636-40-8,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 3,Notified C&L,7,H318:6;H400:6;H412:6;H317:1
39483,"[2R-[2R*(4R*,8R*)]]-3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl nicotinate",256-101-7,43119-47-7,Not Classified,Notified C&L,52,Not classified:52
39484,"Cellulose, ethyl 2-hydroxyethyl ether",619-061-5,94700-07-9,Not Classified,Notified C&L,1,Not classified:1
39488,"(1S)-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)methyl acetate",214-088-5,1079-01-2,Not Classified,Notified C&L,115,Not classified:115
39493,5-chloro-1-ethyl-2-methyl-benzimidazole,220-576-9,2818-76-0,Acute Tox. 2;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H300:38;H335:38;H315:38
39494,"propiconazole (ISO); (2RS,4RS;2RS,4SR)-1-{[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl}-1H-1,2,4-triazole",262-104-4,60207-90-1,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H302:0;H400:0;H317:0;H360:0;H410:0
39496,Alkane substituted alkyl chain,482-390-6,,Not Classified,Notified C&L,1,Not classified:1
39497,"5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, disodium salt, [6R-(6α,7α)]-",277-834-9,74356-00-6,Not Classified,Notified C&L,4,Not classified:2;H317:2;H334:2;H319:1;H315:1
39509,Hexadec-7-en-16-olide,204-644-5,123-69-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,146,H319:108;H335:108;H315:108;Not classified:28;H400:10;H410:10
39510,"Extracts (petroleum), light vacuum gas oil solvent, clay-treated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C",309-675-9,100684-05-7,Carc. 1B,Harmonised C&L,0,H350:0
39513,"demephion-S (ISO);O,O-dimethyl S-2-methylthioethyl phosphorothioate",219-971-9,2587-90-8,Acute Tox. 2;Acute Tox. 3,Harmonised C&L,0,H311:0;H300:0
39520,"8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine monomaleate",261-775-0,59467-94-6,Acute Tox. 4;STOT SE 3;Repr. 2;Lact.,REACH registration C&L,95,H361:2;H302:43;H336:2;H362:2;H319:52;H315:52;H411:3
39525,"β-Alanine, N-(2-aminoethyl)-N-(2-hydroxyethyl)-, N-coco acyl derivs., monosodium salts",298-632-7,93820-52-1,Eye Irrit. 2,Notified C&L,77,H319:75;Not classified:2
39526,Procarbazine hydrochloride,206-678-6,366-70-1,Acute Tox. 4;Muta. 2;Carc. 1B;Repr. 1A,Notified C&L,40,H302:39;H350:40;H360:40;H341:39;H340:1;H411:1
39528,"(3E,13Z)-octadeca-3,13-dienyl acetate",258-373-2,53120-26-6,Skin Irrit. 2,Notified C&L,6,H315:6;H400:1
39530,"1-Propanamine, 3-(triethoxysilyl)-, reaction products with wollastonite (Ca(SiO3))",309-512-1,100402-75-3,Not Classified,Notified C&L,35,Not classified:35
39531,"Ethanol, 2-butoxy-, manufacture of, by-products from",310-287-7,161907-77-3,Eye Irrit. 2,Notified C&L,7,H319:5;H318:2
39533,"Amines, di-C12-18-alkyl",268-899-4,68153-95-7,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,36,H314:35;H400:35;H410:35;Not classified:1
39535,2-butoxyethyl 2-(4-chloro-2-methylphenoxy)propionate,245-609-4,23359-62-8,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H317:1;H302:1;H400:1;H410:1
39538,"(±)-3,4-dihydroxyphenylglycolic acid",238-956-8,14883-87-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
39540,diphenoxymethylenecyanamide,427-300-8,79463-77-7,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H412:0
39541,Ethyl trimethylsilyl malonate,242-340-4,18457-03-9,Flam. Liq. 3,Notified C&L,38,H226:38
39542,Lithium hexafluorosilicate,241-372-6,17347-95-4,,Notified C&L,4,H302:4
39544,o-methoxybenzenesulphinic acid,236-107-6,13165-78-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
39547,"1,2-Propanediol, 3-(2-ethylhexyloxy)",615-116-2,70445-33-9,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,113,H318:113;H412:113;H312:31;H332:2
39548,CARTASOL GEEL K-3GL CONC.,401-780-9,,Not Classified,Notified C&L,31,Not classified:31
39549,"1-naphthalenesulfonic acid, 4-amino-, diazotized, coupled with diazotized aniline and Dyer’s mulberry (Chlorophora tinctoria) extract, sodium salts",283-232-7,84583-80-2,Not Classified,Notified C&L,37,Not classified:37
39550,D-leucine,206-327-7,328-38-1,Not Classified,Notified C&L,17,Not classified:17
39558,Polychloro copper phthalocyanine,215-524-7,1328-53-6,Not Classified,REACH registration C&L,1163,Not classified:1138;H319:25;H312:20;H335:3
39559,"2H-1-Benzopyran-7-ol, 3,4-dihydro-3-(4-hydroxyphenyl)-",618-999-2,94105-90-5,Not Classified,Notified C&L,1,Not classified:1
39560,Piperidin-2-ylmethanol,222-333-2,3433-37-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H318:1;H314:1
39562,"1,3-Benzenedimethanamine, N-(2-phenylethyl) derivs.",445-790-1,404362-22-7,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;STOT RE 2;Aquatic Acute 1,Notified C&L,6,H302:6;H400:6;H317:6;H373:6;H314:6;H410:6;H318:1
39565,Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content greater than 18 % by weight,924-055-3,,Carc. 2,REACH registration C&L,2,H351:2
39566,"3,5-dimethyl-1,2-dioxolane-3,5-diol",237-438-9,13784-51-5,Org. Perox. D;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,14,H317:14;H319:14;H242:14
39568,"2,3,4,6-tetramethylphenol",221-799-4,3238-38-8,Not Classified,Notified C&L,33,Not classified:33
39571,4-methoxypyridine,210-624-7,620-08-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,61,H319:61;H335:59;H315:61;H227:1
39572,2-(p-tolyl)propionaldehyde,202-782-0,99-72-9,Not Classified,Notified C&L,258,Not classified:258
39576,2-methyloctan-3-ol,247-762-2,26533-34-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
39579,o-bis(epoxyethyl)benzene,218-837-7,2246-49-3,Not Classified,Notified C&L,31,Not classified:31
39580,Sodium hydrogen N-(1-oxododecyl)-L-glutamate,249-958-3,29923-31-7,Eye Irrit. 2,REACH registration C&L,120,H319:113;H315:87;Not classified:40
39582,"Vanadate(1-), oxo[phosphato(3-)-.kappa.O]-, hydrogen, hydrate (2:1)",618-920-1,93280-40-1,Acute Tox. 3;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Muta. 2;Repr. 2;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,1,H361:1;H335:1;H317:1;H318:1;H411:1;H301:1;H372:1;H332:1;H341:1
39586,"5-acetyl-3-chloro-10,11-dihydro-5H-dibenz[b,f]azepine",247-371-7,25961-11-9,Not Classified,REACH registration C&L,161,Not classified:4;H335:157;H315:157
39587,reaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane;dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane,413-780-6,,Aquatic Chronic 3,Harmonised C&L,0,H412:0
39589,2-methyl-2-thiazoline,219-071-6,2346-00-1,Flam. Liq. 3,Notified C&L,49,H226:48;Not classified:1
39591,Piperidine-1-propionic acid,247-633-0,26371-07-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
39596,Dihydroxy-4-bromophenylborane,226-779-9,5467-74-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,55,H319:54;H335:53;H315:54;H302:2;H332:1;H312:1
39607,"Fatty acids, C16-22, ammonium salts",271-684-8,68604-31-9,Not Classified,Notified C&L,4,Not classified:4
39608,"Glycine, N,N-bis(2-aminoethyl)-, N-C8-18-alkyl and N,N'-di-C8-18-alkyl derivs., hydrochlorides",284-067-3,84777-40-2,Skin Corr. 1B,Notified C&L,7,H314:7
39612,"Limestone, reaction product with bauxite and gypsum",293-319-1,91053-53-1,Eye Dam. 1,Notified C&L,66,H318:66
39614,1-(3-aminophenyl)ethanol,219-525-3,2454-37-7,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H319:39;H332:38;H315:39;H335:38
39615,"(R)-2,3-dihydroxypropyl stearate",238-880-5,14811-92-8,Not Classified,Notified C&L,1,Not classified:1
39617,3-methylanthranil acid,224-505-2,4389-45-1,Acute Tox. 4,Notified C&L,48,H302:41;H319:9;H335:7;H315:9
39621,Naloxone,207-365-7,465-65-6,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,44,H302:44;H318:3;H319:40;H335:40;H315:41;H317:1;H334:1;H332:1
39628,Dibarium calcium wolframate,239-606-7,15552-14-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1
39630,N-benzyloxycarbonylglycine,214-516-0,1138-80-3,Not Classified,REACH registration C&L,3,Not classified:3
39634,"Propane-1,3-diylbis(oxypropane-1,3-diyl) diacrylate",272-647-9,68901-05-3,Not Classified,Notified C&L,1,Not classified:1
39642,Ethyl acetoacetate,205-516-1,141-97-9,Not Classified,REACH registration C&L,2517,Not classified:1847;H319:532;H318:117;H335:98;H315:117;H226:22
39644,"1,3-Dioxolane-4-butanol, 2-ethenyl-",607-343-0,2421-08-1,Acute Tox. 3;Acute Tox. 1;Eye Irrit. 2;Acute Tox. 4,Notified C&L,2,H319:2;H332:2;H310:2;H301:2
39646,"2,2-dimethyl-3-phenylpropanol",236-400-9,13351-61-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,255,H319:15;H302:255;H315:15;H412:255
39647,1-allylpyridinium bromide,233-362-5,10129-44-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
39650,"4,5-dihydroxy-1,3-bis(methoxymethyl)imidazolidin-2-one",221-082-6,3001-61-4,Not Classified,Notified C&L,99,Not classified:99
39651,"Disodium 2-[(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydropyridin-3-yl)diazenyl]-4-[[4-chloro-6-[[4-[[2-(sulfonatooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-benzenesulfonate",412-720-6,,Not Classified,REACH registration C&L,3,Not classified:3
39654,"1-bromo-2,4-dinitrobenzene",209-539-8,584-48-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,43,H317:43;H319:43;H315:43;H302:4;H335:4;H312:4;H311:1;H301:1
39655,"Astragalus gummifer, ext.",285-353-0,85085-21-8,Flam. Liq. 3,Notified C&L,1286,H226:1286
39656,4-chloro-2-fluorotoluene,207-210-3,452-75-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45;H226:45
39659,Di-tert-butyl oxalate,211-723-8,691-64-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,41,H319:41;H315:41;H335:1
39661,3-bromobenzyl alcohol,239-975-4,15852-73-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:3;H335:3;H315:3;H302:1;H332:1
39662,"1,2-epithiocyclohexane",206-008-2,286-28-2,Flam. Liq. 3,Notified C&L,41,H226:41;H319:2;H335:2;H315:2
39664,Diyttrium dioxide sulphide,235-600-3,12340-04-4,,Notified C&L,18,Not classified:18
39667,m-cresol,203-577-9,108-39-4,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B,Harmonised C&L,0,H311:0;H314:0;H301:0
39668,Bis(2-hydroxyethyl)ammonium hexadecyl hydrogen phosphate,265-483-4,65122-24-9,Eye Irrit. 2,Notified C&L,23,H319:23
39673,"Artemisia pallens, ext.",295-155-6,91844-86-9,Asp. Tox. 1,Notified C&L,1491,H304:1455;H315:25;H317:13;H319:10;H412:12
39677,"α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate",445-060-2,203574-04-3,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,Not classified:0;H400:0;H410:0
39680,"3-nitro-2,6-xylidine",266-566-8,67083-28-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
39688,"Benzene, 2-fluoro-1-iodo-4-methyl-",610-236-1,452-79-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
39694,"Ichthyolic acid, sodium salt",215-671-7,1340-06-3,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H319:2;H411:2
39695,Colchicoside,207-513-0,477-29-2,,Notified C&L,2,H301:2
39699,"3β,21-dihydroxy-16α-methylpregn-5-en-20-one 21-acetate",214-633-7,1173-09-7,Not Classified,REACH registration C&L,1,Not classified:1
39700,"Dehydrogenase, alcohol (nicotinamide adenine dinucleotide phosphate)",232-823-8,9028-12-0,Skin Sens. 1;Resp. Sens. 1,Notified C&L,43,H317:41;H334:43
39703,"Diethyl 2,6-dibromoheptanedioate",212-781-7,868-68-8,Acute Tox. 4,Notified C&L,39,H302:38;H311:1;H331:1;H314:1;H301:1
39710,"3',6'-dichlorospiro(phthalide-3,9'-xanthene)",211-147-7,630-88-6,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,38,H302:38;H411:38
39713,Undec-1-en-3-yl acetate,302-023-4,94088-25-2,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H302:38;H413:38
39715,"2-amino-8-hydroxy-6-naphthalenesulfonic acid, 1-[[[4-[4-[bis-(2-hydroxyethyl)amino]-6-[(2-sulfoethyl)amino]]-1,3,5- triazin-2-yl]amino]-2-sulfo-phenyl]azo], trisodium salt",920-709-7,,Not Classified,Notified C&L,1,Not classified:1
39718,Nickel bis(dibutyldithiocarbamate),237-696-2,13927-77-0,Eye Irrit. 2;Carc. 2;Aquatic Chronic 4,REACH registration C&L,11,H319:6;H413:5;H351:4;Not classified:4;H317:1;H350:1;H334:1
39720,tris(pentafluorophenyl)borane,414-000-7,1109-15-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,58,H319:58;H335:58;H315:58;H301:57
39721,2-methylbutyl 2-methylisocrotonate,262-900-1,61692-77-1,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H317:1;H304:1;H411:1;H226:1
39722,"tetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate",404-320-5,116889-78-2,Skin Sens. 1,Harmonised C&L,0,H317:0
39723,Trilithium citrate,213-045-8,919-16-4,Not Classified,Notified C&L,28,Not classified:27;H302:1
39726,"α,α'-dibromo-p-xylene",210-781-1,623-24-5,Skin Corr. 1B,Notified C&L,45,H314:45;H330:1;H318:1;H290:1;H311:1;H331:1;H301:1;H302:1
39727,"N,N''-(methylenedi-4,1-phenylene)bis[N'-octylurea]",451-060-3,122886-55-9,Aquatic Chronic 4,Harmonised C&L,0,H413:0
39728,(1-phenylethyl)xylene,255-068-6,40766-31-2,Acute Tox. 4;Asp. Tox. 1;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;STOT SE 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,63,H302:63;H304:63;H400:63;H315:63;H317:63;H373:63;H371:63;H312:63;H410:63;H332:63
39733,Indol-5-ylamine,225-977-2,5192-03-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,95,H319:95;H336:47;H335:94;H315:95;H302:47;H312:4;H332:4
39734,"1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene",423-300-7,911674-82-3,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
39737,"N,N-dimethylpiperidin-4-amine",256-617-2,50533-97-6,Acute Tox. 4,Notified C&L,63,H302:39;H314:24;H332:1;H312:1
39738,Tributyl phosphite,203-061-3,102-85-2,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,615,H319:576;H315:130;H412:450;H410:71;H312:60;H314:38;H332:17;Not classified:1
39741,2-[2-[2-(hexyloxy)ethoxy]ethoxy]ethanol,247-372-2,25961-89-1,Not Classified,Notified C&L,105,Not classified:83;H314:22
39742,4-methyl-1-propylquinolinium iodide,251-268-2,32863-55-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
39751,"5,5'-(3-carboxy-4-oxocyclohexa-2,5-dienylidenemethylene)di(salicylic acid)",224-628-1,4431-00-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:44;H315:44
39754,5-nitro-2-pyridylaminoethyl-2-amine,249-721-4,29602-39-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:38;H335:38;H315:38;H314:4
39755,(-)-Dibenzoyl-L-tartaric Acid,613-072-9,62708-56-9,Eye Irrit. 2,Notified C&L,62,H319:60;Not classified:2
39757,2-chloro-4-nitro-1H-imidazole,611-554-3,57531-37-0,Not Classified,REACH registration C&L,4,Not classified:2;H319:2;H335:2;H315:2
39761,"Castor oil, sulfated, potassium salt",271-680-6,68604-21-7,Eye Irrit. 2,Notified C&L,2,H319:2
39767,cis-4-methylpent-2-ene,211-721-7,691-38-3,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H225:39;H335:38;H315:38;H304:39;H319:38
39768,Lead(2+) selenite,231-300-1,7488-51-9,Acute Tox. 4;Acute Tox. 3;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H302:38;H400:42;H373:42;H360:42;H331:38;H301:42;H410:42;H332:38;H330:4
39769,"N,N-bis(2-hydroxypropyl)dodecanamide",259-395-5,54914-38-4,Not Classified,Notified C&L,3,Not classified:3
39770,Ethyl 4-nitrobenzoate,202-786-2,99-77-4,,Notified C&L,1,H302:1
39774,Methyl palmitate,203-966-3,112-39-0,Not Classified,REACH registration C&L,1668,Not classified:103;H315:1378;H317:186;H318:1
39777,"4-amino-1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one monohydrochloride",244-832-4,22198-72-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H302:2;H315:2;H335:1
39783,4-(4-Oxocyclohexyl)-cyclohexanonethylenketal,611-378-7,56309-94-5,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H317:1;Not classified:1;H412:1
39784,Clozapine,227-313-7,5786-21-0,Acute Tox. 3;Muta. 2;Repr. 2,Notified C&L,118,H361:104;H301:118;H341:100;H400:5;H362:5;H410:7;H336:2;H319:3;H335:1;H315:3;H372:2;H331:2;H330:1
39785,"1,1,1-trimethyl-2-(methoxycarbonylethyl)hydrazonium bromide",463-070-5,,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H302:1;H412:1
39788,1-methylpyrrolidine-2-methylamine,247-496-7,26171-06-2,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,1,H314:1;H226:1
39789,"Lecithins, acetylated",293-316-5,91053-50-8,Not Classified,REACH registration C&L,46,Not classified:46
39795,"2'-(dibenzylamino)-6'-(diethylamino)spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",251-971-4,34372-72-0,,Notified C&L,96,Not classified:90;H412:6
39796,"5-nitropyrimidine-4,6-diol",218-504-6,2164-83-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
39797,"N-[2-(4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]naphthalene-2-sulphonamide",233-360-4,10128-55-9,Not Classified,REACH registration C&L,100,Not classified:45;H400:47;H413:8
39798,"1-[2-[[4-[(2,6-dichloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]pyridinium hydroxide",300-005-0,93919-20-1,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H319:2;H302:2;H411:2
39799,2-(dimethylamino)ethyl acrylate,219-460-0,2439-35-2,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1A;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,154,H302:148;H400:144;H311:144;H317:148;H314:148;H412:104;H330:144;H318:85;H226:121;Not classified:6;H312:4;H361:1;H370:1
39800,Guanfacine,249-442-8,29110-47-2,Acute Tox. 3,Notified C&L,1,H301:1
39801,3-chloro-5-methoxyphenol,265-661-1,65262-96-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
39803,"4,4'-azodianiline",208-690-7,538-41-0,,Notified C&L,8,H301:6;H302:2;H332:2;H312:2;H341:1
39804,"Sodium O,O-dimethyl dithiophosphate",247-636-7,26377-29-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,38,H302:38;H318:38;H315:38
39805,"3,3,4,4,5,5,6,6,6-nonafluorohexanol",218-050-9,2043-47-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:2;H335:2;H315:2;H302:1;Not classified:1
39814,Ethyl 2-oxo-4-phenylbutyrate,265-276-9,64920-29-2,Not Classified,REACH registration C&L,3,Not classified:3
39819,"2,5-difluorobenzylamine",285-658-9,85118-06-5,Skin Corr. 1B,Notified C&L,47,H314:47;H318:1;H319:1;H335:1
39824,2-hydroxypropyl 2-ethylhexanoate,261-499-0,58921-10-1,Not Classified,Notified C&L,3,Not classified:3
39826,Hexylboronic Acid (contains varying amounts of Anhydride),605-325-7,16343-08-1,,Notified C&L,5,H319:5;H335:4;H315:5
39827,N-(Cyclopent-3-enylmethyl)methaneamine,923-551-7,,Not Classified,Notified C&L,1,Not classified:1
39828,"Amines, N-(C8-18 and C18-unsatd. alkyl)trimethylenedi-, reaction products with 2-chloroethanol and sodium chloroacetate",305-883-9,95193-70-7,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H411:1
39832,"1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, hydrochloride (1:1), (1R,4R)-rel-",616-707-8,79617-89-3,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,40,H302:40;H400:2;H410:2;H412:38
39836,"3-methyl-1,3-butandiol",459-270-7,,Not Classified,Notified C&L,1,Not classified:1
39838,Diisotridecyl maleate,258-804-4,53817-59-7,Not Classified,Notified C&L,3,Not classified:2;H315:1
39842,"9,10-anthracenedione, hydroxybis(phenylamino)-, sulfonated, sodium salt",215-366-9,1324-21-6,Not Classified,Notified C&L,1,Not classified:1
39843,Hex-4-en-3-one,219-681-2,2497-21-4,Flam. Liq. 3;Acute Tox. 4,Notified C&L,1594,H302:1594;H226:1593;H335:41;H315:41;H319:41
39846,tris[2-[2-(2-butoxyethoxy)ethoxy]ethyl] orthoborate,927-409-5,,Not Classified,REACH registration C&L,2,Not classified:2
39853,"2,3-dibromo-1,4-naphthoquinone",236-223-7,13243-65-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
39861,fluoroacetic acid,205-631-7,144-49-0,Acute Tox. 2;Aquatic Acute 1,Harmonised C&L,0,H300:0;H400:0
39865,"tetrasodium 3-amino-4-{[4-({4-fluoro-6-[phenyl(2-{[2-(sulfonatooxy)ethyl]sulfonyl}ethyl)amino]-1,3,5-triazin-2-yl}amino)-2-sulfonatophenyl]diazenyl}-5-hydroxynaphthalene-2,7-disulfonate",457-630-8,2041206-19-1,Not Classified,REACH registration C&L,1,Not classified:1
39871,Allyl methyl sulphide,233-422-0,10152-76-8,Skin Sens. 1,Notified C&L,1419,H317:1364;H225:133;H319:1;H335:1;H315:1
39872,Ethyl 2-naphthoate,221-119-6,3007-91-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
39873,2-amino-o-cresol,258-438-5,53222-92-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
39874,ACID BROWN 325,612-830-6,61967-97-3,Aquatic Chronic 3,Notified C&L,1,H412:1
39877,"Calcium 5,5'-[(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methylene]bissalicylate (2:3)",264-193-5,63451-31-0,Aquatic Chronic 3,Notified C&L,2,H412:1;Not classified:1
39886,"1,2-dibromopropane",201-139-1,78-75-1,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4,Notified C&L,47,H302:47;H332:42;H226:43;H315:5;H411:4;H319:5
39887,(4S)-4-cyclohexyl-L-proline,600-406-3,103201-78-1,Acute Tox. 4;Skin Sens. 1;Repr. 2,Notified C&L,4,H317:2;H302:2;H361:2;Not classified:1;H319:1;H335:1;H315:1
39890,"3,4-dihydro-2,5,8-trimethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol",205-708-5,148-03-8,Acute Tox. 4,Notified C&L,1,H302:1
39894,4-[(methylamino)acetyl]morpholine,255-381-8,41458-73-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1;H312:1;H332:1
39898,"Benzoic acid, 4-[[1-[[2-[(2-methyl-1-oxo-2-propenyl)oxy]ethoxy]carbonyl]-2-oxopropyl]azo]-, ethyl ester,",606-582-8,205744-30-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H317:1;H319:1;H335:1;H315:1
39902,"2,4,6-tribromotoluene",228-672-2,6320-40-7,,Notified C&L,5,H319:5;H335:5;H315:5
39905,2-(2-methylbutan-2-yl)cyclohexan-1-ol,618-712-0,91242-72-7,Not Classified,REACH registration C&L,4,Not classified:4
39910,"nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2)",258-051-1,52625-25-9,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H350:0;H400:0;H317:0;H334:0;H360:0;H410:0;H372:0;H341:0
39911,(N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride,401-840-4,55845-90-4,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H411:0
39913,C.I. Direct Blue 290,600-965-3,110444-91-2,Aquatic Chronic 2,Notified C&L,86,H411:84;Not classified:2
39916,Aluminum alkyl acetate glycol complexes,452-190-3,,Not Classified,Notified C&L,1,Not classified:1
39918,"1-Butyloxy-2,3-difluor-4-(4-trans-pentylcyclohexyl)-benzen",607-909-7,263017-37-4,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
39920,Spectinomycin dihydrochloride,244-554-3,21736-83-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,57,H317:55;H334:55;H319:1;H335:1;Not classified:1
39922,"L-Ascorbic acid, 2-O-α-D-glucopyranosyl-",603-337-7,129499-78-1,,Notified C&L,1,Not classified:1
39925,Metaxalone,216-777-6,1665-48-1,Acute Tox. 4,Notified C&L,44,H302:44;H332:1
39926,"Disodium 4-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]-3-[(4-nitrophenyl)azo]phenyl]azo]-5-hydroxynaphthalene-2,7-disulphonate",229-637-4,6637-87-2,Not Classified,Notified C&L,31,Not classified:27;H412:3;H315:1
39927,"Extracts (petroleum), light paraffinic distillate solvent, carbon-treated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C",309-672-2,100684-02-4,Carc. 1B,Harmonised C&L,0,H350:0
39928,"Tar bases, coal, picoline fraction;Distillate Bases;[Pyridine bases boiling in the range of approximately 125°C to 160°C (257°F 320°F) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.]",295-548-2,92062-33-4,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
39930,Disodium 5-(4-(4-sulphophenylazo)phenylazo)salicylate,222-645-9,3564-27-0,Not Classified,Notified C&L,2085,Not classified:2085
39936,2-amino-4-(ethylsulphonyl)phenol,256-100-1,43115-40-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H400:1;H311:1;H373:1;H331:1;H301:1
39938,"Sorgassum, Laminaria, Ascophylum nodosum seaweed extract",919-174-2,,,Notified C&L,4,Not classified:4
39939,"Protein hydrolyzates, pea",606-962-3,222400-29-5,Not Classified,Notified C&L,1,Not classified:1
39943,"Hydrogen bis[2-(3-chlorophenyl)-2,4-dihydro-4-[[2-hydroxy-5-mesylphenyl]azo]-5-methyl-3H-pyrazol-3-onato(2-)]chromate(1-)",275-660-8,71598-35-1,Not Classified,REACH registration C&L,3,Not classified:3
39944,"N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine",431-060-1,153719-38-1,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H302:0;H412:0
39947,"Waste solids, coal-tar pitch coking;Coal Tar Solids Residue;[The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.]",295-549-8,92062-34-5,Carc. 1B,Harmonised C&L,0,H350:0
39948,"Propanoic acid, 2-[[]4-[[](6-chloro-2-quinoxalinyl)oxy]phenoxy]-",616-350-8,76578-12-6,Not Classified,Notified C&L,3,Not classified:3
39949,Diammonium hexabromoosmate(2-),246-340-5,24598-62-7,,Notified C&L,4,H319:4;H302:4;H335:4;H315:4
39951,Benzyl isocyanide,233-738-9,10340-91-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,41,H302:41;H332:41;H312:41;H335:1;H315:1;H319:1
39952,5-chloro-o-toluidine,202-452-6,95-79-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:46;H302:49;H335:38;H315:39;H350:7;H412:4;H411:2;H312:2;H351:3;H370:1;H372:1
39954,"(3S)-2-((2S)-N-((1S)-1-Carboxy-3-phenylpropyl)alanyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid, 2-ethyl ester, monohydrochloride",617-363-1,82586-52-5,Aquatic Acute 1,Notified C&L,40,H400:38;H318:2
39957,"Sorbus domestica, ext.",290-330-3,90131-20-7,Flam. Liq. 3,Notified C&L,1,H226:1
39958,Sodium diisobutylnaphthalenesulphonate,248-326-4,27213-90-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,301,H302:301;H315:138;H319:217;H412:282;H332:298;H335:85;H318:84
39959,Hept-2-enoic acid,242-738-8,18999-28-5,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
39961,"Reaction products of N-(2-aminoethyl)ethane-1,2-diamine and methyl methacrylate and octane-1-thiol",929-305-5,,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H317:1;H318:1;H400:1;H410:1
39962,3-[ethyl[4-[(6-nitrobenzothiazol-2-yl)azo]phenyl]amino]propiononitrile,247-055-9,25510-81-0,Not Classified,Notified C&L,1,Not classified:1
39964,Anilinium chloride,205-519-8,142-04-1,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;Muta. 2;Carc. 2;STOT RE 1;Aquatic Acute 1,Notified C&L,51,H400:50;H311:50;H317:51;H318:50;H351:51;H331:50;H301:50;H372:51;H341:50;Not classified:2;H410:1
39966,4-methylpiperazin-1-amine,230-053-7,6928-85-4,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,90,H319:86;H315:86;H302:39;H335:79;H312:39;H332:39;H314:4;Not classified:2;H226:1
39968,(2H5)benzoic acid,214-089-0,1079-02-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1;STOT SE 3,Notified C&L,38,H302:38;H335:38;H315:38;H317:38;H334:38;H318:38
39972,"(3,4-dichlorophenyl)hydrazine monohydrochloride",243-278-0,19763-90-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H302:44;H335:43;H315:44;H319:44;H312:44;H332:44
39978,trans-4-cyclohexyl-L-proline monohydrochloride,419-160-1,90657-55-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Repr. 2,Harmonised C&L,0,H361:0;H302:0;H315:0;H317:0;H318:0
39979,"2,6-dimethyl-p-benzoquinone",208-420-8,527-61-7,,Notified C&L,6,H302:5;H335:6;H315:6;H319:5;H332:4;H318:1
39985,"sodium((n-butyl)x(ethyl)y-1,5-dihydro)aluminate) x = 0,5, y = 1,5",418-720-2,,Flam. Sol. 1;Pyr. Sol. 1;Water-react. 1;Skin Corr. 1A;Acute Tox. 4,Harmonised C&L,0,H250:0;H314:0;H228:0;H332:0;H260:0
39987,2-bromo-1-cyclohexylethan-1-one,611-350-4,56077-28-2,,Notified C&L,2,H319:1;H302:1;H332:1;H312:1;H314:1
39988,Methyl cis-9-tetradecenoate,628-495-4,56219-06-8,Not Classified,REACH registration C&L,6,Not classified:5;H413:1
39990,"2,3-dihydrobenzofuran-5-carboxaldehyde",259-788-1,55745-70-5,Resp. Sens. 1,Notified C&L,42,H334:39;H319:4;H335:2;H315:3
39992,3-ethylhexane,210-621-0,619-99-8,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H225:0;H400:0;H315:0;H304:0;H410:0;H336:0
39994,Hydroxyzine dihydrochloride,218-586-3,2192-20-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,63,H319:39;H302:63;H335:40;H315:39;H317:16;H360:16;H314:7;H318:1
39996,3-amino-N-(isopropyl)benzamide,279-842-8,81882-62-4,,Notified C&L,1,H319:1;H335:1;H315:1
40000,3-hydroxyphenyl benzoate,205-241-7,136-36-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,57,H319:46;H302:56;H335:44;H315:57;H317:12;H310:4
40007,"Bis(1,1,1,5,5,5-hexafluoropentane-2,4-dionato-O,O')nickel",239-028-5,14949-69-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 1B,Notified C&L,40,H302:39;H350:40;H335:39;H315:40;H317:40;H334:40;H319:40;H312:40;H332:40;H261:1
40011,"N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide",422-560-9,149591-38-8,Eye Irrit. 2;Aquatic Chronic 4;Repr. 2,Harmonised C&L,0,H361:0;H319:0;H413:0
40013,reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate;sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate,410-230-7,,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H314:0;H411:0
40014,"(3Z,13Z)-octadeca-3,13-dienyl acetate",258-374-8,53120-27-7,Skin Irrit. 2,Notified C&L,6,H315:5;H400:1
40015,"1-(4-trans-Propyl-[1,1-bicyclohexyl]-4-trans-yl)-4-trifluormethoxybenzene",603-782-7,133937-72-1,Not Classified,REACH registration C&L,1,Not classified:1
40017,Fetuins,232-762-7,9014-81-7,Not Classified,Notified C&L,1,Not classified:1
40019,"bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide",412-010-6,145052-34-2,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H410:0
40020,"Bis(diethyldithiocarbamato-S,S')lead",241-534-6,17549-30-3,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H302:38;H400:38;H373:38;H360:38;H410:38;H332:38
40022,"Fatty acids, C12-20 and C12-20-unsatd., 2-ethylhexyl esters",292-811-3,91001-42-2,Not Classified,Notified C&L,40,Not classified:40
40023,Indan,207-814-7,496-11-7,Flam. Liq. 3;Asp. Tox. 1,Notified C&L,103,H304:96;H226:103
40024,"N-benzoyl-5'-O-(p,p'-dimethoxytrityl)-2'-deoxycytidine",266-605-9,67219-55-0,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,41,H319:40;H400:2;H410:2;H335:38;H315:38;H351:1
40030,N-[(2-chlorophenyl)methyl]-1-phenylpropan-2-amine,616-349-2,76553-22-5,Acute Tox. 4,REACH registration C&L,2,H302:2
40035,"Di-earth alkali metal 2,2',2'',2''' - (heteromonocyclic)tetraalkanate",927-740-5,,Eye Irrit. 2,REACH registration C&L,2,H319:2
40036,tert-Butyl 4-bromobutanoate,600-981-0,110661-91-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:2;H335:2;H315:2;H318:1
40037,4-bromoresorcinol,229-586-8,6626-15-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H302:39;H335:38;H315:39;H319:39;H312:39;H332:39
40038,2-hydroxyfluoren-9-one,230-119-5,6949-73-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
40043,"3'-Fluor-4''-propyl-1,1':4',1''-terphenyl-4-carbonitril",601-451-1,116831-09-5,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
40045,"8,9-Difluoro-3-methyl-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid",700-160-8,82419-35-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41
40046,Dodecylammonium chloride,213-205-7,929-73-7,,Notified C&L,38,Not classified:33;H319:5;H302:5;H335:4;H315:5
40047,2-amino-5-methoxybenzenesulphonic acid,236-224-2,13244-33-2,Not Classified,Notified C&L,1,Not classified:1
40050,Tetraethyl [(dimethylamino)methylene]bisphosphonate,242-627-4,18855-52-2,,Notified C&L,4,H319:4;H335:4;H315:4
40054,Midazolam,261-774-5,59467-70-8,Acute Tox. 3,Notified C&L,74,H301:58;H317:20;H312:21;H334:20;H361:13;H302:16;H362:11;H411:17;H332:6;H319:2;H315:2;H350:1;H373:1;H336:2
40055,"1,2-epoxycyclopentane",206-005-6,285-67-6,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H225:47;H335:46;H315:47;H341:5
40056,2-(4-dipropylaminophenylazo)benzoic acid,220-140-8,2641-01-2,Aquatic Chronic 4,Notified C&L,38,H413:38
40057,α-(4-aminocyclohexyl)-ptoluidine,249-051-2,28480-77-5,Acute Tox. 3;Skin Corr. 1B,Notified C&L,23,H317:23;H314:23;H301:23
40059,"Oak, Quercus robur petraea, ext.",308-636-3,98143-70-5,Flam. Liq. 1;Acute Tox. 4;Skin Sens. 1;Acute Tox. 3;Carc. 2,Notified C&L,25,H302:25;H224:25;H317:25;H331:25;H351:25
40060,Methylbis(3-methylaminopropyl)amine,204-645-0,123-70-6,Skin Corr. 1B,Notified C&L,38,H314:38
40064,Erythromycin ethyl succinate,215-033-8,1264-62-6,Eye Irrit. 2,Notified C&L,90,H319:50;H317:42;H334:42;H335:2;H315:2
40065,"N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide",402-430-8,105076-77-5,Aquatic Chronic 4,Harmonised C&L,0,H413:0
40067,3-fluoro-p-toluic acid,206-498-8,350-28-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
40077,Ethylmalonic acid,210-007-2,601-75-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
40081,2-(2-hydroxyethoxy)ethyl monooleate,203-364-0,106-12-7,Not Classified,Notified C&L,14,Not classified:14
40083,"2,5-dimethylhexane-2,5-diol",203-731-5,110-03-2,Eye Dam. 1,REACH registration C&L,115,H318:88;H315:22;H319:5
40087,3-(3-hydroxypropyl)oxazolidin-2-one,431-840-1,87010-29-5,Not Classified,Notified C&L,86,Not classified:84;H319:2;H335:2;H315:2
40088,"1,2,3,4-Tetrahydrocarbazol-4-one",604-791-9,15128-52-6,Not Classified,Notified C&L,3,Not classified:1;H319:2;H315:2;H302:1;H335:1;H317:1
40090,CORPS GUAVA,439-850-6,,Not Classified,Notified C&L,36,Not classified:36
40095,"cis-cyclohexane-1,2-dicarboxylic anhydride",236-086-3,13149-00-3,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H317:0;H318:0;H334:0
40097,Octyl isobutyrate,203-651-0,109-15-9,Not Classified,Notified C&L,137,Not classified:137
40100,Ethyl pyridine-4-acetate,259-150-2,54401-85-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
40107,"Barium hydroxide (Ba(OH)2), monohydrate",606-983-8,22326-55-2,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,72,H302:72;H314:72;H332:71;H318:3
40108,Trimethoxy(pentafluorophenyl)silane,607-005-2,223668-64-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
40110,4-phenoxybutyric acid,228-603-6,6303-58-8,,Notified C&L,9,H319:6;H335:5;H315:6;Not classified:3
40112,o-tolyl isothiocyanate,210-390-6,614-69-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H302:45;H335:41;H315:41;H319:41;H312:45;H332:45;H314:4;H331:1;H301:1;H317:1;H334:1
40113,"(2,4,6-trioxo-1,3,5-triazine-1,3,5(2H,4H,6H)-triyl)triethane-2,1-diyl tris(3-mercaptopropionate)",252-907-8,36196-44-8,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1A;Aquatic Chronic 2,REACH registration C&L,41,H317:1;H302:1;H411:1;H312:1;H319:40;H335:38;H315:40
40115,"4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one hydrochloride",618-311-0,898543-06-1,Skin Sens. 1,Notified C&L,5,H317:3;H319:2;H332:1;H315:1;H335:1;Not classified:1
40116,"Soaps, stocks, peanut-oil, acidulated",283-101-4,84540-11-4,Not Classified,Notified C&L,1,Not classified:1
40118,"Bursera aloexylon, ext.",295-156-1,91844-87-0,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,4,H304:3;H400:3;H315:3;H317:4;H226:3;H410:3;H412:1
40119,Isopropylurea,211-722-2,691-60-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
40121,5-CHLOROTHIOPHENE-2-CARBOXYLIC ACID,480-060-6,24065-33-6,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,7,H302:4;H318:3;H317:3;H319:4;H315:3;H335:2
40127,m-xylene,203-576-3,108-38-3,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,Harmonised C&L,0,H312:0;H332:0;H315:0;H226:0
40130,Sodium hexyl sulphate,218-628-0,2207-98-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
40131,"Zeolites, NaX",614-877-8,68989-23-1,Acute Tox. 4;Skin Irrit. 2,Notified C&L,1,H302:1;H315:1
40132,"1,2-Cyclohexanedicarboxylic acid, 1,2-dinonyl ester, branched and linear",610-353-8,474919-59-0,Not Classified,Notified C&L,8,Not classified:8
40136,8-bromoxanthosine,221-081-0,3001-46-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H335:38;H315:38
40138,4-nitrophthalic anhydride,226-776-2,5466-84-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H335:43;H315:44;H318:1
40139,"2S-isopropyl-5R-methyl-1R-cyclohexyl (2R,5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1.3]-oxathiolane-2-carboxylate",425-250-1,147027-10-9,Aquatic Chronic 2,Harmonised C&L,0,H411:0
40141,Chlorocycloheptane,219-522-7,2453-46-5,Flam. Liq. 3,Notified C&L,1,H226:1
40142,"4-(2-hydroxyethyl)benzene-1,2-diol",600-704-3,10597-60-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:43;H335:39;H315:42;H302:2;H412:1
40146,5-methoxy-4'-(trifluoromethyl)valerophenone,425-000-1,61718-80-7,Aquatic Chronic 2,Harmonised C&L,0,H411:0
40153,"1,5-dichloro-1,1,3,3,5,5-hexamethyltrisiloxane",222-707-5,3582-71-6,Skin Corr. 1B,Notified C&L,39,H314:39;H318:1;H290:1
40155,Oct-2-en-4-ol,225-357-1,4798-61-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
40158,"trichloronate (ISO);O-ethyl O-2,4,5-trichlorophenyl ethylphosphonothioate",206-326-1,327-98-0,Acute Tox. 2;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H311:0;H300:0;H400:0;H410:0
40159,"(7-Methoxy-3,4-dihydronaphthalen-1-yl)acetonitrile",617-813-7,861960-34-1,Not Classified,REACH registration C&L,4,Not classified:4
40160,Reaction mass of Octadec-9-en-1-yl ammonium di-n-hexyl phosphorodithioate and Octadec-9-en-1-yl ammonium mono- and di-butylphosphate,434-280-4,,Skin Irrit. 2;Eye Irrit. 2A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,8,H400:2;H315:8;H373:8;H319:8;H410:8
40161,Quinaldine blue,220-457-1,2768-90-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
40164,Methyl 3-bicyclo[2.2.1]hept-5-en-2-yl-3-methyloxirane-2-carboxylate,276-437-8,72175-33-8,Not Classified,Notified C&L,88,Not classified:88
40165,"Manganese alloy, base, Mn 65-68,Fe 10-23,Si 12-21,C 0.5-3,P 0-0.2 (ASTM A483)",603-202-2,12743-28-1,Not Classified,Notified C&L,1,Not classified:1
40169,Calcium dibenzoate,218-235-4,2090-05-3,Eye Irrit. 2,REACH registration C&L,70,H319:59;Not classified:11
40171,"(3,5-difluorophenyl)boronic acid",605-060-7,156545-07-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H335:47;H315:48
40172,"(3AS,4S,6AR)-4-METHOXYTETRAHYDROFURO[3,4- B]FURAN-2(3H)-ONE",443-930-6,,Not Classified,REACH registration C&L,1,Not classified:1
40174,Pearl Powder,917-340-9,,Not Classified,Notified C&L,36,Not classified:36
40176,"1-(2,4,6-trichlorophenyl)-1H-pyrrole-2,5-dione",236-108-1,13167-25-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
40178,Triamcinolone benetonide,250-427-3,31002-79-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2,Notified C&L,1,H361:1;H319:1;H335:1;H315:1
40179,2-amino-5-(4-aminophenoxy)benzamide,255-067-0,40763-98-2,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Muta. 1B;Carc. 1B;Repr. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,32,H361:32;H350:32;H400:32;H311:32;H317:32;H373:32;H340:32;H331:32;H301:32;H410:32
40182,Diamminedichloropalladium,237-437-3,13782-33-7,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,40,H335:39;H315:39;H311:38;H319:39;H331:38;H301:38;H317:1;H302:1;H318:1;H413:1
40191,"poly(oxy-1,2-ethanediyl),alpha-carboxymethyl-,omega-hydroxy-,C12-14-alkyl ethers",615-153-4,70750-17-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
40194,"2,6-dimethyl-3-pyridylamine",222-332-7,3430-33-9,,Notified C&L,5,H302:5;H335:5;H315:5;H319:5;H312:5;H332:5
40197,"(9α,13α,14α)-3-methoxy-17-methylmorphinan hydrobromide",204-750-1,125-69-9,Acute Tox. 4,Notified C&L,156,H302:154;H411:60;Not classified:1;H361:2;H362:3;H301:1
40198,Tetradec-7-ene,233-815-7,10374-74-0,Asp. Tox. 1,Notified C&L,1,H304:1
40199,3-bromo-4-hydroxybenzyl alcohol,249-957-8,29922-56-3,,Notified C&L,6,H319:6;H335:6;H315:6
40200,3-Fluoro-p-cresol,610-235-6,452-78-8,,Notified C&L,7,H302:7;H314:5;H312:7;H332:2;H315:1;H319:1;H318:1;H227:1
40205,"Bis(glycinato-N,O)zinc",238-173-1,14281-83-5,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1,Notified C&L,89,H302:86;H318:86;H400:87;Not classified:2;H410:2;H319:1;H316:1
40206,1-(trifluoromethyl)vinyl acetate,218-838-2,2247-91-8,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H302:41;H225:46;H335:46;H319:46;H312:40;H332:41;H315:6
40207,"1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol",240-838-6,16808-63-2,Acute Tox. 3,REACH registration C&L,2,H300:2
40210,"1-(3,4-difluorophenyl)ethan-1-one",206-717-7,369-33-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
40211,Isobutyl chloroformate,208-840-1,543-27-1,,REACH registration C&L,57,H331:41;H302:50;H314:57;H226:57;H304:9;H311:5;H301:5;H330:7;H318:3
40212,"Clover, Trifolium pratense, ext.",285-356-7,85085-25-2,Not Classified,Notified C&L,116,Not classified:115;H319:1;H335:1;H315:1
40213,p-nitrophenyl pivalate,224-076-1,4195-17-9,Skin Sens. 1,Notified C&L,38,H317:38
40214,"Hydrochloric acid, reaction products with aniline and nitrobenzene",291-453-5,90411-75-9,,Notified C&L,33,Not classified:33
40217,"Decanoic acid, ester with 2,2-bis(hydroxymethyl)-1,3-propanediol 2-ethylhexanoate octanoate",268-582-0,68130-25-6,Not Classified,REACH registration C&L,11,Not classified:11
40219,"1,1,1-trifluoro-5,5-dimethylhexane-2,4-dione",245-211-0,22767-90-4,Flam. Liq. 3,Notified C&L,44,H226:44;H319:1;H335:1;H315:1
40223,"1,3-dimethylpentylamine",203-296-1,105-41-9,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,38,H335:38;H302:38;H314:38;H226:38
40227,"isoxaflutole (ISO);5-cyclopropyl-1,2-oxazol-4-yl α,α,α-trifluoro-2-mesyl-p-tolyl ketone",604-222-4,141112-29-0,Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H361:0;H400:0;H410:0
40228,4-pyridiniopyridinium dichloride,226-543-5,5421-92-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
40231,"2',4'-Dichlorobutyrophenone",613-927-6,66353-47-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
40237,"Carbonic acid, aluminum salt, basic",215-670-1,1339-92-0,Eye Irrit. 2,Notified C&L,83,H319:83
40241,[2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl](2-hydroxypropyl)dimethylammonium chloride,259-033-6,54229-13-9,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,117,H302:117;H400:1;H317:1;H318:117;H410:1;H412:116
40243,Sodium toluene-4-thiosulphonate,223-156-3,3753-27-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
40251,triphenyl phosphite,202-908-4,101-02-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H319:0;H400:0;H315:0;H410:0
40253,"5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione",601-029-7,111025-46-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,5,H302:5;H332:4;H312:4;H319:1;H335:1;H315:1
40255,"2-[2-(2,3-dihydro-2-methyl-1H-indol-1-yl)vinyl]-1,3,3-trimethyl-3H-indolium thiocyanate",283-199-9,84560-11-2,Acute Tox. 3;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H319:2;H400:2;H301:2;H410:2
40260,"4-Piperidinecarboxylic acid, 3-methyl-1-[(4-methylphenyl)sulfonyl]-4-phenyl-, compd. with α-methylbenzenemethanamine (1:1)",617-710-7,85395-96-6,Flam. Sol. 1,Notified C&L,1,H228:1
40262,"(R)-1,1'-Binaphthalene-2,2'-diol",606-048-4,18531-94-7,Eye Irrit. 2,REACH registration C&L,49,H319:49;H301:46;H335:5;H315:7;H341:1
40264,"2,2'-Oxydiethanol, propoxylated",500-031-4,9051-51-8,Not Classified,REACH registration C&L,93,Not classified:93
40265,2-(1-piperazinyl)quinoline maleate,227-314-2,5786-68-5,Acute Tox. 3,Notified C&L,38,H301:38
40268,Sodium heptane-1-sulphonate,245-210-5,22767-50-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,8,H319:5;H335:5;H315:5;Not classified:3
40269,"2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionyl fluoride",218-173-8,2062-98-8,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,2,H318:1;H314:2;H290:1
40272,"2-(bromomethyl)-2,3-dihydro-1,4-benzodioxin",218-503-0,2164-34-3,Eye Irrit. 2,Notified C&L,46,H319:46;H335:7;H315:8;H302:1
40273,2-methylcyclohexylamine,230-277-5,7003-32-9,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,Notified C&L,67,H302:61;H314:67;H226:61;H311:22;H331:22;H225:6;H318:1
40277,2-methylallyl 2-methylisocrotonate,262-901-7,61692-78-2,Not Classified,Notified C&L,88,Not classified:88
40282,"2,2',2''-nitrilotrisethanol, compound with 5-methyl-1H-benzotriazole (1:1)",270-909-7,68480-31-9,Not Classified,Notified C&L,6,Not classified:6
40285,"5,6-dichloro-1-ethyl-2-methyl-1H-benzimidazole",221-797-3,3237-62-5,Acute Tox. 2;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,39,H413:38;H335:38;H315:39;H318:38;H300:38;H319:1
40286,Hexadecene,248-131-4,26952-14-7,Asp. Tox. 1,REACH registration C&L,103,H304:100;Not classified:3
40287,"6α-fluoro-11β,21-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione 21-hexanoate",206-140-0,303-40-2,Repr. 1A;STOT RE 1,Notified C&L,24,H360:24;H372:24
40288,"Formaldehyde, polymer with 2-methylphenol",607-513-4,25053-96-7,Not Classified,Notified C&L,9,Not classified:5;H317:4;H302:1;H312:1
40289,Trihexylamine,203-062-9,102-86-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,130,H302:130;H400:85;H315:130;H317:85;H319:129;H410:85;H335:39;H411:45;H312:1;H332:1
40293,5-[(3-ethylbenzothiazol-2(3H)-ylidene)ethylidene]-4-oxo-2-thioxothiazolidin-3-acetic acid,247-373-8,25962-03-2,,Notified C&L,1,H315:1
40295,Methyl O-tert-butyl-L-tyrosinate hydrochloride,257-234-3,51482-39-4,Eye Irrit. 2;Resp. Sens. 1,Notified C&L,39,H334:39;H319:39
40300,4-chloro -3-ethyl-1-methyll-N-[4 -(p-tolypoxy) benzyl] pyrazole-5-carboxamide,603-342-4,129558-76-5,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,195,H302:194;H400:195;H332:195;H410:195;H373:1;H301:1;H372:1
40302,"3,4-difluorobenzophenone",285-659-4,85118-07-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
40310,"Oils, sesame",232-370-6,8008-74-0,Not Classified,Notified C&L,107,Not classified:107
40313,2-hydroxyethyl methacrylate,212-782-2,868-77-9,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H317:0;H319:0;H315:0
40318,Rubidium sulphate,231-301-7,7488-54-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,30,H319:30;H315:30
40319,"Castor oil, sulfurized",271-681-1,68604-22-8,Not Classified,Notified C&L,34,Not classified:33;H319:1;H315:1
40324,"Tricyclo[3.3.1.13,7]dec-1-ylacetic acid",225-585-1,4942-47-6,,Notified C&L,6,H319:6;H335:4;H315:6
40327,4-methylpent-1-ene,211-720-1,691-37-2,Flam. Liq. 2,REACH registration C&L,114,H225:87;H304:48;H319:55;H335:55;H315:55;H302:22;H224:22;H332:22;Not classified:5
40328,Perylene,205-900-9,198-55-0,Not Classified,Notified C&L,4,Not classified:4
40330,"3-[4-[1-[4-(2,3-epoxypropoxy)phenyl]-1-methylethyl]phenoxy]propane-1,2-diol",278-357-9,76002-91-0,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,38,H334:38;H319:38;H315:38
40334,Methyl 4-hydroxybenzoate,202-785-7,99-76-3,Aquatic Chronic 2,REACH registration C&L,3213,H411:30;H319:1756;H335:1652;H315:1759;Not classified:1110;H412:307;H318:11;H341:5;H302:5;H317:8;H334:2;H360:1
40337,"Pentasodium 2,2'-((2,4-diamino-5-(4-methoxy-2-sulfophenylazo)-1,3-phenylene)bis(azo))bis(5-(2-(sulfonatooxyethyl)sulfonyl)benzenesulfonate",475-300-1,910030-59-0,Eye Irrit. 2,REACH registration C&L,1,H319:1
40351,"1-[4-(phenylamino)naphthyl]-1H-pyrrole-2,5-dione",256-618-8,50539-45-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
40360,"Sulfonic acids, C10-18-alkane, Ph esters",615-163-9,70775-94-9,Not Classified,Notified C&L,6,Not classified:6
40363,"N-(aminoiminomethyl)-2,6-dichlorophenylacetamide monohydrochloride",249-443-3,29110-48-3,Acute Tox. 3,Notified C&L,11,H301:11;H361:2;H362:1;H373:1;H411:1
40365,"2,6-dimethyl-10-methylenedodeca-2,6,11-trien-1-al",262-043-3,60066-88-8,Not Classified,Notified C&L,89,Not classified:89
40366,"reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate;ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate;ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate",407-320-3,,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H315:0;H412:0
40372,"2,2-bis[[3-(dodecylthio)-1-oxopropoxy]methyl]propane-1,3-diyl bis[3-(dodecylthio)propionate]",249-720-9,29598-76-3,STOT RE 2,REACH registration C&L,182,H373:6;Not classified:176
40373,"Naphtha (petroleum), light steam-cracked arom., polymer with light steam-cracked arom. petroleum naphtha piperylene conc. and medium steam-cracked arom. petroleum naphtha",614-573-5,68527-25-3,Not Classified,Notified C&L,72,Not classified:72
40375,"2-Naphthalenesulfonic acid, 6-[(2,4-diaminophenyl)azo]-3-[[4-[[4-[[7-[(2,4-diaminophenyl)azo]-1-hydroxy-3-sulfo-2-naphthalenyl]azo]phenyl]amino]-3-sulfophenyl]azo]-4-hydroxy-, compd. with 2-(diethylamino)ethanol (1:3)",303-286-8,94160-05-1,Not Classified,Notified C&L,1,Not classified:1
40377,"1,2-Benzenedicarboxylic acid, di-C8-10-alkyl esters",275-809-7,71662-46-9,Not Classified,REACH registration C&L,59,Not classified:59
40378,"Amides, C12-22, N-[2-[(2-aminoethyl)amino]ethyl], reaction products with phenyloxirane",305-882-3,95193-69-4,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H317:1;H411:1
40379,"Trisodium 3-[(o-arsonatophenyl)azo]-4,5-dihydroxynaphthalene-2,7-disulphonate",266-069-6,66019-20-3,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H331:39;H400:38;H301:39;H410:39;H311:1
40380,Octyl laurate,226-149-3,5303-24-2,Skin Sens. 1,REACH registration C&L,27,H317:2;Not classified:25
40382,"2-Propenoic acid, 2-methyl-, 3-(trimethoxysilyl)propyl ester, reaction products with quartz",309-515-8,100402-78-6,Not Classified,Notified C&L,23,Not classified:21;H252:2
40387,Dodecane,203-967-9,112-40-3,Asp. Tox. 1,REACH registration C&L,1071,H304:593;H319:479;H335:36;H315:44;H226:54;Not classified:4
40391,4-methoxy-α-methylbenzyl alcohol,222-019-5,3319-15-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3;H227:1
40392,ethyl 2-amino-5-(diaminomethylideneamino)pentanoate dihydrochloride,609-261-0,36589-29-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
40393,Diethyl butylmalonate,205-089-1,133-08-4,Eye Irrit. 2,REACH registration C&L,3,H319:3
40394,"Patchouli, ext.",282-493-4,84238-39-1,Asp. Tox. 1,Notified C&L,1586,H304:1448;Not classified:135;H411:69;H319:26;H315:29;H412:1
40395,"Thiocarbonic acid, anhydrosulphide with methyl thiohypochlorite",247-801-3,26555-40-8,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,44,H314:44;H226:43;H318:1
40396,Tolmetin,247-497-2,26171-23-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
40398,"1,2-ethanedisulphonic acid",203-732-0,110-04-3,,Notified C&L,8,H314:8;H318:2;H290:2;H319:1
40400,"α,α,α',α'-tetramethyl-p-xylene-α,α'-diol",220-964-8,2948-46-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:42;H335:42;H315:42;Not classified:1
40403,6-aminonaphthol,245-933-6,23894-12-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
40404,Isopropylmalonic acid,210-008-8,601-79-6,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H318:39;H335:44;H315:45;H301:40;H319:6
40405,N-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea;3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate,432-520-2,232938-43-1,Aquatic Chronic 2,Harmonised C&L,0,H411:0
40406,2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-methylbenzothiazolium hydroxide,300-004-5,93919-19-8,Eye Irrit. 2,Notified C&L,2,H319:2
40407,"sodium 1,2-benzoxazol-3-ylmethanesulfonate",615-908-8,73101-64-1,Acute Tox. 4;Muta. 2,REACH registration C&L,2,H302:2;H341:2
40408,4-methyl-4-phenylpentan-2-one,231-007-9,7403-42-1,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,275,H315:12;H412:12;Not classified:225;H302:38
40410,Aminophylline,206-264-5,317-34-0,Acute Tox. 3,Notified C&L,101,H301:95;H302:6;H318:2;H315:2;H361:1;H370:1;H317:1;H362:1;H372:1;H312:1;H332:1
40417,N-dodecylaniline,221-118-0,3007-74-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H302:1;H315:1;H319:1;H312:1;H332:1
40419,Oxeladin dihydrogen citrate,257-910-8,52432-72-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,41,H311:39;H331:39;H301:40;Not classified:1
40421,"Reaction products of diazotised 2-amino-1,5-naphthalene sulfonic acid coupled with resorcinol, subsequently coupled with diazotized 2-amino-4,6-dinitrophenol, chelated with iron",612-831-1,61967-98-4,Aquatic Chronic 2,REACH registration C&L,4,H411:4
40423,"Oxidase, pyruvate",232-644-5,9001-96-1,Resp. Sens. 1,Notified C&L,1,H334:1
40424,Bis(triethylammonium)decahydrodecaborate,601-736-0,12075-73-9,Flam. Sol. 1;Self-react. E;Acute Tox. 3;Acute Tox. 3;Acute Tox. 2,Notified C&L,2,H311:1;H301:1;H242:1;H228:1;H330:1;H319:1;H335:1;H315:1
40429,"1,1,2-tribromoethane",201-138-6,78-74-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H302:38;H335:38;H315:39;H311:1;H331:1;H301:1
40430,Colchiceine,207-512-5,477-27-0,Acute Tox. 2;Eye Dam. 1;Acute Tox. 2;Muta. 1B,Notified C&L,1,H318:1;H300:1;H340:1;H330:1
40432,Disodium 2-[4-[[2-cyano-3-[4-[methyl(2-sulphonatoethyl)amino]phenyl]-1-oxoallyl]amino]phenyl]-6-methylbenzothiazole-7-sulphonate,219-694-3,2498-95-5,Not Classified,REACH registration C&L,85,Not classified:85
40433,(S)-(-)-N-Benzyl-1-phenylethylamine,605-736-1,17480-69-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H302:42;H335:38;H315:43
40435,"(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;dihydrate;hydrochloride",610-669-6,51481-60-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,109,H319:93;H335:93;H315:93;H302:16;H318:9;H332:5;H312:3;H317:2;H334:2;H336:1;H361:1
40436,"L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9- yl)methoxy)ethyl ester",603-015-6,124832-26-4,Acute Tox. 4,Notified C&L,1,H302:1
40438,Bis(phenylsulphonyl)(fluoro)amine,603-762-8,133745-75-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:49;H335:47;H315:48;H302:1;H317:1;Not classified:1;H270:1
40439,Bismuth oxide salicylate,238-953-1,14882-18-9,Not Classified,REACH registration C&L,141,Not classified:52;H400:83;H410:83;H319:6;H335:6;H315:6
40443,"N-methylbenzene-1,2-diammonium hydrogen phosphate",424-460-0,,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H302:0;H411:0
40445,Lead carbonate,247-054-3,25510-11-6,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H302:1;H400:1;H373:1;H360:1;H410:1;H332:1
40448,[No public or meaningful name is available],460-890-5,,Aquatic Chronic 1,Notified C&L,3,H410:3
40449,"Bromobenzo[rst]phenanthro[10,1,2-cde]pentaphene-9,18-dione",215-365-3,1324-17-0,Not Classified,Notified C&L,22,Not classified:22
40450,"Potassium 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate",246-341-0,24598-73-0,Not Classified,Notified C&L,2,Not classified:2
40451,Ammonium 2-mercaptopropionate,236-526-4,13419-67-5,Met. Corr. 1;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,37,H302:37;H315:37;H317:1;H290:1;H319:37
40453,methyl 2-(2-nitrobenzylidene)acetoacetate,400-650-9,39562-27-1,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
40456,"4-(2,2-dimethyl-6-methylenecyclohexyl)but-3-en-2-one, monomethyl derivative",248-449-3,27417-37-4,Not Classified,Notified C&L,16,Not classified:10;H319:6;H411:6;H315:6
40457,"Fatty acids, tallow, tallow alkyl esters, chlorinated",296-757-1,93028-64-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
40459,3-sulphino-L-alanine,214-228-5,1115-65-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H302:1
40461,"Cholesta-5,7-diene-1α,3β-diyl diacetate",255-382-3,41461-10-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 2,Notified C&L,1,H361:1;H302:1;H332:1;H312:1
40466,"α,α'-dichloro-p-xylene",210-782-7,623-25-6,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,53,H302:53;H400:51;H315:45;H317:4;H319:45;H410:52;H314:7;H330:7;H318:2;H290:1
40474,Hexyl crotonate,240-997-1,16930-96-4,Not Classified,Notified C&L,130,Not classified:91;H319:39;H335:39;H315:39
40475,Methyl 2-ethylhexanoate,212-429-2,816-19-3,Flam. Liq. 3;Skin Irrit. 2,REACH registration C&L,41,H315:41;H226:28
40476,"4-methylcyclohexylamine, mixed isomers",228-673-8,6321-23-9,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,39,H314:39;H226:39;H318:1
40479,1-ethoxydodecane,614-582-4,68551-13-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1371,H400:1226;H410:932;H319:250;H315:242;Not classified:45;H411:49;H302:21;H318:15
40480,p-menth-1-en-8-ol,233-986-8,10482-56-1,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,1539,H318:2;H315:1536;H319:1525;H335:38;Not classified:3
40485,"N,N-diethyl-N'-phenylethylenediamine",216-778-1,1665-59-4,Acute Tox. 3;Eye Dam. 1,Notified C&L,38,H318:38;H301:38
40486,"Extracts (petroleum), light paraffinic distillate solvent, clay-treated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C",309-673-8,100684-03-5,Carc. 1B,Harmonised C&L,0,H350:0
40487,4-nitrophenyl dichlorophosphonate,212-289-2,777-52-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H314:38
40488,"1,3-dihydro-5-methoxy-2H-benzimidazole-2-thione",253-326-2,37052-78-1,Acute Tox. 4;Skin Sens. 1;STOT SE 1,REACH registration C&L,115,H317:64;H302:55;H370:14;H412:13;H319:63;H335:84;H315:63
40489,"Sodium 3-[(2,4-dihydroxyphenyl)azo]-4-hydroxybenzenesulphonate",222-644-3,3564-26-9,Not Classified,Notified C&L,1,Not classified:1
40504,"1-Propanamine, 3-(C12-15-branched alkyloxy) derivs.",283-234-8,84583-82-4,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 1,Notified C&L,22,H302:22;H314:22;H410:22
40506,"1,1'-(p-tolylimino)dipropan-2-ol",254-075-1,38668-48-3,Acute Tox. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,353,H319:143;H300:141;H412:286;H301:212;H318:4
40509,"Paraffin waxes and Hydrocarbon waxes, sulfochlorinated",297-891-3,93763-69-0,Skin Corr. 1B;Aquatic Chronic 3,Notified C&L,3,H314:1;H412:2;H335:1
40510,"Heterotheca inuloides, ext.",289-933-4,90045-70-8,Not Classified,Notified C&L,1,Not classified:1
40513,1-dodecyl-1H-imidazole,224-314-4,4303-67-7,Acute Tox. 4;Skin Sens. 1A;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,91,H302:90;H400:90;H317:90;H319:91;H410:90;H335:1;H315:1
40516,"Main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol;Main component 8 (isomer): asym. 1:2 Cr-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol",417-280-9,30785-74-1,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H318:0;H400:0;H410:0
40519,"1-Propanesulfonic acid, 2,3-dihydroxy-, mono-C10-16-alkyl ethers, sodium salts",268-362-4,68081-95-8,Not Classified,Notified C&L,36,Not classified:36
40522,"Hydrochloric acid, reaction products with aniline and nitrobenzene, sulfonated, sodium salts",291-454-0,90411-76-0,Not Classified,REACH registration C&L,13,Not classified:13
40523,Sodium toluene-4-sulphinate,212-538-5,824-79-3,Not Classified,REACH registration C&L,12,Not classified:9;H302:1;H315:3;H319:3;H312:1;H332:1;H335:2
40525,p-(trifluoromethyl)benzamide,217-571-9,1891-90-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
40527,4-benzyloxyphenylacetic acid,229-463-9,6547-53-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:2;H315:3
40529,Undecan-3-ol,230-054-2,6929-08-4,Flam. Liq. 3,Notified C&L,1,H226:1
40532,"3-[2,2-dimethyl-1-oxo-3-[(1-oxoallyl)oxy]propoxy]-2,2-dimethylpropyl acrylate",250-072-4,30145-51-8,Skin Sens. 1,Notified C&L,61,H317:42;H319:18;Not classified:5
40535,Tris(4-chlorophenyl)phosphine,214-596-7,1159-54-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:44;H315:44
40538,3-chloro-p-tolyl isocyanate,249-050-7,28479-22-3,Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,45,H335:41;H400:2;H317:2;H318:2;H314:6;H410:2;H330:3;H302:38;H315:39;H334:43;H319:39;H312:38;H332:38;H412:4
40539,"2-amino-4,6-dichlorophenol",208-421-3,527-62-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H315:2;H311:1;H331:1;H301:2;H302:1;H335:1;H312:1;H332:1
40541,"Spartium junceum, ext.",290-331-9,90131-21-8,Aquatic Chronic 3,Notified C&L,1394,H412:1294;Not classified:37;H332:63;H315:34;H317:1;H319:1;H312:1
40542,5-methylfurfural,210-622-6,620-02-0,Not Classified,Notified C&L,373,Not classified:325;H319:48;H335:47;H315:48;H360:1
40543,Ethyl indole-2-carboxylate,223-206-4,3770-50-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
40544,"Colistin, sulfate (salt)",215-034-3,1264-72-8,Acute Tox. 3,Notified C&L,119,H301:113;H302:6
40549,Diazoaminobenzene,205-240-1,136-35-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H302:40;H335:39;H315:40;H319:40;H312:39;H332:39;H242:1
40554,"2-amino-3,5-xylenesulphonic acid",201-811-4,88-22-2,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,14,H319:4;H302:13;H315:9;H312:9;H412:9;Not classified:1
40556,methyl-ONN-azoxymethyl acetate;methyl azoxy methyl acetate,209-765-7,592-62-1,Carc. 1B;Repr. 1B,Harmonised C&L,0,H360:0;H350:0
40557,"2-chloro-1,4-diethoxybenzene",257-728-9,52196-74-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
40564,Di-m-tolyl ether,243-343-3,19814-71-2,Aquatic Chronic 4,Notified C&L,33,H413:33
40566,3-chloropropoxy(trimethyl)silane,605-943-7,18171-15-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H335:2;H315:2;H226:2
40567,"Ethanone, 1-(3-ethoxyphenyl)-",610-866-7,52600-91-6,,Notified C&L,1,H319:1;H335:1;H315:1
40568,[vinyl-2-ylidenetris(oxy)]tris[trimethylsilane],273-864-1,69097-20-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41;H226:41
40575,"Enzymatic Hydrolysate of Soy, Pancreatic",918-321-8,,Not Classified,Notified C&L,1,Not classified:1
40578,"Ethyl 4,4-dimethoxy-3-methyl-2-butenoate",280-901-5,83803-81-0,Not Classified,REACH registration C&L,1,Not classified:1
40581,"N,N'-diethylpropane-1,3-diamine",233-200-3,10061-68-4,Flam. Liq. 3;Skin Corr. 1B;Skin Sens. 1,Notified C&L,39,H317:39;H314:39;H226:39;H302:1;H311:1;H334:1
40582,3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,415-750-8,106447-44-3,Skin Sens. 1,Harmonised C&L,0,H317:0
40584,Fatty alcohol polyoxyethylene ether,609-406-8,37335-03-8,Aquatic Chronic 2,Notified C&L,2,H411:2;H302:1;H318:1
40586,3-methoxy-2-methylbenzoyl chloride,607-388-6,24487-91-0,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,16,H317:16;H318:16;H314:16;H412:16
40589,tert-butylpyrocatechol,248-325-9,27213-78-1,Skin Sens. 1,Notified C&L,55,H317:39;H302:16;H314:16;H319:1;H315:1
40590,2-chloro-4-mesylaniline,236-225-8,13244-35-4,Eye Irrit. 2,Notified C&L,40,H319:40;H302:1;H335:2;H315:2;H312:1;H332:1
40591,"3,6,9-trioxaundecamethylenediamine",213-206-2,929-75-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:39;H335:38;H315:39
40592,"14H-benz[4,5]isoquino[2,1-a]perimidin-14-one",229-904-5,6829-22-7,Skin Sens. 1B,REACH registration C&L,3675,H317:38;H319:3429;Not classified:208
40593,"L-Glutamic acid, N-[(1,1-dimethylethoxy)carbonyl]-, 5-cyclohexyl ester",616-021-9,73821-97-3,,Notified C&L,1,Not classified:1
40598,(Z)-hex-3-enyl 2-methylbutyrate,258-517-4,53398-85-9,Not Classified,Notified C&L,183,Not classified:140;H411:41;H319:2;H315:2
40599,5-aminobenzimidazole-2-thiol,220-574-8,2818-66-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45;H302:1
40601,4'-chloro-2'-methylacetoacetanilide,243-540-4,20139-55-3,Acute Tox. 4,Notified C&L,38,H302:38
40607,Amobarbital,200-330-7,57-43-2,Acute Tox. 3,Notified C&L,40,H301:40
40609,"N,N,N',N'-tetramethylbenzidine",206-676-5,366-29-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
40613,"Reaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1)",407-710-3,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
40614,"3,6-dioxabicyclo[3.1.0]hexane",206-006-1,285-69-8,Flam. Liq. 3,Notified C&L,1,H226:1
40616,"Kalanchoe daigremontiana, ext.",308-635-8,98143-69-2,Not Classified,Notified C&L,1,Not classified:1
40618,Diisodecyl maleate,258-806-5,53817-61-1,Not Classified,REACH registration C&L,86,Not classified:86
40619,"Zeolites, NaA",614-876-2,68989-22-0,Not Classified,Notified C&L,6,Not classified:6
40620,butyraldehyde,204-646-6,123-72-8,Flam. Liq. 2,Harmonised C&L,0,H225:0
40621,2-chloro-1-fluoro-4-nitrobenzene,206-499-3,350-30-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,46,H302:40;H318:39;H335:41;H315:46;H311:6;H373:6;H319:7;H301:6;H331:2;H400:2;H341:2
40625,2-(2-hydroxyethoxy)ethyl stearate,203-363-5,106-11-6,Not Classified,Notified C&L,69,Not classified:69
40629,[No public or meaningful name is available],482-180-4,,Skin Sens. 1B;Aquatic Chronic 2,Notified C&L,24,H317:24;H411:24
40633,"1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-",603-776-4,133909-99-6,Aquatic Chronic 4,Notified C&L,36,H413:35;H302:1
40636,"Peptidase, entero-",232-761-1,9014-74-8,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,39,H334:39;H319:39;H335:39;H315:39
40642,"5-O-(3,4-dihydroxycinnamoyl)-L-quinic acid",206-325-6,327-97-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,14,H319:10;H335:10;H315:10;Not classified:4
40643,"Urea, N-(3-silylpropyl)-, Si-(ethoxy and methoxy) derivs.",601-461-6,116912-64-2,Not Classified,Notified C&L,5,Not classified:5
40644,1-chloromethyl-2-methylnaphthalene,229-587-3,6626-23-9,Skin Corr. 1B;STOT SE 3,Notified C&L,38,H335:38;H314:38
40645,"2,2'-ethylenedioxydiethyl dimethacrylate",203-652-6,109-16-0,Skin Sens. 1B,REACH registration C&L,494,H317:194;Not classified:261;H319:113;H335:86;H315:113;H334:1
40649,Bis[4-(tert-butyl)benzoato-O]hydroxyaluminium,236-109-7,13170-05-3,Not Classified,REACH registration C&L,6,Not classified:5;H319:1;H335:1;H315:1
40650,4-dimethylaminocinnamaldehyde,228-267-0,6203-18-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H335:46;H315:48;Not classified:2
40652,3-(dimethoxymethylsilyl)propanethiol,250-426-8,31001-77-1,Acute Tox. 4;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,86,H317:40;H302:40;H411:40;H319:45;H335:44;H315:45;H318:1;H312:1;H336:1
40654,3-Chloro-4-fluorobenzoic Acid,609-818-8,403-16-7,,Notified C&L,9,H319:9;H335:8;H315:9
40656,"4,5-dichloropyrocatechol",222-331-1,3428-24-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H319:38;H335:38;H315:38;H400:38
40659,Diisobutyl hydrogen phosphate,228-602-0,6303-30-6,Skin Corr. 1;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,4,H317:2;H318:2;H314:4
40661,"Soaps, stocks, palm-oil, acidulated",283-100-9,84540-10-3,Not Classified,Notified C&L,3,Not classified:3
40665,"Hexasodium 2,2'-[vinylenebis[(3-sulphonato-4,1-phenylene)imino[6-[(2-cyanoethyl)[2-(2-hydroxyethoxy)ethyl]amino]-1,3,5-triazine-4,2-diyl]imino]]bis[benzene-1,4-disulphonate]",279-087-4,79135-87-8,Not Classified,REACH registration C&L,39,Not classified:39
40666,Ethyl 3-(4-pyridyl)-3-oxopropionate,247-635-1,26377-17-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H302:2;H335:2;H315:2;H319:2;H312:1;H332:1
40669,Hydrogen bis[1-[(5-(aminosulphonyl)-2-hydroxyphenyl)azo]2-naphtholato(2-)]chromate(1-),254-143-0,38833-00-0,Not Classified,Notified C&L,4,Not classified:4
40672,"Potassium 1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazine-2-carboxylate",218-627-5,2207-75-2,Not Classified,Notified C&L,1,Not classified:1
40674,Isopropyl bromoacetate,249-956-2,29921-57-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,41,H318:40;H314:41;H301:1
40677,"4,4'-diiodobiphenyl",221-080-5,3001-15-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H302:38;H332:38;H312:38;H412:4;H319:1;H335:1;H315:1
40679,"1,2-difluoro-4-nitrobenzene",206-718-2,369-34-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,46,H319:46;H335:45;H315:46;H302:7;H373:5;H312:6;H332:6;H340:1
40681,Isobutyl carbamate,208-841-7,543-28-2,Eye Irrit. 2,Notified C&L,38,H319:38
40682,3-bromo-3-methylpentane,246-878-0,25346-31-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H226:1
40683,Methyl p-toluate,202-784-1,99-75-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,REACH registration C&L,195,H317:32;H319:146;H335:145;H315:184;H318:31;Not classified:12
40686,2-oxo-4-imidazolinecarboxylic acid,244-309-0,21277-16-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
40691,Dodecyldimethylammonium chloride,217-953-5,2016-48-0,Not Classified,Notified C&L,34,Not classified:34
40699,"Lecithins, reaction products with diethanolamine",293-317-0,91053-51-9,Not Classified,Notified C&L,1,Not classified:1
40703,"3-{[3-Acetylamino-4-(2-cyano-4,6-dinitro-phenylazo)-phenyl]-ethyl-amino}-propionic acid 2-oxo-2-phenyl-ethyl ester",454-440-7,682809-44-5,Ox. Sol. 1;Aquatic Chronic 4,Notified C&L,37,H413:37;H271:37
40705,3-methylvaleric acid,203-297-7,105-43-1,Skin Corr. 1B,Notified C&L,1458,H314:1434;Not classified:24;H318:13;H290:1
40706,"2-(1,3(2H)-dioxo-1H-isoindol-2-yl)ethyl acetate",226-777-8,5466-90-0,Acute Tox. 4;Aquatic Acute 1,Notified C&L,38,H302:38;H400:38
40708,Tetra-O-acetyl-D-ribofuranose,249-174-1,28708-32-9,,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
40711,N-butyl isocyanide,220-458-7,2769-64-4,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H225:38;H332:38;H312:38
40712,Ditetradecyl fumarate,233-739-4,10341-03-4,Not Classified,REACH registration C&L,113,Not classified:113
40714,"2,5-xylidine",202-451-0,95-78-3,Acute Tox. 4;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,124,H373:121;H302:7;H412:6;H311:116;H411:117;H331:116;H301:116;H371:1;H310:2;H300:2;H330:2;H315:1;H319:1
40716,"Butanedioic acid, sulfo-, 1,4-bis(C14-18 and C16-18 unsatd. alkyl) esters, sodium salts",295-020-1,91782-49-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,36,H319:30;H315:30;Not classified:6
40719,6-bromo-2-naphthyl β-D-glucopyranoside,239-604-6,15548-61-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
40722,N-[2-[(2-aminoethyl)amino]ethyl]stearamide monoacetate,276-436-2,72175-32-7,Not Classified,Notified C&L,1,Not classified:1
40724,"2,3-dibromopentane",226-427-4,5398-25-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
40730,hexachlorocyclopentadiene,201-029-3,77-47-4,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H400:0;H311:0;H314:0;H410:0;H330:0
40732,3-Chloro-5-iodobenzoic acid,608-277-5,289039-25-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
40736,Bis(acetato-O)hydroxyaluminium,205-518-2,142-03-0,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,14,H318:9;H400:9;H412:9;Not classified:2;H319:3;H335:2;H315:3
40738,"tetrasodium 2,2'-ethene-1,2-diylbis[5-({4-[diethylamino]-6-[(4-sulfonatophenyl)amino]-1,3,5-triazin-2-yl}amino)benzenesulfonate]",619-874-5,42355-78-2,Not Classified,REACH registration C&L,2,Not classified:2
40741,3-chloro-4-hydroxy-5-methoxybenzoic acid,263-766-7,62936-23-6,,Notified C&L,5,H319:5;H335:5;H315:5;H302:1
40744,[No public or meaningful name is available],639-870-7,151213-43-3,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,Notified C&L,33,H302:33;H373:33;H314:33;H411:33;H332:33
40747,"2H-1,5-Benzodioxepin-3(4H)-one, 7-(3-methylbutyl)-",447-630-6,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1288,H302:1288;H315:1288;H317:1288;H318:1288;H412:1288
40750,m-bromocinnamic acid,251-267-7,32862-97-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:41;H315:41
40751,Indium bromide,238-172-6,14280-53-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H302:38;H335:38;H315:38;H319:38;H312:38;H332:38;H314:5;H318:1
40755,"Dl-bornane-2,3-dione",233-814-1,10373-78-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,17,H319:15;H335:15;H315:15;Not classified:2
40756,1-bromo-3-chlorobenzene,203-575-8,108-37-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53,H319:51;H335:46;H315:51;H311:1;H330:1;H301:1;H302:1;H332:1;H312:1
40758,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, (1-methyl-1H-imidazolyl)methyl derivs., acetates",284-918-9,84989-29-7,,Notified C&L,83,Not classified:83
40759,Levomethorphan,204-751-7,125-70-2,Acute Tox. 4,Notified C&L,39,H302:38;H361:1;H301:1
40760,"Phosphinic acid, diethyl-, zinc salt",457-580-7,284685-45-6,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,34,H318:34;H400:34;H410:34
40762,"3-formyl-2,2,5,5-tetramethylthiazolidine-4-carboxylic acid",259-542-3,55234-12-3,Eye Dam. 1,Notified C&L,1,H318:1
40763,Ethyl bromopyruvate,200-729-6,70-23-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:41;H335:41;H315:41;H314:7;Not classified:2;H318:1
40764,3-methoxycyclohex-2-en-1-one,240-837-0,16807-60-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
40773,"3-(benzyloxy)propane-1,2-diol",225-358-7,4799-67-1,Not Classified,Notified C&L,1,Not classified:1
40774,"Ethanol, 2-methoxy-, manufacture of, by-products from",310-289-8,161907-79-5,Not Classified,Notified C&L,119,Not classified:94;H319:25
40777,"terbufos (ISO);S-tert-butylthiomethyl O,O-diethylphosphorodithioate",235-963-8,13071-79-9,Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H300:0;H400:0;H310:0;H410:0
40778,"Estra-1,3,5(10)-triene-3,17β-diol 17-butyrate",241-977-5,18069-79-9,,Notified C&L,1,H334:1;H302:1
40779,3-methylpent-1-en-3-ol,213-044-2,918-85-4,Flam. Liq. 3;Acute Tox. 4,REACH registration C&L,128,H302:128;H226:128
40781,"Benzyl (S)-N-(1-oxopentyl)-N-((2'-(1H-tetrazole-5-yl)-1,1'-biphenyl-4-yl)methyl)-L-valinate",604-047-3,137863-20-8,Acute Tox. 4,Notified C&L,42,H302:41;H412:2;H303:1;H313:1;H402:1;H410:1
40784,"Disodium dibromodibenzo[b,def]chrysene-7,14-diyl bis(sulphate)",215-364-8,1324-15-8,Not Classified,Notified C&L,1,Not classified:1
40785,Allyl cyclohexaneacetate,225-230-0,4728-82-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,233,H315:233;H302:233;H319:233;H312:233
40786,"Ferula assa-foetida, ext.",289-863-4,90028-70-9,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,173,H302:171;H315:172;H317:171;H226:147;H319:169;Not classified:1
40787,"3,4-dihydro-2,2,4,7-tetramethyl-2H-quinoline-1-ethanol",258-802-3,53817-44-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
40789,"Bis([?]5-cyclopenta-2,4-dien-1-yl)chromium",215-036-4,1271-24-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4,Notified C&L,100,H302:95;H317:56;H318:55;H314:56;H312:95;H332:95;H335:44;H315:44;H319:44;H250:4;H252:4;H228:1
40796,"Bis[OO,OO'-tert-butyl] O,O'-hexane-1,6-diyl bis[peroxycarbonate]",253-092-1,36536-42-2,Org. Perox. C;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;H242:2
40800,"1,2,3-Propanetricarboxylic acid, 1,1'-(1-(2-amino-9,11-dihydroxy-2-methyltridecyl)-2-(1-methylpentyl)-1,2-ethanediyl) ester",601-424-4,116355-84-1,Acute Tox. 2;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1;STOT SE 3;Carc. 2,Notified C&L,41,H335:41;H315:41;H319:41;H310:40;H300:40;H330:41;H351:41;H311:1;H301:1
40803,"Tetradecane-1,14-diol",243-341-2,19812-64-7,Not Classified,Notified C&L,1,Not classified:1
40804,"Lauric acid, ester with hydroxypropanediyl diacetate",250-379-3,30899-62-8,Not Classified,REACH registration C&L,11,Not classified:11
40805,"3-[[4-(diethylamino)phenyl]azo]-1,2-dimethyl-1H-indazolium methyl sulphate",284-138-9,84788-00-1,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H319:2;H302:2;H400:2;H410:2
40806,12-hydroxy-N-(2-hydroxyethyl)octadecan-1-amide,203-367-7,106-15-0,Not Classified,REACH registration C&L,56,Not classified:55;H318:1;H315:1
40809,"Ethanaminium, N,N,N-trimethyl-2-[(1-oxo-2-propen-1-yl)oxy]-, chloride (1:1), homopolymer",611-090-1,54076-97-0,Not Classified,Notified C&L,20,Not classified:20
40810,sec-octadecylnaphthalene,304-230-5,94247-61-7,,Notified C&L,1,Not classified:1
40811,"Brain, ext.",283-072-8,84539-85-5,Not Classified,Notified C&L,1,Not classified:1
40818,Tetradecene,248-130-9,26952-13-6,Asp. Tox. 1,REACH registration C&L,2,H304:2
40821,5-chloro-2-nitrodiphenylamine,247-261-9,25781-92-4,Not Classified,REACH registration C&L,10,Not classified:5;H319:5;H335:4;H315:5
40822,Tinoridine,246-102-0,24237-54-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
40823,"Benzenesulfonic acid, di-C10-18-alkyl derivs., calcium salts",298-637-4,93820-57-6,Eye Irrit. 2,Notified C&L,1041,H319:1016;H413:137;H317:61;H315:14;Not classified:2
40825,"Fatty acids, tallow, hydrogenated, lead salts",271-722-3,68605-98-1,Not Classified,Notified C&L,1,Not classified:1
40830,"[4-[bis[4-(diethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]diethylammonium chloride",219-231-5,2390-59-2,Not Classified,Notified C&L,53,Not classified:34;H302:19;H400:15;H410:15;H335:4;H315:5;H319:4;H312:4;H332:5;H318:1
40831,[No public or meaningful name is available],480-130-6,,Eye Irrit. 2,Notified C&L,32,H319:32
40832,"Cyclohexa-1,3-diene",209-764-1,592-57-4,Flam. Liq. 2,Notified C&L,46,H225:46;H335:6
40834,"(RS)-2-(2,4-Dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol",616-763-3,79983-71-4,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,230,H317:230;H302:230;H411:230
40835,"2,6-dimethylcyclohexan-1-one",220-570-6,2816-57-1,Flam. Liq. 3,Notified C&L,54,H226:54;H319:1;H335:1;H315:1
40838,"fatty acids, C",447-880-6,206565-89-1,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H315:0;H317:0;H318:0;H410:0
40839,"Sodium bis[3-[[1-(2,5-dichlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]-4-hydroxybenzene-1-sulphonamidato(2-)]chromate(1-)",276-775-6,72709-84-3,Aquatic Chronic 3,Notified C&L,13,H412:9;H319:3;H411:3;Not classified:1
40840,1-[[2-[[2-[(2-aminoethyl)amino]ethyl]amino]ethyl]amino]propan-2-ol,249-677-6,29513-72-2,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Notified C&L,1,H317:1;H302:1;H314:1;H312:1
40846,4-(1H-Imidazol-1-yl)aniline,606-953-4,2221-00-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
40847,2-Fluoro-4-methylpyridine,625-585-5,461-87-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:49;H335:48;H315:49;H226:8;H302:2;H312:2;H332:2
40850,"Isobutyl 2,4,5-trichlorophenoxyacetate",225-580-4,4938-72-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H302:38;H335:38;H315:38;H400:38;H319:38;H410:38
40854,4-hydroxybenzaldehyde,204-599-1,123-08-0,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1533,H319:75;H315:75;H318:27;H335:58;Not classified:1430;H302:2
40859,1-O-octyl-β-D-glucopyranoside,249-887-8,29836-26-8,Not Classified,Notified C&L,7,Not classified:3;H319:4;H335:4;H315:4;H228:1
40860,Sodium (Z)-octadec-9-enyl sulphate,217-430-1,1847-55-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,28,H318:28;H315:28
40865,"4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide",412-650-6,121487-83-0,Aquatic Chronic 4,Harmonised C&L,0,H413:0
40870,Trizinc dicitrate,208-901-2,546-46-3,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,111,H319:31;H400:36;H411:30;H410:35;Not classified:72
40875,"2-pentenoic acid, 2-cyano-3-methyl-, methyl ester (2E)",600-305-4,102363-72-4,Not Classified,Notified C&L,1,Not classified:1
40877,"Soaps, stocks, cottonseed-oil, acidulated",273-629-3,68990-86-3,Not Classified,Notified C&L,1,Not classified:1
40880,"Star anise, Illicium verum, ext.",283-518-1,84650-59-9,Not Classified,REACH registration C&L,1463,Not classified:12;H317:1441;H351:1440;H412:1297;H341:1439;H411:142;H315:12;H319:10;H226:1;H413:1;H304:1
40882,"Gases (petroleum), fluidized catalytic cracker splitter residues",272-892-1,68919-19-7,Flam. Gas 1,Notified C&L,2,H220:2
40883,Aminoglutethimide,204-756-4,125-84-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40;H302:1;H360:1
40886,Guanosine 5'-(disodium phosphate),226-914-1,5550-12-9,Not Classified,Notified C&L,101,Not classified:101
40887,Isopentyl 2-methylcrotonate,233-985-2,10482-55-0,Not Classified,Notified C&L,234,Not classified:233;H411:1
40890,"5,7-Dihydroxy-4-propylcoumarin",613-925-5,66346-59-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
40892,"Spinach, ext.",290-336-6,90131-25-2,Not Classified,Notified C&L,3,Not classified:3
40894,"3-phenoxypropane-1,2-diol",208-692-8,538-43-2,Not Classified,Notified C&L,25,Not classified:25
40896,"Castor oil, ethoxylated",500-151-7,61791-12-6,Not Classified,REACH registration C&L,1029,Not classified:807;H319:221;H335:25;H315:26;H317:1;H334:1;H413:1;H302:1
40899,"cis-tetrahydrofuran-3,4-diol",224-433-1,4358-64-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
40900,"Naphthenic acids, rare earth salts",263-114-1,61790-20-3,Not Classified,Notified C&L,9,Not classified:5;H332:4
40904,"6-ethylideneoctahydro-5,8-methano-2H-benzo-1-pyran",300-376-9,93939-86-7,Skin Sens. 1B;Aquatic Chronic 2,Notified C&L,1412,H317:1327;H411:1327;Not classified:85
40905,"Phosphoric trichloride, polymer with 1,3-benzenediol, phenyl ester",603-113-9,125997-21-9,Aquatic Acute 1;Aquatic Chronic 3,Notified C&L,463,H400:441;H412:463;H319:22
40908,2-methoxyethyl isothiocyanate,254-070-4,38663-85-3,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H225:38;H335:39;H315:39;H319:39;H312:42;H301:38;H332:42;H302:4;H314:4
40909,"Metaphosphoric acid, sodium salt",256-779-4,50813-16-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:40;H315:40
40910,"2,4-dimethylnonan-4-ol",277-838-0,74356-31-3,Not Classified,Notified C&L,127,Not classified:88;H318:38;H335:38;H315:38;H413:38;H319:1
40912,"Oils, palm, hydrogenated",271-056-3,68514-74-9,Not Classified,Notified C&L,82,Not classified:82
40913,ethyl bromoacetate,203-290-9,105-36-2,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2,Harmonised C&L,0,H330:0;H300:0;H310:0
40914,"3,3'-iminobisphenol",265-787-7,65461-91-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
40915,"Trisodium 3-[[4-[[6-(anilino)-1-hydroxy-3-sulphonato-2-naphthyl]azo]-5-methoxy-o-tolyl]azo]naphthalene-1,5-disulphonate",228-327-6,6227-20-9,Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2;Repr. 2,REACH registration C&L,140,H317:97;H319:97;H302:97;H361:97;Not classified:43
40918,Codeine sulphate,215-818-5,1420-53-7,Acute Tox. 3;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Repr. 2,REACH registration C&L,47,H361:8;H317:8;H334:8;H301:8;H336:6;H332:6;H302:39;H311:1;H331:1;H362:1
40919,"2,2'-[[3-chloro-4-[(2,6-dichloro-4-nitrophenyl)azo]phenyl]imino]bisethanol",245-604-7,23355-64-8,Acute Tox. 4;Eye Dam. 1,Notified C&L,64,H302:51;H318:51;H317:13;Not classified:9;H412:1;H334:1
40920,"4-[2,5,6,6-tetramethyl-1(or 2)-cyclohexen-1-yl]-3-buten-2-one",259-427-8,54992-91-5,Not Classified,Notified C&L,1375,Not classified:1375
40923,"Fatty acids, C18, Bu esters",268-908-1,68154-28-9,Not Classified,Notified C&L,1,Not classified:1
40927,"2-[2-(3,4-dihydro-6-methoxy-1(2H)-naphthylidene)ethyl]-2-ethylcyclopentane-1,3-dione",212-705-2,850-92-0,Skin Sens. 1B;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,1,H317:1;H401:1;H411:1
40930,4-(methylthio)-o-anisic acid,276-948-6,72856-73-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39;H302:1
40931,(2E)-4-oxo-4-phenylbut-2-enoic acid,605-817-1,17812-07-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39;H301:38;H302:1;H312:1;H332:1
40932,"D-Glucopyranose, oligomers, decyl glycosides",500-520-2,161074-85-7,Not Classified,Notified C&L,1,Not classified:1
40933,Diethyl acetylsuccinate,214-223-8,1115-30-6,Not Classified,REACH registration C&L,35,Not classified:35
40935,Phloroglucinol dihydrate,612-061-6,6099-90-7,,Notified C&L,8,H319:7;H335:6;H315:8;H317:1
40936,"2,2'-dithiobis[N-methylbenzamide]",219-768-5,2527-58-4,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,614,H317:609;H400:584;H410:551;H319:55;H315:57;H411:16;H318:5
40937,"1,1'-[[3-(dimethylamino)propyl]imino]bispropan-2-ol",264-261-4,63469-23-8,Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,255,H318:254;H314:178;H412:83;H315:77
40942,"1,5-diazobicyclo[4.3.0]non-5-ene",221-087-3,3001-72-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,135,H318:89;H314:134;Not classified:1;H411:1
40943,"Fatty acids, C8-12, calcium salts",283-978-3,84776-51-2,Not Classified,Notified C&L,1,Not classified:1
40949,2-[(4-chlorophenyl)acetyl]benzoic acid,258-444-8,53242-76-5,Not Classified,Notified C&L,3,Not classified:1;H302:2;H361:1;H413:1;H317:1;H351:1
40950,Fatty acids,614-045-4,67254-79-9,Not Classified,Notified C&L,1,Not classified:1
40952,(4-phenylbutyl)phosphinic acid,420-450-5,86552-32-1,Eye Dam. 1;Carc. 2,Harmonised C&L,0,H318:0;H351:0
40954,C.I. Reactive Red 195,618-900-2,93050-79-4,Not Classified,Notified C&L,6,Not classified:6
40955,(2-hydroxyethyl)ammonium dihydrogen citrate,241-814-8,17863-38-6,Not Classified,Notified C&L,60,Not classified:53;H319:7;H315:7
40957,N-(1-phenylethyl)formamide,230-112-7,6948-01-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H302:39;H318:39;H335:39;H315:39
40959,8-hydroxy-7-(1-naphthylazo)quinoline-5-sulphonic acid,256-619-3,50539-65-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
40961,Tin diiodide,233-667-3,10294-70-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 1B,Notified C&L,45,H302:38;H335:38;H315:38;H317:38;H360:38;H319:38;H312:38;H332:38;H314:7;H318:1;H290:1
40962,"2,2'-methylenedi-p-cresol",221-794-7,3236-63-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,39,H319:39;H335:38;H315:39;H400:38
40965,Choline methyl sulphate,265-542-4,65151-62-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H319:38;H315:38
40966,Lead titanium zirconium oxide,235-727-4,12626-81-2,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,15,H302:15;H400:14;H373:15;H360:15;H410:15;H332:15;H350:6;H315:6;H319:6
40968,"1,1,1-triethoxypentane",213-047-9,919-29-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H226:2
40970,"2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide",407-680-1,98809-11-1,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H318:0;H411:0
40971,Lead tartrate,212-426-6,815-84-9,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H302:43;H400:43;H373:43;H360:43;H410:43;H332:43
40973,"Spiramycin, hexanedioate (1:1) (salt)",272-570-0,68880-55-7,Not Classified,Notified C&L,4,Not classified:1;H317:1;H319:2;H335:3;H315:3
40979,"5-methyl-1,3,4-thiadiazol-2-ylamine",203-573-7,108-33-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H302:42;H335:42;H315:43;H312:2;H332:2
40982,"3,4,5-trimethoxybenzylamine",242-468-0,18638-99-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H302:39;H335:39;H315:39;H319:39;H312:39;H332:38;H314:6;H318:1
40983,"1,2,3-triphenylguanidine",202-907-9,101-01-9,Acute Tox. 4,Notified C&L,43,H302:39;H319:4;H335:4;H315:4;H332:1;H312:1
40985,Pheneticillin potassium,205-084-4,132-93-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,2,H317:2;H334:2
40987,"1,3,3-trimethyl-N-(2-methylpropylidene)-5-[(2-methylpropylidene)amino]cyclohexanemethylamine",259-393-4,54914-37-3,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,203,H317:198;H314:198;H412:194;H318:26;H332:25;Not classified:5;H319:2;H312:2
40989,"reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance",431-120-5,,Acute Tox. 4;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 3,Harmonised C&L,0,H317:0;H319:0;H302:0;H331:0
40992,"2,7-dichloro-4-methylquinoline",261-847-1,59666-16-9,,Notified C&L,1,H302:1;H335:1;H315:1;H319:1;H312:1;H332:1
40995,Calcium phosphate,233-283-6,10103-46-5,Not Classified,Notified C&L,36,Not classified:27;H318:9
40996,"Aminopeptidase, pyroglutamate",232-981-8,9075-21-2,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,38,H334:38;H319:38;H335:38;H315:38
41001,3-bromopentane,217-314-0,1809-10-5,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,54,H319:54;H225:54;H335:53;H315:54
41002,p-ethoxybenzamide,259-847-1,55836-71-0,Acute Tox. 4,Notified C&L,38,H302:38
41003,Copper (II) nitrate hydrate,600-060-3,10031-43-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,330,H319:183;H302:325;H315:271;H400:180;H318:109;H272:189;H335:48;H312:31;H332:31;H410:53;H270:16;H314:34;H317:10;H373:10;Not classified:5
41005,Veratroyl chloride,222-568-0,3535-37-3,Skin Corr. 1B,Notified C&L,45,H314:45;H318:1;H290:1;H341:1
41006,"4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine",416-770-1,73754-27-5,Aquatic Chronic 4,Harmonised C&L,0,H413:0
41009,Calcium neodecanoate,248-375-1,27253-33-4,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,67,H318:16;H315:58;Not classified:9
41013,Calcium bis(tetrapropylenebenzenesulphonate),234-360-7,11117-11-6,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,282,H318:282;H411:156;H315:198;H312:123;H314:84;H412:123;Not classified:39
41020,"5,5-dimethyl-1,3,2-dioxaphosphorinane 2-oxide",223-832-8,4090-60-2,Skin Corr. 1B,Notified C&L,39,H314:39;H317:1;H302:1;H290:1
41027,3-chloro-1H-indazole,249-444-9,29110-74-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
41029,"1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluoro-8-iodononane",253-994-5,38550-34-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
41046,"2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, phosphate",258-053-2,52628-03-2,Skin Corr. 1A;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,1125,H317:100;H318:741;H314:822;H335:719;H302:223;H315:240;H319:75;Not classified:61;H412:1
41050,reaction mass of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene;5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20),435-180-3,,Skin Irrit. 2;Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H304:0;H400:0;H315:0;H410:0
41051,2-methoxyhydroquinone,212-530-1,824-46-4,,Notified C&L,7,H319:6;H335:5;H315:6;H302:1;H400:1
41052,5-methylhexan-2-one;isoamyl methyl ketone,203-737-8,110-12-3,Flam. Liq. 3;Acute Tox. 4,Harmonised C&L,0,H332:0;H226:0
41054,"Butanedioic acid, sulfo-, 4-C10-16-alkyl esters, disodium salts",295-021-7,91782-50-2,Eye Dam. 1,Notified C&L,27,H318:26;H315:14;Not classified:1
41056,Phosphinic acid,228-601-5,6303-21-5,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,1041,H318:855;H314:1025;H290:333;Not classified:16
41058,7-(β-D-glucopyranosyloxy)-4-methyl-2H-1-benzopyran-2-one,242-736-7,18997-57-4,Not Classified,Notified C&L,3,Not classified:3
41061,Pentyl isovalerate,246-954-3,25415-62-7,Not Classified,Notified C&L,137,Not classified:137
41062,5-fluorotryptophan,205-822-5,154-08-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
41064,"2,2'-[sulphonylbis(4,1-phenyleneoxy)]bisethanol",248-320-1,27205-03-4,Not Classified,Notified C&L,4,Not classified:4
41068,2-(hydroxymethylamino)ethanol,251-974-0,34375-28-5,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,311,H317:87;H319:183;H302:180;H332:127;H315:119;H335:74;H318:88;Not classified:37;H412:13;H314:2;H411:2;H331:2
41069,"Phosphoric acid, 1-methylethyl ester",278-477-1,76483-21-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,28,H302:25;H318:25;H314:3
41071,"[1,1'-Bicyclohexyl]-4-ol, 4'-propyl-",617-974-3,87144-93-2,Not Classified,Notified C&L,1,Not classified:1
41073,"Pyrrolo[3,4-c]pyrrole-1,4-dione, 3,6-bis(4-chlorophenyl)-2,5-dihydro-",617-603-5,84632-65-5,Not Classified,Notified C&L,276,Not classified:276
41081,DIMETHYL-M- ISOPROPYNL BENZYLAMINE,437-810-2,,Acute Tox. 4;Acute Tox. 3;Acute Tox. 4,Notified C&L,18,H311:18;H302:18;H332:18
41082,"Dibutyl 2,2'-oxybisacetate",229-630-6,6634-18-0,Not Classified,Notified C&L,69,Not classified:69
41083,"2-ethyl-2-(((3,5,5-trimethylhexanoyl)oxy)methyl)propane-1,3-diyl bis(3,5,5-trimethylhexanoate)",613-848-7,65870-94-2,Not Classified,REACH registration C&L,1,Not classified:1
41084,4H-cyclopenta[def]phenanthrene,205-905-6,203-64-5,Not Classified,Notified C&L,3,Not classified:3
41090,p-bromobenzhydryl alcohol,249-568-3,29334-16-5,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H318:39;H335:40;H315:40;H319:1;H411:1
41091,"1,2-dihydro-2-oxo-3-pyridyl acetate",262-698-5,61296-14-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H335:38;H315:38;H317:38;H319:38
41093,2-(4-fluorophenyl)tetrahydro-2-phenylfuran,282-550-3,84255-03-8,Acute Tox. 4,Notified C&L,38,H302:38
41095,(2-butoxyethoxy)acetic acid,451-650-0,,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
41099,p-terphenyl,202-205-2,92-94-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,53,H319:48;H335:46;H315:48;H400:42;Not classified:4;H302:4;H410:1
41100,phosphonic acid,237-066-7,13598-36-2,Acute Tox. 4;Skin Corr. 1A,Harmonised C&L,0,H302:0;H314:0
41101,"2,5-dimethylpyrrolidine",222-178-0,3378-71-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H225:39;H335:38;H315:38;H318:1;H314:1
41103,"prothioconazole (ISO); 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione",605-841-2,178928-70-6,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,272,H400:267;H410:266;H411:6
41114,"2-[[(4-methoxyphenyl)methylhydrazono]methyl]-1,3,3-trimethyl-3H-indolium thiocyanate",279-844-9,81892-56-0,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H318:2;H400:2;H301:2;H410:2
41116,"1,3-dibromobenzene",203-574-2,108-36-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:41;H315:47;Not classified:1
41118,"Hydrocarbons, C4, ethylene-manuf.-by-product",270-691-3,68476-52-8,Flam. Gas 1;Press. Gas (Liq.);Muta. 1B;Carc. 1A,REACH registration C&L,172,H350:172;H220:172;H340:172;H280:172
41120,"4,4'-methylene bis(dibutyldithiocarbamate)",233-593-1,10254-57-6,Aquatic Chronic 4,REACH registration C&L,259,H413:188;Not classified:70;H319:1;H315:1
41121,fluazifop-butyl (ISO);butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate,274-125-6,69806-50-4,Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H360:0;H400:0;H410:0
41122,"2-[2-[4-[(2-chloroethyl)ethylamino]-o-tolyl]vinyl]-1,3,3-trimethyl-3H-indolium chloride",229-227-5,6441-82-3,Aquatic Chronic 3,REACH registration C&L,52,H412:3;Not classified:40;H302:9;H318:9;H410:9
41123,"3,7-dimethyloctan-3-ol",201-133-9,78-69-3,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,1793,H317:1423;H319:1651;H315:1654;Not classified:139
41126,"Octene, hydroformylation products, low-boiling",273-110-1,68938-03-4,Flam. Liq. 2;Asp. Tox. 1;Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,1,H317:1;H225:1;H412:1;H304:1
41127,"2-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide",414-170-2,135937-20-1,Aquatic Chronic 4,Harmonised C&L,0,H413:0
41128,"Fatty acids, C18-unsatd., dimers, hydrogenated, dimethyl esters",500-449-7,160901-12-2,Not Classified,Notified C&L,1,Not classified:1
41132,"Benzenesulfonic acid, 2,3(or 3,4)-dimethyl-, mono-C10-14-branched alkyl derivs.",290-704-6,90218-30-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,30,H318:30;H314:30;H412:9
41133,Methyl docosanoate,213-207-8,929-77-1,Not Classified,Notified C&L,8,Not classified:6;H302:1;H335:1;H315:1;H319:2;H312:1;H332:1
41134,"Triammonium salt of 2,2',2'',2'''-(cyclohexane-1,2-diyldinitrilo)tetraacetic acid",700-166-0,,Not Classified,Notified C&L,1,Not classified:1
41135,"2-AMINO-4,5-DIHYDROBENZO[D]THIAZOL-6(7H)-ONE",601-223-1,113030-24-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H315:3;H302:2;H335:2
41136,"Benzene, mono-C10-14-alkyl derivs., fractionation bottoms, sulfonated",285-598-3,85117-48-2,Skin Sens. 1,Notified C&L,17,H317:17
41139,"1,5-difluoro-2,4-dinitrobenzene",206-324-0,327-92-4,Acute Tox. 2;Acute Tox. 3;Acute Tox. 3;STOT RE 2,Notified C&L,45,H311:40;H331:40;H373:39;H300:44;H315:5;H317:5;H319:5;H312:4;H301:1;H341:1
41140,"Phosphonic acid, P,P',P'',P'''-[1,2-ethanediylbis[[(phosphonomethyl)imino]-3,1-propanediylnitrilobis(methylene)]]tetrakis-, sodium salt (1:?)",606-372-6,197592-17-9,Not Classified,Notified C&L,1,Not classified:1
41141,[No public or meaningful name is available],620-005-7,9010-06-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,24,H319:24;H335:24;H315:24
41143,Indoline,207-816-8,496-15-1,,Notified C&L,10,H319:7;H302:5;H335:6;H315:7;Not classified:2;H412:1
41148,"(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; 4-chlorobenzene-1-sulfonic acid",618-775-4,916439-93-5,Lact.,REACH registration C&L,1,H362:1
41150,"(S)-α,α,4-trimethylcyclohex-3-ene-1-methyl acetate",261-165-4,58206-95-4,Aquatic Chronic 2,Notified C&L,2,H411:2
41152,Sulfathiazole sodium,205-638-5,144-74-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,41,H319:40;H335:40;H315:40;Not classified:1
41154,"7,10-dichloro-2-methoxybenzo[b]-1,5-naphthyridine",229-588-9,6626-40-0,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H413:38;H335:38;H315:38;H318:38;H301:38
41156,N-(o-tolyl)benzenesulphonamide,242-343-0,18457-86-8,Acute Tox. 4,Notified C&L,38,H302:38
41164,"4-Pyrimidinamine, 5-chloro-N-[2-[4-(2-ethoxyethyl)-2,3-dimethylphenoxy]ethyl]-6-ethyl-",600-677-8,105779-78-0,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,195,H400:194;H301:195;H410:194
41165,"Formaldehyde, oligomeric reaction products with 1-chloro-2,3-epoxypropane and phenol, reaction products with acrylic acid and lauric acid",500-756-6,162492-21-9,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1
41169,"β-d-Glucan, (1→3),(1→6)-",258-443-2,53238-80-5,,Notified C&L,58,Not classified:58
41175,Vinylsilane,230-719-7,7291-09-0,,Notified C&L,2,H317:2
41184,Methyl 4-amino-3-methoxybenzoate,255-456-5,41608-64-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
41188,Metoprolol tartrate,260-148-9,56392-17-7,Repr. 2;Aquatic Chronic 3,Notified C&L,80,H361:60;H412:65;H319:10;H411:5;H335:7;H315:14;H302:9;H362:4;H360:4;H336:1;Not classified:1;H332:1
41189,(E)-2-butenal;(E)-crotonaldehyde,204-647-1,123-73-9,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;STOT SE 3;Muta. 2;STOT RE 2;Aquatic Acute 1,Harmonised C&L,0,H225:0;H335:0;H315:0;H400:0;H311:0;H318:0;H373:0;H301:0;H330:0;H341:0
41191,"3-hydroxy-2,2-dimethylpropyl 3-hydroxy-2,2-dimethylpropionate",214-222-2,1115-20-4,Eye Dam. 1,REACH registration C&L,342,H318:149;H319:188;Not classified:5
41193,4-(chlorosulphonyl)benzoic acid,233-367-2,10130-89-9,Skin Corr. 1B,Notified C&L,44,H314:44
41196,"2-hydroxycyclohepta-2,4,6-trienone",208-577-2,533-75-5,Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,18,H400:15;H317:15;H318:15;H314:15;H410:15;Not classified:2;H319:1;H335:1;H315:1
41201,"Benzenesulfonamide, 4-methyl-, polymer with formaldehyde and 1,3,5-triazine-2,4,6-triamine",607-522-3,25067-00-9,Not Classified,Notified C&L,1,Not classified:1
41204,Galactomannanase,256-778-9,50812-17-4,Resp. Sens. 1,Notified C&L,1,H334:1
41209,6-chloro-m-toluidine,202-454-7,95-81-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H302:42;H335:39;H315:44;H319:44;H312:42;H332:42;H373:4;H311:3;H331:3;H301:3;H370:1;H372:1
41211,"Alkanes, C13-17",292-447-5,90622-45-0,Not Classified,Notified C&L,35,Not classified:31;H304:4
41212,"Phenol, sulfonylbis-, sulfonated",291-848-2,90481-08-6,Not Classified,Notified C&L,1,Not classified:1
41214,"1,1'-[ethane-1,2-diylbisoxy]bis[2,4,6-tribromobenzene]",253-692-3,37853-59-1,Not Classified,Notified C&L,30,Not classified:29;H319:1;H335:1;H315:1
41216,"[1R-(1R*,4R*,6R*,10S*)]-4,12,12-trimethyl-9-methylene-5-oxatricyclo[8.2.0.04,6]dodecane",214-519-7,1139-30-6,Aquatic Chronic 2,Notified C&L,185,H411:85;Not classified:59;H319:42;H315:42;H335:1
41217,"Amines, dicoco alkyl",263-086-0,61789-76-2,Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,580,H318:579;H314:446;H412:478;H413:446;H400:83;H315:133;H410:83;Not classified:1
41220,"Propanenitrile, 3-[2-(2-hydroxyethoxy])ethoxy]-",600-212-9,10143-54-1,Skin Corr. 1B,Notified C&L,22,H314:22
41221,3-(difluoromethyl)-1-methyl-1 H-pyrazole-4-carbonyl chloride,619-511-0,141573-96-8,Flam. Liq. 3;Skin Corr. 1,REACH registration C&L,157,H314:1;H226:1;H317:156;H318:156;H412:156
41223,Methyl (±)-glycolate,224-434-7,4358-87-6,,Notified C&L,1,Not classified:1
41227,"1,2-dimethylcyclopentane",219-520-6,2452-99-5,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H225:1;H335:1;H315:1
41229,Ethyl glycinate hydrochloride,210-787-4,623-33-6,Eye Dam. 1,REACH registration C&L,63,H318:52;Not classified:7;H319:4;H335:3;H315:3
41230,"Diethyl 1,1-cyclobutanedicarboxylate",223-239-4,3779-29-1,Not Classified,REACH registration C&L,7,Not classified:6;H319:1;H335:1;H315:1
41231,(S)-pyrrolidine-2-carboxamide,231-397-0,7531-52-4,Not Classified,REACH registration C&L,20,Not classified:17;H319:3;H335:3;H315:3
41234,"N-(2-Methyl-4,5,6,7-tetrahydro-benzothiazol-6-yl)-acetamide hydrobromide",600-588-4,104617-50-7,Not Classified,Notified C&L,1,Not classified:1
41239,5-aminotoluene-2-sulphonic acid,205-120-9,133-78-8,Eye Irrit. 2,Notified C&L,1,H319:1
41242,α-(methylsulphonyl)toluene,221-478-9,3112-90-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,157,H319:157;H335:157;H315:157
41244,Propyl 2-methylcrotonate,262-906-4,61692-83-9,Flam. Liq. 3,Notified C&L,38,H226:38
41249,"2,4,6-trimethyl-benzenesulfonic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl ester",620-061-2,473584-10-0,Aquatic Chronic 2,Notified C&L,3,H411:3
41252,Tetrapentylammonium iodide,219-688-0,2498-20-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45;Not classified:1
41254,"Cobaltate(2-), [4-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonamidato(2-)][3-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonato(3-)]-, sodium",285-247-4,85049-75-8,Not Classified,Notified C&L,88,Not classified:88
41258,"Sodium (2S-cis)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide",273-984-4,69388-84-7,STOT RE 2,Notified C&L,36,H373:32;H317:4;H334:4;H302:2
41262,2-furoyl chloride,208-422-9,527-69-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,REACH registration C&L,96,H302:45;H314:96;H312:6;H332:6;H318:36;H290:1;H341:1;H335:1
41263,2-bromoacetophenone,200-724-9,70-11-1,Skin Corr. 1B,Notified C&L,62,H314:46;H335:15;H315:16;H311:11;H319:16;H301:13;H330:12;H331:6;H318:3;H310:1;H300:1;H302:1
41264,2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol,419-750-9,98809-58-6,Aquatic Chronic 4,Harmonised C&L,0,H413:0
41269,"1,1,1,3,5,7,7,7-octamethyltetrasiloxane",240-209-6,16066-09-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,126,H319:100;H335:99;H315:100;H226:28;Not classified:4
41272,"Soybean oil, epoxidized, acrylate",294-415-6,91722-14-4,Not Classified,REACH registration C&L,245,Not classified:146;H317:57;H319:42;H315:14
41274,"reaction mass of: α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene);1,2-(or 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol;1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylene-co-oxypropylene)]propane]",415-870-0,,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
41275,Trimethyl-3-[(1-oxo-10-undecenyl)amino]propylammonium methyl sulphate,304-990-8,94313-91-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,45,H318:4;H411:4;H400:4;H315:45;H319:41
41276,Heptadecafluorooctanesulphonyl fluoride,206-200-6,307-35-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,73,H318:71;H314:40;H360:33;H411:33;H331:33;H301:33;H372:33
41277,Phosphonoacetic acid,224-558-1,4408-78-0,Acute Tox. 4,Notified C&L,42,H302:38;H314:4
41279,5-ethylfuran-2(5H)-one,219-304-1,2407-43-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H302:2;H335:2;H315:2
41281,Carmine lake,215-527-3,1328-60-5,Not Classified,Notified C&L,6,Not classified:6
41282,"9-octadecene-1,12-diol",216-419-9,1577-55-5,Aquatic Chronic 4,Notified C&L,38,H413:38
41283,Propylphosphonic dichloride,225-195-1,4708-04-7,Met. Corr. 1;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,44,H318:40;H314:44;H290:1;H311:38;H331:38;H301:38
41285,Dinitolmide,205-706-4,148-01-6,Acute Tox. 4,Notified C&L,42,H302:41;Not classified:1
41286,"Waxes and Waxy substances, rice bran",232-409-7,8016-60-2,Not Classified,Notified C&L,371,Not classified:371
41289,N-bromophthalimide,219-467-9,2439-85-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
41291,"Hydrogen di(benzyl)[4-[[4-(dibenzylamino)phenyl](2,4-disulphonatophenyl)methylene]cyclohexa-2,5-dien-1-ylidene]ammonium, sodium salt",229-343-6,6483-73-4,Eye Irrit. 2,Notified C&L,1,H319:1
41294,4-ethyloxazolidine,258-299-0,53019-53-7,Not Classified,Notified C&L,1,Not classified:1
41297,"Nitric acid, reaction products with cyclododecanol and cyclododecanone, by-products from, high-boiling fraction",276-431-5,72162-23-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,461,H318:441;H315:443;H319:18;Not classified:2;H411:1
41303,Octadecyl heptanoate,266-065-4,66009-41-4,Not Classified,Notified C&L,19,Not classified:19
41307,"1,4,5,6,7,7-hexachlorobicyclo[2.2.1]hept-5-ene-2,3-dimethanol",218-467-6,2157-19-9,Aquatic Acute 1,Notified C&L,38,H400:38
41308,"Oxirane, 2-methyl-, polymer with oxirane, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1)",610-877-7,52624-57-4,Not Classified,Notified C&L,1186,Not classified:568;H319:447;H335:447;H315:447;H318:171
41309,12-hydroxystearic acid,203-366-1,106-14-9,Not Classified,REACH registration C&L,414,Not classified:322;H319:92;H335:91;H315:92
41310,Diisotridecyl dodecanedioate,283-822-4,84731-63-5,Not Classified,Notified C&L,17,Not classified:17
41311,"[1R-(1α,2β,5α)]-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-ol",235-908-8,13040-03-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
41312,(2-chloro-5-iodophenyl){4-[(3S)-tetrahydrofuran-3-yloxy]phenyl}methanone,619-598-5,915095-87-3,Aquatic Chronic 4,REACH registration C&L,86,H413:3;Not classified:83
41314,Cholest-4-en-3-one,210-005-1,601-57-0,Aquatic Chronic 4,Notified C&L,39,H413:38;H302:1;H312:1
41316,"4'-(1,1-dimethylethyl)[1,1'-biphenyl]-4-ol",243-342-8,19812-92-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3;Aquatic Chronic 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1;H412:1
41317,"2-[5-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)penta-1,3-dienyl]-1,3,3-trimethyl-3H-indolium iodide",253-091-6,36536-22-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H302:39;H335:39;H315:39;H319:39;H312:39;H332:39
41319,4-bromo-2-fluoro-1-trifluoromethoxybenzene,430-850-1,105529-58-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
41323,"Dibromodibenzo[b,def]chrysene-7,14-dione",215-363-2,1324-11-4,Not Classified,REACH registration C&L,9,Not classified:9
41324,"cis-1,2-cyclohexanedimethanol",239-843-6,15753-50-1,Not Classified,Notified C&L,1,Not classified:1
41325,"Disodium 4,4'-bis[[6-anilino-4-[(2-hydroxyethyl)methylamino]-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonate",237-600-9,13863-31-5,Not Classified,REACH registration C&L,142,Not classified:91;H412:51
41326,"2,3,5,6-tetrabromohydroquinone",220-142-9,2641-89-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
41327,2-methoxy-4-prop-1-enylphenyl benzoate,224-074-0,4194-00-7,Skin Sens. 1,Notified C&L,88,H317:88
41331,dichlorobis(η-cyclopentadienyl)titanium,215-035-9,1271-19-8,Acute Tox. 4;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,70,H302:10;H335:63;H400:4;H318:5;H410:4;H315:60;H319:21;H301:16;H341:22;H314:6;H312:6;H332:6;H373:1;H360:1;H351:1;H371:1
41332,"Methyl 2,4-dichlorobenzoate",252-374-1,35112-28-8,,Notified C&L,4,H319:4;H335:4;H315:4
41333,Barbital,200-331-2,57-44-3,Acute Tox. 4,REACH registration C&L,40,H302:40
41334,"Resin acids and Rosin acids, Me esters",269-035-9,68186-14-1,Aquatic Chronic 3,REACH registration C&L,342,H412:42;Not classified:300
41337,"N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide",449-940-7,368450-39-9,Aquatic Chronic 4,Harmonised C&L,0,H413:0
41343,"Disodium 4,4'-diamino-9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo[1,1'-bianthracene]-3,3'-disulphonate",227-877-4,6022-22-6,Not Classified,REACH registration C&L,87,Not classified:87
41344,"1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine",411-370-1,82857-68-9,Acute Tox. 3;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H411:0;H301:0
41345,N-benzyloxycarbonyl-L-3-phenylalanine,214-599-3,1161-13-3,Not Classified,Notified C&L,3,Not classified:1;H334:1;H319:1;H335:1;H315:1
41350,"Dihydrogen (ethyl)[4-[[4-[ethyl(3-sulphonatobenzyl)amino]phenyl](2-sulphonatophenyl)methylene]cyclohexa-2,5-dien-1-ylidene](3-sulphonatobenzyl)ammonium, aluminium salt",272-939-6,68921-42-6,Not Classified,REACH registration C&L,188,Not classified:141;H412:47
41352,Metipranolol,245-151-5,22664-55-7,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H302:1;H411:1
41353,Hexakis(1H-imidazole-N3)nickel(2+) dichloride,239-841-5,15751-00-5,Skin Sens. 1;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,14,H317:14;H410:14;H400:14;H351:14
41357,"Tea, ext.",283-519-7,84650-60-2,Flam. Liq. 2,Notified C&L,1623,H225:1290;Not classified:284;H317:33;H302:13;H304:12;H315:12;H226:9;H319:7;H412:1
41360,2-thiohydantoin,207-977-4,503-87-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H302:44;H332:38;H312:38
41361,"2,4,6-trimethyl-2,4,6-triphenylcyclotrisiloxane",208-900-7,546-45-2,,Notified C&L,2,H302:2;H332:2;H312:2
41365,"1-[[2,4,6-tris(isopropyl)phenyl]sulphonyl]-1H-1,2,4-triazole",259-035-7,54230-60-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
41367,"Poly(difluoromethylene), α-fluoro-ω-[2-[(1-oxooctadecyl)oxy]ethyl]-",613-815-7,65530-65-6,Not Classified,Notified C&L,7,Not classified:6;H373:1;H302:1;H413:1;H372:1
41374,"Dihydro-3-(octadecenyl)furan-2,5-dione",249-210-6,28777-98-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,512,H317:508;H319:481;H334:446;H315:448;H413:20;Not classified:2;H318:1;H335:1
41375,"Copper, [[]29H,31H-phthalocyaninato(2-)-[?]N29,[?]N30,[?]N31,[?]N32]-, chlorosulfonyl sulfo derivs.",618-513-9,90247-34-0,Not Classified,Notified C&L,1,Not classified:1
41379,2-chloro-5-nitrobenzoyl chloride,247-262-4,25784-91-2,,Notified C&L,7,H314:7;H318:1;H290:1
41383,o-anisamide,219-465-8,2439-77-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H302:43;H335:44;H315:44
41386,"Fatty acids, tallow, hydrogenated, compds. with triethanolamine",271-721-8,68605-97-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:4;H315:4
41390,"4,4'-{[4-(Methylimino)-2,5-cyclohexadien-1-ylidene]methylene}bis(N,N-dimethylaniline)",610-776-8,52080-58-7,Not Classified,Notified C&L,52,Not classified:49;H302:3;H335:1;H411:1;H319:1;H332:1;H318:2;H315:1;H410:1
41391,4-(chloromethyl)-m-xylene,212-531-7,824-55-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H335:38;H315:38;H226:38;H319:38;H332:38;H314:7;H318:1;H290:1
41392,2-bromoethyl ethyl ether,209-763-6,592-55-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H225:44;H335:43;H315:44
41393,trans-hex-3-enoic acid,216-417-8,1577-18-0,Skin Corr. 1B,Notified C&L,1356,H314:1356;H318:25;Not classified:1;H335:2;H319:1
41397,"Formaldehyde, polymer with 4-nonylphenol and oxirane",608-548-8,30846-35-6,Not Classified,Notified C&L,75,Not classified:62;H319:13
41398,2-(bromomethyl)propenoic acid,276-774-0,72707-66-5,Skin Corr. 1B,Notified C&L,40,H314:40;H318:1;H290:1
41400,(isobutyl)quinoline,215-598-0,1333-58-0,Not Classified,Notified C&L,91,Not classified:49;H302:42
41403,TA 02849,435-070-5,,Not Classified,Notified C&L,1,Not classified:1
41404,2-methyl-2H-isothiazol-3-one hydrochloride,247-499-3,26172-54-3,Acute Tox. 3;Skin Corr. 1A;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,61,H400:5;H317:61;H318:5;H314:61;H301:6;H410:6;H334:55
41405,"[(2-hydroxyethyl)imino]di-2,1-ethanediyl dioleate",259-428-3,54999-00-7,Not Classified,Notified C&L,31,Not classified:31
41407,N-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide,408-110-4,110483-07-3,Aquatic Chronic 4,Harmonised C&L,0,H413:0
41409,Sodium 2-(dodecyloxy)-2-oxoethane-1-sulphonate,217-431-7,1847-58-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,122,H302:80;H335:119;H315:118;H318:120;H312:78;H319:2;H411:2;H412:1
41414,"Licorice, Glycyrrhiza uralensis, ext.",305-209-3,94349-91-4,Not Classified,Notified C&L,1,Not classified:1
41416,trans-hex-2-enoic acid,236-528-5,13419-69-7,Skin Corr. 1B,Notified C&L,1504,H314:1504;H318:25;H290:1
41418,4-ethylphenol,204-598-6,123-07-9,Eye Dam. 1,REACH registration C&L,1757,H318:1364;H314:1612;H302:90;H332:61;H312:65;H319:79;H335:54;H315:54;Not classified:6
41424,Clorsulon,262-100-2,60200-06-8,Eye Irrit. 2,Notified C&L,2,H319:1;Not classified:1
41433,"2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate",413-850-6,123968-25-2,Aquatic Chronic 4,Harmonised C&L,0,H413:0
41435,"Hydrocarbons, C12-20, catalytic alkylation by-products",272-891-6,68919-17-5,Not Classified,Notified C&L,5,Not classified:5
41440,Hexadecyltrimethoxysilane,240-464-3,16415-12-6,Not Classified,REACH registration C&L,145,Not classified:3;H319:96;H335:113;H315:142
41441,Potassium thiosulphate,233-666-8,10294-66-3,Not Classified,REACH registration C&L,677,Not classified:34;H319:643;H315:643
41442,"Nardostachys jatamansi, ext.",290-089-4,90064-28-1,Asp. Tox. 1,Notified C&L,160,H304:141;Not classified:18;H302:1;H315:1
41443,"Disodium 5-amino-4-hydroxy-3-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-2,7-disulphonate",222-646-4,3564-28-1,Skin Sens. 1,Notified C&L,1,H317:1
41444,"Benzenesulfonic acid, di-C10-18-alkyl derivs., barium salts, overbased",298-636-9,93820-56-5,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4,Notified C&L,446,H317:446;H302:446;H332:446
41449,"butroxydim (ISO);5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one",414-790-3,138164-12-2,Acute Tox. 4;Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H361:0;H302:0;H400:0;H315:0;H410:0
41456,Sodium triethylhydroborate(1-),241-903-1,17979-81-6,Water-react. 2;Skin Corr. 1B,Notified C&L,38,H314:38;H261:38
41457,C.I. Reactive Blue 235,604-686-8,149315-82-2,Not Classified,Notified C&L,3,Not classified:3
41459,Ethylenetetracarbonitrile,211-578-0,670-54-2,Acute Tox. 2;Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H312:38;H300:44;H332:38;H335:5;H315:6;H319:6;H310:5;H331:1
41463,1-methoxy-1-methylcyclododecane,253-534-3,37514-30-0,Eye Irrit. 2,Notified C&L,1599,H319:1599;H302:1;H304:1;H335:1;H315:1;H318:1;H336:1
41468,L-(pyrrolidin-1-yl)methanol,245-605-2,23356-96-9,Acute Tox. 4;Eye Dam. 1;STOT SE 3,REACH registration C&L,56,H302:2;H318:2;H335:51;H319:54;H315:54
41472,Tetrakis(2-methylpropyl) orthosilicate,211-658-5,681-98-1,,Notified C&L,4,H318:4;H335:4;H315:4
41475,"Fatty acids, coco, 2-[(2-hydroxyethyl)amino]ethyl esters",268-909-7,68154-34-7,Not Classified,Notified C&L,1,Not classified:1
41479,"N-(2,5-dimethoxyphenyl)-4-[[5-[(dimethylamino)sulphonyl]-2-hydroxyphenyl]azo]-3-hydroxynaphthalene-2-carboxamide",279-084-8,79135-84-5,Not Classified,Notified C&L,31,Not classified:31
41480,N-methyl-tert-butylamine,238-646-2,14610-37-8,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,44,H302:39;H225:44;H314:44;H312:39;H332:39
41483,Meticillin sodium,205-083-9,132-92-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,39,H335:38;H315:38;H317:38;H334:38;H319:38;Not classified:1
41485,"Slack wax (petroleum), low-melting, hydrotreated;[A complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]",295-525-7,92062-11-8,Carc. 1B,Harmonised C&L,0,H350:0
41488,Triisobutylaluminium,202-906-3,100-99-2,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,REACH registration C&L,82,H250:82;H314:82;H260:82;H318:33;H224:2;H252:2
41490,4-Benzyloxy-3-methoxybenzoic acid benzyl ester,618-708-9,91203-74-6,Acute Tox. 3,Notified C&L,1,H301:1
41491,4-[(4-chlorophenyl)methyl]phthalazin-1(2H)-one,258-445-3,53242-88-9,,Notified C&L,2,H302:2;H335:1;H315:1;H312:1;H332:1
41494,"(S)-4-Amino-3-(3,4-dichlorophenyl)-1-butanol",605-222-7,160707-16-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
41495,Calcium glucoheptonate,241-203-6,17140-60-2,Not Classified,Notified C&L,20,Not classified:20
41498,"1,1,1,3,5,5,5-Heptamethyl-3-(propyl(poly(EO))hydroxy) Trisiloxane",614-100-2,67674-67-3,Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,311,H318:165;H411:175;H332:205;Not classified:51;H319:95;H412:34;H331:1
41499,Dioctyl phosphonate,217-315-6,1809-14-9,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,148,H319:86;H412:85;H315:120;H335:25;Not classified:1
41501,"Fatty acids, C18-24, calcium salts",283-979-9,84776-52-3,Not Classified,Notified C&L,7,Not classified:7
41504,Hex-1-en-3-ol,225-355-0,4798-44-1,Flam. Liq. 3;Acute Tox. 4,Notified C&L,302,H302:263;H226:302
41507,"Oils, vegetable, sulfated",263-113-6,61790-19-0,Not Classified,REACH registration C&L,124,Not classified:95;H318:29;H315:29
41509,"Amines, coco alkyl, ethoxylated",500-152-2,61791-14-8,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1190,H319:480;H302:1156;H411:338;H314:502;H400:559;H410:238;H318:194;H412:75;H315:161;Not classified:15;H335:2;H332:2;H301:1;H317:1;H413:1
41515,"Acetic acid, mercapto-, C10-16-alkyl esters",282-495-5,84238-40-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1,REACH registration C&L,2,H317:2;H302:2;H315:2
41516,Niobium(5+) ethanolate,221-795-2,3236-82-6,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,47,H314:46;H226:47;H318:1;H319:1;H315:1
41518,2-(dimethylamino)-2-methylpropan-1-ol,230-279-6,7005-47-2,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,211,H302:132;H318:116;H315:131;H226:72;H314:75;H335:25;H319:16;Not classified:5;H312:1;H332:1
41522,Methyl(2-pyridylmethyl)amine,244-160-1,21035-59-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H302:39;H318:39;H335:39;H315:39
41528,"N,N''-hexane-1,6-diylbis[N'-hexylurea]",289-486-5,89307-23-3,Not Classified,Notified C&L,83,Not classified:83
41529,"3,3-bis(p-hydroxyphenyl)-3H-isobenzofuran-1-one mono(dihydrogen phosphate), compound with cyclohexylamine (1:2)",238-884-7,14815-59-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
41530,"Hexane-2,5-dione",203-738-3,110-13-4,Skin Irrit. 2;Eye Irrit. 2;Repr. 2;STOT RE 2,REACH registration C&L,141,H361:8;H319:140;H373:137;H315:138;H302:10;H335:6;H332:7;Not classified:2;H331:3;H312:1
41532,ethyl propionate,203-291-4,105-37-3,Flam. Liq. 2,Harmonised C&L,0,H225:0
41537,2-ethylhexyl 4-methoxycinnamate,226-775-7,5466-77-3,Not Classified,Notified C&L,2002,Not classified:1968;H413:30;H315:4;H302:2;H335:2;H319:2;H312:2
41539,"4-(3-hydroxypropylamino)-1,3-dimethyluracil",252-128-3,34654-80-3,Not Classified,REACH registration C&L,2,Not classified:2
41544,"Dimethyl N,N'-[thiobis[(methylimino)carbonyloxy]]bis(thioimidoacetate)",261-848-7,59669-26-0,Acute Tox. 3;Acute Tox. 2;Aquatic Acute 1,Notified C&L,132,H400:129;H330:130;H301:132;H317:2;H331:2;H410:1
41546,"16β-acetoxy-3β-(2,6-dideoxy-3-O-methyl-L-arabino-hexopyranosyloxy)-14-hydroxycard-20(22)-enolide",207-361-5,465-16-7,Acute Tox. 2;Acute Tox. 2;STOT RE 2,Notified C&L,40,H373:40;H300:40;H330:40
41547,propylene carbonate,203-572-1,108-32-7,Eye Irrit. 2,Harmonised C&L,0,H319:0
41548,1-(4-bromo-3-nitrophenyl)ethan-1-one,242-469-6,18640-58-9,,Notified C&L,7,H319:7;H335:5;H315:7;H302:1;H312:1;H332:1
41550,"1,6-Octadiene, 7-methyl-3-methylene-, acid-hydrated, α-terpineol fractions",276-949-1,72869-31-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,112,H319:112;H315:112
41560,"(S)-2-methyl-3,4,5,6-tetrahydropyrimidine-4-carboxylic acid",431-910-1,,Not Classified,Notified C&L,1,Not classified:1
41567,"5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one;(2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one",423-090-7,156732-13-7,Aquatic Chronic 4,Harmonised C&L,0,H413:0
41570,"21-hydroxy-2'-methyl-16β-5'H-pregn-4-eno[17,16-d]oxazole-3,20-dione 21-acetate",244-306-4,21269-13-6,Eye Dam. 1,REACH registration C&L,2,H318:2
41572,"[N,N',N''-tris[3-(dimethylamino)propyl]-29H,31H-phthalocyaninetrisulphonamidato(2-)-N29,N30,N31,N32]copper trihydrochloride",280-055-7,82864-58-2,Aquatic Chronic 3,REACH registration C&L,41,H412:4;Not classified:37
41573,"3,3-dichloro-2-oxoindoline-5-sulphonyl chloride",298-221-2,93783-15-4,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H335:1;H302:1;H314:1
41575,"2-chloro-5,5-dimethyl-1,3,2-dioxaphosphorinane 2-oxide",223-831-2,4090-55-5,Skin Corr. 1B,Notified C&L,39,H314:39
41578,"(1S)-1-{(2R)-3,4-bis[(2-hexyldecanoyl)oxy]-5-oxo-2,5-dihydrofuran-2-yl}ethane-1,2-diyl bis(2-hexyldecanoate)",430-110-8,183476-82-6,Skin Sens. 1;Aquatic Chronic 1,Notified C&L,2,H317:2;H410:1;H413:1
41581,"(R)-1,2,3,4,5,6,7,8-octahydro-1-[(4-methoxyphenyl)methyl]isoquinoline",250-145-0,30356-08-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
41589,4-phenoxybenzaldehyde,200-650-7,67-36-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
41590,"2',5'-difluoropropiophenone",249-445-4,29112-90-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
41591,"cypermethrin cis/trans +/- 40/60;(RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;cypermethrin cis/trans +/- 80/20;(RS)-α-cyano-3-phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;α-cypermethrin (ISO);racemate comprising (R)-α-cyano-3-phenoxybenzyl (1S,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;(S)-α-cyano-3-phenoxybenzyl (1R,3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate",257-842-9,52315-07-8,,,0,H400:0;H335:0;H373:0;H301:0;H410:0
41593,"reaction product of boric acid, 2-aminoethanol and morpholine",921-049-2,,Not Classified,Notified C&L,1,Not classified:1
41596,"1,5-dihydro-3-isopropyl-8-methyl-[1,3]dioxepino[5,6-c]pyridin-9-yl acetate",296-417-2,92671-67-5,Not Classified,REACH registration C&L,1,Not classified:1
41599,"Tin [R-(R*,R*)]-tartrate",212-427-1,815-85-0,,Notified C&L,4,H319:4;H335:4;H315:4
41604,"Hexanedioic acid, ester with 2,2-bis(hydroxymethyl)-1,3-propanediol",258-052-7,52627-55-1,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H317:1;H319:1
41608,m-diethylbenzene,205-511-4,141-93-5,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,1041,H304:971;H335:1031;H315:1033;H411:973;H226:1040;H319:1033;Not classified:1
41610,Sodium 8-aminonaphthalene-2-sulphonate,228-679-0,6322-37-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,2,H317:1;H319:2;H315:2;H335:1
41613,"Propane-1,2-dinitrilotetraacetic acid",224-559-7,4408-81-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
41615,Ethyl 4-methylvalerate,246-955-9,25415-67-2,Flam. Liq. 3,Notified C&L,38,H226:38
41616,(6-methoxy-pyridin-2-yl)-methyl-thiocarbamic acid O-(3-tert.-butyl-phenyl) ester,618-200-7,88678-67-5,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,194,H400:194;H410:194
41618,"3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-y)-1-piperidinyl)-ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pirydo(1,2-a)-pyrimidin-4-one",600-733-1,106266-06-2,Acute Tox. 3,Notified C&L,142,H301:141;H331:18;H351:18;H411:27;H336:10;H300:1;H361:5;H360:2;H372:3;H350:1;H362:2;H315:1;H319:1
41619,Dimethyl trimethylsilyl phosphite,252-908-3,36198-87-5,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,38,H314:38;H226:38
41634,"1-chloro-1,2,3,4-tetrahydronaphthalene",611-664-1,58485-68-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,2,H302:1;H335:1;H315:2;H319:2;H312:1;H332:1
41635,Chloromethyl pivalate,242-735-1,18997-19-8,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,51,H302:42;H335:43;H315:42;H226:51;H319:43;H312:42;H332:42;H314:7;H318:3
41640,"2,3-dihydrobenzofuran",207-817-3,496-16-2,Not Classified,REACH registration C&L,1,Not classified:1
41641,"dodecane-12-lactam, manufacturing of, by-products from, distillation residues",923-400-5,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H302:1;H315:1;H412:1
41645,"[1,1'-Bicyclohexyl]-4-ol, 4'-pentyl-",617-973-8,87144-92-1,Not Classified,Notified C&L,1,Not classified:1
41650,tert-butyl peroxyisobutyrate,203-650-5,109-13-7,Org. Perox. B;Asp. Tox. 1;Acute Tox. 3;Aquatic Chronic 2,REACH registration C&L,48,H331:4;H241:8;H411:4;H304:4;H242:40
41653,3-(2-methyl-1-piperidyl)propylamine,247-102-3,25560-00-3,Skin Corr. 1B,Notified C&L,40,H314:40;H318:1;H335:1
41654,1-methoxydecane,230-718-1,7289-52-3,Not Classified,Notified C&L,88,Not classified:88
41659,"1,3,5-triazine-2,4,6-triamine, compound with 3,9-dihydroxy-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 3,9-dioxide (2:1)",274-866-5,70776-17-9,Not Classified,Notified C&L,2,Not classified:2
41668,"famoxadone (ISO);3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione",603-520-1,131807-57-3,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H400:0;H410:0
41673,Bis(dimethylamino)dimethylsilane,223-200-1,3768-58-9,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,46,H225:46;H314:46;H318:2
41675,"6,6'-dithiodi-2-naphthol",228-025-4,6088-51-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
41677,"2-Thiazolecarboxylic acid, 4-(1-methylethyl)-",608-441-6,300831-06-5,,Notified C&L,2,H319:2;H335:2;H315:2
41683,"D-Streptamine, O-3-deoxy-4-C-methyl-3-(methylamino)-β-l-arabinopyranosyl-(1→6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-α-d-glycero-hex-4-enopyranosyl-(1→4)]-2-deoxy-N1-ethyl-, sulfate (2:5) (salt)",260-147-3,56391-57-2,Acute Tox. 4;Acute Tox. 4;Repr. 1B,Notified C&L,55,H312:41;H360:54;H332:42;H361:1;H302:1;H315:1;H319:1
41687,"2,2'-dimethyl-2,2'-azodipropiononitrile;ADZN",201-132-3,78-67-1,Self-react. C;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H332:0;H242:0
41689,"2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(4-methoxyphenyl)-3-oxobutyramide]",250-797-6,31775-16-3,Not Classified,REACH registration C&L,28,Not classified:27;H412:1
41690,"Butanedioic acid, sulfo-, 1,4-di-C12-16-alkyl esters, sodium salts",295-022-2,91782-51-3,Not Classified,Notified C&L,7,Not classified:7
41695,"Hydrocarbons, C",270-690-8,68476-50-6,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
41696,"Nonene, hydroformylation products",273-111-7,68938-04-5,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,4,H411:4;H315:4
41699,4-ethylguaiacol,220-500-4,2785-89-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1566,H319:1423;H302:1485;H335:1421;H315:1448;H312:10;Not classified:1
41701,1-(vinyloxy)octadecane,213-208-3,930-02-9,Skin Sens. 1B,REACH registration C&L,99,H317:84;H412:8;Not classified:7
41702,2-Chloro-1-(1-chlorocyclopropyl)-1-ethanone,446-620-9,,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 1;Muta. 2;Repr. 2;Aquatic Chronic 1,Notified C&L,1,H361:1;H317:1;H314:1;H410:1;H301:1;H372:1;H330:1;H341:1
41703,Teflubenzuron,617-441-5,83121-18-0,,Notified C&L,240,H410:240;H400:83
41707,"5-Thiazolecarboxamide, N-[2,6-dibromo-4-(trifluoromethoxy)phenyl]-2-methyl-4-(trifluoromethyl)-",603-378-0,130000-40-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,128,H400:127;H410:127;H319:1;H411:1
41708,"6-[(3-chloropropyl)amino]-1,3-dimethyluracil",252-129-9,34654-81-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,85,H317:83;H319:84;H302:83;H315:84;Not classified:1
41709,"4-(tricyclo[5.2.1.02,6]dec-8-ylidene)butyraldehyde",250-078-7,30168-23-1,Skin Irrit. 2;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1619,H332:37;H315:1619;H400:37;H410:37;H319:1517
41711,"Benzene, mono-C10-14-alkyl derivs., fractionation bottoms, intermediate cut, sulfonated, sodium salts",285-597-8,85117-47-1,Skin Sens. 1B,REACH registration C&L,3,H317:2;Not classified:1
41712,Methyl N-(p-methoxybenzylidene)anthranilate,238-796-9,14735-72-9,Not Classified,Notified C&L,89,Not classified:89
41717,3-butyl-2-[3-(3-butyl-(3H)-benzothiazol-2-ylidene)propen-1-yl]benzothiazolium iodide,258-430-1,53213-85-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
41719,1-(2-fluorophenyl)piperazine,213-780-4,1011-15-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H302:40;H335:38;H315:39;H319:39;H312:40;H332:39;H314:6;H301:5;H318:1
41722,"4,5-epiminophenanthrene",205-906-1,203-65-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38;H335:38;H315:38
41723,Chloro(methyl)diphenylsilane,205-639-0,144-79-6,Skin Corr. 1B,Notified C&L,44,H314:44;H302:1;H318:1;H290:1;H312:1;H332:1
41724,N-(ETHOXYCARBONYLMETHYL)-N-METHYL-BETA-ALANINE ETHYL ESTER,603-556-8,13220-24-1,Eye Irrit. 2,Notified C&L,38,H319:38
41727,"Hydrogen 5,6-dichloro-2-[3-[2H-benzimidazol-2-ylidene-5,6-dichloro-1-ethyl-1,3-dihydro-3-(4-sulphonatobutyl)]propen-1-yl]-1-ethyl-3-(4-sulphonatobutyl)-1H-benzimidazolium, sodium salt",242-344-6,18462-64-1,Not Classified,Notified C&L,1,Not classified:1
41735,4-amino-10-methyl folic acid ethylester hydroiodide,617-385-1,82784-24-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Muta. 1B;Carc. 2;Repr. 1B,Notified C&L,1,H335:1;H315:1;H311:1;H360:1;H340:1;H319:1;H331:1;H301:1;H351:1
41738,"3,5,5-trimethylhexylamine",222-177-5,3378-63-0,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,3,H302:3;H318:3;H314:3;H411:3;H226:3
41740,"[1S-(1α,6aβ,9aβ)]-2,3,6a,9a-tetrahydro-1-hydroxy-4-methoxycyclopenta[c]furo[3',2':4,5]furo[2,3-h][1]benzopyran-11(1H)-one",249-727-7,29611-03-8,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;Carc. 1B;Repr. 1B,Notified C&L,40,H350:40;H360:39;H310:40;H300:40;H330:40;H335:1;H315:1;H319:1
41742,Hex-4-en-3-ol,225-356-6,4798-58-7,Flam. Liq. 3,Notified C&L,38,H226:38
41744,"Decanoic acid, ester with 2,2'-[oxybis(methylene)]bis[2-(hydroxymethyl)-1,3-propanediol] octanoate pentanoate",268-581-5,68130-24-5,Not Classified,REACH registration C&L,6,Not classified:6
41746,Tetrapropyl orthosilicate,211-659-0,682-01-9,Not Classified,REACH registration C&L,141,Not classified:18;H319:122;H315:117;H335:47;H314:2;H318:1
41747,"(4-amino-N-pyrimidin-2-ylbenzenesulphonamidato-NN,O1)silver",244-834-5,22199-08-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:43;H335:43;H315:44;Not classified:3;H318:2
41752,Sodium 3-mercaptopyruvate,233-594-7,10255-67-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
41755,"3-methylpenta-1,4-diene",214-221-7,1115-08-8,Flam. Liq. 2;Skin Irrit. 2,Notified C&L,38,H225:38;H315:38
41757,Pyrrolidine,204-648-7,123-75-1,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,1617,H302:1609;H225:331;H318:187;H314:1617;H332:1614;H312:16;H331:3;H301:8;H371:1;H290:1;H412:1
41760,3-(dimethylamino)acrylonitrile,219-305-7,2407-68-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H301:2
41764,"disodium bis[(oxoboranyl)oxy]bicyclo[5.5.1]hexaboroxane-3,5-bis(olate)",602-894-3,12280-03-4,Repr. 1B,Notified C&L,117,H360:111;H319:20;H315:4;Not classified:2
41765,1-(2-methoxyphenyl)piperazine,252-537-7,35386-24-4,Not Classified,REACH registration C&L,55,Not classified:7;H314:47;H301:4;H302:2;H318:2;H312:2;H319:1;H335:1;H315:1
41769,1-chloro-3-fluoro-2-nitrobenzene,264-723-5,64182-61-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H302:1;H335:2;H315:2;H319:2;H312:1;H332:1
41772,"2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate",403-960-2,147014-52-6,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
41775,reaction mass of isomers of: C,406-040-9,125643-61-0,Aquatic Chronic 4,Harmonised C&L,0,H413:0
41776,"Butanoic acid, 4-amino-4-oxo-2-sulfo-, N-coco alkyl derivs., disodium salts",283-744-0,84712-53-8,Eye Dam. 1,Notified C&L,8,H318:8
41777,Cytarabine,205-705-9,147-94-4,Skin Sens. 1;Repr. 2,Notified C&L,72,H317:41;H361:41;H360:30;H340:30;Not classified:1;H319:2;H335:1;H315:1;H351:1
41778,"alpha-D-glucopyranoside, methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-(9Cl), 1,4-butynediol",615-293-6,714269-57-5,Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,2,H317:2;H319:2;H302:2
41780,Potassium propionate,206-323-5,327-62-8,Not Classified,REACH registration C&L,109,Not classified:71;H317:38;H302:38
41783,"1,1'-[(phenylmethylene)bis[(2-methoxy-4,1-phenylene)azo]]bis(2-naphthol)",229-342-0,6483-64-3,,Notified C&L,72,Not classified:72
41784,"2-ethyl-4-methyl-1,3-dioxolane",224-435-2,4359-46-0,,Notified C&L,5,H226:5
41787,"1,3-diisopropylurea",223-940-5,4128-37-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
41789,"(1S,2S,3R,5S)-3-(7-{[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol",619-540-9,274693-27-5,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,18,H319:12;H411:15;H335:2;H315:2;H362:1
41792,"Quaternary ammonium compounds, dicoco alkyldimethyl, chlorides",263-087-6,61789-77-3,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,1405,H302:1280;H314:1299;H400:1239;H318:538;H411:193;H410:279;Not classified:97;H290:13;H315:9;H301:12;H413:1;H335:1
41793,"2-Propenoic acid, octyl ester, branched",292-071-1,90530-31-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
41794,"1,3-dimethylcyclopentane",219-521-1,2453-00-1,Not Classified,Notified C&L,3,Not classified:3
41795,Metoprolol,253-483-7,37350-58-6,Not Classified,Notified C&L,3,Not classified:1;H361:1;H302:2;H335:2;H315:2;H319:2;H228:1;H332:1
41798,Tetramethylene bis(chloroformate),218-466-0,2157-16-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H314:38
41799,Tetraphenylphosphonium iodide,218-179-0,2065-67-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H302:38;H335:42;H315:44;H301:1
41802,Zinc bis(nonylphenolate),278-638-6,77194-15-1,Not Classified,Notified C&L,2,Not classified:2
41803,"2-Chloro-4,6-dimethoxypyrimidine",603-561-5,13223-25-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H319:42;H302:40;H335:3;H315:4
41805,methyl 3-(p-tolyl)oxirane-2-carboxylate,924-646-6,,Skin Sens. 1,REACH registration C&L,1,H317:1
41808,"Cobaltate(3-), bis[2-hydroxy-5-nitro-3-[[2-oxo-1-[(phenylamino)carbonyl]propyl]azo]benzenesulfonato(3-)]-, sodium",285-246-9,85049-74-7,Aquatic Chronic 3,Notified C&L,83,H412:83
41809,1H-tetrazol-1-acetic acid,244-551-7,21732-17-2,Unst. Expl.;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,54,H315:53;H319:53;H335:53;H200:2;H204:52;H318:1;H314:1
41810,"1-[1-oxo-3-(2-pyridyldithio)propoxy]pyrrolidine-2,5-dione",269-034-3,68181-17-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:41;H315:42
41816,Bifonazole,262-336-6,60628-96-8,Acute Tox. 4,Notified C&L,198,H302:198;H373:1;H360:1
41817,3-Vinylphenylboronic Acid (contains varying amounts of Anhydride),604-722-2,15016-43-0,Acute Tox. 3,Notified C&L,43,H301:38;H319:5;H335:4;H315:5
41818,"cis-4,4'-dinitrostilbene",210-620-5,619-93-2,Not Classified,Notified C&L,31,Not classified:31
41820,2-thenoic acid,208-423-4,527-72-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,51,H319:50;H335:49;H315:50;H302:5;H314:1
41821,"Disodium 4,4'-bis[6-anilino-[4-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonate",224-073-5,4193-55-9,Not Classified,REACH registration C&L,283,Not classified:281;H319:2
41822,Proteinase,232-642-4,9001-92-7,Resp. Sens. 1,Notified C&L,1803,H334:1803;H319:399;H335:399;H315:399;H317:2
41823,"2,3,3,3-tetrafluoro-2-[1,1,2,3,3,3-hexafluoro-2-(heptafluoropropoxy)propoxy]propionyl fluoride",220-141-3,2641-34-1,Skin Corr. 1B,Notified C&L,2,H314:2;H318:1;H290:1
41827,"Disodium 3-[[4-(acetylamino)phenyl]azo]-4-hydroxy-5-[[(p-tolyl)sulphonyl]amino]naphthalene-2,7-disulphonate",233-366-7,10130-48-0,Not Classified,Notified C&L,10,Not classified:10
41830,"[1S-[1α,2α(Z),4α]]-2-methyl-5-(2-methyl-3-methylenebicyclo[2.2.1]hept-2-yl)-2-penten-1-ol",201-027-2,77-42-9,Not Classified,Notified C&L,113,Not classified:78;H317:35
41832,"Sulfurous acid, monosodium salt, reaction products with bisphenol A disodium salt and formaldehyde",292-238-9,90583-38-3,Not Classified,Notified C&L,1,Not classified:1
41833,Dimethyl (2-hydroxyethyl)phosphonate,259-310-1,54731-72-5,,Notified C&L,34,Not classified:33;H319:1;H315:1
41836,(E)hex-2-enyl hexanoate,258-519-5,53398-86-0,Not Classified,Notified C&L,138,Not classified:137;H413:1
41838,Oct-3-enoic acid,216-418-3,1577-19-1,Skin Corr. 1B,Notified C&L,89,H314:89;H318:37;H290:1
41840,"4-methyl-m-phenylenediamine;2,4-toluenediamine",202-453-1,95-80-7,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1;Muta. 2;Carc. 1B;STOT RE 2;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H361:0;H350:0;H317:0;H373:0;H411:0;H312:0;H301:0;H341:0
41845,WALNUT ESTER,434-720-5,,Skin Sens. 1B,Notified C&L,24,H317:24
41852,Tridec-2-en-1-ol,270-902-9,68480-25-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
41853,"2,6-diiodo-4-nitroaniline",226-429-5,5398-27-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
41857,Phenonip,617-140-9,8066-38-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,28,H319:28;H302:28
41859,Zinc bis(dihydrogen phosphate),237-067-2,13598-37-3,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,100,H302:94;H400:94;H411:50;Not classified:5;H319:1;H315:1
41864,"1,3-Oxathiane, 2-methyl-4-propyl",614-109-1,67715-80-4,Flam. Liq. 3,Notified C&L,205,H226:205;H319:1;H335:1;H315:1
41865,"3D-O-(4-O-acetyl-2,6-dideoxy-3-C-methyl-α-L-arabino-hexopyranosyl)-7-methylolivomycin D",230-348-0,7059-24-7,Acute Tox. 2;Repr. 1B,Notified C&L,39,H360:39;H300:39
41871,2-methylthiazole,222-702-8,3581-87-1,Flam. Liq. 3,Notified C&L,42,H226:41;H302:1;H335:2;H315:2;H318:1;H319:1
41872,4-nitro-m-toluic acid,221-479-4,3113-71-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,78,H319:78;H335:77;H315:78
41874,butyryl chloride,205-498-5,141-75-3,Flam. Liq. 2;Skin Corr. 1B,Harmonised C&L,0,H225:0;H314:0
41876,(R)-[2-hydroxy-3-(naphthyloxy)propyl]isopropylammonium chloride,235-961-7,13071-11-9,Acute Tox. 4,Notified C&L,41,H302:41;H362:3;H360:3;H411:3
41877,Zinc decanoate,235-909-3,13040-17-0,Not Classified,Notified C&L,2,Not classified:2
41878,"2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-, hydrochloride (1:1)",602-903-0,122883-93-6,Not Classified,Notified C&L,1,Not classified:1
41879,5-bromothiazol-2-amine monohydrobromide,262-699-0,61296-22-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,46,H319:46;H302:39;H335:7;H315:8
41881,ETHYLENE GLYCOL BIS(BENZENESULFONATE),601-434-9,116-50-7,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,39,H319:39;H302:39
41885,"Chromate(3-), [4-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonato(3-)][3-hydroxy-4-[(2-hydroxy-1-naphthalenyl)azo]-7-nitro-1-naphthalenesulfonato(3-)]-, trisodium",289-071-9,85959-76-8,Not Classified,Notified C&L,22,Not classified:20;H319:2;H335:2;H315:1;H317:1
41886,"2-benzo[f]quinolin-3-yl-1H-indene-1,3(2H)-dione, disulpho derivative",215-362-7,1324-04-5,Not Classified,Notified C&L,1,Not classified:1
41889,4-methylpyrocatechol,207-214-5,452-86-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56,H319:56;H335:55;H315:56;H302:6;H312:6;H332:5
41892,Mephenoxalone,200-723-3,70-07-5,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H332:1;H315:1
41894,"Ethanone, 2-(acetyloxy)-1-phenyl-",607-077-5,2243-35-8,Acute Tox. 4,Notified C&L,42,H302:38;H319:4;H335:4;H315:4
41896,"2,6-difluorobenzylamine",273-983-9,69385-30-4,Skin Corr. 1B,Notified C&L,47,H314:47;H319:1;H335:1;H318:1;H227:1
41905,"2-[[(4-methoxyphenyl)methylhydrazono]methyl]-1,3,3-trimethyl-3H-indolium hydroxide",279-843-3,81892-55-9,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H318:2;H400:2;H301:2;H410:2
41906,physostigmine,200-332-8,57-47-6,Acute Tox. 2;Acute Tox. 2,Harmonised C&L,0,H300:0;H330:0
41909,"Glycerides, C16-18 and C18-unsatd. mono- and di-, 2,3-bis(acetyloxy)butanedioates",294-577-8,91744-16-0,Not Classified,Notified C&L,1,Not classified:1
41913,"Hydrocarbons, C5-32, polyethylene pyrolysis",300-254-5,93924-58-4,Not Classified,Notified C&L,1,Not classified:1
41915,2-[4-[(2-chloro-4-nitrophenyl)azo]-N-(2-cyanoethyl)anilino]ethyl acetate,227-876-9,6021-61-0,Not Classified,REACH registration C&L,53,Not classified:53
41918,Rhodium dioxide,235-237-0,12137-27-8,Not Classified,Notified C&L,2,Not classified:2
41921,"1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-(C8-18 and C18-unsatd. acyl) derivs., inner salts",604-575-4,147170-44-3,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,156,H318:156;H412:155
41922,"2-(bromomethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolane",262-101-8,60207-30-9,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Repr. 2;STOT RE 2,Notified C&L,1,H361:1;H225:1;H304:1;H315:1;H373:1;H336:1
41923,Trialuminium bismuth hexaoxide,235-552-3,12284-76-3,Not Classified,REACH registration C&L,45,Not classified:45
41926,2-hydroxyethyl ricinoleate,203-369-8,106-17-2,Not Classified,Notified C&L,20,Not classified:20
41930,"1,3,5-tributylhexahydro-1,3,5-triazine",235-905-1,13036-83-4,Not Classified,Notified C&L,1,Not classified:1
41935,Triethoxyhexadecylsilane,240-465-9,16415-13-7,Not Classified,REACH registration C&L,4,Not classified:3;H319:1;H315:1
41936,2-(dimethylamino)propan-1-ol,239-558-7,15521-18-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;H314:1;H226:1
41938,"2,3-dihydro-6-methyl-4H-1-benzothiopyran-4-one",230-114-8,6948-34-1,Eye Irrit. 2,Notified C&L,38,H319:38
41942,2-amino-p-cresol,202-457-3,95-84-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,94,H319:87;H335:86;H315:87;H302:12;H410:6;H332:1;Not classified:1;H317:1;H312:1
41944,"1,3-bis[[[3-(aminomethyl)phenyl]methyl]amino]propan-2-ol",289-362-0,87994-61-4,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,5,H302:5;H411:5
41945,"Benzenesulfonic acid, di-C10-18-alkyl derivs., barium salts",298-635-3,93820-55-4,Skin Sens. 1B,REACH registration C&L,1018,H317:4;H302:1014;H332:1014;H413:125
41946,"2,2,4-trimethylhexane-1,6-diamine",221-792-6,3236-53-1,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,463,H317:463;H302:463;H314:463;H412:463
41950,Pent-4-enenitrile,209-762-0,592-51-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,40,H302:38;H332:38;H312:38;H319:1;H315:1;H301:2;H226:1;H311:1
41951,3-(2-furyl)acrylaldehyde,210-785-3,623-30-3,Acute Tox. 4;Skin Corr. 1B,Notified C&L,1417,H302:1329;H314:1330;Not classified:87;H318:1;H312:1;H332:1
41953,N-(cyclohex-1-en-1-yl)morpholine,211-579-6,670-80-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
41955,"3-amino-α,α,α-trifluorotoluene-4-sulphonic acid",216-151-2,1513-44-6,,Notified C&L,1,H302:1;H314:1;H312:1;H332:1
41958,Methyltriphenylphosphonium iodide,218-178-5,2065-66-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H335:43;H315:44;H301:5
41962,"Lyase, pectate",232-766-9,9015-75-2,Resp. Sens. 1,REACH registration C&L,73,H334:73
41968,"dibutylbis(pentane-2,4-dionato-O,O')tin",245-152-0,22673-19-4,STOT RE 1;Repr. 1B,Harmonised C&L,0,H360:0;H372:0
41973,Cycloheptylmethylamine,224-692-0,4448-77-5,,Notified C&L,5,H314:5
41979,3-(dimethylamino)-1-(thiophen-2-yl)propan-1-ol,603-957-8,13636-02-7,Acute Tox. 4,Notified C&L,3,H302:2;H319:1;H315:1;H318:1;H332:1
41980,2-ethyl-3-hydroxy-4-pyrone,225-582-5,4940-11-8,Acute Tox. 4,REACH registration C&L,2238,H302:2232;H400:55;Not classified:6;H332:1;H410:1
41983,DETA-formaldehyde reaction product,610-846-8,52470-47-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,81,H319:81;H315:81
41984,Phenoxymethylpenicillin potassium,205-086-5,132-98-9,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,95,H317:93;H302:92;H334:93;H341:1;Not classified:1
41988,"Trihydrogen bis[4-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonato(3-)]chromate(3-)",259-721-6,55613-78-0,Not Classified,Notified C&L,1,Not classified:1
41989,"1,4-dioxa-8-azaspiro[4.5]decane",205-868-6,177-11-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
41992,"6,7-dihydro-5,8-dimethyl-dibenzo[b,j][1,10]phenanthroline",226-146-7,5298-71-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,127,H319:127;H335:127;H315:127
41993,"Ethanol, 2,2'-(methylimino)bis-, phosphate (salt)",608-425-9,29870-31-3,Not Classified,Notified C&L,63,Not classified:55;H319:8
41995,"Oils, palm kernel, oleins, hydrogenated",273-627-2,68990-82-9,Not Classified,Notified C&L,1,Not classified:1
41996,Ammonium mercaptoacetate,226-540-9,5421-46-5,Met. Corr. 1;Acute Tox. 3;Skin Sens. 1,REACH registration C&L,111,H317:111;H290:61;H301:107;H319:2;H315:3;H318:1;H335:1
41999,5-amino-o-cresol,220-618-6,2835-95-2,Skin Sens. 1A;Aquatic Chronic 2,REACH registration C&L,235,H317:187;H411:42;H335:205;H315:194;H400:130;H319:206;H410:129;H302:1;H312:1;H332:1
42001,reaction product of 2-aminoethanol and boric acid,926-266-6,,Not Classified,Notified C&L,1,Not classified:1
42005,Benzylideneaniline,208-694-9,538-51-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
42009,"Fatty acids, soya, potassium salts",263-116-2,61790-24-7,Not Classified,Notified C&L,442,Not classified:442
42010,"4,5-dimethoxy-1,3-bis(methoxymethyl)imidazolidin-2-one",224-431-0,4356-60-9,Not Classified,Notified C&L,1,Not classified:1
42012,Zeranol,247-769-0,26538-44-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B,Notified C&L,67,H319:39;H360:66;H335:38;H315:39;H372:28;H351:28;H361:1;H373:1
42015,Sodium N-(2-hydroxyethyl)-N-[2-[(1-oxooctadecyl)amino]ethyl]glycinate,269-543-0,68298-17-9,Not Classified,Notified C&L,2,Not classified:2
42018,N-(tetrahydrofurfuryl)-N-methylamine,219-464-2,2439-57-8,,Notified C&L,2,H314:1;H319:1;H335:1;H315:1;H226:1
42021,"Lithium, di-Me sebacate 12-hydroxyoctadecanoate naphthenate complexes",272-894-2,68919-36-8,Not Classified,Notified C&L,2,Not classified:2
42022,4-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate,404-980-4,124737-31-1,Self-react. C;Acute Tox. 3;Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H317:0;H318:0;H373:0;H331:0;H312:0;H410:0;H301:0;H242:0
42023,Fructose,200-333-3,57-48-7,Not Classified,Notified C&L,197,Not classified:197
42024,3-chlorobutan-2-one,223-834-9,4091-39-8,Flam. Liq. 3;Acute Tox. 4,Notified C&L,45,H302:45;H226:45;H335:4;H315:5;H319:6;H332:1
42025,Ethyl DL-valinate hydrochloride,245-606-8,23358-42-1,Flam. Liq. 3,Notified C&L,7,H226:6;H319:1;H335:1;H315:1
42026,"4-Penten-1-one, 1-spiro[4.5]dec-6-en-7-yl-",639-250-6,224031-71-4,Skin Sens. 1;Aquatic Acute 1,Notified C&L,113,H317:113;H400:89;H410:34
42027,Fluometuron,218-500-4,2164-17-2,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,179,H400:128;H410:132;H302:44;H361:4;H362:4;H351:5;Not classified:3;H319:4;H411:3;H332:4;H318:1;H412:1
42031,"3-[(1,1-dimethylethyl)dithio]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-alanine",277-574-6,73724-43-3,Not Classified,Notified C&L,2,Not classified:2
42032,Pirenoxine,213-872-4,1043-21-6,Acute Tox. 4,Notified C&L,38,H302:38
42037,"2(3H)-Benzofuranone, 3a,4,5,7a-tetrahydro-3,6-dimethyl-",611-573-7,57743-63-2,Not Classified,Notified C&L,88,Not classified:88
42038,Ethyl hydroxymethoxycinnamate,215-597-5,1333-54-6,Not Classified,Notified C&L,1,Not classified:1
42040,brucine nitrate,227-317-9,5786-97-0,Acute Tox. 2;Acute Tox. 2;Aquatic Chronic 3,Harmonised C&L,0,H300:0;H330:0;H412:0
42041,"1,2,3-Propanetriol, phosphate",234-921-6,12040-65-2,Not Classified,Notified C&L,1,Not classified:1
42042,Bicyclo[2.2.1]heptane-2-carboxylic acid,212-532-2,824-62-4,,Notified C&L,5,H314:5
42043,(E)-pent-2-en-1-ol,216-416-2,1576-96-1,Flam. Liq. 3,Notified C&L,38,H226:38
42046,"2,5-dimethoxy-4-[(4-nitrophenyl)azo]benzenediazonium tetrachlorozincate (2:1)",264-656-1,64071-86-9,Eye Irrit. 2,Notified C&L,40,H319:40
42048,"Evernia prunastri, ext.",289-861-3,90028-68-5,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,1481,H317:1439;H319:71;H315:71;Not classified:4;H411:1289;H335:38;H302:1
42050,4-(4-Fluorobenzoyl)butyric Acid,604-692-0,149437-76-3,Aquatic Chronic 2,Notified C&L,17,H411:10;H319:7;H335:6;H315:7;H302:1;H312:1;H332:1
42054,Benzo[ghi]fluoranthene,205-903-5,203-12-3,STOT SE 2,Notified C&L,12,H371:12
42055,"Methyl 3,3-dimethylbutyrate",233-590-5,10250-48-3,,Notified C&L,4,H226:4
42056,O-isobutyl-N-ethoxy carbonylthiocarbamate,434-350-4,103122-66-3,Flam. Liq. 3;Acute Tox. 4;Skin Sens. 1;Muta. 1B;Carc. 1B;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H350:0;H317:0;H373:0;H340:0;H411:0;H226:0
42060,Sulfapyrazole,212-707-3,852-19-7,,Notified C&L,1,H302:1
42062,Chlorodecyldimethylsilane,253-761-8,38051-57-9,Skin Corr. 1B,Notified C&L,44,H314:44;H335:1;H318:1;H290:1
42063,"[N,N',N''-tris[3-(dimethylamino)propyl]-29H,31H-phthalocyaninetrisulphonamidato(2-)-N29,N30,N31,N32]copper triacetate",280-054-1,82864-57-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,71,H319:40;H335:40;H315:40;Not classified:31
42064,Chlorooctylmagnesium,254-147-2,38841-98-4,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,Notified C&L,68,H250:38;H314:68;H260:39;H225:30;H318:1
42065,"(8S-cis)-10-[(3-amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride",260-145-2,56390-09-1,Acute Tox. 4,Notified C&L,127,H302:126;H350:35;H360:35;H340:36;H335:1;H315:2;H341:1;H370:1;H319:2;H372:1;H351:2;H371:1;H361:2;H312:2;H332:2
42070,(Z)-3-methyl-5-phenylpent-2-enenitrile,258-446-9,53243-59-7,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,715,H317:681;H302:680;H412:681;Not classified:34;H301:1
42071,"[1R-(1α,2β,5α)]-2,6,6-trimethylbicyclo[3.1.1]heptane",225-352-4,4795-86-2,Flam. Liq. 3,Notified C&L,38,H226:38
42075,"Benzenediazonium, 2,4,6-tris(hexyloxy)-salt, with 5-benzoyl-4-hydroxy-2-methoxybenzenesulfonic acid",442-880-2,220476-38-0,Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H317:1;H318:1
42078,sec-hexadecylnaphthalene,304-232-6,94247-63-9,,Notified C&L,3,Not classified:3
42081,"Isocyanic acid, 1,4-cyclohexylene ester, trans- (8CI)",616-193-5,7517-76-2,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;Resp. Sens. 1,Notified C&L,42,H311:38;H334:42;H314:38;H331:38;H301:42;H335:4;H315:4;H317:4;H318:4;H330:4
42082,"Glycine, N-(3-aminopropyl)-, N'-C10-16-alkyl derivs.",284-065-2,84777-38-8,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H318:1;H400:1;H315:1
42087,"(1S,6S)-2,8-Diazabicyclo[4.3.0]nonane",604-778-8,151213-40-0,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,50,H317:1;H319:2;H318:48;H315:11;H335:1
42098,1-chloro-4-iodobutane,233-669-4,10297-05-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:38;H315:43
42099,Ethyl cyanocyclohexylideneacetate,229-878-5,6802-76-2,Acute Tox. 4,Notified C&L,38,H302:38
42102,"(E)-(4-methoxy-2,3,6-trimethylphenyl)-3-buten-2-one",263-760-4,62924-31-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,3,H319:2;H411:2;H315:2;Not classified:1
42109,Bis[(cyanomethyl)ammonium] sulphate,226-772-0,5466-22-8,Acute Tox. 3;Acute Tox. 2,Notified C&L,60,H330:55;H301:60;H319:5;H335:4;H315:5
42111,"Carbonic acid, compound with 2-aminoethanol (1:2)",244-600-2,21829-52-7,Acute Tox. 4,REACH registration C&L,2,H302:2
42115,Octadecanedioic Acid,617-978-5,871-70-5,Not Classified,Notified C&L,3,Not classified:2;H319:1;H315:1
42119,"3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate homopolymer, isocyanurate type, caprolactam-blocked",603-188-8,127184-53-6,STOT RE 1,REACH registration C&L,15,H372:15
42122,(1-benzofuran-2-yl)methanol,611-222-8,55038-01-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
42124,methenamine;hexamethylenetetramine,202-905-8,100-97-0,Flam. Sol. 2;Skin Sens. 1,Harmonised C&L,0,H317:0;H228:0
42125,"Slack wax (petroleum), low-melting;[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C",295-524-1,92062-10-7,Carc. 1B,Harmonised C&L,0,H350:0
42130,maleic anhydride,203-571-6,108-31-6,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Skin Sens. 1A;Resp. Sens. 1;STOT RE 1,Harmonised C&L,0,H302:0;H317:0;H334:0;H318:0;H314:0;H372:0
42138,Dibutyl phosphonate,217-316-1,1809-19-4,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,585,H319:546;H315:585;H412:489;H335:39;H318:72;H312:40;H351:38
42139,"2-(Chloromethyl)-2-(2,4-difluorophenyl)oxirane",605-357-1,164347-62-0,Skin Irrit. 2;Skin Sens. 1B;STOT RE 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,2,H315:2;H317:2;H373:2;H401:2;H411:2
42141,Vinyl pivalate,222-175-4,3377-92-2,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 1B,Notified C&L,41,H302:39;H225:40;H335:39;H315:39;H350:40;H319:40;H312:39;H332:39;Not classified:1;H340:1
42142,"tetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate",405-240-3,,Skin Sens. 1,Harmonised C&L,0,H317:0
42143,"(2S)-2-(1,3-DIOXO-2,3-DIHYDRO-1H-ISOINDOL-2-YL)PENTANEDIOIC ACID",608-945-6,340-90-9,Eye Dam. 1,REACH registration C&L,1,H318:1
42153,4-amino-N-(4-aminophenyl)benzenesulphonamide,240-834-4,16803-97-7,Aquatic Chronic 3,REACH registration C&L,5,H412:2;Not classified:3
42154,2-Ethyl-5-nitroaniline,606-462-5,20191-74-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H302:39;H332:38;H312:38;H319:1;H315:1
42155,"Anthriscus cerefolium, ext.",285-352-5,85085-20-7,Flam. Liq. 3;Acute Tox. 4;Skin Sens. 1;Muta. 2;Carc. 2;Aquatic Chronic 3,Notified C&L,3,H302:1;H341:3;H317:3;H226:2;H412:1;H351:3;H304:1;H315:1;H410:1
42156,Dextrorphan,204-754-3,125-73-5,Acute Tox. 4,Notified C&L,39,H302:39
42160,5-nitrovanillin,229-633-2,6635-20-7,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,46,H319:46;H315:46;H335:44
42169,"Benzenesulfonic acid, 4-[(1,3-dioxobutyl)amino]-, sodium salt (1:1)",613-240-1,63503-98-0,Not Classified,Notified C&L,34,Not classified:34
42170,methyltriphenylphosphonium chloride,418-400-2,1031-15-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H315:0;H318:0;H411:0;H312:0
42172,2-aminotoluene-4-sulphonic acid,210-540-0,618-03-1,Eye Irrit. 2,REACH registration C&L,40,H319:40
42173,3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol,410-910-3,104226-19-9,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H412:0
42174,Tetraisopropylstannane,220-969-5,2949-42-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H302:42;H335:38;H315:38;H319:38;H312:42;H332:42
42178,3-(triethoxysilyl)propanethiol,238-883-1,14814-09-6,Aquatic Chronic 2,REACH registration C&L,160,H411:48;Not classified:52;H319:60;H335:59;H315:60;H317:23;H302:38;H320:1;H402:1;H226:1;H412:1;H227:1
42181,Decamethonium iodide,215-816-4,1420-40-2,Acute Tox. 3,Notified C&L,39,H301:39
42182,Protein A (Staphylococcus aureus strain Cowan I),295-242-9,91932-65-9,Eye Irrit. 2,Notified C&L,1,Not classified:1;H319:1
42183,Pentapotassium bis(peroxymonosulphate) bis(sulphate),274-778-7,70693-62-8,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,230,H302:192;H318:105;H314:230;H412:104;H271:38;H272:34;H332:3;H312:1;H270:1
42188,"Sodium O,O-diisopropyl dithiophosphate",248-322-2,27205-99-8,Skin Corr. 1C,REACH registration C&L,50,H314:50;H318:45
42193,2-methoxy-N-[2-nitro-5-(phenylthio)phenyl]acetamide,264-263-5,63470-85-9,Not Classified,Notified C&L,4,Not classified:4
42195,"N,N'-(2,2-dimethylpropylidene)hexamethylenediamine",401-660-6,1000-78-8,Skin Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H317:0;H315:0
42196,Sodium dihydrogen citrate,242-734-6,18996-35-5,Not Classified,REACH registration C&L,97,Not classified:95;H302:2
42200,"6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-, sodium salt (1:1)",614-996-5,69657-51-8,,Notified C&L,1,H319:1;H335:1;H315:1
42203,ethyl 2-amino-2-methylpropanoate hydrochloride,605-648-3,17288-15-2,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
42205,S-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride;prothiocarb hydrochloride,243-193-9,19622-19-6,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0
42207,2-Acetyloxypropanoic acid,609-562-7,3853-80-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
42213,"D-Glucopyranose, oligomers, lauryl glycosides",500-522-3,161074-87-9,Eye Irrit. 2,Notified C&L,75,H319:73;Not classified:2
42219,Dichlorodivinylstannane,231-399-1,7532-85-6,,Notified C&L,4,H400:4;H311:4;H301:4;H410:4;H330:4
42220,"Fatty acids, C18-unsatd., dimers, oligomeric reaction products with tall-oil fatty acids, triethylenetetramine and C12-C14 aliphatic glycidyl ether",923-070-2,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H317:1;H319:1;H315:1
42227,(methylsulphonyl)benzene,221-476-8,3112-85-4,Acute Tox. 4,Notified C&L,47,H302:46;H319:2;H335:2;H315:2;H312:2;H332:2
42229,Diisopropyl phosphonate,217-317-7,1809-20-7,Not Classified,Notified C&L,42,Not classified:33;H302:8;H335:7;H315:8;H319:9;H332:5;H331:1
42232,Diphenyl tridecyl phosphite,262-335-0,60628-17-3,Skin Irrit. 2,Notified C&L,1,H315:1
42235,"Cobaltate(3-), bis[6-amino-5-[(2-hydroxy-3,5-dinitrophenyl)azo]-1-naphthalenesulfonato(3-)]-, sodium",285-249-5,85049-76-9,Aquatic Chronic 3,REACH registration C&L,57,H412:16;H317:33;H319:33;H334:33;Not classified:8
42238,"A mixture of: but-1,3-diyl didecanoate; but-1,3-diyl dioctanoate; but-1,3-diyl 1-decanoate-3-octanoate; but-1,3-diyl 1-octanoate-3-decanoate",424-180-9,,Not Classified,REACH registration C&L,2,Not classified:2
42245,"Formamide, N,N'-(4-methyl-1,3-phenylene)bis-, reaction products with [1,1'-biphenyl]-4,4'-diamine and sulfur",215-437-4,1326-66-5,Not Classified,Notified C&L,6,Not classified:6
42251,"2,5-bis(tert-dodecyldithio)-1,3,4-thiadiazole",261-844-5,59656-20-1,Not Classified,Notified C&L,15,Not classified:14;H412:1
42252,"4-(4-chloro-1,2,5-thiadiazol-3-yl)morpholine",250-077-1,30165-96-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,5,H319:3;H302:3;H335:3;H315:3;Not classified:2
42255,Tert-butyl 2-[4-(2-pyridinyl) phenylmethyl] hydrazine carboxylate,429-080-9,,Acute Tox. 4;Eye Irrit. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,2,H319:2;H302:2;H373:2;H411:2
42256,m-hydroxybenzohydrazide,227-389-1,5818-06-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
42258,Pullulanase,232-983-9,9075-68-7,Resp. Sens. 1,REACH registration C&L,10,H334:10
42262,Phenethyl cinnamate,203-120-3,103-53-7,Aquatic Chronic 1,REACH registration C&L,1607,H410:26;Not classified:1543;H319:38;H335:38;H315:38
42263,"Methyl 2,4-dihydroxy-3,6-dimethylbenzoate",225-193-0,4707-47-5,Skin Sens. 1B,REACH registration C&L,1646,H317:47;Not classified:1560;H319:39;H335:39;H315:39
42267,"Glycerides, C14-18 and C16-22-unsatd., hydrolyzed, distn. residues",293-169-7,91052-12-9,Not Classified,Notified C&L,6,Not classified:6
42271,"2-Oxepanone, polymer with 2,2-dimethyl-1,3-propanediol",614-924-2,69089-45-8,Acute Tox. 4;Acute Tox. 4,Notified C&L,452,H302:446;H312:446;Not classified:6
42273,"β-Alanine, N-(2-aminoethyl)-N-[2-(2-carboxyethoxy)ethyl]-, N-coco acyl derivs., disodium salts",270-131-8,68411-57-4,Not Classified,REACH registration C&L,13,Not classified:13
42275,"α-Bitter acids, hop, hydrogenated, isomerized",295-619-8,92113-15-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,3,H302:2;H317:2;H318:2;H314:2;H312:2;Not classified:1
42276,"1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;[containing < 0.1 % 4-chloroaniline (EC No 203-401-0)];[containing ≥ 0.1 % 4-chloroaniline (EC No 203-401-0)]",433-580-2,214353-17-0,,,0,H302:0;H350:0;H314:0;H411:0
42282,"(3R,3'R)-β,β-carotene-3,3'-diol",205-636-4,144-68-3,Not Classified,Notified C&L,98,Not classified:92;H413:6
42299,Benzofuran-2-carboxylic acid,207-818-9,496-41-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H335:44;H315:45;H302:1;H332:1;H312:1
42301,"trimagnesium(2+) bis((2R)-2-[(1S)-1,2-dihydroxyethyl]-5-oxo-4-(phosphonooxy)-2,5-dihydrofuran-3-olate)",423-710-6,,Not Classified,REACH registration C&L,86,Not classified:86
42304,4-Methyl-2-propyl-6-benzimidazolecarboxylic Acid,604-867-1,152628-03-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:1;H315:1;Not classified:1;H411:1
42312,4-oxovaleric acid,204-649-2,123-76-2,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,1806,H317:113;H302:1804;H318:114;H319:1679;H315:1684;H335:53;H314:9;H290:2
42321,4-sec-butylphenol,202-781-5,99-71-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,145,H318:55;H314:145;H400:38;H302:1;H412:1
42322,8-oxabicyclo[5.1.0]octane,206-009-8,286-45-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,39,H302:39;H314:39;H226:39;H312:39;H332:39
42326,"3,5,5-trimethylhexanoic acid hexaester with dipentaerythritol",453-460-3,,Not Classified,Notified C&L,2,Not classified:2
42327,3-(2-chlorophenyl)-5-methylisoxazole-4-carboxylic acid,245-770-0,23598-72-3,Acute Tox. 4,Notified C&L,45,H302:41;H319:4;H335:4;H315:4
42336,1-cyclohexylpiperidine,222-016-9,3319-01-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H302:39;H318:38;H335:38;H315:43;H319:5
42340,[No public or meaningful name is available],603-329-3,129318-43-0,Acute Tox. 4,Notified C&L,1,H302:1
42341,"21-amino-N-[2-[[2-[[2-[(2-aminoethyl)amino]ethyl]amino]ethyl]amino]ethyl]-9-(1-hydroxynonyl)-9,12,15,18-tetraazahenicosanamide",269-542-5,68298-14-6,Not Classified,Notified C&L,23,Not classified:23
42342,Bis[(1-oxoallyl)amino]acetic acid,224-500-5,4387-85-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H314:38
42345,"2,4-difluoro-1,1'-biphenyl",253-690-2,37847-52-2,Not Classified,REACH registration C&L,41,Not classified:2;H302:38;H335:38;H315:39;H400:38;H318:38;H319:1
42348,"Cuprate(6-), [2-[[[[3-[[4-chloro-6-[[4-[[4-chloro-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2,5-disulfophenyl]amino]-1,3,5-triazin-2-yl]amino]-2-hydroxy-5-sulfophenyl]azo]phenylmethyl]azo]-5-sulfobenzoato(8-)]-, pentasodium hydrogen, (SP-4-3)-",268-655-7,68132-91-2,Aquatic Chronic 2,REACH registration C&L,40,H411:1;H320:14;H335:22;H334:30;Not classified:8;H319:9;H412:1
42352,"N,N,2-trimethylquinolin-6-amine",202-207-3,92-99-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 2;Carc. 2;Repr. 2;Aquatic Chronic 4,REACH registration C&L,40,H361:2;H302:40;H413:2;H335:40;H315:40;H351:2;H319:40;H341:2
42354,4-amino-o-cresol,220-619-1,2835-96-3,Acute Tox. 4;Eye Dam. 1;Resp. Sens. 1,Notified C&L,40,H334:38;H302:38;H318:38;H319:2;H315:2
42356,"4,5-dimethylthiazole",222-703-3,3581-91-7,Acute Tox. 4,Notified C&L,1448,H302:1420;H226:126;H335:42;H315:68;H318:40;H319:3
42360,"Quaternary ammonium compounds, (C12-18 and C18-unsatd. alkyl)(hydroxyethyl)dimethyl, chlorides",310-286-1,159702-65-5,Skin Corr. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H314:2;H400:2;H410:2
42364,2-isopropylvaleric acid,263-529-8,62391-99-5,,Notified C&L,2,H302:2;H319:1;H335:1;H315:1
42366,"6-methyl-4-oxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide",601-694-3,120279-88-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
42367,3-methylbut-2-enyl hexanoate,278-515-7,76649-22-4,Not Classified,Notified C&L,89,Not classified:89
42368,"Orthoboric acid, compound with 2,2'-iminodiethanol",267-886-0,67952-33-4,Not Classified,Notified C&L,10,Not classified:4;H319:6;H315:5;H302:2
42373,"4,4'-methylenebis[3-hydroxy-2-naphthoic] acid, compound with (E)-1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidine (1:1)",244-837-1,22204-24-6,Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 3,Notified C&L,52,H317:27;H334:27;H412:26;Not classified:21;H319:6;H315:4
42377,"Hydrogen bis[3-[[1-(3-chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]-4-hydroxy-N-methylbenzenesulphonamidato(2-)]cobaltate(1-)",289-070-3,85959-75-7,Not Classified,REACH registration C&L,4,Not classified:4
42378,"(±)-2-amino-4,4,4-trifluoro-3-(trifluoromethyl)butyric acid",240-207-5,16063-80-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
42379,"Copper(2+), [N,N'-bis[2-(amino-κN)ethyl]-1,2-ethanediamine-κN,κN']-, (SP-4-2)-",610-273-3,45840-81-1,Not Classified,Notified C&L,1,Not classified:1
42381,(carboxymethyl)dimethyl-3-[(1-oxooctyl)amino]propylammonium hydroxide,277-600-6,73772-46-0,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,34,H318:25;H314:2;H319:9
42385,2-acetamido-4-methylthiazole-5-sulphonyl chloride,274-127-7,69812-29-9,Skin Corr. 1B;Eye Dam. 1,Notified C&L,41,H318:40;H314:41;H290:1
42386,"(2,4,6-trimethylphenyl)acetic acid",224-556-0,4408-60-0,,Notified C&L,6,H319:6;H335:5;H315:6;H302:1
42387,"1,1'-dioxybiscyclohexan-1-ol;1,1’-dioxybiscyclohexan-1-ol",219-306-2,2407-94-5,,,0,H302:0;H314:0;H242:0
42389,ethyl N-(diphenylmethylidene)glycinate,614-987-6,69555-14-2,,Notified C&L,37,Not classified:34;H319:3;H335:3;H315:3
42390,Mesuximide,201-026-7,77-41-8,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,40,H302:40;H412:39
42394,"Cocculus indicus, ext.",294-946-3,91771-54-9,,Notified C&L,1,H302:1;H225:1;H332:1
42396,"bis(O,O-2-ethylhexyl-thiophosphoryl)polysulfide",605-708-9,174125-93-0,Skin Sens. 1B;Aquatic Chronic 4,REACH registration C&L,1,H317:1;H413:1
42397,"1,4-diethylpiperazine",229-341-5,6483-50-7,,Notified C&L,5,H319:4;H335:4;H315:4;H318:1;H314:1;H226:1
42398,2-mercaptobenzoic acid,205-704-3,147-93-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:49;H335:48;H315:49;H302:1;H312:1;H332:1;Not classified:1
42403,"cyanophos (ISO);O-4-cyanophenyl O,O-dimethyl phosphorothioate",220-130-3,2636-26-2,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H400:0;H312:0;H410:0
42406,3-chloro-2-(isopropylthio)aniline,421-700-6,179104-32-6,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0
42409,Chloro(2-methyl-2-phenylpropyl)magnesium,252-492-3,35293-35-7,Skin Corr. 1B,Notified C&L,73,H314:73;H225:25;H302:10;H311:10;H331:10;H351:10
42412,"2,6-difluorobenzamide",241-972-8,18063-03-1,Acute Tox. 4,REACH registration C&L,297,H302:87;H319:209;H332:128;H315:209;H335:208;H312:1;Not classified:1;H400:1;H410:1
42414,"benfuracarb (ISO);ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate",617-356-3,82560-54-1,Acute Tox. 4;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H361:0;H302:0;H400:0;H331:0;H410:0
42416,"Perchloric acid, sodium salt, monohydrate",616-573-0,7791-07-3,Ox. Sol. 1;Acute Tox. 4,Notified C&L,129,H302:128;H271:128;H319:1;H373:1;Not classified:1
42417,"Rhamnus purshiana, ext.",283-515-5,84650-55-5,Acute Tox. 4,Notified C&L,2,H302:1;H319:1;H335:1;H315:1
42419,C.I. Reactive Violet 13,602-874-4,12270-87-0,Not Classified,Notified C&L,2,Not classified:2
42420,Manganese phosphonate,245-215-2,22775-65-1,Acute Tox. 4;Skin Corr. 1C;Aquatic Chronic 2,Notified C&L,2,H302:2;H314:2;H411:2
42422,12-hydroxyoctadecan-1-amide,230-349-6,7059-49-6,Not Classified,Notified C&L,1,Not classified:1
42423,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane and 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol, reaction products with polymethylenepolyphenylene polyisocyanate",500-754-5,162492-19-5,Not Classified,Notified C&L,55,Not classified:55
42425,"Quaternary ammonium compounds, dicoco alkyldimethyl, nitrates",263-088-1,61789-78-4,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H302:1;H318:1;H314:1;H400:1
42426,"1-(bromomethyl)-2,4-difluorobenzene",245-938-3,23915-07-3,Flam. Liq. 3;Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1,Notified C&L,47,H317:44;H334:40;H314:47;H226:42;H318:1;H290:1;H341:1;H319:1;H335:1
42427,3-iodopropionic acid,205-499-0,141-76-4,Skin Corr. 1B,Notified C&L,44,H314:44;H302:1;H318:1;H290:1;H312:1;H332:1;H341:1
42429,3-chloro-1-phenylpropan-1-ol,606-122-6,18776-12-0,Acute Tox. 4,REACH registration C&L,5,H302:3;H319:2;H315:2;H341:1;H335:1
42431,N-[2-[4-(aminosulphonyl)phenyl]ethyl]acetamide,255-386-5,41472-49-5,Not Classified,REACH registration C&L,5,Not classified:5
42434,"Siloxanes and Silicones, di-Me, hydroxy-terminated, ethoxylated propoxylated",613-581-6,64365-23-7,Not Classified,Notified C&L,12,Not classified:12
42436,4-mesyl-2-nitroaniline,244-550-1,21731-56-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H302:2;H335:2;H315:2;H319:2;H312:2;H332:2
42437,"Hydrogen bis[2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-), compound with 3-[(2-ethylhexyl)oxy]propylamine (1:1)",254-539-3,39609-25-1,Not Classified,Notified C&L,2,Not classified:2
42441,"2,4-difluorotoluene",207-211-9,452-76-6,Flam. Liq. 2,Notified C&L,47,H225:47;H319:4;H335:4;H315:4;H332:3
42442,3-benzoylphenylacetic acid,244-760-3,22071-22-3,,Notified C&L,2,H361:1;H301:1;H319:1;H335:1;H315:1
42443,"3,3'-(p-phenylene)diacrylic acid",240-399-0,16323-43-6,,Notified C&L,5,H319:5;H335:4;H315:5
42446,"Bis(η5-2,4-cyclopentadien-1-yl)nickel",215-039-0,1271-28-9,Flam. Sol. 1;Acute Tox. 4;Skin Sens. 1;Carc. 1A,Notified C&L,47,H317:46;H228:43;H350:46;H302:47;H250:4;H252:4;H334:2;H413:1;H335:1;H315:1;H319:1;H332:1
42450,"3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indenyl acrylate",251-678-1,33791-58-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,88,H319:87;H411:87;H335:87;H315:83;Not classified:1
42457,N-(2-benzoyl-4-chlorophenyl)-2-chloro-N-methylacetamide,227-875-3,6021-21-2,Not Classified,REACH registration C&L,5,Not classified:4;H302:1
42461,2-bromo-N-[2-(2-fluorobenzoyl)-4-nitrophenyl]-N-methylacetamide,275-027-6,70931-08-7,Not Classified,REACH registration C&L,1,Not classified:1
42464,"(+/-)-2,2'-Bis(diphenylphosphino)-1,1'-dinaphthalene (BINAP)",619-338-0,98327-87-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,21,H319:20;H335:20;H315:20;H413:1
42465,"trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate",403-670-6,92408-46-3,Aquatic Chronic 3,Harmonised C&L,0,H412:0
42467,"Trisodium 7-[[4-chloro-6-[(3-sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(4-methoxy-2-sulphonatophenyl)azo]naphthalene-2-sulphonate",264-721-4,64181-81-3,,Notified C&L,23,Not classified:9;H320:7;H335:7;H334:9;H317:5
42469,Allyl propionate,219-307-8,2408-20-0,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1564,H319:1564;H315:1564;H301:1526;H226:1564;H335:266
42472,"poly(oxy-1,2-ethanediyl), -[2,4,6-tris(1-phenylethyl)phenyl]- -hydroxy-",615-124-6,70559-25-0,Aquatic Chronic 3,Notified C&L,233,H412:156;Not classified:77
42473,"Benzene-1,2-dithiol",241-530-4,17534-15-5,,Notified C&L,6,H302:6;H315:6;H318:4;H312:6;H332:6;H319:2
42475,"Spilanthes acmella, ext.",290-335-0,90131-24-1,Skin Sens. 1B,REACH registration C&L,1378,H317:1;H331:897;H226:897;Not classified:400;H332:67;H319:13
42476,Flurazepam hydrochloride,214-630-0,1172-18-5,Acute Tox. 4;STOT RE 2,Notified C&L,41,H373:38;H302:41;H361:1;H336:1;H362:1
42477,p-[(4-amino-5-methoxy-o-tolyl)azo]benzenesulphonic acid,255-151-7,40947-69-1,Not Classified,REACH registration C&L,2,Not classified:2
42479,"3-bromo-4,5-dimethoxybenzaldehyde",230-113-2,6948-30-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
42482,(S)-2-amino-3-(p-hydroxyphenyl)-N-(2-naphthyl)propionamide,224-432-6,4357-95-3,Carc. 2,Notified C&L,39,H351:38;H350:1
42487,"Fatty acids, tall-oil, ethoxylated",500-150-1,61791-00-2,Skin Sens. 1B,REACH registration C&L,335,H317:18;H319:112;H315:194;Not classified:122
42491,N-methyloctadecylamine,219-463-7,2439-55-6,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,73,H318:34;H411:34;H315:73;H319:39;H335:38
42499,4-chloro-o-phenylenediamine,202-456-8,95-83-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2,Notified C&L,47,H319:40;H335:40;H315:40;H351:39;H350:4;H302:4;H341:1;H312:1;H332:1
42503,"2,5-dichlorohydroquinone",212-533-8,824-69-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,42,H318:38;H314:38;H319:4;H335:4;H315:4
42504,Difluoromethanesulphonyl chloride,216-150-7,1512-30-7,Skin Corr. 1B;Acute Tox. 1,REACH registration C&L,85,H314:85;H330:39;H225:46;H318:37
42505,Oxydiethylene diricinoleate,277-837-5,74356-18-6,Not Classified,Notified C&L,1,Not classified:1
42507,1-fluoropentane,209-761-5,592-50-7,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H225:39;H335:39;H315:39
42508,cis-pent-2-ene-1-ol,216-415-7,1576-95-0,Flam. Liq. 3,Notified C&L,1424,H226:1424
42511,7-(β-D-glucopyranosyloxy)-2-[3-(β-D-glucopyranosyloxy)-4-hydroxyphenyl]-5-hydroxy-4H-1-benzopyran-4-one,257-724-7,52187-80-1,Not Classified,Notified C&L,1,Not classified:1
42514,Codeine hydrochloride,215-829-5,1422-07-7,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Lact.,Notified C&L,3,H317:3;H302:2;H318:1;H362:2;H361:2;H334:2;H301:1;H311:1;H331:1
42516,"triadimefon (ISO);1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone",256-103-8,43121-43-3,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H302:0;H411:0
42517,Cycloheptanemethanol,224-691-5,4448-75-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
42519,"[N,N',N'',N'''-tetrakis[3-(dimethylamino)propyl]-29H,31H-phthalocyaninetetrasulphonamidato(2-)-N29,N30,N31,N32]copper tetrahydrochloride",280-053-6,82864-56-0,Not Classified,Notified C&L,31,Not classified:31
42520,dilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate,401-010-1,,Skin Sens. 1,Harmonised C&L,0,H317:0
42521,"2-dodecyl-4,5-dihydro-1H-imidazole-1-ethanol",240-205-4,16058-17-6,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,7,H314:7;H400:7;H410:7
42523,2-ethyl-1H-benzimidazole,217-433-8,1848-84-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H302:39;H318:38;H335:39;H315:39;Not classified:1;H319:1
42525,"Isononanoic acid, manganese salt",249-884-1,29826-51-5,Skin Irrit. 2,Notified C&L,3,H315:3
42527,"3a,4,5,6,7,7a-hexahydro-5-methoxy-4,7-methano-1H-indene",258-296-4,53018-24-9,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,120,H319:120;H412:2
42528,"Benzene, diethenyl-, polymer with ethenylbenzene and ethenylethylbenzene, [(aminothioxomethyl)amino]methyl derivs.",601-234-1,113114-10-6,,Notified C&L,33,Not classified:33
42531,"(1R-trans)-N-[[2-(2,3-Dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide;Propanamide,N- [[(1R,2R)-2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]-;N-(((1R,2R)-2-(2,3-Dihydro-1- benzofuran-4-yl)cyclopropyl)methyl)propanamide",612-059-5,609799-22-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H302:2;H332:1;H312:1
42536,"3-[[4-[(6-amino-1-hydroxy-3-sulpho-2-naphthyl)azo]-5-methoxy-o-tolyl]azo]naphthalene-1,5-disulphonic acid, lithium salt, compound with 2,2',2''-nitrilotriethanol",268-653-6,68132-89-8,Acute Tox. 4;Eye Dam. 1;STOT RE 2,Notified C&L,69,H373:36;H302:36;H318:36;Not classified:33
42537,5-(4-fluorophenyl)pyridine-3-carboxylic acid,609-242-7,364064-17-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H335:1;H315:1
42539,(R)-12-hydroxy-N-(2-hydroxyethyl)oleamide,203-368-2,106-16-1,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,2,H318:2;H315:1
42543,"nonanol, branched and linear",614-557-8,68515-81-1,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1,H319:1;H412:1
42546,"(2E,4E)-octa-2,4-dienal",250-147-1,30361-28-5,Skin Irrit. 2,Notified C&L,1403,H315:1393;Not classified:10
42557,Sucrose,200-334-9,57-50-1,Not Classified,Notified C&L,414,Not classified:407;H302:8;H400:8;H315:8;H311:8;H331:8;H332:8;H373:4;H335:2;H372:1
42558,Barium thiosulphate,252-375-7,35112-53-9,Acute Tox. 4;Acute Tox. 4,Notified C&L,331,H302:331;H332:280
42559,"Gases (petroleum), fluidized catalytic cracker splitter overheads;Petroleum gas;[A complex combination of hydrocarbons produced by the fractionation of the charge to the C3-C4 splitter. It consists predominantly of C3 hydrocarbons.]",272-893-7,68919-20-0,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H350:0;H220:0;H340:0
42560,7-methylenepentadecane,603-419-2,13043-55-5,Asp. Tox. 1,REACH registration C&L,2,H304:2
42569,"Boric acid, calcium salt",234-920-0,12040-58-3,Not Classified,Notified C&L,34,Not classified:34
42570,Asparaginase,232-765-3,9015-68-3,Skin Sens. 1;Repr. 2,Notified C&L,43,H317:40;H361:40;H334:4
42571,Disodium 4-hydroxy-3-[[2-methoxy-5-methyl-4-[(4-sulphonatophenyl)azo]phenyl]azo]-7-(phenylamino)naphthalene-2-sulphonate,228-326-0,6227-14-1,Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,28,H317:1;H319:1;H302:3;Not classified:25;H318:2;H412:2
42572,"Benzenemethanol, 4-fluoro-α-phenyl-",609-254-2,365-22-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
42575,"4-Penten-1-one, 1-Spirodec-7-en-7-yl",620-555-8,224031-70-3,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,178,H317:178;H400:142;H410:168;H411:10
42582,"N-(5-methylhexan-2-yl)benzene-1,4-diamine",613-198-4,63302-43-2,Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,50,H318:50;H411:34
42583,"2'-anilino-6'-(diethylamino)-3'-methylspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",249-676-0,29512-49-0,Not Classified,Notified C&L,93,Not classified:86;H412:6;H413:1
42584,Corticosterone,200-019-6,50-22-6,Skin Sens. 1,Notified C&L,39,H317:38;H400:1
42585,"Slack wax (petroleum), hydrotreated;[A complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C",295-523-6,92062-09-4,Carc. 1B,Harmonised C&L,0,H350:0
42586,Z-85,482-100-8,,Eye Dam. 1,REACH registration C&L,445,H318:445
42589,"Bis(1,1,1,5,5,5-hexafluoropentane-2,4-dionato-O,O')palladium",265-271-1,64916-48-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
42594,"(8S-cis)-8-acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxynaphthacene-5,12-dione hydrochloride",260-144-7,56390-08-0,Acute Tox. 4;Muta. 2;Carc. 2;Repr. 1B,Notified C&L,1,H302:1;H351:1;H360:1;H341:1
42596,"2-methoxy-N,N,β-trimethyl-10H-phenothiazine-10-propylamine",212-706-8,851-68-3,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,5,H302:5;H315:4;H411:1;H332:1;H312:1
42597,"Fabiana imbricata, ext.",289-862-9,90028-69-6,Skin Sens. 1,Notified C&L,2,H317:1;Not classified:1
42600,"2,2-bis(chloromethyl)trimethylene bis(bis(2-chloroethyl)phosphate)",253-760-2,38051-10-4,Not Classified,REACH registration C&L,60,Not classified:60
42602,Triammonium trihydrogen [nitrilotris(methylene)]trisphosphonate,276-591-6,72333-13-2,Not Classified,Notified C&L,1,Not classified:1
42604,"Oils, animal, mixed with vegetable oil Me esters, sulfurized",273-626-7,68990-81-8,Skin Irrit. 2,Notified C&L,66,H315:38;Not classified:28
42605,"Estra-1,3,5(10)-triene-3,17β-diol diacetate",222-335-3,3434-88-6,Carc. 2,Notified C&L,39,H351:38;H361:1;H319:1;H315:1
42609,(E)-3-methyl-5-phenylpent-2-enenitrile,258-447-4,53243-60-0,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1202,H317:1168;H302:1168;H412:1168;Not classified:34
42612,(±)-2-allyl-4-hydroxy-3-methylcyclopent-2-en-1-one,249-724-0,29605-88-7,Aquatic Acute 1,Notified C&L,2,H400:2
42615,Ethyl 2-Chloro-2-(hydroxyimino)acetate,604-347-4,14337-43-0,Skin Irrit. 2;Eye Dam. 1;Resp. Sens. 1;STOT SE 3,Notified C&L,45,H334:43;H318:44;H335:43;H315:44;H317:2;H314:1;H319:1
42624,5-(2-Bromophenyl)-1H-tetrazole,615-906-7,73096-42-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H335:43;H315:44;H301:1
42628,"(17β)-3-oxoestra-4,6-dien-17-yl acetate",425-330-6,,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H302:1;H411:1
42629,"Glycerides, C14-18 mono- and di-, ethoxylated",614-329-8,68153-76-4,Not Classified,Notified C&L,16,Not classified:16
42630,"Fatty acids, vegetable-oil, potassium sodium salts",271-723-9,68606-06-4,Eye Irrit. 2,Notified C&L,1,H319:1
42641,Vinyl propionate,203-293-5,105-38-4,Flam. Liq. 2;Eye Irrit. 2;Acute Tox. 3;Carc. 2;Aquatic Chronic 3,REACH registration C&L,45,H225:45;H319:41;H331:2;H412:2;H351:2;H315:38
42642,4-Cyano-2nitrobenzoic acid methyl ester,610-840-5,52449-76-0,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,4,H317:4;H411:4
42645,Trichloro(dichlorophenyl)silane,248-254-3,27137-85-5,Skin Corr. 1B,Notified C&L,38,H314:38
42646,"Benzene, 2-(3-chloropropoxy)-1,4-dimethyl-",608-597-5,31264-51-4,,Notified C&L,1,H302:1
42647,"Benzenesulfonic acid, 4-C1-13-sec-alkyl derivates, sodium salt",603-187-2,127184-52-5,Acute Tox. 4,Notified C&L,33,H302:31;H319:2;H318:3;H335:2;H315:1;H412:1
42650,"2,3-diaminopropionic acid hydrobromide",242-467-5,18635-45-5,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:39;H335:39;H315:39
42653,"Heptanal, cyclic acetal with glycerol",276-947-0,72854-42-3,Not Classified,Notified C&L,234,Not classified:234
42654,succinic anhydride,203-570-0,108-30-5,Acute Tox. 4;Skin Corr. 1;Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H302:0;H317:0;H334:0;H318:0;H314:0
42656,"2,3-bis(bromomethyl)quinoxaline",221-538-4,3138-86-1,Skin Corr. 1B;STOT SE 3,Notified C&L,38,H335:38;H314:38
42657,N-acetyl-DL-methionine,214-224-3,1115-47-5,Not Classified,Notified C&L,4,Not classified:3;H318:1
42659,"D-Glucopyranose, oligomers, branched and linear undecyl glycosides",500-521-8,161074-86-8,Not Classified,Notified C&L,1,Not classified:1
42663,m-ethoxybenzamide,259-846-6,55836-69-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:39;H302:38;H335:1;H315:1
42664,"linalool; 3,7-dimethyl-1,6-octadien-3-ol; dl-linalool",201-134-4,78-70-6,Skin Sens. 1B,Harmonised C&L,0,H317:0
42670,3-bromohexane,222-174-9,3377-87-5,Flam. Liq. 3;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,43,H302:38;H413:38;H226:43
42671,"Fatty acids, sunflower-oil, reaction products with diethanolamine",307-861-4,97766-03-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,4,H318:4;H315:4
42672,"Fatty acids, vegetable-oil, sulfurized",304-821-8,94279-76-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
42676,6-ethoxy-1H-purine,241-813-2,17861-06-2,Acute Tox. 4,Notified C&L,38,H302:38
42677,"Decahydro-5,5,8a-trimethyl-2-naphthyl acetate",246-105-7,24238-95-7,Not Classified,Notified C&L,246,Not classified:199;H317:47
42678,"4-dimethylamino-2,2-diphenylvaleronitrile",204-755-9,125-79-1,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Muta. 2;Repr. 1B;Lact.,REACH registration C&L,5,H315:4;H360:4;H362:4;H319:4;H300:4;H341:4;H301:1;H361:1
42679,"3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarbonyl chloride",257-840-8,52314-67-7,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,8,H400:4;H315:4;H317:4;H301:4;H410:4;H302:4;H314:4;H335:1;H373:1;H332:1
42682,"2-Propenoic acid, 2-methyl-, methyl ester, polymer with butyl 2-propenoate, 2-ethylhexyl 2-propenoate and 2-propenoic acid",610-024-9,42398-14-1,Not Classified,Notified C&L,72,Not classified:72
42683,Diiron manganese zinc pentaoxide,235-606-6,12357-52-7,Not Classified,Notified C&L,1,Not classified:1
42684,Tris(acetonitrile)tricarbonyltungsten,240-833-9,16800-47-8,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,38,H330:38;H300:38;H310:38
42685,"carbadox (INN);methyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide;2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide",229-879-0,6804-07-5,Flam. Sol. 1;Acute Tox. 4;Carc. 1B,Harmonised C&L,0,H228:0;H350:0;H302:0
42686,"Rhus succedanea, ext.",310-125-5,103798-70-5,Not Classified,Notified C&L,3,Not classified:3
42687,"Reaction mass of 3,6,9-tris(2-{[(2-hydroxyethyl)amino]oxy}-2-oxoethyl)-3,6,9-triazaundecan-1,11-dioic acid and water",453-140-3,,Not Classified,REACH registration C&L,2,Not classified:2
42689,"Fatty acids, mustard-oil, Me esters",282-485-0,84238-16-4,Not Classified,Notified C&L,1,Not classified:1
42692,"2,3-dihydroxypropanesulphonic acid",233-668-9,10296-76-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H315:1
42694,Hexetidine,205-513-5,141-94-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:46;H335:42;H315:46;H302:6;H332:6;H312:6
42695,"(±)-malic acid, sodium salt",254-952-9,40520-93-2,,Notified C&L,33,Not classified:33
42697,benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate,416-050-5,87460-09-1,Eye Dam. 1,Harmonised C&L,0,H318:0
42700,Ammonium zinc chloride,258-054-8,52628-25-8,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 1,REACH registration C&L,2,H302:2;H314:2;H410:2
42701,3-aminopropyltriethoxysilane,213-048-4,919-30-2,Acute Tox. 4;Skin Corr. 1B,Harmonised C&L,0,H302:0;H314:0
42712,"Copper [R-(R*,R*)]-tartrate",212-425-0,815-82-7,Acute Tox. 4,Notified C&L,39,H302:39
42726,2-[3-(dodecanoylamino)propyl-dimethylazaniumyl]acetate,617-861-9,86438-79-1,Eye Dam. 1,Notified C&L,3,H318:3
42728,"4-[(2-ethylhexyl)amino]-4-oxoisocrotonic acid, compound with 2,2',2''-nitrilotris[ethanol] (1:1)",286-316-1,85204-21-3,Skin Sens. 1B;Eye Dam. 1,Notified C&L,83,H317:83;H318:83
42731,2-methoxyfuran,246-953-8,25414-22-6,Flam. Liq. 2,Notified C&L,43,H225:43
42732,"Urea, N,N'-dimethyl-, reaction products with glyoxal and 1,6-hexanediol",602-991-0,124358-37-8,Not Classified,Notified C&L,1,Not classified:1
42736,Trifluormethanesulfonic acid 4-(trans-5-propyl-tetrahydropyran-2-yl)-phenyl ester,921-739-3,,Not Classified,REACH registration C&L,2,Not classified:2
42750,Broquinaldol,239-680-0,15599-52-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
42753,"Amines, bis(hydrogenated tallow alkyl)",263-089-7,61789-79-5,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,180,H373:83;H400:127;H410:121;H315:80;Not classified:13;H318:13;H412:9;H411:4
42756,"9,10-Anthracenedione, 1,4-diamino-, N,N'-bis(4-C7-17-branched alkylphenyl) derivs.",308-067-0,97862-23-2,Not Classified,REACH registration C&L,17,Not classified:15;H302:1;H400:1;H336:1;H411:1;H351:1
42768,Dipropyl phosphonate,217-318-2,1809-21-8,Skin Corr. 1B,Notified C&L,38,H314:38
42769,"A mixture mainly based on: 2,3-dihydro-6-(2-hydroxy-2-methyl-1-oxopropyl)-1,1,3-trimethyl-3-[4-(2-hydroxy-2-methyl-1-oxopropyl)phenyl]-1H-indene; 2,3-dihydro-5-(2-hydroxy-2-methyl-1-oxopropyl)-1,1,3-trimethyl-3-[4-(2-hydroxy-2-methyl-1-oxopropyl)phenyl]-1H-indene",402-990-3,163702-01-0,Repr. 2;STOT RE 1;Aquatic Chronic 4,REACH registration C&L,37,H361:30;H413:28;H372:21
42770,"2,2-bis[[(2-hexyl-1-oxodecyl)oxy]methyl]-1,3-propanediyl bis(2-hexyldecanoate)",262-334-5,60623-04-3,Not Classified,REACH registration C&L,2,Not classified:2
42771,"reaction mass of: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane;1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane",426-510-7,196965-91-0,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
42775,"(3,5-Dimethyl-4-nitro-2-pyridyl)-1-methanol",604-675-8,149082-03-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:39;H335:38;H315:39;H302:4;H332:4;H312:4
42780,"2,2,3,3,3-pentafluoropropionamide",206-569-3,354-76-7,,Notified C&L,6,H319:6;H335:6;H315:6
42784,4-(ethylamino)-3-methylbenzenediazonium tetrafluoroborate,228-023-3,6087-59-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
42788,Dihydrogen hexahydroxyplatinate,257-471-2,51850-20-5,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,143,H319:58;H400:99;H410:99;H302:85;H315:126;H317:85;H334:85;H318:84;H332:39;H335:42
42789,"Tallow, hydrogenated, reaction products with diethylenetriamine, compds. with di-Et sulfate",276-946-5,72854-26-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H318:1;H315:2;H319:1
42790,4-methylhex-1-ene,223-202-2,3769-23-1,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,39,H225:39;H304:39
42792,Dibenzyldimethylammonium chloride,202-903-7,100-94-7,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,91,H317:2;H302:2;H318:2;H412:84;Not classified:3;H319:2;H315:2;H335:1
42794,2-nitroimidazole,208-425-5,527-73-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,135,H319:134;H302:128;H335:133;H315:134;H301:7;H311:2;H331:1
42796,"reaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate;bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate",428-050-2,,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H410:0
42799,2-mercaptopropanol,221-084-7,3001-64-7,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H226:1;H319:1
42802,"(2,4-dibromophenoxy)acetic acid",233-364-6,10129-78-9,,Notified C&L,4,H319:4;H335:4;H315:4
42806,"3,6-diamino-2,7,10-trimethylacridinium chloride",229-224-9,6441-73-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
42810,"Amides, from diethylenetriamine, tall-oil fatty acids and triethylenetetramine",273-113-8,68938-06-7,Skin Corr. 1B;Aquatic Acute 1,Notified C&L,1,H314:1;H400:1;H410:1
42813,"2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(4-ethoxyphenyl)-3-oxobutyramide]",250-799-7,31775-20-9,Not Classified,Notified C&L,2,Not classified:2
42814,5-nitro-N-phenylpyridin-2-amine,229-900-3,6825-25-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
42816,"1,8-DIAZABICYCLO[5.4.0]UNDEC-7-ENE, COMPOUND WITH 2-ETHYLHEXANOIC ACID (1:1)",608-915-2,33918-18-2,Skin Corr. 1B,Notified C&L,24,H314:23;H302:1
42818,"2-methyl-6-methyleneoct-7-en-2-ol, dihydro derivative",258-432-2,53219-21-9,Eye Irrit. 2,Notified C&L,178,H319:138;Not classified:39;H315:33
42820,"Diacenaphtho[1,2-b:1',2'-d]thiophene",205-904-0,203-42-9,Acute Tox. 3,Notified C&L,38,H301:38
42830,"Disodium [(9,10-dihydro-9,10-dioxo-1,4-anthrylene)bis[imino[3-isopropylpropane-1,3-diyl]]]bis(benzenesulphonate)",276-822-0,72749-90-7,Aquatic Chronic 2,Notified C&L,17,H411:17
42834,"2-Thiophenecarboxylic acid, 3-(((((4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino)carbonyl)amino)sulfonyl)-",616-675-5,79277-67-1,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H412:1
42838,2-(2-thienyl)ethyl benzenesulphonate,287-765-6,85567-51-7,Acute Tox. 4,Notified C&L,1,H302:1
42839,Bis(trimethylsilyl) malonate,242-342-5,18457-04-0,Flam. Liq. 3,Notified C&L,39,H226:39
42841,Epoxiconazole,600-739-4,106325-08-0,Carc. 2;Repr. 2;Aquatic Chronic 2,Notified C&L,70,H361:70;H411:70;H351:70
42842,Chloramben,205-123-5,133-90-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 1B,Notified C&L,197,H319:194;H350:194;H335:194;H315:194;Not classified:3
42844,"Phosphoric acid, butyl ester, potassium salt",258-379-5,53126-06-0,Not Classified,Notified C&L,25,Not classified:19;H318:3;H315:4;H319:3
42848,2-(4-bromophenyl)-2-methylpropionic acid methyl ester,604-979-0,154825-97-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,12,H319:11;H335:12;H315:11;H317:1;H411:1
42854,"3,3,4,4-tetrafluoro-4-iodo-1-butene",439-500-2,33831-83-3,Acute Tox. 4;Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0;H315:0
42855,"1,6-Octadiene, 8-methoxy-",604-471-9,14543-49-8,Flam. Liq. 3;Asp. Tox. 2;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 3,Notified C&L,56,Not classified:55;H315:56;H317:56;H226:56;H305:56;H412:56;H402:1
42859,"Sulfonamides, C10-21-alkane",293-706-5,91081-97-9,,Notified C&L,45,Not classified:44;H319:1;H335:1;H315:1
42860,C.I. Acid Yellow 116,602-740-5,12239-18-8,Not Classified,Notified C&L,1,Not classified:1
42861,Cyclohexyl-((diethoxymethylsilanyl)-methyl)-amine,608-099-8,27445-54-1,Aquatic Chronic 3,Notified C&L,1,H412:1
42862,4-amino-3-fluorophenol,402-230-0,399-95-1,Acute Tox. 4;Skin Sens. 1;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H302:0;H350:0;H411:0
42867,"4-bromo-2-fluoro-1,1'-biphenyl",255-453-9,41604-19-7,Not Classified,REACH registration C&L,46,Not classified:2;H302:39;H400:39;H315:38;H319:38;H410:38;H412:4;H311:1;H373:1;H331:1;H301:1;H330:1
42868,5-butyl-6-methyl-2-thiouracil,249-447-5,29113-41-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H302:38;H318:38;H335:38;H315:38
42878,"4-(2,4-Difluorobenzoyl)piperidine Hydrochloride",600-732-6,106266-04-0,,Notified C&L,6,H319:5;H335:4;H315:5;Not classified:1
42879,"Cyclohexane-1,3-diol",207-979-5,504-01-8,Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39
42880,Methyliminodiacetic acid,224-557-6,4408-64-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
42885,C.I. Vat Yellow 46,602-690-4,12237-50-2,,Notified C&L,9,H315:8;Not classified:1
42892,Norleucine,206-321-4,327-57-1,Skin Sens. 1,Notified C&L,42,H317:38;Not classified:3;H334:1
42895,"1-phenylpentane-2,4-dione",222-015-3,3318-61-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
42898,6-aminonaphthalene-2-sulphonic acid,202-208-9,93-00-5,Not Classified,REACH registration C&L,186,Not classified:143;H317:43
42903,reaction mass of branched and linear C,407-000-3,127519-17-9,Aquatic Chronic 2,Harmonised C&L,0,H411:0
42906,"Naphthalene, chloro derivs.",274-864-4,70776-03-3,Aquatic Chronic 4,Notified C&L,1,H413:1
42908,(2-chloro-5-iodophenyl)(4-fluorophenyl)methanone,619-596-4,915095-86-2,Aquatic Chronic 1,REACH registration C&L,10,H410:10
42909,"N,N,N',N',-tetrakis(2-hydroxyethyl)hexanediamide",405-370-0,,Not Classified,REACH registration C&L,91,Not classified:91
42913,Perfluorostearic acid,240-582-5,16517-11-6,,Notified C&L,5,H314:5
42915,"1-benzyl-1,2,5,6-tetrahydro-2-[(4-methoxyphenyl)methyl]-3,4-dimethylpyridine",245-937-8,23909-52-6,Acute Tox. 4,Notified C&L,1,H302:1
42917,(-)-D-arginine hydrate,205-866-5,157-06-2,,Notified C&L,45,Not classified:38;H319:7
42918,[2-hydroxy-3-(naphthyloxy)propyl]isopropylammonium chloride,206-268-7,318-98-9,Acute Tox. 4,Notified C&L,123,H302:121;H362:4;H360:4;H411:5;H312:4;H332:4;H361:4;H317:2;H410:1;H341:1
42919,"2-Oxa-7-thia-3,8-disiladecane, 3-methoxy-3,8,8,9,9-pentamethyl-",485-260-7,,Flam. Liq. 2;Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,3,H317:3;H225:2;H412:3;H315:1
42927,3-methylbut-2-enyl isobutyrate,278-516-2,76649-23-5,Not Classified,Notified C&L,89,Not classified:89
42928,(2-hydroxypropyl)ammonium phosphate,267-885-5,67952-32-3,Not Classified,Notified C&L,74,Not classified:74
42933,Methyl 4-tert-butylbenzoate,247-768-5,26537-19-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,28,H302:27;H332:27;H312:27;H301:1
42934,"Phosphoric acid, 2-chloro-1-(2,4-dichlorophenyl)ethenyl dimethyl ester",607-152-2,2274-67-1,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H301:38;H410:38
42936,"1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol)",405-840-5,110866-35-8,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H410:0
42939,"(9β,11β,16α)-9,11-epoxy-21-hydroxy-16, 17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione",609-736-2,39672-75-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 2;Repr. 2,Notified C&L,1,H361:1;H319:1;H335:1;H315:1
42943,"1-butyl-5-[(4-chlorophenyl)azo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxonicotinonitrile",274-126-1,69808-32-8,Acute Tox. 4,REACH registration C&L,18,H302:13;H317:12;H319:12;H336:12;Not classified:5
42945,Clindamycin,242-209-1,18323-44-9,Eye Irrit. 2;Lact.,Notified C&L,9,H362:9;H319:9
42949,"azaconazole (ISO);1-{}{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}}-1H-1,2.4-triazole",262-102-3,60207-31-0,Acute Tox. 4,Harmonised C&L,0,H302:0
42950,"4,4'-(1-methylpropylidene)bisphenol; bisphenol B",201-025-1,77-40-7,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,40,H319:40;H302:39;H413:38;H335:1;H315:2;H312:1;H332:1;H317:1
42951,"N-[3-(isodecyloxy)propyl]propane-1,3-diamine",276-432-0,72162-46-0,Acute Tox. 3;Skin Corr. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,96,H400:68;H314:96;H301:52;H410:94;H302:44;H318:16;H411:2
42952,Testosterone benzoate,218-232-8,2088-71-3,Carc. 2,Notified C&L,39,H351:38;H302:1;H341:1
42953,"Benzenesulfonic acid, mono-C10-14-alkyl derivs.",285-599-9,85117-49-3,Acute Tox. 4;Skin Corr. 1B,Notified C&L,192,H302:192;H314:192;H335:60;H318:80;H412:80
42955,"2,5-dichloroaniline",202-455-2,95-82-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1,REACH registration C&L,205,H400:119;H311:204;H373:121;H331:204;H301:204;H410:121;H317:3;H318:3;Not classified:1;H371:1
42956,"Formaldehyde, reaction products with N,N-dimethylbenzenamine and N-methylbenzenamine, oxidized",282-630-8,84281-86-7,Acute Tox. 4;Eye Dam. 1,Notified C&L,16,H302:12;H318:11;H335:3;H315:3;H332:3;Not classified:1
42957,"10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide",222-649-0,3564-73-6,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,40,H317:39;H302:40;H334:40
42958,o-(1-piperazinyl)phenol,213-782-5,1011-17-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:38;H335:38;H315:38;H301:38;H302:4;H314:5
42960,4-bromopyrocatechol,241-370-5,17345-77-6,,Notified C&L,2,H319:2;H335:1;H315:2
42964,Pyridine-2-thiol,220-131-9,2637-34-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:50;H335:48;H315:50;H302:1;Not classified:1
42966,"Formaldehyde, oligomeric reaction products with 1-chloro-2,3-epoxypropane and phenol, reaction products with acrylic acid",500-755-0,162492-20-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:2;H315:2;H317:1;H314:1;H411:1;Not classified:1
42967,[(phenylmethyl)sulphonyl]benzene,221-477-3,3112-88-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
42970,"2(1H)-Quinolinone, 5-acetyl-8-hydroxy-",613-124-0,62978-73-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
42977,3-(2-HYDROXYETHYLTHIO)PROPIONITRILE,605-107-1,15771-37-6,Acute Tox. 4,Notified C&L,38,H302:38
42985,Glutathione,200-725-4,70-18-8,Not Classified,Notified C&L,56,Not classified:46;H341:9;H302:1;H318:2;H335:2;H315:2
42987,"2,2'-[ethylenebis(oxyphenyl-2,1-eneazo)]bis[N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutyramide",278-770-4,77804-81-0,Not Classified,REACH registration C&L,396,Not classified:396
42991,3-fluoro-p-toluidine,207-212-4,452-77-7,Acute Tox. 1;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H335:41;H315:43;H319:43;H312:45;H300:40;H332:45;H302:5;H373:5;H314:4;H311:2;H331:2;H301:2
42994,"Trisodium 4-amino-3-[[4-[[4-[(4-amino-2-hydroxyphenyl)azo]phenyl]amino]-3-sulphonatophenyl]azo]-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulphonate",304-392-7,94249-18-0,Not Classified,Notified C&L,7,Not classified:4;H319:2;H318:1;H411:1;H315:1
42997,"1-[2-[ethyl(m-tolyl)amino]ethyl]pyrrolidine-2,5-dione",219-687-5,2498-03-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H335:38;H315:38
42999,3-(bromomethyl)benzophenone,244-761-9,22071-24-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1;H312:1;H332:1
43000,"4-(diaminomethylidene)cyclohexa-2,5-dien-1-one hydrochloride",609-525-5,38148-63-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46;H302:2;H312:1;H332:1
43002,"Benzenesulfonic acid, di-C10-18-alkyl derivs.",298-634-8,93820-54-3,Skin Corr. 1C;Eye Dam. 1,Notified C&L,568,H318:566;H314:568
43003,mefenacet (ISO);2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide,277-328-8,73250-68-7,Aquatic Chronic 2,Harmonised C&L,0,H411:0
43004,Ethyl benzoate,202-284-3,93-89-0,Not Classified,REACH registration C&L,1775,Not classified:1668;H319:71;H315:71;H313:2;H411:39
43005,"2,3-dihydro-2-oxobenzoxazole-6-sulphonyl chloride",248-605-0,27685-90-1,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H335:1;H302:1;H314:1
43006,"reaction mass of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt;7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt;7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt;7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt",429-070-4,214362-06-8,Eye Dam. 1,Harmonised C&L,0,H318:0
43008,"Fatty acids, olive-oil, sodium salts",263-096-5,61789-88-6,Not Classified,Notified C&L,1,Not classified:1
43009,3-(cis-3-hexenyloxy)propanenitril,415-220-6,142653-61-0,Acute Tox. 4;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H331:0;H302:0;H400:0;H410:0
43011,dieldrin (ISO),200-484-5,60-57-1,Acute Tox. 3;Acute Tox. 1;Carc. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H310:0;H301:0;H372:0;H351:0
43012,Dimethyltetradecyl[3-(trimethoxysilyl)propyl]ammonium chloride,255-451-8,41591-87-1,Skin Corr. 1B;Skin Sens. 1;Aquatic Acute 1,Notified C&L,35,H317:35;H314:35;H400:35
43013,"2,3,5-trichlorophenol",213-272-2,933-78-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H302:41;H335:38;H315:41;H400:38;H319:41;H410:38;Not classified:1
43015,Hydroxylamine-O-sulphonic acid,220-971-6,2950-43-8,Acute Tox. 4;Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,137,H302:89;H318:88;H314:137;H412:86;H400:86;H303:1;H317:8;H341:7;H351:2;H290:1;H312:1;H332:1;H311:1;H330:1;H301:1
43016,"2-bromo-4,6-dichlorophenol",224-855-6,4524-77-0,,Notified C&L,7,H319:7;H302:7;H335:7;H315:7
43019,"4'-Chloro-2,2-dimethylpropionanilide",613-847-1,65854-91-3,Acute Tox. 4,Notified C&L,39,H302:39;H332:1;H312:1
43020,"6-amino-1,3-dimethyl-5-nitrosouracil",229-629-0,6632-68-4,Carc. 2,Notified C&L,39,H351:39;H319:1;H335:1;H315:1
43021,Caraway oil,616-773-8,8000-42-8,Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,144,H302:105;H304:106;H400:106;H315:106;H317:106;H410:105;H312:42;H226:4
43022,2-methyl-3-nitroanisole,225-424-5,4837-88-1,Acute Tox. 4,Notified C&L,44,H302:44;H332:1;H312:1
43026,"2-(4-{2-[(1Z)-2-hydroxy-1-[(5-sulfonaphthalen-1-yl)carbamoyl]prop-1-en-1-yl]diazen-1-yl}phenyl)-6-methyl-1,3-benzothiazole-7-sulfonic acid 2-[bis(2-hydroxyethyl)amino]ethan-1-ol amine potassium hydride sodium hydride",400-940-5,,Not Classified,Notified C&L,37,Not classified:37
43029,Chlorodimethyl(3-phenylpropyl)silane,241-208-3,17146-09-7,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
43031,4-(phenylcarbonyl)phenyl dodecanoate,604-316-5,142857-24-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H335:2;H315:2
43033,Tetrakis(diethylamino)titanium,437-500-7,4419-47-0,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,1,H225:1;H314:1
43035,"Slags, copper smelting",266-968-3,67711-92-6,Not Classified,REACH registration C&L,23,Not classified:23
43037,methyl (E)-3-methyl-4-oxo-but-2-enoate,609-870-1,40835-18-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,85,H302:85;H315:85;H318:85;H401:2;H411:85
43039,Quinoline-2-ethanol,213-784-6,1011-50-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
43040,Dimethyl aminomalonate hydrochloride,240-284-5,16115-80-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
43044,5-chloro-2-methoxy-N-(2-phenylethyl)benzamide,251-745-5,33924-49-1,,Notified C&L,1,H302:1
43045,"1,1-bis(benzyloxy)trimethylamine",217-946-7,2016-04-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
43049,"Selenicereus grandiflorus, ext.",232-364-3,8007-78-1,Not Classified,Notified C&L,36,Not classified:36
43053,Octopamine,203-179-5,104-14-3,,Notified C&L,1,H302:1;H312:1
43056,"Acacia decurrens, ext.",308-877-4,98903-76-5,Not Classified,Notified C&L,52,Not classified:52
43057,"3-amino-2,4,6-triiodo-5-[(methylamino)carbonyl]benzoic acid",218-917-1,2280-89-9,Not Classified,REACH registration C&L,1,Not classified:1
43058,"Pentane-2,4-diol",210-907-5,625-69-4,Not Classified,Notified C&L,1,Not classified:1
43059,"3,3-diethoxypropyne",233-430-4,10160-87-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:49;H335:48;H315:49;H226:49
43067,Cinnamyl acetate,203-121-9,103-54-8,Not Classified,REACH registration C&L,1636,Not classified:1569;H319:39;H317:26;H315:2
43074,"5,6-dihydro-2-[trans,trans-4'-pentyl(1,1'-bicyclohexyl-4-yl)-4H-1,3-dithiin-1-iumtrifluoromethanesulfonate",608-918-9,339315-67-2,Skin Corr. 1B,Notified C&L,1,Not classified:1;H314:1
43075,"Octanoic acid, mixed diesters with hexanoic acid and triethylene glycol",268-590-4,68130-48-3,,Notified C&L,1,Not classified:1
43082,"2-(4-methoxyphenyl)-4,6-bis(trichloromethyl)-1,3,5-triazine",222-711-7,3584-23-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,12,H319:12;H315:12
43084,3-aminopropan-1-ol,205-864-4,156-87-6,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,228,H302:210;H318:96;H314:228;H312:28;H332:22;H290:1
43085,"clopyralid (ISO);3,6-dichloropyridine-2-carboxylic acid",216-935-4,1702-17-6,Eye Dam. 1,Harmonised C&L,0,H318:0
43087,2-(2-dodecoxyethoxy)acetic acid,608-079-9,27306-90-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2058,H318:2056;H315:2042;Not classified:2
43093,"2-chloro-4,6-dimethoxy-1,3,5-triazine",221-541-0,3140-73-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,106,H302:55;H315:101;H317:53;H318:53;H411:54;H319:54;H335:57
43094,(allylthio)benzene,226-142-5,5296-64-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,45,H312:44;H332:44;H302:5;H335:1;H315:1;H311:1;H319:1;H331:1;H301:1
43096,N-acetylglycine,208-839-6,543-24-8,Not Classified,Notified C&L,3,Not classified:3
43098,6-chlorohexanoyl chloride,242-979-9,19347-73-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,43,H318:39;H314:43
43100,Bromodichloromethane,200-856-7,75-27-4,Acute Tox. 4,Notified C&L,14,H302:13;H350:5;H335:6;H315:6;H319:5;H360:1;H340:1;H336:1;H351:2;H318:1;Not classified:1
43104,2-amino-5-bromobenzoylpyridine,216-352-5,1563-56-0,Not Classified,REACH registration C&L,5,Not classified:2;H302:3;H335:1;H315:1;H319:1;H312:1
43107,"1-Dodecene, polymer with 1-octene, hydrogenated",605-316-8,163149-29-9,Aquatic Chronic 4,Notified C&L,442,H413:442
43108,4-chlorobutan-2-one,228-680-6,6322-49-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H226:1
43109,"Acrylic acid/AMPS Copolymer, Sodium salt",609-413-6,37350-42-8,Aquatic Chronic 3,Notified C&L,25,H412:20;Not classified:5
43111,"Fatty acids, mixed coco and tallow, sodium salts",273-120-6,68938-26-1,Not Classified,Notified C&L,52,Not classified:52
43112,3-amino-5-sulphosalicylic acid,228-261-8,6201-86-1,Skin Corr. 1B,Notified C&L,34,H314:33;Not classified:1
43116,"Fatty acids, vegetable-oil, compds. with ethanolamine",272-199-4,68783-56-2,,Notified C&L,72,H318:39;Not classified:33
43119,4-Amino-3-nitrobenzonitrile,613-403-7,6393-40-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H335:42;H315:43;H302:4;H312:4;H332:4;H311:2;H331:2;H301:2
43120,Galactitol,210-165-2,608-66-2,Not Classified,Notified C&L,3,Not classified:2;H319:1;H335:1;H315:1
43122,"2,4,6-Trioxaheptane",818-227-6,628-90-0,Flam. Liq. 2,Notified C&L,1,H225:1
43125,"5'-deoxy-5-fluorouridine 2',3'-diacetate",278-472-4,76462-82-3,Not Classified,Notified C&L,1,Not classified:1
43126,Titanium oxide (TiO2),619-318-1,98084-96-9,Not Classified,Notified C&L,1,Not classified:1
43139,"Fusanus acuminatus, ext.",296-825-0,93062-70-5,Not Classified,Notified C&L,1,Not classified:1
43140,sodium 2-ethylhexanolate,406-150-7,38411-13-1,Flam. Sol. 1;Skin Corr. 1B;Aquatic Chronic 3,Harmonised C&L,0,H228:0;H314:0;H412:0
43144,4-methyl-2-oxovaleric acid,212-435-5,816-66-0,Skin Corr. 1B,Notified C&L,42,H314:42;H318:2;H290:1
43145,Tris(4-nitro-m-tolyl) phosphate,271-291-1,68527-98-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H335:38;H315:38
43148,"Esterification of tall oil, alcohols, C8-22, distn. residues and alcohols, C16-18",921-816-1,,Not Classified,Notified C&L,36,Not classified:36
43150,"Cobalt, borate neodecanoate complexes",270-601-2,68457-13-6,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,118,H302:113;H400:58;H317:113;H411:38;H319:30;H372:18;H318:6;H315:71;H410:40;H361:20;Not classified:5;H314:2
43151,"2,5-Furandione, 3-(dodecenyl)dihydro-, reaction products with propylene oxide",270-132-3,68411-58-5,Skin Irrit. 2,Notified C&L,975,H315:975;H413:1
43158,Dicesium chromate,236-640-4,13454-78-9,Ox. Sol. 2;Skin Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,72,H350:72;H400:42;H317:72;H272:68;H410:72;H335:26;H315:26;H340:26;H319:26;H361:1
43161,"2,5-Dimethoxyphenylmagnesium bromide",613-102-0,62890-98-6,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,26,H225:26;H314:26
43162,1-benzyl-α-phenylpiperidine-4-acetonitrile,230-674-3,7254-21-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H319:38;H335:38;H315:38;H400:38
43166,2-pentylfuran,223-234-7,3777-69-3,Acute Tox. 4,Notified C&L,1453,H302:1450;H226:164;H318:66;H335:10;H315:10;H319:10;Not classified:3;H317:1;H411:1
43170,dicrotophos (ISO);(Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate,205-494-3,141-66-2,Acute Tox. 2;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H311:0;H300:0;H400:0;H410:0
43171,"3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-1-benzopyrylium chloride",205-125-6,134-01-0,Not Classified,Notified C&L,1,Not classified:1
43175,"(2R,5R,2'R,5'R)-1,1'-benzene-1,2-diylbis(2,5-dimethylphospholane)",604-579-6,147253-67-6,Acute Tox. 4,Notified C&L,2,H302:2
43179,(Bromomethylene)dimethylammonium bromide,607-436-6,24774-61-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H302:38;H335:38;H315:38;H319:38;H312:38;H332:38
43181,(S)-5-bromo-6-methoxy-α-methylnaphthalene-1-acetic acid,282-475-6,84236-26-0,,Notified C&L,1,H302:1
43185,"D-Glucopyranose, oligomers, branched dodecyl glycosides",500-523-9,161074-88-0,Not Classified,Notified C&L,1,Not classified:1
43186,2-Amino-4'-fluorobenzophenone,609-505-6,3800-06-4,,Notified C&L,2,H335:1;H315:2;H317:1;H411:1;H319:2
43189,"tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate",415-400-4,148878-22-2,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H318:0
43196,Potassium dodecyl sulphate,225-190-4,4706-78-9,Not Classified,REACH registration C&L,40,Not classified:2;H334:38
43197,6-amino-5-[[2-[(ethylphenylamino)sulphonyl]phenyl]azo]-4-hydroxynaphthalene-2-sulphonic acid,235-396-6,12217-34-4,Not Classified,Notified C&L,46,Not classified:46
43200,Fenipentol,209-493-9,583-03-9,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,39,H319:39;H400:39
43205,Disodium hexafluorozirconate(2-),240-990-3,16925-26-1,Skin Corr. 1B,Notified C&L,38,H314:38
43209,2-chlorothioxanthen-9-one,201-667-2,86-39-5,Not Classified,REACH registration C&L,44,Not classified:5;H228:39
43215,Ammonium sodium sulphate,237-603-5,13863-45-1,Not Classified,Notified C&L,2,Not classified:2
43216,o-toluamide,208-427-6,527-85-5,Acute Tox. 4,Notified C&L,38,H302:38
43217,"Distillates (petroleum), acid-treated light naphthenic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-118-9,64742-19-4,Carc. 1A,Harmonised C&L,0,H350:0
43220,"Mesosulfuron-methyl, sodium salt",606-652-8,208465-19-4,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,106,H400:106;H410:106
43221,"2,5-dimethylbenzonitrile",237-297-3,13730-09-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
43223,"[μ-[2,2'-[ethylenebis(thio)]bis[2-methylpropane]-S:S']]hexahydrodiboron",275-595-5,71522-78-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
43225,Sodium 5-oxo-1-palmitoyl-L-prolinate,261-406-3,58725-33-0,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,2,H318:2;H315:2
43226,"1,1,2,2-tetrafluoro-1,2-diiodoethane",206-567-2,354-65-4,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3,Notified C&L,53,H335:52;H315:53;H319:53;H336:47;H330:47
43227,Nisoldipine,264-407-7,63675-72-9,Acute Tox. 4;Acute Tox. 4,Notified C&L,67,H302:67;H312:41;H361:25;H360:24;H411:24;H332:1
43228,"Amines, hydrogenated tallow alkyl, compds. with C15-20-unsatd. alkylsuccinic anhydride",270-419-3,68439-82-7,Not Classified,Notified C&L,1,Not classified:1
43231,Oct-2-ene,203-894-2,111-67-1,Flam. Liq. 2;Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,24,H225:24;H400:12;H304:24;H410:12;H335:1;H315:1;H411:1
43234,Decyl acrylate,218-462-9,2156-96-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,216,H319:183;H411:182;H335:184;H315:184;Not classified:32;H317:4;H318:1
43236,Ethyl 3-cyano-3-phenylpyruvate,228-844-7,6362-63-6,,Notified C&L,4,H302:4
